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ABSTRACT 
A fundamental problem in non-viral gene delivery is the poor efficiency of DNA transfer into 
the nucleus. In the work described in this thesis, in vitro-assembled chromatin was investigated 
for the first time as a potential vehicle for non-viral gene delivery. Chromatin is formed by a 
hierarchical process of sequential folding and compaction of DNA, beginning with the 
formation of the basic repeating unit, the nucleosome, comprised of two turns of DNA around 
an octameric association of the core histones. It was reasoned that chromatin-induced 
compaction might facilitate the nuclear entry of large plasmids (greater than 5 kb) and provide 
resistance to cytoplasmic degradation. In addition, histones have intrinsic nuclear localisation 
sequences (NLSs) that mediate their passage to the nucleus and may provide a means for the 
nuclear import of the in vitro-assembled chromatin constructs as well. Since chromatin is the 
physiological form in which DNA occurs in the nucleus, endogenous mechanisms for the 
decompaction of chromatin exist, which might also facilitate decompaction and expression of 
the chromatinised plasmid. 
Histone octamers were reconstituted from recombinant Xenopus laevis core histones H2A, 
H2B, H3 and H4 and assembled in vitro with the reporter plasmid, pGeneGrip-RFP, into 
chromatin. A range of constructs was generated with stoichiometries between O and 40 
octamers per plasmid. Chromatin formation was verified using sedimentation velocity 
ultracentrifugation, DNA supercoiling, micrococcal nuclease digestion and atomic force 
microscopy. Chromatinised constructs were transfected into Cos-7 and HTC cells usmg 
electroporation and lipofection and reporter gene expression was quantitated by flow cytometry. 
Unexpectedly, reporter gene expression decreased upon plasmid chromatinisation at high 
nucleosome densities. pGeneGrip-RFP was labelled using a fluorescein-conjugated peptide 
nucleic acid (PNA) hybridisatio~ probe in order to analyse gene expression and tracking in the 
same experiment. Flow cytometric analysis of isolated nuclei revealed that chromatinisation at 
high nucleosome densities corresponded to diminished nuclear accumulation of the plasmid. 
Greater proportions of nuclei accumulated plasmid chromatinised at high histone octamer 
stoichiome_tries than proportions of cells that expressed the reporter gene. This suggested that, 
in addition to reduced nuclear accumulation, gene expression may have been further 
compromised with chromatinisation at high nucleosome densities. 
A high affinity interaction between histones and nuclear import proteins, mediated 
predominantly by importin ~' was demonstrated using a modified ELISA method. Importin 
binding affinity was abolished when histones were assembled with DNA into chromatin, 
implying that nuclear import of the chromatin constructs was unlikely to be mediated via this 
pathway. 
V 
Incorporation of an optimised Simian Virus 40 large tumour-antigen NLS peptide into the 
chromatin transfection constructs was investigated as a means to enhance their nuclear uptake. 
A carboxy-terminal fusion protein comprised of histone H2A and the NLS sequence was 
generated but this did not assemble into a histone octamer under standard reconstitution 
conditions. The same NLS peptide was synthesised and coupled to the reporter plasmid via a 
PNA-maleimide linker. Transfection efficiency in the presence of the coupled NLSs was 
decreased relative to in their absence but appeared to be rendered insensitive to the degree of 
chromatinisation of the plasmid. As a means to potentiate the transcriptional permissiveness of 
the chromatinised plasmid, chromatin was assembled using histone octamers containing H2AZ 
instead of H2A, since H2AZ had been implicated in the formation of transcriptionally primed 
regions of chromatin. However, the impairment of transfection efficiency was more pronounced 
with chromatinisation at higher stoichiometries of H2AZ-containing histone octamers. An 
alternative reporter gene expression system involving the plasmid pGMLuc, which contains the 
endogenous granulocyte-monocyte colony stimulating factor promoter known to recruit 
transcription complexes in Jurkat cells, was investigated. Reporter gene expression in Jurkat 
cells using pGMLuc was not repressed upon chromatinisation at increasing nucleosome 
densities. In contrast, reporter gene expression in Jurkat cells using the chromatinised 
pGeneGrip-RFP plasmid was inhibited, consistent with the trend observed in HTC and Cos-7 
cells. 
Overall, the results indicate that both the nuclear uptake and the transcriptional permissiveness 
of transfection constructs are limiting factors for efficient transgene expression using non-viral 
methods of gene delivery. Furthermore, with incorporation of appropriate promoter elements 
into the plasmid, which are able to recruit chromatin decompaction and transcription . 
complexes, in vitro-assembled chromatin may have potential for use as a gene delivery vehicle 
in the context of tissue-specific trans gene expression. 
Vl 
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CHAPTERl 
Introduction 
1.1. OVERVIEW 
The successful alleviation of human disease using gene therapy has been anticipated keenly 
since the first approved clinical trial, which was conducted over 10 years ago (Rosenberg et al., 
1990). In this trial, a neomycin resistance reporter gene was introduced ex vivo into tumour-
infiltrating lymphocytes of cancer patients as a proof-of-principle. The reporter gene was 
detected for up to two months in the circulating transduced cells, demonstrating the potential of 
this therapeutic strategy. Several thousand patients since have been involved in clinical trials for 
the treatment of diseases such as severe combined immunodeficiency-adensosine deaminase 
disorder (SCID-ADA), cystic fibrosis, haemophilia and cancer. Only recently though have 
clinically significant outcomes been achieved in a trial for the treatment of X-chromosome-
linked SCID (Hacein-Bey-Abina et al., 2002; Cavazzana-Calvo et al., 2000). Despite initially 
encouraging results, these clinical trials were marred by one of the disadvantages of the 
therapeutic approach used - random genomic insertion of the therapeutic gene. The insertion 
occurred adjacent to a human T-cell oncogene locus, LM02, and resulted in the development of 
T-cell leukaemia condition in two of the ten patients treated (ESOGT, 2003; Hacein-Bey-Abina 
et al., 2003a; Hacein-Bey-Abina et al., 2003b ). This highlights not only the complexities 
associated with gene therapy but, also, is a reminder of the risks involved with this emerging 
therapeutic strategy. 
Methods of introducing genes into cells are conventionally grouped into viral- and non-viral-
based gene delivery systems. Viral delivery systems use the genome of viruses as the vector 
into which the genes of interest are inserted and the viral capsid to transport this therapeutic 
vector. In non-viral methods of gene delivery, the DNA may be introduced into cells 
encapsulated within a lipid formulation (liposomes ), by electroporation, complexed to heavy 
metal particles such as gold that are introduced into cells ballistically, or by receptor-mediated 
endocytosis where the DNA is linked to a receptor-specific ligand and taken up into only those 
cells expressing the receptor. 
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Whether viral or non-viral gene delivery systems are used, the vector must overcome each of 
several obstacles which exist in the cell before ultimately reaching the nucleus (Figure 1.1 ). The 
first limitation to entry into the cell is the plasma membrane, which must be traversed. 
Depending on the mode of uptake into the cell, the vector may be internalised within an 
endosome from which it must escape. Surviving passage through the cytoplasm is the next 
crucial step before the final barrier, the nuclear envelope (NE), is reached. The ultimate 
transfection efficiency of the gene delivery vehicle is the product of overcoming all of these 
barriers. As viruses have evolved mechanisms in order to overcome each of these, viral-based 
gene delivery vectors have proven to be highly efficient in gene transfer but are difficult to 
control. In contrast, while non-viral vectors have exhibited disappointing transfection 
efficiency, they have advantages over viral-based gene delivery systems such as being non-
immunogenic and non-pathogenic. 
Therapeutic plasmid 
Degradation ? 
Cytoplasm Nucleus 
Figure 1.1. Cellular barriers to non-viral gene delivery. A schematic representation of the path of 
therapeutic plasmid DNA to the nucleus of a target cell is shown. Barriers to the passage of plasmid DNA 
are numbered in red. Entry into the cell across the plasma membrane is either mediated by endocytosis 
for receptor-mediated and liposomal delivery G) or is directly into the cytoplasm when using 
electroporation and ballistic delivery. Internalisation ~ in receptor-mediated uptake or liposomal 
delivery results in sequestration within endosomes or vesicles and subsequent endosomal exit ® is 
crucial for the DNA to be able to reach the nucleus. This may be facilitated by chloroquine, endosomal 
exit sequences or pH-sensitive lipids within the transfection constructs. Once in the cytoplasm, the DNA 
may be subjected to degradation by cytosolic nucleases. Finally, uptake into the nucleus, which occurs 
through nuclear pore complexes (NPCs) ®, is a key limiting step in non-viral gene delivery. The ideal 
pathway for gene delivery is delineated in red. 
Specialised peptide sequences, that act as ligands- for cell surface receptors to facilitate cell-
specific uptake or nuclear localisation sequences (NLSs) that mediate nuclear uptake, may be 
incorporated into the non-viral vector in order to enhance transfection efficiency. This may also 
be achieved by usurping endogenous cellular mechanisms, such as the trafficking pathways of 
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certain proteins into the nucleus. A number of proteins, such as transcription factors and 
histones, have efficient nuclear transport pathways, presented in Sections 1.3.3.3 and 1.5.2, 
respectively, which, when combined with their intrinsic capacity for binding DNA, warrants 
their investigation as potential enhancers of transfection efficiency. Indeed, transfection studies 
using individual histones suggested that histone/DNA complexes constituted a promising non-
viral DNA delivery vehicle (Section 1.5.3). The desire for the delivery of large plasmids, 
however, necessitates the use of DNA-compacting agents. Physiologically, in the form of 
histone octamers, histones fulfil this role also, whereby large lengths of DNA are compacted 
into chromatin in the nucleus. 
In this chapter, the gene delivery systems are reviewed briefly and the means by which cellular 
barriers are circumvented are discussed. The current view on the nuclear import of plasmid 
DNA is presented and, finally, the premise for investigating transgene delivery into cells in the 
form of 'chromatinised' plasmids is expanded upon. 
1.2. GENE DELIVERY SYSTEMS 
The viral and non-viral gene delivery systems differ fundamentally in several ways; the 
capacity of DNA construct that can be accommodated, the manner of integration into the host 
genome and whether expression of the transgene is transient or stable. A transfection vehicle 
may therefore be engineered to a particular outcome, depending upon the application. 
Viruses are exceptionally efficient at introducing their genetic material into host cells, which 
makes them attractive as vehicles for gene delivery (for reviews see Johnson-Saliba and Jans, 
2001; Robbins and Ghivizzani, 1998). Their use, however, may be associated with some degree 
of risk to the patient, such as oncogenicity, pathogenicity and the stimulation of an immune or 
inflammatory reaction. In order to address some of these disadvantages, non-viral gene delivery 
systems were developed. 
Advantages of non-viral systems include the lack of pathogenicity and immunogenicity and the 
capacity to accommodate large inserts of exogenous genetic material (for reviews see Johnson-
Saliba and Jans, 2001; Pouton and Seymour, 2001; Luo and Saltzman, 2000). The lack of 
intrinsic mechanisms to overcome the cellular membrane barriers shown_ in Figure 1.1 is, 
however, a major limitation of non-viral gene delivery. As a result, the major challenge in non-
viral gene delivery continues to be potentiating the level of transfection efficiency at each of the 
membrane barriers. 
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The more extensively used and, consequently, investigated systems of both viral- and non-viral-
mediated gene delivery are presented in this section and the defining properties of each system 
are detailed in Tables 1.1 and 1.2, respectively. 
1.2.1. Viral-mediated gene delivery 
1.2.1.1. Retroviral vectors 
Retroviruses are RNA viruses that can infect animal and human hosts (Weiss and Tailor, 1995). 
The genome is comprised of a single strand of RNA of 7 - 10 kilo bases (kb) containing the gag, 
pro, pol and env genes ( encoding proteins involved in viral replication and virion packaging) 
and the long terminal repeat regions (facilitating transcriptional control and integration into the 
host genome; Cullen, 1992). The pol-encoded reverse-transcriptase converts the viral RNA into 
double-stranded DNA, which then accesses the nucleus. 
The majority of retroviral vectors are based on the murine Moloney leukaemia virus (MML V). 
The gene delivery vector is generated by delecting the genes that encode proteins involved in 
viral proliferation. This reduces the probablity of the viral particles re-infecting cells and serves 
to create the capacity to carry 6 - 7 kb of exogenous therapeutic DNA (Miller et al., 1993). The 
process of cell division, which involves breakdown of the NE, is essential for the retrovirus to 
gain access to the nucleus. Here, aided by the viral integrase and the long terminal repeat 
regions, the viral vector integrates randomly into the host genome (Roe et al., 1993). Since the 
site of integration is not specific, the possibility of insertional mutagenesis or oncogenesis has 
been of major concern in gene therapy trials (Dave et al., 2004). On the other hand, an 
advantage of genomic insertion is stable integration, should long-term expression of the gene 
product be desired (Bordignon et al., 1995). 
A limitation of the use of retroviral vectors, such as MML V, is the requirement for a mitotic 
cycle in order for nuclear entry to occur, restricting their use to dividing cells only. 
Lentiviruses, a subgroup of retroviruses, of which the human immunodeficiency virus (HIV) is 
a member, are able to infect non-dividing cells and thus provide a broader target cell range 
when used as therapeutic vectors (Miyake et al., 1998; Naldini et al., 1996a; Naldini et al., 
1996b ). As HIV exhibits a natural tropism for haematopoietic cells, HIV-based vectors have 
potential in the treatment of diseases such as AIDS and T-cell pathologies (Costello et al., 
2000). Current clinical trials that involve retroviral vectors are directed at treating SCID, 
haematological neoplasias, tumours of the central nervous system (CNS), a variety of peripheral 
solid tumours (in conjunction with chemotherapy) and chronic granulomatous disease (see 
websites http://clinicaltrials.gov/ct/ gui and http: //www.wiley.co. uk/ genetherapy/clinical/). 
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1.2.1.2. Adenoviral vectors 
Adenovirus is a linear double-stranded DNA virus that infects a wide range of tissues 
(Bergelson et al., 1997; Wickham et al., 1993) and may cause infections of the gastroenteric 
and upper respiratory tracts (Albert, 1986). Adenovirus infects non-dividing cells and does not 
need to integrate into the host genome for propagation. Deletion of the adenoviral genes that 
orchestrate viral gene expression, replication and propagation generates a replication-defective 
viral vector which may accommodate up to 35 kb of inserted DNA (Fisher et al., 1996; 
Kochanek et al., 1996; Bett et al., 1994). 
A disadvantage of using adenoviral vectors, particularly for in vivo applications, is that a 
vigorous host immune response directed against the adenoviral structural proteins is elicited. 
This immune response is both humoral and cell-mediated and infected cells are rapidly cleared, 
thus eliminating the therapeutic vector within 1 - 2 weeks post-infection (Yang and Wilson, 
1995). While the cell-mediated response results in a localised inflammatory reaction, the 
humoral response was found to decrease the chance for successful re-introduction of the vector 
(Jooss et al., 1998; Mack et al., 1997). 
Most of the clinical protocols involving adenoviral vectors are for the treatment of cystic 
fibrosis (http://clinicaltrials.gov/ct/ gui; http://www.wiley.co.uk/ genetherapy/clinical/), however 
encouraging results have also been observed in the treatment of cancer (Alemany et al., 2000; 
Hu and Garen, 2000; Roth et al., 1998) and neurodegenerative diseases such as Parkinson's 
disease and motor neuron disorders (Barkats et al., 1998). 
1.2.1.3. Adeno-associated viral vectors 
The adeno-associated virus (AA V) is a single-stranded DNA virus that infects eukaryotic cells 
but without related pathology, which enhances its utility for gene therapy purposes (for review 
see Athanasopoulos et al., 2000). In addition, unlike the other viruses used for gene delivery, 
AA V exhibits the unique property of site-specific integration into the host genome (human 
chromosome 19Q13.3qter; Young et al., 2000; Surosky et al., 1997; Samulski, 1993). Here, the 
virus remains dormant in the form of a provirus until a helper virus such as adenovirus (Ding et 
al., 1997; Weger et al., 1997) or herpes simplex virus (HSV) (Buller et r;il., 1981) induces 
infectivity. Since AA V is also able to infect non-dividing cells (Russell et al., 1994), 
collectively, these characteristics make it an attractive vector for gene therapy. 
The genome of AA Vis around 4.7 kb comprising the rep and cap genes, flanked by inverted 
terminal repeat regions (Chiarini et al., 1999; Srivastava et al., 1983). The rep-encoded proteins 
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are responsible for DNA binding (Im and Muzyczka, 1992; Im and Muzyczka, 1989) and site-
and strand-specific integration (Young et al., 2000; Im and Muzyczka, 1992; Im and Muzyczka, 
1990). AA Y vectors have been generated by deleting the rep and cap genes but leaving the 
inverted terminal repeat regions intact to function in viral integration (Xiao et al., 1997b; 
Rolling and Samulski, 1995). This allows around 4.5 kb of exogenous DNA to be cloned.within 
the inverted terminal repeat regions of the vector. In the absence of the rep gene, however, 
integration into the host genome reverts to being random (Keams et al., 1996) and the 
likelihood of insertional mutagenesis or, in certain cell types, episomal maintenance of the viral 
DNA is increased (Ferrari et al., 1996). In an elegant series of experiments, rep cloned outside 
of the inverted terminal repeat regions was shown to restore site-specific integration of the 
reporter gene (Pieroni et al., 1998). Although some rearrangement or partial deletion of the 
inserted gene and flanking regions occurred at the site of integration, this functionality of rep in 
trans demonstrated potential for the site-specific integration of therapeutic DNA (Pieroni et al., 
1998). 
AA Y vectors have been used to transfect muscle (Fisher et al., 1997; Xiao et al., 1996b ), brain 
(Kaplitt et al., 1994 ), liver (Koeberl et al., 1997), lung (Flotte et al., 1993) as well as 
haematopoietic cells (Fisher Adams et al., 1996). Clinical trials have focused mainly on the 
treatment of cystic fibrosis (see websites http://clinicaltrials.gov/ct/gui and 
http://www.wiley.co.uk/ genetherapy/clinical/). 
1.2.1.4. Herpes Simplex viral vectors 
HSY type 1 is a double-stranded DNA virus that, through its ability to attach to cell surface· 
heparan sulphate moieties common to many different cells (Yeung et al., 1999; Gruenheid et 
al. , 1993), is able to infect a broad range of cell types (for review see Gamer, 2003). HSY has 
become a promising candidate vector for the gene therapy of certain neurological disorders 
(Latchman, 2003; Lachmann and Efstathiou, 1999) due to its natural tropism for neural tissue in 
which it is able to establish lifelong latency (Lachmann et al., 1999; Wagner and Bloom, 1997). 
The 152 kb HSY genome encodes 84 known genes which are expressed sequentially at 
different stages of infection. Replication-defective HSY vectors have been generated by 
deletion of the 'immediate-early' genes which are involved in viral protein expression, DNA 
replication and virion production. In addition to rendering the virus incapable of replication and 
thus suitable as a gene delivery vector, this deletion provides accommodation for the insertion 
of 10 - 100 kb of exogenous DNA (Krisky et al., 1998a; Krisky et al., 1998b; Marconi et al., 
1996). This is the largest DNA carrying capacity amongst the viral-based gene delivery systems 
developed thus far (Wang et al., 2000; Table 1.1 ). Replication-defective HSY vectors have 
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been used to transfect melanoma cells (Krisky et al., 1998a), muscle (Akkaraju et al., 1999) and 
synovial fibroblast cells (Oligino et al., 1999). Amplicon HSV vectors differ from replication-
defective HSV vectors in that they still contain the viral origin of replication but have a 
defective packaging sequence (Federoff et al., 1997). These have been investigated for 
therapeutic gene delivery to the CNS (Herrlinger et al., 2000; Dumas et al., 1999). 
HSV infection may be either lytic or latent. Lytic infection is suitable for the treatment of 
cancer (for review see Lou, 2003), whereby cellular toxicity due to HSV proteins and altered 
host cell protein synthesis (Greco et al., 2000) is exploited to mediate anti-tumour effects 
(Miyatake et al., 1999; Toda et al., 1999; Todryk et al., 1999). With the exception of cancer 
treatment, cytotoxicity is a major obstacle that limits the application of HSV vectors as gene 
delivery vehicles and, furthermore, has been shown to result in suppression of transgene 
expression within two weeks of transfection (Huard et al., 1997). In contrast, latent infection, 
which is mediated by the neurotropic latency promoter, was shown to maintain gene expression 
for up to 18 months in the CNS (Lachmann and Efstathiou, 1999). Efforts to minimise toxicity, 
maximise the term of gene expression and maintain cell-specificity could enhance the utility of 
HSY-derived gene delivery vectors and broaden their range of applications. 
1.2.2. Non-viral-mediated gene delivery 
1.2.2.1. Liposomes 
Liposomes are the most extensively used means of non-viral gene delivery. They have been 
derived using the basic principles of lipid chemistry and are comprised of a polar component 
attached to a non-polar component so that water-soluble material such as plasmid DNA may be 
encapsulated in a hydrophillic recess surrounded by a lipid bilayer (Figure 1.2). 
Liposomes may be cationic, anionic or neutral, depending on the charge on the polar head 
group of the lipid used (for review see Katsel and Greenstein, 2000). Cationic liposomes set the 
precedent for the rational use of liposomes as pharmacological agents. The liposome 
formulation comprised an equal ratio mixture of N-[1-(2,3-dioleyloxy)propyl]-N,N,N-
trimethylammonium chloride (DOTMA) and dioleoyl phosphotidylethanolamine (DOPE), in 
which DNA formed a complex with DOTMA through electrostatic interactio_ns and the 'helper 
lipid' DOPE increased the capacity of the liposome to fuse with the cell membrane. 
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Table 1.1. Characteristics of viral-mediated gene delivery systems. 
Viral vector I nfectivity Genome Capacity Site of integration Expression Advantages Disadvantages ApplicationsA 
Retrovirus MMLV infects wide vari ety RNA, transcribed into 6 - 7 kb Genomic (Miyake et Stable (Bordignon et Stable expression Infects dividing cells Haematological 
of ti ssues with cell entry via double-stranded DNA al. , 1998; Naldini et al., 1995) Efficient transfer (Roe et al. , 1993) but neoplasias, CNS 
Ram- I receptor (Porter et al. , 1996a; Roe et al. , HIV -based vectors can tumours and various 
al. , 1996; Weiss and Tailor, ~ 7 - IO kb 1993) infect non-dividing solid tumours in 
1995; Miller et a!., 1994; cells conjunction with 
Vanzeijl et al., 1994) Random integration chemotherapy 
Insertional Chronic 
HfV infects CD4+ T-cell s mutagen es is granulomatous disease 
(Costello et al. , 2000; Risk ofreplication 
Suzuki and Shimada, 20002 
Adenovirus Wide variety of tissues Linear double-stranded ~ 35 kb (Fisher et al. , Episomal (Zeng et al., Transient Can infect non- Immunogenicity Cystic fibrosis 
Cell entry via CAR, DNA 1996; Kochanek et al. , 1997) dividing cells (Jooss et al. , 1998; Urea cycle disorders 
integrins and heparan 1996; Bett et al. , 1994) Efficient transfer Mack et al., 1997; such as omithine 
sulphate (Berge Ison et al. , ~ 36 kb Yang and Wilson, transcarbamylase 
1997; Wickham et al. , 1994; 1995) Risk of deficiency 
Wickham et al. , 1993) replication- Various solid tumours 
competency at high 
viral titres 
Adeno- Brain (Kaplitt et al., 1994), Single-stranded DNA ~ 4.5 kb (Rolling and Episomal or site- Transient or stable Site-specific genomic Small insert DNA Cystic fibrosis 
associated Ii ver (Koeberl et al., 1997), Samulski, 1995) specific into integration (Pieroni et capacity 
virus lung (Flotte et al., 1993), ~ 4.7 kb chromosome l 9Q 13 .3 al., 1998) Risk of replication 
muscle (Fisher et al. , 1997; (Young et al., 2000; Can infect non- Rearrangement of 
Xiao et al., 1996b ), vascular Pieroni et al., 1998; dividing cells (Russell DNA insert during 
endothelial and Surosky et al., 1997; eta!., 1994) integration (Pieroni et 
haematopoietic cells Samulski, 1993) Efficient transfer al., 1998) 
(FisherAdams et al. , 1996), Low immunogenicity Loss of site-specific 
via HSP, FGFl and integrin integration in absence 
receptors (Summerford et of rep (Keams et al., 
al. , 1999; Summerford and 1996) 
Samulski, 1998 
Herpes Latent infecti vity of neural Linear double-stranded 10 - 100 kb (Krisky et Stable episomal Transient, but up to 18 Tropism for neural Pathogenicity Brain tumours 
Simplex cells (Lachmann et al. , 1999; DNA al., 1998b; Marconi et months in CNS tissue Cytotoxicity (Greco et 
virus Wagner and Bloom, 1997) al., 1996) (Lachmann and Large DNA insert al., 2000; Miyatake et 
Broad infectivity - cell ~ 152 kb Efstathiou, 1999) capacity al., 1999; Toda et al. , 
surface heparan sulphates Efficient transfer 1999; Todryk et al., 
(Yeung et al. , 1999; Unlikely reactivation 1999) 
Gruenheid et al. , 1993) of latency promoter Latency in neural 
Wan et al., 1997) tissues 
A See websites http://clinicaltrials.gov/ct/gui and http://www.wiley.eo.uk/genetherapy/clinical/ for current clinical trials. 
Unlike earlier some formulations (Wang and Huang, 1984; Schaeferridder et al., 1982), the 
DOTMA/DOPE formulation entrapped DNA completely and enhanced gene transfer by 5 -
100-fold in a range of cultured cells (Felgner et al., 1987). 
Liposome structure may be unilamellar ( Gershon et al., 1993) or multilamellar. Multilamellar 
liposomes consist of alternate layers of lipid membrane and DNA (Battersby et al., 1998; 
Radler et al., 1997), an example of which is shown in Figure 1.2. Formation of the final 
structure is believed to occur in two steps; initially a rapid exothermic electrostatic interaction 
between DNA and the liposome surface, followed by a slower endothermic reaction resulting in 
coalescence of the DNA and lipid components (Pector et al., 2000). Variations of polar head 
groups, counterions and the nature of the acyl chains determine the properties of each liposome 
formulation and influence their potential as gene transfer agents ( for review see Kats el and 
Greenstein, 2000). The lipid to DNA ratio, the size and shape of the liposome/DN A complex 
and the type of cells transfected play an important role in transfection efficiency (Wangerek et 
al., 2001; Liu et al., 1997). 
Polar head group J 
. Lipid bilayer 
Non-polar acyl cham 
.:.. 
~ Hydrophillic compartment 
l 
/ 
Unilamellar cationic liposomes 
+ 
Plasmid DNA 
Multilamellar liposome/DNA complexes 
Figure 1.2. Formation of cationic lipidillNA complexes. Model proposed by Battersby et al. (1998), 
whereby unilamellar cationic liposomes and DNA spontaneously form cationic lipid/DNA complexes 
comprising of spherical multilamellar liposomes. The image shown is from Battersby et al. (1998), 
obtained by cryo-electron microscopy of cationic lipid/DNA complexes embedded in vitreous ice. The 
DNA is believed to be aligned between the lipid bilayers in parallel helices with orthorhombic or 
tetragonal packing, seen as a fingerprint-like pattern within the complexes (boxed). 
Cellular uptake of liposomes occurs primarily through endocytosis (Matsui et al., 1997; 
Zabner et al., 1995). After internalisation, liposomes have been shown to exhibit perinuclear 
localisation within large endosomal aggregates (Zahner et al., 1995). Endosomal sequestration 
is one of the major disadvantages of using liposomes for gene delivery. It is crucial that the 
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DNA escapes sequestration in order to be able to enter the nucleus so that the transgene can be 
expressed. Other disadvantages associated with the use of liposomes in vivo include rapid 
clearance of liposomes from the bloodstream and uptake by the reticulo-endothelial system 
(within minutes of intravenous injection, liposomes are detected in the liver, spleen or lungs) 
(for review see Pouton and Seymour, 2001). This problem has been largely overcome _by the 
addition of polyethylene glycol to the liposome surface, which inhibits binding of serum 
proteins. In so doing, this decreases clearance of the liposomes by macrophages, increasing 
their plasma circulation time (Allen et al., 1991; Klibanov et al., 1990; Allen et al., 1989). 
Liposomes may be produced on a large-scale, are available commercially, lack the 
immunogenicity and pathgogenicity of viruses and impose only a modest restriction on the size 
of DNA accommodated (Compton et al., 2000). In addition, liposomes are easily modified to 
incorporate moieties that enhance transfection efficiency, facilitating cell-specific targeting or 
endosomal escape (Sections 1.3.1 and 1.3.2). Despite these advantages, around only 15 % of all 
gene therapy protocols 1n clinical trials involve the use of liposomes 
(http://clinicaltrials.gov/ct/ gui and http://www.wiley.co. uk/ genetherapy/clinical/). 
1.2.2.2. Electroporation 
Electro-gene therapy involves the application of an electric field to cells that induces a transient 
structural re-organisation of the cell membrane. During this time, the cell membrane is, in 
effect, permeabilised to facilitate the uptake of DNA (Robello and Gliozzi, 1989; Neumann et 
al., 1982; Neumann and Rosenheck, 1972). The extent of permeabilisation depends on the 
number, intensity and duration of the electric pulses (Rols and Teissie, 1990). Proximity of the 
DNA at the cell membrane is required at the precise moment of application of the electric 
pulses and DNA transfer is localised to only the permeabilised areas of cell membrane (Wolf et 
al., 1994). 
In vitro electro-gene transfer has been applied to various cell types, in suspension or monolayer 
culture, and large volumes of cells may be electroporated at a time (Rols et al., 1992). 
Transfection efficiencies when using electroporation have been reported to be comparable and, 
in some cases, even superior to transfection using liposomes (Wells et al., 2000; Yanez and 
Porter, 1999; Spiller eta/. , 1998). 
Electroporation techniques have been described for applications in vivo, in which electrodes 
have been applied in situ to target tissue into which plasmid DNA had been injected (for review 
see Muramatsu et al. , 1998). Although the injection of the therapeutic plasmid and application 
of electrodes favours selective uptake in only the target tissue, a potential problem is that the 
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electric field may extend to non-target cells within the tissue. These cells could be rendered 
permeable to the plasmid simply by proximity ('bystander effect'), leading to possible 
undesirable side-effects if the therapeutic gene product is toxic. This concern may be addressed 
by optimising parameters influencing the efficiency of plasmid uptake, such as the electric field 
itself and the concentration of DNA (high concentrations may lead to cell lysis; Wolf et al., 
1994). 
Using in situ electroporation, trans genes have been expressed at various sites in rats, including 
the liver (Heller et al., 2000; Suzuki et al., 1998) and brain (Nishi et al., 1996), and in mice, 
including in breast (Wells et al., 2000) and colon adenocarcinoma cells maintained 
subcutaneously (Goto et al., 2000). In situ electro-gene therapy has also proven successful in 
skeletal muscle, which is reputedly difficult to transfect using cationic liposomes (Mathiesen, 
1999); expression of fibroblast growth factor could be maintained for up to nine months in 
mouse, rat, rabbit and monkey (Mir et al., 1999) and expression of erythropoietin in mice for at 
least six months (Rizzuto et al., 1999). This demonstrates the potential of skeletal muscle to be 
utilised for the production of proteins with therapeutic value, in addition to the potential of 
electro-gene therapy in the treatment of muscle disorders. 
1.2.2.3. Receptor-mediated gene delivery 
Receptor-mediated gene delivery facilitates the uptake of transgenes in a cell-specific manner. 
By conjugating the DNA to ligands for cellular receptors, receptor-specific binding may be 
achieved which, in turn, initiates the process of cellular internalisation by endocytosis (for 
review see Varga et al., 2000). The ligand may be covalently attached by conventional cross-
linking procedures to a DNA-binding moiety, such as poly-L-lysine (pLy) (Chan and Jans, 
2001; Chan et al., 2000; Chan and Jans, 1999; Synnes et al., 1999) or a DNA-binding protein 
(Uherek et al., 1998; Paul et al., -1997; Fominaya and Wels, 1996). Bi-functional fusion proteins 
capable of binding to both a specific receptor and DNA have also been described (Chan and 
Jans, 2001; Chan and Jans, 1999). 
The stability of the DNA/ligand complex, the distribution and number of receptors on the cell 
surface, receptor-DNA/ligand complex binding affinity and the efficiency of endocytosis all 
influence the efficacy of receptor-mediated gene delivery. In order to promote cellular uptake, 
naked DNA may be condensed into a more compact form, for which purpose pLy not only 
functions as the DNA-binding moiety but is also the most commonly used DNA-condensing 
agent (for review see Garnett, 1999). 
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The liver has been a frequently targeted organ in receptor-mediated gene delivery applications 
(Smith and Wu, 1999), primarily via the asialoglycoprotein (Edwards et al., l 996; Perales et al., 
1994) and galactose (Han and Il Yeom, 2000) receptors expressed on hepatocytes. The first 
reported study using receptor-mediated gene delivery involved the galactose receptor and its 
ligand, asialioorosomucoid, which was linked via pLy to a reporter plasmid (Wu and Wu~ 1988; 
Wu and Wu, 1987). Reporter gene expression was detected in cultured hepatocytes expressing 
the receptor, but not in cells lacking it. Since then, this approach has been applied to a number 
of other receptors, including mannose receptors on alveolar macrophages (Liang et al., 1996), 
lactose receptors on respiratory epithelial cells (Kollen et al., 1999), the epidermal growth 
factor (EGF) receptor on squamous carcinoma cells (Chen et al., 1998; Chen et al., 1994b) and 
tyrosine kinase receptors on neuroblastoma cells (Yano et al., 2000). 
A limitation of receptor-mediated gene delivery is that cellular uptake is by endocytosis and, 
thus, invariably leads to endosomal sequestration. A consequence of this may be degradation of 
the transfection construct within lysosomes. Endosomolytic agents are therefore often used in 
conjunction with this mode of delivery and are discussed in Section 1.3.2. 
1.2.2.4. Ballistic particle-mediated gene delivery 
Ballistic particle-mediated gene transfer was originally developed to deliver genes into plant 
cells (Klein et al., l 992). DNA is precipitated onto gold or tungsten particles and accelerated 
into cells by a helium propellant using a 'gene gun' (Williams et al., 1991 ). The gold particles 
(1 - 5 µm diameter) are small enough to traverse the cell membrane without measurable damage 
and have a carrying capacity of 0.5 - 5 µg of DNA per milligram of gold. 
Using the gene gun, neither the target cell type nor the size of the transfecting DNA is 
restricted, there is no risk of immunogenicity or toxicity and plasmids may be re-introduced 
into cells as often as required. Another distinct advantage of this method is the ability to deliver 
multiple genes encoded by several different plasmids simultaneously. A disadvantage, however, 
is that the particles penetrate only through the epidermis, and a few layers intradermally 
(Tanigawa et al., 2000), which possibly limits use to the treatment of cutaneous disorders (for 
review see Lin et al., 2000). Recently though, in situ introduction of DNA into the heart 
(Nishizaki et al., 2000) liver (Kuriyama et al., 2000) and cornea (Blair-Parks et al., 2002; 
Tanelian et al., 1997) has been reported. 
The gene gun has been used extensively in the development of DNA vaccines (for review see 
Robinson, 1999), particularly against cancer (Irvine et al., 1996; Yang and Sun, 1995). In this 
application, expression of an antigen-encoding gene introduced into the skin was reportedly 
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maintained for up to one month, during which time predominantly CD8+ T-cells were shown to 
be recruited in the immune response (Irvine et al., 1996; Yang and Sun, 1995). Other cancer 
vaccine applications have described the introduction of recombinant cytokines, such as 
granulocyte-monocyte colony stimulating factor (GMCSF) (Tanigawa et al., 2000; Turner et 
al., 1998; Mahvi et al., 1996), interleukin-12 (Sakai et al., 2000; Rakhmilevich et al., 1999) or 
interferon-a (Tuting et al., 1997), near to the tumour in order to enhance the immune response 
locally. 
Although non-viral-mediated gene delivery methods have not been subject to the problems 
associated with viral-mediated gene delivery, such as random genomic insertion of the 
transgene, immune reactivity and cytotoxicity, the efficiency of transgene delivery using viral 
vectors is superior in comparison. Viral vectors are, however, restricted in terms of the size of 
the DNA that may be accommodated. In combination in a hybrid system, the advantageous 
properties of viral-and non-viral mediated gene delivery may overcome the limitations of both 
of these gene delivery systems (Kaneda, 2000). 
1.3. BARRIERS TO GENE DELIVERY 
Whether viral or non-viral gene delivery systems are used, the therapeutic plasmid faces a 
challenging route to the nucleus that necessitates traversing a series of membrane barriers and 
running the gauntlet of cytosolic nucleases (Pollard et al., 2001; Lechardeur et al., 1999) before 
the NE is reached, which plays a crucial role also in limiting transfection efficiency (Zahner et 
al., 1995) (Figure 1. 1). This is attested to by the low transfection efficiency of non-viral gene 
delivery systems, using which, an estimated 0.01 - 10 % of the original transfected DNA has 
been shown to reach the nucleus (Chu et al., 1990; Capecchi, 1980). 
Viruses have evolved intrinsic mechanisms that enable them to bind selected host cells, cross 
the cell membrane, escape endosomal sequestration and enter the nucleus (Figure 1.3). Efforts 
to enhance viral gene delivery have therefore focused on targeting cells other than those 
corresponding to the innate tropism of the virus (Anderson et al., 2000; Chandler et al., 2000; 
Curiel, 1999; Doukas et al., 1999; Douglas et al., 1996). In contrast, the rational design of non-
viral vectors requires a comprehensive understanding of each of the membrane barriers and the 
nuclear transport processes. In this section the membrane barriers and the approaches adopted 
to optimise non-viral gene delivery are examined in more detail. 
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Table 1.2. Characteristics of non-viral-mediated gene delivery systems. 
Capacity 
Primary site of vector 
Expression 
Advantages 
Disadvantages 
ApplicationsA 
Liposomes Receptor-mediated 
No limitation No limitation 
Episomal Episomal 
Transient Transient 
Controlled encapsulation capacity (Liu Targets specific cells 
et al. , I 997) 
Easil y modified with targeting ligands 
(Cao and Suresh, 2000; Maruyama, 
2000; Ward, 2000; Singh, 1999; Hart 
et al. , 1998) 
Variable lipid composition (Saravolac 
et al. , 2000; Zou et al., 2000) 
Rapid plasma clearance (Allen et al., Requires endosomal escape agent 
1989; Poste et al. , 1982) 
Systemic toxicity at high 
concentrations 
Perinuclear aggregation (Zahner et al. , 
1995) 
Electroporation 
No limitation 
Episomal 
Transient 
Up to 9 months in muscle (Mir et al., 
1999; Rizzuto et al. , 1999) 
Target specific tissue by in situ 
application of electrodes ( Goto et al., 
2000; Heller et al., 2000; Wells et al., 
2000; Y oshizato et al., 2000; 
Muramatsu et al., 1998; Suzuki et al., 
1998; Nishi et al., 1996) 
Introduction of multiple genes 
Transfection of adjacent cells; 
'bystander effect' 
In vitro and animal trials only 
In situ application of electodes for 
subcutaneous, liver and muscle gene 
delivery 
A See websites http://clinicaltrials.gov/ct/gui and http://www.wiley.co.uk/genetherapy/clinical/ for current clinical trials. 
Ballistic 
No limitation 
Episomal 
Transient 
Up to 2 months expression in muscle 
(Zelenin et al., 1997) 
Target specific tissue by in situ 
application of the gene gun 
(Kuriyama et al., 2000; Nishizaki et 
al., 2000; Tanelian et al., 1997) 
Possible introduction of multiple 
genes encoded by several different 
plasmids 
Primarily suitable for cutaneous 
delivery (Lin et al. , 2000) 
Expensive 
DNA vaccines (Tanigawa et al., 
2000; Rakhmilevich et al. , 1999; 
Robinson, 1999; Turner et al., 1998; 
Rakhmilevich et al. , 1997; Tuting et 
al. , 1997; Irvine et al. , 1996; Mahvi 
et al., 1996; Yang and Sun, 1995) 
Cutaneous disorders 
Adenovirus 
..., 
Cytoplasm Nucleus 
L------.....J 
Figure 1.3. Cellular uptake and nuclear translocation of an adenoviral vector. A schematic diagram 
of the pathway of internalisation and nuclear translocation of an adenoviral vector is shown, illustrating 
the intrinsic properties of viruses utilised in viral-based gene delivery systems. Adenoviral capsid proteins 
attach to the Coxsackie and Adenovirus receptor (CAR), integrins and heparan sulphate proteoglycans on 
the cell surface (Bergelson et al., 1997; Wickham et al., 1994; Wickham et al., 1993) G)_ Internalisation 
occurs by receptor-mediated endocytosis into an endosome ~. The acidic environment of the endosome 
induces a conformational change in the capsid proteins, which disrupts the endosome and the adenoviral 
capsid is released into the cytoplasm (Seth et al., 1984) @. Docking of the adenovirus capsid occurs at 
the NPC, where histone Hl binds the adenoviral capsid and initiates disassembly. Nuclear transport 
proteins bind to HI and translocate the partially disassembled capsid and viral DNA into the nucleus 
(Trotman et al., 2001) ©. Within the nucleus, the viral capsid is lost and the viral vector is free to be 
transcribed ~. 
1.3.1. Crossing the cell membrane 
The outer cell membrane consists of a lipid bilayer punctuated by pores, channels, transporters 
and receptors, each of which displays unique properties in controlling what enters and leaves 
the cell. Cellular uptake occurs through a number of mechanisms, including pinocytosis, 
phagocytosis, fusion with the cell membrane or receptor-mediated endocytosis, dictated largely 
by the nature of the molecules presenting at the cell surface. 
Particular membrane receptors expressed exclusively on certain cell types provide the basis for 
viral tropism but, also, facilitate a conduit for cell-specific non-viral gene delivery. An 
understanding of the differential expression profiles of cell-surface proteins is important in 
order to ensure that the gene delivery vector targets only the desired cells. This becomes 
extremely important when toxic gene products are produced, such as in an anti-cancer therapy. 
By incorporating receptor-specific ligands into the liposomal membrane, cells expressing EGF 
(Chen et al., 1998; Uherek et al., 1998; Foster and Kem, 1997), integrin (Compton et al., 2000; 
Hart et al., 1998), folate (Reddy and Low, 2000; Reddy et al., 1999; Lee and Huang, 1996) and 
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transferrin (Simoes et al., 1999; Simoes et al., 1998) have been targeted successfully. 
Glycosylation of liposomes has been shown to enable targeting to different liver cell types 
through the respective glycolipid-ligands for asialoglycoprotein, mannose or fucose receptors 
(Kawakami et al., 2000). Antibodies directed against cell surface antigens provide another 
avenue along which to mediate cell-specificity of liposomes (immuno-liposomes; Martin and 
Papahadjopoulos, 1982). Some applications have included targeting colon carcinoma (Kamps et 
al., 2000) and HIV-infected cells (Bestman-Smith et al., 2000; Dufresne et al., 1999). An 
effective way of expanding the target cell range of immuno-liposomes is the use of streptavidin-
conjugated antibodies and biotinylated liposomes, in which the biotinylated liposomes may be 
targeted to a variety of cell types by selecting an array of streptavidin-conjugated antibodies 
(Cao and Suresh, 2000). 
The repertoire of cell-surface receptors and antigens is vast, making the scope for designing 
cell-specific gene delivery systems considerable. The major caveat of gene delivery approaches 
that occur via cell-surface receptors, however, remains that following internalisation the vectors 
become entrapped within endosomes. 
1.3.2. Sequestration within endosomes 
Ligands that bind to external cellular receptors initiate receptor-mediated endocytosis, whereby 
the ligand-receptor complexes are internalised within endosomes (Figure 1.4). Apart from 
receptor-mediated gene delivery, transfection using liposomes also proceeds via endocytosis 
(Zabner et al., 1995; Zhou and Huang, 1994; Legendre and Szoka, 1992). Sequestration 
imposes a significant limitation on gene delivery methods that target the endosomal pathway 
(Zabner et al., 1995). Since endosomes mature through various stages of acidification and 
eventually fuse with lysosomes which contain degradative enzymes, prior escape of the 
transfecting DNA is critical. Moreover, notwithstanding degradation, entrapment of the 
therapeutic constructs also decreases the quantity available for nuclear uptake. 
Viruses which enter their host cells by receptor-mediated uptake have specialised 'endosomal 
escape mechanisms' (see Figure 1.3). For example, adenovirus takes advantage of the 
decreased pH within the endosomes that causes the hydrophobic domains of the adenoviral 
capsid proteins become exposed. This facilitates interaction with the enctosomal membrane in 
such a way as to bring about endosomal disruption (Seth et al., 1984). In order to extend this 
function to non-viral gene delivery systems, adenoviral particles have been incorporated into 
non-viral vectors by co-infection (Curiel et al., 1991), covalent linking (Ogier et al., 1994), 
non-covalent interactions (Fasbender et al., 1997), bi-functional antibodies and streptavidin-
biotin bridges between adenoviral particles and the DNA complexes (Gao et al., 1993). 
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Figure 1.4. General endocytosis pathway for gene delivery mediated by receptors on the cell 
surface. Endocytosis is initiated by ligands binding to their associated receptors on the cell surface. 
Internalisation occurs through clathrin-coated pits, in the process forming early endosomes. Within these, 
receptors are sorted and are either returned to the cell surface via recycling endosomes or late endosomes 
are formed. Late endosomes may fuse with vesicles containing lysosomal degradative enzymes, forming 
lysosomes. Throughout this process, endosomes undergo progressive acidification from pH ~ 7 at the cell 
surface to pH ~ 4 within lysosomes. It is imperative that the gene delivery vectors escape endosomal 
sequestration to avoid degradation within lysosomes. Adapted from Varga et al. (2000). 
The amino terminal peptide of influenza virus (haemagglutinin HA-2) has been coupled to pLy-
condensed DNA and was shown to enhance transgene expression by greater than 5000-fold 
upon lipofection into cultured liver cells (Plank et al., 1994). The authors proposed that the 
acidic interior of the endosome (pH~ 5) induced a conformational change to an a-helix within 
the HA-2 peptide, that enabled it to insert into the endosomal membrane, thereby facilitating 
fusion between the liposomal and endosomal membranes and, hence, enabling extrusion of the 
liposome contents into the cytoplasm. Synthetic peptides have been derived from this 
archetype, some of which form pores in the endosomal membrane (Chung and Thompson, 
1996), while others, such as GALA (Plank et al., 1994; Parente et al., 1990; Subbarao et al., 
1987) and KALA (Wyman et al., 1997) have fusogenic activity. 
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Fusion of the liposomal and endosomal membranes appears to be essential in order to bring 
about release of the transfecting DNA (Wrobel and Collins, 1995; Zhou and Huang, 1994). The 
release of DNA from cationic liposomes was postulated to occur due to the interaction of 
anionic lipids, destabilised from the cytoplasmic side of the endosomal membrane, with the 
cationic lipids of the liposome (Xu and Szoka, 1996; Zelphati and Szoka, 1996). This 
interaction would neutralise the cationic lipid/DNA interaction, thereby facilitating DNA 
release into the cytoplasm. Indeed, the ability of specialised pH-sensitive lipids, which take on a 
net positive charge at low pH, to mediate gene transfer has been correlated with their capacity 
to facilitate fusion with the endosomal membrane (Mui et al., 2000). Furthermore, the 
modification of the lipid membrane by attachment of amine groups with selected pKa' s (Budker 
et al., 1996) generated a range of pH sensitivities which, potentially, might be used to facilitate 
DNA release at various stages of endosomal maturation (from early to late endosomes). 
Chemical agents may be used to facilitate the release of transfected DNA trapped within 
endosomal compartments (Wagner, 1998); chloroquine being the most widely used 
lysosomotropic chemical. While effective in vitro, chloroquine is unsuitable for in vivo gene 
therapy applications as the concentrations required for lysis of endosomes are toxic. 
Polyethylenimine (PEI) has a similar endosomalytic mechanism of action to chloroquine and 
has become a widely used non-viral DNA delivery agent (Abdallah et al., 1996; Behr, 1994 and 
for review see Remy et al., 1998). The mechanism of action of these lysosomotropics has been 
demonstrated recently (Sona wane et al., 2003). As these agents are polybasic, they accumulate 
in acidic compartments ( such as endosomes) inside the cell, where they become protonated. 
This removes free H+ from the endosomal interior, prompting these agents to be termed 'proton 
sponges'. An influx of counterions (Cl) occurs due to the depletion of W (to restore a net 
neutral charge) and concomitant osmotic swelling causes the endosome to burst (Sona wane et 
al., 2003). In addition, the shift towards basic pH would inhibit lysosomal enzymes and thus 
reduce the degradation of DNA complexes (Seglen, 1983). 
1.3.3. Transport into the nucleus 
Transfected DNA must reach the nucleus in order for transcription to occur so that the desired 
gene product is ultimately expressed. As viruses have intrinsic mechanisms that enable them to 
access the nucleus (for review see Whittaker et al., 2000), these may be extended to the viral-
based gene delivery systems. In contrast, non-viral gene delivery systems require additional 
extrinsic modifications to enhance the nuclear delivery step. 
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1.3.3.1. The nuclear membrane 
The nucleus is bound by a double membrane called the NE. It partitions the cell into two 
specialised compartments by separating nuclear material and activity from that in the 
cytoplasm. In so doing, this necessitates a mechanism which allows regulated communication 
between the two compartments. This portal is provided by nuclear pore complexes (NPCs ), 
distributed within the NE (Figure 1.5). All nuclear transport takes place through the NPC (Rout 
et al., 2003). The number of NPCs in a single cell varies according to cell type and metabolic 
activity. A yeast cell contains around 200 NPCs (Rout and Blobel, 1993), a proliferating human 
cell several thousand and a mature Xenopus laevis oocyte around 5xl07 (Cordes et al., 1995). 
Inner spoke ring 
Outer spoke ring 
Nuclear envelope 
consisting of 
inner nuclear membrane 
outer nuclear membrane 
Cytoplasmic side 
Nucleoplasmic side 
Filaments 
,.___ Cytoplasmic ring 
,._-Nucleoplasmic ring 
Nuclear 
basket 
Figure 1.5. Model of the nuclear pore complex. The NPC consists of a central channel, comprising 
around 30 different proteins (nucleoporins) which associate to form a basic repeated subunit, and 
attached filaments, which extend outwards on the cytoplasmic side and join to form a basket-like 
structure on the nucleoplasmic side (from Blobel and Wozniak, 2000). 
The NPC is an intricate, cylindrical, multi-subunit arrangement, with attached fibrils or 
filaments on the cytoplasmic side and a basket-like structure on the nucleoplasmic side (Blobel 
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and Wozniak, 2000) (Figure 1.5). This overall structure is highly species-conserved, implying a 
fundamental role in nuclear transport processes. A group of around 30 different proteins, 
termed nucleoporins, make up 5 - 10 % of the NPC mass and provide around 150 docking sites 
at hydrophobic repeat sequences (Phe-Gly) for nuclear transport complexes during their transit 
into the nucleus (Rout and Aitchison, 2001; Blobel and Wozniak, 2000). The NPC may be 
blocked by interaction between a lectin, wheat germ agglutinin (WGA), and N-
acetylglucosamine groups on its cytoplasmic side (Finlay et al., 1987). WGA has been used 
extensively in nuclear transport experiments to determine whether transport may be inhibited, 
thereby demonstrating involvement of the NPC. 
The diameter of the central channel of the NPC is around 9 nm. It is the central channel which 
plays a role in the molecular sieve-like function of the pore, proposed to be mediated through 
entropy related events (Rout et al., 2003). Molecules of molecular mass less than 45 kDa and 
diameter less than 9 nm diffuse freely into and out of the nucleus, whereas molecules larger 
than this require a specific sequence, the NLS, which confers interaction with the cellular 
nuclear import machinery in order to bring about nuclear uptake of the protein (Kalderon et al., 
1984a; Kalderon et al., 1984b). The presence of an NLS appears to bring about a 
conformational change in the central channel, allowing passage of particles up to 26 nm in 
diameter (Akey, 1990; Dworetzky and Feldherr, 1988). There are, however, some exceptions to 
this molecular weight cut-off (MWCO) rule, as some lower mass proteins, such as histones 
(around 14 kDa; Baake et al., 2001b; Lin and Clarke, 1996; Breeuwer and Goldfarb, 1990) and 
tRNAs (Zasloff et al., 1982) also undergo active transport into the nucleus in association with 
the nuclear transport proteins. 
1.3.3.2. The mechanism of nuclear transport 
If a protein contains NLSs, its transport to the nucleus occurs via the importin-mediated 
pathway. This involves three main stages: binding of the NLS by importin, docking of the 
transport complex at the NPC and finally translocation through the pore into the nucleus. 
In the ' conventional pathway' of importin-mediated nuclear transport (Figure 1.6), a 
heterodimeric complex consisting of importin a (karyopherin; Kap60p in yeast) and importin 
~ 1 (Kap95p in yeast) forms the NLS receptor'. Importin a presents two functional domains, 
namely an importin ~-binding domain (Gorlich et al., 1996) and an NLS-binding site (Conti et 
al., 1998). Binding of importin ~ to the importin ~~binding domain within importin a displaces 
an auto-inhibitory sequence from the NLS-binding site (Kobe, 1999), allowing importin a to 
bind the NLS-containing protein specifically (Gorlich et al., 1995; Imamoto et al., 1995b; 
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Imamoto et al., 1995a; Moroianu et al., 1995a; Moroianu et al., 1995b; Radu et al. , 1995). 
Importin ~ mediates docking of the importin alp heterodimer/NLS-protein transport complex to 
the distal end of the cytoplasmic fibrils of the NPC ( see Figure 1. 5) through high affinity 
interactions with hydrophobic amino acids (Moroianu et al., 1995a). The complex is 
subsequently transferred to the central channel and, through a series of docking events 
involving different nucleoporins within the NPC, travels 100 - 120 nm to the nucleoplasmic 
side (Bayliss et al., 2000). 
1. Signal recognition 2. NPC docking 
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Figure 1.6. NLS-dependent nuclear import of proteins. A schematic representation of the nuclear 
uptake of an NLS-containing protein is shown. Nuclear translocation of proteins that contain an NLS is 
mediated through the 'NLS receptor', a heterodimeric complex of importin a, which specifically binds 
the NLS (1) and importin ~, which mediates docking at the NPC (2). Translocation through the NPC 
occurs via a series of interactions wfrh nucleoporins within the pore (3). The complex is dissociated in the 
nucleus when Ran-OTP, generated by the nucleotide exchanger RCCl, binds importin ~ (4). The nuclear 
transport factor NTF2 transports Ran in its GDP-bound form from the cytoplasm into the nucleus in order 
to replenish the stores of nuclear Ran. 
The monomeric guanine nucleotide binding-protein Ran, in its GTP bound form (mediated by 
the nucleotide exchanger RCCl; Klebe et al., 1995), dissociates the transport complex from the 
nucleoplasmic side of the NPC by binding to importin ~ (Gorlich et al., 1995; Moroianu et al., 
1995b). The NLS-containing protein and importin a are thus released into the nucleus, while 
importin ~ remains at the NPC. 
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1.3.3.3. Classes of nuclear localisation sequences 
NLSs may be characterised into 3 major classes: those resembling the NLS of the Simian Virus 
40 large tumour antigen (SV 40 T-ag) that are comprised of a short stretch of basic amino acids 
(PKKKRKV133, referred to as 'classical' NLSs; Kalderon et al., 1984a; Kalderon et al., _1984b; 
Lanford and Butel, 1984), those which consist of two stretches of basic amino acids separated 
by 10 - 12 amino acids (referred to as bipartite NLSs; Robbins et al., 1991) and a third, less 
well-defined class made up of NLSs resembling those of the yeast homeodomain containing 
protein Matcx.2 in which charged or polar residues are interspersed with non-polar residues (Hall 
et al., 1990; Hall et al., 1984). Examples of each of these NLSs are presented in Table 1.3. 
Table 1.3. Selected examples of NLSs conferring nuclear import by the 'conventional 
pathway' (importin a/~ and Ran-dependent). 
Protein 
T-ag-like NLSs 
SV40 T-ag 
Dorsal 
PKKKRKV132 
RRKRQR340 
c-rel KAKRQR 294 
NF-KB p65 (RelA) EEKRKR286 
Bipartite NLSs 
SWI5 
Rb 
Nucleop lasmin 
Nl/N2 
Mata.2-like NLSs 
Matcx2 
KK -10 aa spacer- RKRGRPRK655 
KR -11 aa spacer- KKLR869 
KR - 9 a.a. spacer- KKKK.Ll 71 
RKKRK- 12 a.a. spacer- KKSK 551 
MNKIPIKDLLNPQ 13 
VRlLESWFAKNr159 
A The single letter amino acid code is used. 
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All three classes of NLSs are recognised specifically by the importin a!P heterodimer during 
the first step of nuclear transport (Hu and Jans, 1999; Hubner et al., 1999; Efthymiadis et al., 
1997; Smith et al., 1997). Competition for this nuclear import pathway is significant in the 
context of the whole cell, considering the large number of nuclear import substrates (Jans et al., 
2000a). In response, higher eukaryotes express multiple forms of importin a (8 in human; 6 in 
mouse), all of which are believed to function as a heterodimer with importin P 1 yet retain 
discrete NLS-substrate binding properties and transport efficiencies (Kohler et al., 1999; Prieve 
et al., 1998; Hubner et al., 1997; Miyamoto et al., 1997; Nadler et al., 1997; Rexach and 
Blobel, 1995). 
The NLS/importin a!P-mediated nuclear import pathway is not the only signal-dependent 
pathway capable of targeting proteins to the nucleus. Certain 'classical' NLSs may be bound by 
importin p in the absence of importin a, which is also not required for subsequent transport into 
the nucleus. HIV-1 Rev protein (Truant and Cullen, 1999; Henderson and Percipalle, 1997), 
transcription factors such as GAL4, (Chan et al., 1998), AP-1 (Forwood et al., 2001a), CREB 
(Forwood et al., 2001a), SRY (Forwood et al., 2001b) and TRFl (Forwood and Jans, 2002), 
parathyroid hormone related protein (Lam et al., 1999) and histones (Baake et al., 200 la; 
Muhlhausser et al., 2001; Johnson-Saliba et al., 2000; Jakel et al., 1999) are amongst the 
importin P-recognised nuclear import 'substrates'. 
There are around 24 homologues of importin p in eukaryotes, having specific import (as well as 
export) roles for particular classes of proteins (Jans et al., 2000a). Importin P2 
(Kap104p/transportin) mediates both the nuclear import and export of mRNA-binding proteins 
by specifically binding to sequences homologous to a 38-amino acid sequence (termed M9) 
within the human mRNA-binding protein hnRNP Al (Michael et al., 1997). Importin P3 
mediates the nuclear import of the transcription factor Pho4 (Komeili and O'Shea, 1999; 
Kaffman et al., 1998). Other proteins are trafficked by more than one importin p homologue; 
the presence of a P-importin-like binding or 'BIB' domain within ribosomal proteins, for 
example, has been shown to confer binding affinity for any one of importin P 1, p2, P3 or Imp7 
(Jakel and Gorlich, 1998). 
There are additional signal-dependent but importin- and Ran-independent pathways. The HIV-1 
Tat protein, for example, is bound neither by importin a nor importin p, but the Tat NLS 
(GRKKRRQRRRAP59) has been shown to target p-galactosidase to the nucleus and appears to 
have both nuclear entry and retention functions (Truant and Cullen, 1999; Efthymiadis et al., 
1998; Siomi et al., 1990). In contrast, the HIV-1 Vpr protein does not have a distinct NLS but 
displays cytosolic factor-dependent intranuclear binding, independent of importin a!P or Ran 
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(Jans et al., 2000b ). Another example of importin-independent nuclear localisation is ~-catenin, 
which is able to bind directly to nucleoporins within the NPC in order to initiate translocation 
(Fagotto et al., 1998). 
It is apparent that a range of nuclear import pathways exists, enabling translocation of proteins 
into the nucleus that is mediated through different types of targeting signals. Many NLS-
containing proteins are, however, not constitutively nuclear due to mechanisms that modulate 
NLS function and accessibility (for review see Jans et al., 2000a). A comprehensive 
understanding of both the pathways that provide access to the nucleus and their associated 
regulatory mechanisms is paramount if these endogenous processes are to be exploited for 
purposes such as enhancing gene delivery to the nucleus. 
1.4. OPTIMISING DNA TRANSL0CA TI0N INTO THE NUCLEUS 
Translocation into the nucleus, as discussed earlier, is governed by the NPCs which present an 
apparent size exclusion barrier. Linear DNA greater than 2 kb in length was found to enter the 
nucleus with reduced efficiency compared to a 1 kb fragment (Ludtke et al., 1999). Given that 
most therapeutic DNA constructs are well in excess of 2 kb, it is clear how transport into the 
nucleus could be a severely limiting step in non-viral gene delivery systems. In a seminal study, 
microinjection of DNA into the nucleus of cultured mammalian cells produced levels of 
transfection greater than 50 %, whereas microinjection into the cytoplasm led to gene 
expression in less than 0.01 % of the cells (Capecchi, 1980). 
1.4.1. The nuclear import of DNA 
Initial studies to delineate the nuclear transport mechanism involved microinjection of gold-
labelled plasmid DNA into cultured cells (Dowty et al., 1995). Detection using electron 
microscopy revealed the DNA to be located at the NPC or within the nucleus. As gene 
expression could be inhibited by the nucleoporin-binding lectin WGA (see Section 1.3.3.1), the 
NPC was implicated as the route of entry into the intact nucleus (Dowty et al., 1995). Similarly, 
using a digitonin-permeabilised cell system, in which nuclear import was reconstituted, 
fluorescently-labelled linear DNA fragments were found to enter the nucleus through the NPC 
and in a strictly size-dependent manner (Ludtke et al., 1999; Hagstrom et al., 1997). 
In the afore-mentioned reconstituted nuclear import system, nuclear import by passive diffusion 
was found to occur but only for linear DNA fragments of less than 310 bp (Ludtke et al., 1999). 
For larger DNA fragments of 510 - 1500 bp, nuclear uptake was shown to be energy-dependent, 
implying an active process. However, the even larger 2 and 3 kb plasmids did not accumulate in 
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the nucleus within the one hour time frame of the experiment (Ludtke et al., 1999; Hagstrom et 
al., 1997). Microinjection into the cytoplasm of intact cells yielded similar results; after 4 hours 
DNA fragments less than 1 kb accumulated in the nuclei, while the larger DNA fragments of 
1.5, 2 and 3 kb did not enter the nucleus (Ludtke et al., 1999). In contrast to these studies, 
Salman et al. (2001) found that the nuclear uptake of linear double stranded DNA 
(bacteriophage )., DNA) occured passively, independently of ATP consumption in a Xenopus 
laevis oocyte model of reconstituted nuclear transport. Collectively, these studies agreed that 
nuclear import of DNA did not require the addition of cytosolic factors. This, the authors 
suggested, implied a nuclear import pathway distinct from that mediated by importins (Salman 
et al., 2001; Ludtke et al., 1999; Hagstrom et al., 1997). Competition experiments in which an 
excess of NLS-fusion proteins did not inhibit DNA transport also suggested divergence from 
the importin-mediated uptake pathway (Hagstrom et al., 1997). 
While shown to be energy-dependent and occur through the NPC, the nuclear import of plasmid 
DNA appears to be different from that of linear DNA. The nuclear import of plasmid DNA was 
found to be sequence dependent (Dean et al., 1999; Dean, 1997) with an absolute requirement 
for cytoplasmic extract (Wilson et al., 1999). The SV 40 promoter/enhancer sequence was 
shown to elicit uptake of plasmid DNA into the nucleus (Dean, 1997). When the plasmid 
contained other sequences derived from SV40, the Roux sarcoma virus promoter region or the 
human cytomegalovirus (CMV) promoter region, nuclear localisation was not observed (Dean 
et al., 1999). The authors proposed that the SV40 sequence contains binding sites for 
transcription factors which contain NLSs, by virtue of which the SV 40-plasmid may be 
transported into the nucleus along the importin-mediated nuclear import pathway (Dean et al., 
1999; Dean, 1997). In addition to this, only when in combination could importins a and~' Ran 
and nuclear extract support plasmid uptake, further implicating the 'conventional' nuclear 
import pathway. As has been observed for the linear fragments of DNA (Ludtke et al., 1999) 
upon completion of the four hour time course, the larger plasmid DNA (14.4 kb) displayed 
perinuclear retention, whereas the comparatively smaller plasmid ( 4.2 kb) had accumulated in 
the nucleus (Wilson et al., 1999). 
Taken together, these results suggest that the nuclear import pathway of linear DNA fragments 
may be distinct from that of plasmid DNA, with plasmids possibly requiring additional import 
factors and a more stringent import mechanism to access the nucleus. For both linear and 
circular plasmid DNA, size-dependency was shown to be critical with larger molecules 
appearing to be precluded from nuclear uptake. 
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1.4.2. DNA condensation 
While there is no formal consensus on a relationship between DNA condensation and gene 
transfer efficiency, evidence from a number of experimental systems alludes to a positive 
correlation (Chan et al., 2000; Chan and Jans, 1999; Ziady et al., 1999; Perales et al.., 1997; 
Vitiello et al., 1996). Condensation of DNA has been reported to facilitate an easier passage 
across cell membranes, including the NE, with a 1. 7-fold enhancement in nuclear uptake 
attributed to condensation of the plasmid DNA (Chan and Jans, 1999). Additionally, condensed 
DNA has been shown to be protected from degradation by cytosolic nucleases (Pollard et al., 
2001; Baeza et al., 1987). 
pLy is the most commonly used DNA-condensing agent (Garnett, 1999). Other molecules with 
DNA condensing properties that have been studied extensively for gene delivery applications 
include protamine (Sorgi et al., 1997; Chen et al., 1995), histones (Fritz et al. , 1996; Chen et 
al., 1994a; Wagner et al., 1991 ), synthetic cationic peptides ( WK; 
Gottschalk et al., 1996) and, more recently, cationic detergents (Dauty et al., 2001; Blessing et 
al., 1998). 
As all of these agents are cationic, interaction with DNA occurs on the basis of electrostatic 
charge. Condensation into a variety of forms has been shown, including rod shapes, toroids, 
spheroids and 'flowers' (for review see Vijayanathan et al. , 2002). Using atomic force and 
electron microscopy, the step-wise condensation of plasmid DNA upon the addition of 
increasing amounts of pLy was shown to proceed from an open, irregular structure through 
intermediate toroid structures (60 nm in diameter) and, finally, into spheroid structures (1 6 nm 
in diameter; Chan et al., 2000; Wagner et al., 1991). Similarly condensed structures have been 
reported using individual histones, Hl and H4 (Lucius et al., 2001; Fritz et al., 1996; Wagner et 
al., 1991). 
In addition to the compaction of the DNA itself, the size and shape of the transfection 
complexes as a whole have also been found to influence gene transfer efficiency. Complexes 
containing lipid, protamine ( or pLy) and DNA were shown to rearrange into virus-like particles 
upon mixing, having diameters not greater than 100 nm. Compared to particles containing only 
lipid and D A, upon inclusion of the polycation, luciferase reporter gene expression was 
enhanced by 10 - 30-fold (Gao and Huang, 1996). Similar nanometric particles have been 
assembled using PEI as the D A-complexing -agent that, additionally, has endosomalytic 
activity (see Section 1.3.2); this dual functionality makes it highly efficient in gene transfer (for 
review see Remy et al., 1998). 
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1.4.3. The use of nuclear localisation sequences 
NLSs have been incorporated into transfection constructs in order to enhance import of plasmid 
DNA into the nucleus. This has been achieved in a variety of ways including direct coupling of 
the NLS to the DNA and indirect coupling by conjugating the NLS to a DNA-carrier molecule 
(for reviews see Escriou et al., 2003; Cartier and Reszka, 2002; Bremner et al., 2001). 
Linking NLSs directly to DNA has involved a number of resourceful chemical and molecular 
approaches. Zanta et al. describe the covalent attachment of the SV 40 T-ag NLS to a linear 
DNA fragment at a terminal stem-loop secondary structure via a modified oligonucleotide 
(Zanta et al., 1999). Compared to the control constructs ( closed circular plasmid, linearised 
plasmid and linear plasmid presenting a mutated form of the NLS), gene expression was 
enhanced 10 - 1000-fold across the range of cell lines tested. 
Another approach is the use of sequence-specific hybridisation to couple functional peptides 
(such as NLSs) to the DNA (Roulon et al., 2002; Branden et al., 1999; Neves et al., 1999a; 
Neves et al., 1999b; Sebestyen et al., 1998). The basis of this technology is the initial 
hybridisation through Watson-Crick base pairing between a site within the reporter plasmid and 
a complementary oligonucleotide to which the NLS has been conjugated. The resulting hybrid 
rearranges into a hairpin-loop triplex structure which has been shown to be extremely stable 
(Zelphati et al., 2000; Zelphati et al., 1999). Collectively, these studies reported that transgene 
expression had occurred upon transfection into cultured cells, however, relative enhancement of 
gene expression due to the NLS was observed in only one of the studies, with an 8-fold increase 
in transfection efficiency (Branden et al., 1999). 
In order to incorporate NLSs into the transfection constructs through the DNA-binding moiety, 
Chan et al. crosslinked an optimised SV 40 T-ag NLS to pLy and demonstrated condensation of 
DNA, nuclear targeting and a 1.3-fold enhanced reporter gene expression (Chan and Jans, 2001; 
Chan et al., 2000; Chan and Jans, 1999). Fusion proteins consisting of a DNA-binding domain 
and NLS peptide have also been generated between, for example, histone Hl and the SV40 T-
ag NLS (Fritz et al., 1996; Hagstrom et al., 1996). While the transfection efficiency of the 
reporter plasmid was enhanced when associated with Hl, no further enhancement was achieved 
in the presence of the NLS (Fritz et al., 1996). 
All of the NLSs listed in Table 1.3 are potential candidates for use in DNA transfection 
constructs to enhance importin-mediated nuclear import. By deleting an inhibitory regulatory 
element (the cyclin-dependent kinase phosphorylation site; Thr to Ala substitution) within the 
SV 40 T-ag NLS without affecting the enhancing sequences, an optimised NLS was generated, 
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which was found to enhance nuclear transport efficiency up to 100-fold (Hubner et al., 1997; 
Xiao et al., 1997a). Furthermore, when coupled to transfection constructs, the optimised SV40 
T-ag NLS enhanced plasmid uptake into the nucleus (Chan and Jans, 2001; Chan et al., 2000; 
Chan and Jans, 1999; Akhlynina et al., 1995; Akhlynina et al., 1993). Modification of NLS 
peptides so that they are either constitutively active or differentially regulated in response to 
cellular signals is another possibility for NLS optimisation (Xiao and Jans, 1998; Xiao et al., 
1998; Xiao et al., 1996a; Jans and Jans, 1994). 
1.4.4. The use of modular DNA-carrier proteins 
Several peptides have been demonstrated to have the capacity to mediate the passage of 
transfected DNA through the cell, endosomal and nuclear membranes. Combinatorial 
approaches, in which all of these sequences are included in one transfection construct, may 
have the potential to enhance non-viral DNA delivery greatly (Figure 1.7). 
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Figure 1.7. Enhancement of nuclear gene delivery using modular targeting sequences. An idealised 
fusion protein is shown, comprising a receptor-specific ligand (L), NLS, endosome exit sequence (EE) 
and D A binding domain (DBD), complexed with plasmid DNA. Cell surface receptor binding is 
facilitated through the L moiety G) . The complex is internalised into an endosome ~ where the EE 
brings about endosomal disruption and escape into the cytoplasm CT). Here, the NLS confers interaction 
with importins, which facilitate nuclear translocation ©. Ran-GTP mediates release of the plasmid from 
the nuclear transport complex (3) and the transgene may be transcribed. The overall enhanced transfection 
efficiency and transgene expression may be reflected in the increased nuclear accumulation of the 
plasmid. Examples using some elements of the modular approach include GAL4 as the DBD (Chan and 
Jans , 2001; Chan et al., 1998) the optimised NLS of the SV40 T-ag as the NLS (Chan and Jans, 2001; 
Chan and Jans, 1999) the diphtheria toxin T-domain as the EE (Uherek et al., 1998; Fisher and Wilson, 
1997; Fominaya and Weis, 1996) and MSH as L (Chan and Jans, 2001). 
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These constructs might be generated by cross-linking individual peptides to a DNA-carrier 
protein or by expressing fusion proteins comprising of a series of different peptide sequences to 
produce a single chimeric protein with modular functionality. A non-viral transfection construct 
incorporating all of the modular targeting elements illustrated in Figure 1. 7 has been described 
recently (Deas et al., 2002). The construct was based around neutravidin, to which various 
functional moieties were attached using biotinylation, including a biotinylated monoclonal 
antibody to target kidney tumour cells, a biotinylated fusogenic peptide to initiate 
endosomolysis and biotinylated histone Hl, which in addition contains intrinsic NLSs, to bind 
and compact the plasmid DNA (Deas et al., 2002). This approach was effective both in vitro, 
where a 30-fold increase in reporter gene expression was detected, and in vivo, where only cells 
expressing the antigen were found to express the reporter gene. 
1.5. THE USE OF CHROMATIN AS A NOVEL VEIDCLE FOR GENE DELIVERY 
Histones have multiple innate functions that could be beneficial in a modular transfection 
construct: histones are able to bind DNA and therefore may act as DNA-carrier proteins; 
histones are able to condense DNA, a property which has been suggested to enhance nuclear 
transport; histones contain intrinsic NLSs which may facilitate import into the nucleus. In this 
section, these properties of individual histones are discussed and their potential utility in the 
context of a transfection construct comprising of in vitro assembled chromatin is presented. 
1.5.1. The structure of chromatin 
Approximately 2 m of DNA is condensed into the nucleus, which is typically 5 - 10 µm in 
diameter. This is achieved through a highly ordered process of folding and compaction into a 
protein/DNA assembly called chromatin. The protein component consists primarily of histones, 
of which there are five main sub-types, namely H2A, H2B, H3, H4, termed the 'core histones, 
and Hl, termed the 'linker histone'. Two copies of each of H2A, H2B, H3 and H4 associate 
into an octamer and form the 'core particle' (Figure 1.8a). The core particle is stabilised as 
approximately 146 base pairs of superhelical DNA are wrapped around twice to form a 
nucleosome (Figure 1.8b ). The nucleosome forms the basic structural unit of chromatin and is 
repeated in a regular fashion, separated by approximately 80 - 120 base pairs of 'linker DNA' 
(Figure 1. 8b ). 
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Figure 1.8. The basic structure of chromatin. Chromatin is formed by a hierarchical process of folding 
and compaction of DNA complexed with histones within the nucleus. Two of each histone, H2A, H2B, 
H3 and H4, highlighted in different colours, associate to form an octamer (a). 146 base pairs of 
superhelical DNA are wrapped twice around the octamer to form the basic repeated unit of chromatin, the 
nucleosome (b ). Consecutive nucleosomes constitute the first level of chromatin packaging into the 
'beads-on-a-string' array. Further packaging into the '30 nm fibre' is mediated through inter-nucleosomal 
interactions facilitated by the histone tail regions. Histone Hl interacts with linker DNA between 
consecutive nucleosomes, enabling stabilisation of the '30 nm fibre'. 
The core histones H2A, H2B, H3 and H4 are structurally similar small proteins, ranging from 
11 - 15 kDa, and exhibit high sequence conservation (Wells and McBride, 1989). There are 
three domains: the amino and carboxy terminal domains, that are highly basic, pliant and 
irregular, and the central globular domain, constituting the well-defined histone-fold region 
which is involved in inter-histone contacts within the nucleosome core (Luger et al., 1997). 
Variant histones with different amino acid sequences and expression profiles exist. Although 
the role of these variant histones is not yet clear, they are believed to be important in 
modulating chromatin structure, which in turn may regulate transcriptional activity. An 
example of this is the variant histone H2AZ, which has been shown to affect nucleosome 
stability and localised chromatin structure (Fan et al., 2002; Suto et al., 2000). 
Members of the H 1 family, comprising H 1 °, HS and H 1, are termed the 'linker his tones' as they 
interact with the ' linker DNA' between consecutive nucleosomes. They have a molecular mass 
of around 22 kDa. Like the core histones, there are three structural domains, but these differ 
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between the histone H 1 subtypes in the distribution of the basic amino acid residues (Doenecke 
and Tonjes, 1986). The Hl subtypes are all involved in higher order condensation of chromatin; 
the central globular domain maintains the two turns of DNA around the nucleosome core (Allan 
et al., 1980), while the C-terminal domain is involved in further compaction into higher order 
chromatin structures (Thoma et al., 1983). Differences in the amino acid composition serve to 
confer functional differences and each variant has a particular role in the stabilisation of the 
higher order chromatin structures formed. 
Several chromatin assembly factors and histone chaperone proteins, such as Nl/N2 and NAP-1 , 
are involved in the formation of chromatin (Akey and Luger, 2003). H3 and H4 associate in the 
cytoplasm to form tetramers (Chang et al., 1997) and are believed to be chaperoned by Nl/N2 
into the nucleus (Dilworth et al., 1987). H2A and H2B form dimers in the cytoplasm and are 
chaperoned into the nucleus by NAP-1 (Mosammaparast et al., 2002a; Mosammaparast et al. , 
2001; Ito et al. , 1996). Here, according to the current model, the chaperone proteins deposit one 
H3/4 tetramer, followed by two H2A/2B dimers onto the DNA (Nakagawa et al. , 2001), to 
form a single core histone octamer (Figure 1.8a). 
Chromatin may be assembled in vitro; nucleosomes are distributed successively along the DNA 
template, in localised arrays, in a process that requires ATP and is driven by the ATP-
dependent chromatin assembly factor (Fyodorov and Kadonaga, 2002). The globular domain of 
Hl , the tail domains of Hl or the N-terminal domain of H3 may act to neutralise the charge on 
the linker DNA between consecutive nucleosomes and facilitate the organisation of the 
nucleosomal array ('beads-on-a-string' model) into the more compact canonical '30 nm fibre ' 
structure (Leuba et al. , 1998; Bustamante et al., 1997; see Figures 1.8 and 7.2). In vivo, the 
chromatin fibre undergoes further compaction into higher order structures to finally form the 
characteristically shaped chromosomes (for review see Hom and Peterson, 2002). 
1.5.2. Transport of histones to the nucleus 
Histones are synthesised in the cytoplasm and, because they are absolutely required as the 
scaffolding proteins in chromatin architecture, must be translocated into the nucleus efficiently. 
Experiments in yeast were the first to suggest that H2A and H2B are transported to the nucleus 
in the form of a heterodimer (Moreland et al., 1987). As the chromatin assembly chaperone 
proteins NAP-1 (Ito et al., 1996; Dilworth et al., 1987) and Nl/N2 (Chang et al., 1997; 
Dilworth et al., 1987) are associated with H2A/2B and H3/4, respectively, in the cytoplasm and 
transfer the histones onto DNA during chromatin assembly, they were assigned a putative 
'shuttle' function to facilitate the nuclear transport of these histones. Considering that the 
molecular weight of histones (11 - 15 kDa) is well within the nuclear pore exclusion limit (~ 45 
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kDa), it would not have been unreasonable to suppose that, alternatively, simple diffusion is the 
mechanism of nuclear uptake. However, as discussed below, several groups have shown that 
histone transport into the nucleus is mediated by the importin nuclear transport proteins and 
requires Ran and ATP. 
In the absence of ATP or at 4°C, histone Hl was no longer transported to the nucleus (Lin and 
Clarke, 1996; Breeuwer and Goldfarb, 1990). Nuclear uptake of the core histones H2A, H2B, 
H3 and H4 was also later demonstrated to be energy-dependent (Baake et al., 2001a; Langer, 
2000). These studies established that diffusion does not contribute significantly to the nuclear 
uptake of histones and implicated active transport for the nuclear uptake of the linker and core 
his tones. 
Protein transfer into the nucleus is generally mediated by the various members of the importin 
family of nuclear transport proteins which bind to NLSs within the protein to be transported 
(presented in Section 1.3.3). The first of the core histone NLSs to be identified as being 
sufficient to mediate nuclear transport was that of yeast H2B (Moreland et al., 1987). This 
function was localised to the amino-terminal (N-terminal) amino acids 21 - 33 and, due to 
sequence homology with the SV 40 T-ag NLS, it was suggested that nuclear import of H2B is 
facilitated by importin a. 
In order to investigate this interaction further, and since histones are transported to the nucleus 
with their binding partners, the in vitro binding affinities of importins were quantitated for the 
core histones in the form of the H2A/2B dimer and H3/4 tetramer using a modified ELISA 
(Johnson-Saliba et al., 2000 and see Section 3 .2). Although all the histones tested were indeed 
bound with high affinity by importin al~, binding by importin ~ was predominant. Moreover, 
the binding affinity of importin a was lower than importin ~ for each of Hl, H2A/2B and H3/4. 
The results implied that the nuclear import of histones would be mediated predominantly by 
importin ~ and not importin a. 
Subsequently, several members of the importin ~ family were shown to play a role in the 
nuclear transport of both H2A and H2B in yeast (Mosammaparast et al., 2001 ). These included 
Kapl 14p, 12lp, 123p and 95p, which correspond to the mammalian importins 9, ~3, ~4 and ~1, 
respectively (Mosammaparast et al. , 2001). In this study, as had been suggested by Moreland et 
al. (1987) , nuclear localisation of H2B was attributed to the N-terminal amino acids 21 - 33. 
Amino acids 1 - 52, in the form of a green fluorescent protein-fusion peptide, were shown by 
fluorescence microscopy to result in greater nuclear accumulation, assigning nuclear import 
function also to sequences flanking the amino acids 21 - 33. The NLS of yeast H2A was 
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similarly mapped to amino acids 24 - 46 and with the inclusion of important flanking sequences 
was extended to encompass amino acids 1 - 46 (Mosammaparast et al., 2001). 
In a similar senes of experiments to those delineating H2A and H2B nuclear import, 
Mosammaparast et al. (2002b) identified the nuclear import proteins involved in H3 and H 4 
trans location in yeast. Kap 123p and 121 p were shown to specifically bind NLSs located in the 
N-terminal domains amino acids 1 - 28 in H3 and amino acids 1 - 42 in H4. 
Mosammaparast et al. (Mosammaparast et al., 2002a) provided insight into the role of the 
chromatin assembly protein Naplp (eukaryotic NAP-I) in the nuclear transport of H2A and 
H2B in yeast (Figure 1.9). Naplp was found to bind to Kapl 14p; the interaction shown to 
increase the affinity of Kap 114p for the histone NLSs but decrease affinity for the other Kaps. 
The authors postulated that, in this way, Kap 114p is primed as the predominant importin 
involved in the rapid nuclear translocation of H2A/2B. Once inside the nucleus, RanGTP 
dissociates Kap 114 from the complex. This leaves N ap-1 to deposit its histone cargo onto 
'chromatinising' DNA. Using a yeast strain lacking Naplp, H2A and H2B were, however, still 
found to localise to the nucleus, suggesting that Naplp is not absolutely required for H2A/2B 
nuclear uptake and that Kap 114p alone may fulfil the nuclear import function (Mosammaparast 
et al., 2001). 
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Figure 1.9. The dual role of Naplp in nuclear transport and chromatin assembly in yeast. Model of 
H2A/2B Naplp-mediated nuclear transport according to Mosammaparast et al. (2002a). Naplp binds 
Kapl 14p, increasing the binding affinity of Kapl 14p for NLSs in the N-terminal tails of H2A and H2B. 
This inhibits the binding of Kap121p and Kap123p for the histones. Kapl 14p translocates H2A/2B and 
Naplp into the nucleus. Here, RanGTP dissociates Kapl 14 from the complex and Naplp fulfils its role 
as a chromatin assembly factor, depositing H2A/2B onto chromatinising DNA. Adapted from 
Mosammaparast et al. (2002a). 
33 
The nuclear import pathways of core histones have been investigated in vertebrate systems. In 
order to define the NLSs, Baake et al. (Baake et al., 2001 a) generated fusion proteins 
comprising p-galactosidase and the core histones, or peptides thereof, and determined their 
subcellular location using an antibody directed against P-galactosidase. Using this approach, 
groups of basic amino acids in the N-terminal domains were found to function as NLSs. The 
overall globular structure of the histones was shown to be important also, analogous to the role 
of the 'flanking sequences' purported to play a role in conferring nuclear localisation of 
histones in the yeast (Mosammaparast et al., 2002b; Mosammaparast et al., 2001). Several 
members of the importin p family, including importin p, transportin, importin 5, importin 7 and 
a novel importin, importin 9, were identified using affinity chromatography as binding to 
immobilised histones and using fluorescence microscopy were shown to mediate nuclear 
transport of fluorescein-labelled histones in a model digitonin permeabilised cell system (Baake 
et al., 2001 b; Muhlhausser et al., 2001 ). 
The nuclear import pathway of the Hl linker histones was shown to be distinct from that of 
core histones (Baake et al., 2001 b ). Competition experiments showed that an excess of the 
linker histone H 1 diminished, but did not entirely abolish, nuclear accumulation of core 
histones, suggesting that while some receptors are common, alternative import receptors exist 
for the core histones. In contrast, each core histone inhibited the nuclear uptake of the other 
histones, implying a communal nuclear import mechanism (Baake et al., 2001 b ). Having 
distinct nuclear import pathways is consistent with having characteristics that distinguish linker 
from core histones, such as different patterns of expression resulting in a cytoplasmic pool of 
H 1 which does not exist for the core histones (Zlatanova et al., 1990) and the absence of a 
conspicuous NLS in H 1 due to the distribution of basic amino acids throughout the protein 
(Schwamborn et al., 1998). In fact, of fourteen HI-derived peptides tested, eight were able to 
mediate nuclear accumulation (Schwamborn et al., 1998). 
The nuclear import of Hl was shown to be dependent on cytosolic factors (Schwamborn et al., 
1998; Kurz et al., 1997; Imamoto et al., 1995a). The nuclear import proteins involved in Hl 
transport were identified as being importin p 1 and importin 7 (Jakel et al. , 1999). Individually, 
each of these importins exhibited weak binding for H 1 but nuclear transport was found to be 
mediated through the formation of a heterodimer, impp 1/imp7. Within the heterodimer, 
importin P 1 was found to have the more dominant import function and also played a role in 
interaction with RanGTP to disassemble the transport complex. Im.pp 1/imp7 was shown to be 
the only import receptor involved in Hl nuclear translocation (Bauerle et al., 2002). Bauerle et 
al. (2002) also investigated putative NLSs within Hl for importin binding activity. The N-
terminal domain amino acids 1 - 20 did not function as an NLS. The central globular domain 
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(amino acids 21 - 95) was found to associate with importin P 1 and the carboxy-terminal (C-
terminal) domain (amino acids 95 - 193) with imppl/imp7. Smaller peptides (>50 amino acids 
> 20) within the C-terminal domain were transported to the nucleus by importin p, transportin, 
importin 5 and importin 7, as are the core histones. The authors suggested that the length of the 
NLS, therefore, may be a key determinant in differentiating between nuclear import pathways. 
Collectively, these studies show that distinct import pathways are involved in the uptake of 
histones into the nucleus and that several pathways may exist to ensure that these crucial 
architectural proteins reach the nucleus. These pathways may provide a direct route into the 
nucleus for histones serving as carrier-proteins of plasmid DNA in gene delivery applications. 
1.5.3. The use of histones as DNA-carrier proteins for gene delivery 
The ability to bind and compact DNA, as well as harbouring intrinsic NLSs which facilitate 
their passage to the nucleus (a crucial step to ensure efficient DNA delivery), suggests the use 
of histones as DNA carrier proteins for gene delivery purposes. The first report outlining the 
use of nuclear proteins for DNA delivery described the co-introduction of DNA with chromatin 
associated high mobility group (HMG)-1 and DNA-binding protein extracts from Xenopus 
laevis oocytes into cells in culture (Kaneda et al., 1989). Nuclear accumulation and reporter 
gene activity were enhanced compared to co-introduction of DNA with non-nuclear proteins. 
These results were substantiated in vivo whereupon 4 days post-injection into the portal veins of 
rats, radio-immunostaining revealed that approximately 10 % of the liver cells had expressed 
the transgene. 
Histones have since been assessed for their ability to function as carriers of DNA for gene 
delivery applications. While in the presence of histones transfection efficiency was enhanced, 
consensus on which his tone has superior transf ection efficiency has not been reached. These 
studies are presented below. 
1.5.3.1. The use of Hl for gene delivery 
Fractions containing Hl, HMG 17 and, to a lesser extent, HMG 1, obtained from acid extraction 
of the nucleus, were identified to be the most active in enhancing transfection (Bottger et al., 
1998; Zaitsev et al., 1997). This group further demonstrated that Hl could facilitate transfection 
of DNA in cardiomyocytes, demonstrating, as a 'proof of principle', DNA delivery into primary 
cells which are usually problematic to transfect (Kott et al., 1998). Compared to the other 
histone subtypes, H2A, H2B, H3 and H4, Chen et al. (Chen et al., 1994a) reported 11 times 
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greater chloramphenicol acetyl transferase reporter gene activity when Hl was used as the 
DNA-carrier protein. In this series of experiments, the histones were galactosylated to facilitate 
receptor-mediated endocytosis into hepatocytes (HepG2 cells). Transfection activity using Hl 
was shown to be a function of the histone and not the degree of galactosylation (Haberland et 
al., 1999; Chen et al., 1994a). 
Similar results were obtained using short peptides derived from Hl. Hl alone and the C-
terminus of H 1 ( amino acids 99 - 193) expressed as a recombinant fusion protein with the T-ag 
NLS were complexed with a luciferase reporter plasmid and found to yield luciferase 
expression 20 - 45 times that of plasmid DNA alone (Fritz et al., 1996). This was also markedly 
greater than when H2A/2B- and H3/4-DNA complexes were transfected. Interestingly, Hl 
mediated transfection in both the absence and presence of the cationic lipid delivery agent used. 
Evidence for how this was possible was provided by a subsequent study which showed that 
despite Hl-NLS-bound DNA being located on the outside of the anionic liposomes, the 
complexes were able to mediate transfection (Hagstrom et al., 1996). 
1.5.3.2. The use of H3 and H4 for gene delivery 
H4 was shown to enhance gene transfer to an extent greater than that of H3 and Hl in K-562 
cells (Wagner et al., 1991). The histones were incubated with DNA that had been pre-
condensed using a transferrin-pLy conjugate. Electron microscopy revealed that the level of 
DNA condensation achieved with the transferrin-pLy conjugate alone was greater than that in 
the presence of H4, yet the respective transfection activities were similar and, moreover, were 
enhanced up to 7-fold when a higher ratio of H4 to transferrin-polylysine was used. The authors 
suggested that the transfection capacity of H4 was independent of its condensation effect. 
H3 and H4 were shown to mediate transfection of the HIV-1 Tat gene in a model T-cell line 
(Jurkat), whereas Hl and H2A were not (Demirhan et al., 1998). Anti-histone lgG was found to 
specifically diminish the transfection activity of H3 and H4 within a histone-based transfection 
system (Hasselmayer et al., 2001 ). Furthermore, as pLy was unable to facilitate gene expression 
in the transfection system described by Demirhan et al. (1998), together, these studies implied 
that histone-mediated transfection was not due simply to the cationic nature and DNA-
condensing ability of the histones. 
1.5.3.3. The use of H2A for gene delivery 
H2A has also been shown to mediate transfection; firstly, as part of a retroviral gene delivery 
system (Singh and Rigby, 1996) and, secondly, in an elegantly conducted series of experiments 
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in which Balicki et al. described the use of H2A for gene transfer in vitro and in vivo (Balicki et 
al., 2002; Balicki et al., 2000; Balicki and Beutler, 1997). 
H2A was found to enhance the levels of p-galactosidase reporter expression in vitro (Cos-7 
cells) compared to when H2B, H3, H4, Hl and pLy were used as the DNA-carriers (Balicki and 
Beutler, 1997). This system was applied in vivo to a mouse model of neuroblastoma (Balicki et 
al., 2000). A plasmid encoding the Il-2 cytokine gene, complexed with H2A, was transferred 
into neuroblastoma cells in culture, which were then injected subcutaneously into mice. Mice 
receiving cells transformed with single chain IL-2 did not develop liver or bone marrow 
metastases and demonstrated an elevated cytotoxic T-lymphocyte and interferon-y response, 
consistent with protective immunity. 
Various peptides spanning the full length of H2A were generated and assessed for their ability 
to mediate gene transfer (Balicki et al., 2002). Activity was localised to a 37-amino acid 
sequence located within the N-terminus of H2A. The authors postulated that the secondary 
structure ( a-helix) and positively charged residues in this region played a vital role in DNA-
binding and nuclear localisation, respectively. In the context of the nucleosome core particle, 
H2A is the only histone to harbour a cluster of DNA binding sites located near to its NLS 
(Luger et al., 1997). This, the authors suggested, would impart on H2A dual DNA binding and 
nuclear targeting functionality within a structurally distinct region, making H2A a superior 
mediator of transfection compared to the other core histones tested. 
Collectively, all of these studies demonstrated the capacity for gene delivery purposes; 
however, transfection efficiency of the individual histones appeared to be highly dependent on 
both the type of histone and cultured cells transfected. 
1.6. HYPOTHESIS, AIMS AND SCOPE OF TIDS PROJECT 
Although there have been many recent advances in the improvement of non-viral transfer, the 
gene transfer efficiency of viral-based delivery systems remains far superior. This is due mainly 
to the intrinsic ability of viruses to target specific cells, circumvent endosomal sequestration 
and enter the nucleus efficiently. Approaches using engineered fusion proteins displaying 
modular characteristics beneficial for gene delivery represent a leap forward in mimicking viral 
systems and might be an indispensable asset to non-viral gene delivery. The aim of this thesis 
was to explore the potential of in vitro assembled chromatin as a novel vehicle for non-viral 
gene delivery. The reasoning for this was based on the observation that chromatin has modular 
properties which may enhance DNA delivery into the nucleus. 
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Firstly, in the form of chromatin, at the first level of compaction, DNA is condensed in length 
up to 5-fold by association with the core histones into a nucleosomal array (Van Holde et al., 
1980). Condensation has been shown to shield the DNA from degradation in the cytoplasm and, 
potentially, allows the accommodation of larger, or even multiple, genes. Condensed DNA also 
has been reported to be transported more efficiently across the nuclear membrane (Chan and 
Jans, 1999). Secondly, in addition to their DNA-carrier protein function, histones contain 
intrinsic NLSs which promote their rapid uptake into the nucleus (Section 1.5.2). This could 
provide a pathway along which a gene delivery vehicle based on chromatin may be targeted to 
the nucleus. Thirdly, as histones may be expressed in recombinant form, they may be modified 
and generated as fusion proteins, incorporating functional sequences for cellular targeting, 
endosomal escape or nuclear import. Finally, chromatin is the physiological form in which 
condensed DNA is found in the nucleus. As mechanisms exist in the nucleus to de-condense 
chromatin and transcribe the DNA (Horn and Peterson, 2002; Kadonaga, 1998), a transfection 
construct based on chromatin may therefore circumvent problems relating to the inhibition of 
gene expression that has been observed previously in the presence of artificial DNA condensing 
agents (Bielinska et al., 1997; Zabner et al., 1995). 
Published data demonstrated the capacity of individual histones to mediate transfection 
(presented in Section 1.5.3). In order to characterise the histone nuclear import pathways, which 
may serve as routes for gene delivery, the binding properties of importins to the core histones 
were determined. This work, presented in Chapter 3, additionally formed the first reported 
study delineating the pathway of histone nuclear import (Johnson-Saliba et al., 2000). As most 
prior studies involving in vitro assembled chromatin were conducted using a linear DNA 
template of specified sequence or small plasmids (Forte et al., 1989; Hansen et al., 1989; 
Simpson et al., 1985), appropriate assembly of large plasmid DNA into chromatin had to be 
verified before transfection into cultured cells could be performed. In Chapter 4, the 
characterisation of chromatinised plasmid DNA assembled at various stoichiometries of 
recombinant histone octamers, usmg assays including sedimentation velocity 
ultracentrifugation, DNA supercoiling, micrococcal nuclease digestion and atomic force 
microscopy, is described. Upon transfection of the chromatin constructs into cells in culture, 
reporter gene expression was found to decrease concomitantly with chromatinisation at 
increasing nucleosome densities. In Chapter 5, possible reasons for this unexpected pattern of 
transfection efficiency were examined. Based on these results, a number of strategies, described 
in Chapter 6, were investigated as a means to improve transfection efficiency, namely 
improving nuclear import of the chromatinised plasmids by incorporating exogenous SV 40 T-
ag NLS peptides and potentiating their transcriptional permissiveness by altering the histone 
composition of the chromatin. 
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In addition to providing a rational approach to the design of non-viral gene delivery vectors, 
this study highlighted the problems associated with large plasmid delivery into the nucleus. 
Transport into the nucleus and the transcriptional permissiveness of the transfection constructs 
were found to be key determinants for gene delivery efficiency. This thesis details these 
findings. 
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CHAPTER2 
Materials and Methods 
2.1. MATERIALS 
2.1.1. Chemicals and reagents 
All chemicals and enzymes used in this study were of analytical grade or higher. 
2.1.2. Culture media, buffers and solutions 
All cell culture media, solutions and buffers were prepared with double-distilled deionised water 
(ddH20) and sterilised by autoclaving at 112°C for 20 minutes. Luria-Bertani (LB) and all cell 
culture media were prepared by the Media Unit, JCSMR. Solutions for plasmid DNA 
manipulation, protein purification, chromatin assembly and in vitro assay techniques are 
tabulated below. 
Table 2.1. Media for bacterial and cell culture 
Use Name of solution Composition Comments 
Bacterial Luria-Bertani per litre: Autoclaved at 121 °C for 20 
culture (LB) 10 g bacto-tryptone minutes. 
5 g bacto-yeast extract Added antibiotics before use. 
10 gNaCl 
SOB medium per 100 ml: Autoclaved at 121 °C for 20 
2 g bacto-tryptone minutes. 
0.55 g bacto-yeast extract 
1 ml 1 MNaCl 
1 ml 1 M KCl 
SOC medium per 10 ml SOB medium: All solutions filtered through 
100 µl 2 M MgCb/MgSO4 0.22 µm Millex® syringe 
(1 :1, v/v) driven filter unit (Millipore). 
100 µl 2 M glucose 
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All cell culture media, solutions and buffers were prepared with double-distilled deionised water 
(ddH20) and sterilised by autoclaving at 112°C for 20 minutes. Luria-Bertani (LB) and all cell 
culture media were prepared by the Media Unit, JCSMR. Solutions for plasmid DNA 
manipulation, protein purification, chromatin assembly and in vitro assay techniques are 
tabulated below. 
Table 2.1. Media for bacterial and cell culture 
Use Name of solution Composition Comments 
Bacterial Luria-Bertani per litre: Autoclaved at 121 °C for 20 
culture (LB) 10 g bacto-tryptone minutes. 
5 g bacto-yeast extract Added antibiotics before use. 
10 g NaCl 
SOB medium per 100 ml: Autoclaved at 121 °C for 20 
2 g bacto-tryptone minutes. 
0.55 g bacto-yeast extract 
1 ml 1 MNaCl 
1 ml 1 M KCl 
SOC medium per 10 ml SOB medium: All solutions filtered through 
100 µ12 M MgCh/MgSO4 0.22 µm Millex® syringe 
(1 :1, v/v) driven filter unit (Millipore). 
100 µ12 M glucose 
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Cell Culture PBS 137 mMNaCl 
6.75 mM Na2HPO3 
2.5 mM NaH2PO3 
Autoclaved at 121 °C for 20 
minutes. 
DMEM per litre: pH 6.8 - 7 .5 with CO2. 
Sterilised using Millipore 
filter 0 .22 µm. 
9.99 g H16 powder (Gibco 
cat. no. 31600-091) 
3.7 gNaHCO3 
0.2g Streptomycin (Thermo 
Trace cat. no. 60-005-PF) 
0 .12 g Penicillin 
(Thermo Trace cat. no. 60-
004-P2) 
RPMI-1640 per litre: pH 6.9 - 7 .0with CO2. 
Sterilised using Millipore 
filter 0.22 µm. 
10 .44 g RPMI powder 
(Gibco, cat. no. 31800-105) 
2 gNaHCO3 
Table 2.2. Solutions used for DNA methods. 
Use 
Gel loading dye 
Gel electrophoresis 
buffer 
DNA storage buffer 
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Name of solution 
6 x DNA loading 
buffer 
50 x TAE 
TE 
Composition 
60 mM Tris-HCl 
75.4mMEDTA 
2.8 % sarkosyl 
0.25 % bromophenol 
blue 
0.25 % xylene cyanol 
40 % sucrose 
2 M Tris 
5. 71 % glacial acetic 
acid 
0.05 M EDTA (pH 8.0) 
10 mM Tris-HCl (pH 
8) 
1 mM EDTA (pH 8) 
Comments 
Table 2.3. Solutions used for protein detection and analysis. 
Use 
Bacterial cell lysis 
Protein loading dye 
Gel electrophoresis 
buffer 
Gel staining solution 
Gel destaining 
solution 
Western blot 
Name of solution 
L ysis solution 
2 x SDS-loading dye 
Composition 
1 % SDS 
0.03 % ~-
mercaptoethano 1 
0.1 M Tris-HCl (pH 
6.8) 
0.2MDTT 
4% SDS 
0.005 % bromophenol 
blue 
20 % glycerol 
5 x SDS-PAGE buffer 0.25 M Tris 
2 M Glycine 
0.5 % SDS 
Coomassie blue O .25 % Coomassie 
brilliant blue R250 
45 % methanol: ddH20 
(1 :1, v/v) 
10 % glacial acetic acid 
Coomassie blue destain 5 % acetic acid 
5 % isopropanol 
Transfer buffer 20 % methanol 
25 mM Tris 
192 mM glycine 
0.1 % SDS 
Ponceau S stain 0.5 % Ponceau S 
1 % acetic acid 
Ponceau S destain 7 % acetic acid 
TBST 10 mM Tris (pH 8) 
150.5 mM NaCl 
0.05 % Tween-20 
Blocking solution 100 ml TBST 
5 g skim milk powder 
(Carnation milk) 
Comments 
Made to 800 ml with 
ddH20 , pH to 8.0, then 
added Tween-20 and 
ddH20 to 1 L. 
Filtered using 0.22 µm 
Millex® syringe driven 
filter unit (Millipore). 
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Table 2.4. Buffers and solutions used for purification of his tones. A 
Use 
Preparation of 
inclusion bodies 
FPLC 
Octamer 
reconstitution 
Name of solution 
Wash buffer 
TWbuffer 
Unfolding buffer 
SAU-1000 
SAU-600 
SAU-200 
Refolding buffer 
Composition 
50 mM Tris-HCl (pH 
7.5) 
100 mMNaCl 
1 mMEDTA 
0.5 mMPMSF 
1 % Triton X-100 
in Wash buffer 
7 Murea 
20 mM Tris-HCl (pH 
7.5) 
l0mMDTT 
7 M urea 
20 mM NaOAc (pH 
5.2) 
1 MNaCl 
5mM~-
mercaptoethano 1 
1 mMEDTA 
as above, but 
600 mMNaCl 
as above, but 
200 mMNaCl 
2.2 MNaCl 
10 mM Tris-HCl (pH 
7.5) 
1 mMEDTA 
5mM~-
mercaptoethanol 
A Buffer composition is as described in Luger et al. (1999). 
Table 2.5. Solutions used for chromatin assembly. 
Use 
Octamer transfer by 
salt dialysis method 
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Name of solution 
1 M NaCl buffer 
0.75 M NaCl buffer 
Chromatin buffer (CB) 
0.135 M NaCl buffer 
Composition 
1 MNaCl 
0.01 M Tris-HCl 
0.75 MNaCl 
0.01 M Tris-HCl 
0.135 M NaCl 
0.01 M Tris-HCl 
Comments 
DTT added just before 
use. 
Comments 
pH7.5 
pH7.5 
pH7.5 
NAP-1 method 
A Buffers were adapted from Luger et al. (1999). 
Table 2.6. Solutions used for the Luciferase assay.A 
Use Name of solution 
Cell lysis L ysis buffer 
Composition 
100 mM K2HPO4 
buffer 
2 % Triton X-100 
20 % glycerol 
4mMDTT 
Assay buffer Luciferase assay buffer 100 mM K2HPO4 
2mMDTT 
Initiate light reaction D-luciferin 
8 mM MgSO4, 
17 5 µM coenzyme A 
750 µM ATP 
1 mM D-luciferin 
5 mM K2HPO4 buffer 
Buffer composition is as described in Himes and Shannon (2000). 
Table 2.7. Solutions used for ELISA. 
Use Name of solution Composition 
See section 2.5.1 for 
details 
Comments 
Solutions stored at 4°C. 
Assembled buffer 
allowed to equilibrate 
at room temperature 
before use. 
Additional 
information 
Coating microtitre 
plates 
Coating buffer 100 mM NaHCO3 (pH 2 x stock solution 
Rinsing plates before 
addition of importins 
9.6) 
Intracellular buffer (IB) 440 mM KCl 
20mMNaHCO3 
20mMMgC12 
4mMEGTA 
Hybridisation buffer 
(HB) 
0.4 mM CaC12 
80 mMHepes 
150ml4 x IB 
1 mMDTT 
Blocking and buffer HB/BSA HB/1 %BSA 
for importin dilutions 
Washing microtitre 
plates 
Wash buffer 0.3 % Tween-20 in 
PBS 
4 x stock solution. 
pH to 7.4 using NaOH. 
Stored at 4°C. 
Stored at 4°C 
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Solution for primary 
and secondary 
antibodies 
Antibody buffer PBS/0.3 % Tween-20 
1 %BSA 
Visualisation of 
antibody reaction 
10 % diethanolamine 
buffer 
10 % diethanolamine 
in 0.5 mM MgCh (pH 
9.8) 
Stored at 4°C. 
Covered with 
aluminium foil. 
2.1.3. Bacterial strains 
Table 2.8. Bacterial strains used in this study. 
Strain 
DHSa 
BL2l(DE3)pLysS 
DB3.1™ 
Genotype 
F- deoR recAI endAI hsdRI 7(rk-, mt) 
supE44 'A- thi-1 gyrA96 relAI 
F- ompT hsdS8 (r8 -m8 -) gal dcm (DE3) pLysS 
(CamR) 
F- gyrA462 endAI !)..(srl- recA) mcrB mrr 
hsdS20(r8 -,m8 ) supE44 aral4 ga!K.2 lacYl 
proA2 rpsL20(SmJ xyl5 !)..leu mtll 
2.1.4. Plasmids and expression vectors 
Table 2.9. Plasmids used in this study. 
Name 
pET3a-H2A 
pET3a-H2AZ 
pET3a-H2B 
pPR28 
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Description 
Contains the coding region ofhistone H2A (Xenopus) subcloned into the pET3a 
vector by M. Clarkson (Chromatin and Transcriptional Regulation Group, 
JCSMR). AmpR. 
Contains the coding region ofhistone H2AZ (mouse) subcloned into the pET3a 
vector by M. Clarkson (Chromatin and Transcriptional Regulation Group, 
JCSMR). AmpR. 
Contains the coding region ofhistone H2B (Xenopus) subcloned into the pET3a 
vector by M. Clarkson (Chromatin and Transcriptional Regulation Group, 
JCSMR). AmpR. 
pPR2 vector containing optimised SV 40 T-ag NLS. AmpR. See Hubner et al. 
(1997) and Rihs et al. (1998). 
pET5a 
pET5a-H2Anls 
pGeneGripTM 
pDsRed-Cl 
pDONR20lTM 
pEntry-RFP 
pGeneGrip-
DestA 
pGeneGrip-RFP 
Cloning vector purchased from Promega. AmpR. 
pET5a vector containing the coding region ofH2A subcloned from pET3a-H2A 
and the SV 40 T-ag NLS sub cloned from pPR28 (P 10) as a C-terminal fusion 
H2A-NLS. AmpR. Generated by Dr M. Lam (Nuclear Signalling Group, JCSMR) 
and sequenced by M. Johnson-Saliba. 
Cloning vector purchased from Gene Therapy Systems. Contains GeneGrip™ site 
for PNA labelling. Contains MCS downstream of CMV promoter. KanR. 
Expression vector (Clontech). Contains coding region of red fluorescent protein 
from Discosoma sp. C-terminal to the MCS. Expression driven by CMV 
promoter. KanR/NeoR. Kindly donated by Dr M. Whitelaw, Adelaide. 
Gateway™ 'Donor' vector containing attP sites for recombination 'BP reaction' 
with attB-containing vectors. KanR/Chlo?. Kindly donated by Dr M. Robertson, 
Plant Industries, CSIRO, Canberra. 
Gateway™ generated 'Entry' vector containing the coding region ofRFP (bases 
601 - 1365), flanked by attL sites. KanR. Derived in this study. 
Gateway™ compatible 'Destination' vector. Generated by ligation of Gateway™ 
reading frame A cassette into the EcoRV site ofpGeneGrip MCS. KanR/Chlo?. 
Can only be propagated in E. coli DB3 .1 cells. Derived in this study. 
Gateway™ generated 'Expression' vector. Generated through recombination of 
pEntry-RFP and pGeneGrip-DestA using 'LR reaction'. Contains the coding 
region ofRFP, flanked by attB sites . RFP expression driven by the CMV 
promoter. KanR. Derived in this study. 
pGMCSF-
1(2)TK-luc+ 
(pGMLuc) 
Luciferase reporter plasmid. Luciferase gene expression driven by a fragment of 
the human GMCSF promoter region (- 620 to + 37). Kindly provided by K. 
Bunting (Cytokine Gene Expression Group, JCSMR). See Himes et al. (1993 ). 
2.1.5. Primers 
Table 2.10. Oligonucleotides used in this study. 
Name Sequence 
H2A-NLS primers 
H2A5' 5'-gcCAtATGAgCGCTTCAGGAAGAGGCAAACAAGGC-3' 
H2A3' 5'-GCGactagtCTTGCTCTTGGCAGATTTGGC-3' 
H2A3 'NLS 5'-GCGaagcttCTTGCTCTTGGCAGATTTGGC-3' 
Pl 05 ' 5'-cggaagcttTCCTCTAGTGATGATGAGGC-3 ' 
P 103' 5'-cgcGGATCCctatGCactagtCCGGGGGTCTTCT ACC-3' 
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Gateway™ 
. A primers 
attBlRFP 5'-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCC CCG GTC 
GCC ACC ATG GTG CGC TCC-3' 
attB2RFP 5'-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTG TTA TCT AGA 
TCC GGT GGA TCC CGG GCC-3' 
pGeneGrip 
sequencing 
primers 
5' forward primer 
3' reverse primer 
5'-CAGACTAACAGACTGTTC-3' 
5'-GGCAAACAACAGATGGC-3' 
The attB sites are highlighted in bold type-face. 
2.1.6. Enzymes 
Table 2.11. Enzymes used in this study. 
Enzyme 
Restriction endonucleases 
BamHI 
Cla I 
EcoRV 
Hpal 
HindIII 
SacII 
Sall 
Xhol 
Ligation and recombination 
T4 DNA ligase 
Calf intestinal phosphatase (CIP) 
BP clonase 
LR clonase 
PCR 
Taq polymerase 
Pfu turbo 
Platinum Taq 
Chromatin characterisation 
Topoisomerase I 
S4 micrococcal nuclease (MNase) 
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Source 
New England Biolabs 
Bresatec 
New England Biolabs 
Promega 
Promega 
Promega 
Promega 
New England Biolabs 
Boehringer 
Boehringer 
Life Technologies 
Life Technologies 
Fermentas 
Strata gene 
Life Technologies 
Promega 
Roche 
2.1.7. Antibodies and conjugates 
Table 2.12. Primary and secondary antibodies used in this study. 
Antibody 
H2Anls immunoblotting 
1 ° H2A antibody 
2° alkaline phosphatase-
conjugated anti-sheep antibody 
ELISA 
1 ° anti-GST antibody 
2° alkaline phosphatase-
conjugated anti-goat antibody 
2.1.8. Kits 
Description 
Raised in sheep. Directed 
against C-terminal epitope 
Used at 1 :500. 
Anti-sheep. Used at 1 :1000. 
Raised in goat. Used at 1 :1000. 
Anti-goat. Used at 1 :25000. 
Table 2.13. Molecular biology kits used in this study. 
Name Company 
Plasmid MiniPrep and MaxiPrep kits Qiagen 
Source 
Chiron mimotopes 
Sigma 
Amersham Pharmacia 
Sigma 
BRESA-clean gel extraction kit BRESAGEN 
SuperSignal West Pico Western Blot Kit Pierce 
Gateway™ vector conversion system Life Technologies 
Gateway™ BP clonase Life Technologies 
Gateway™ LR clonase Life Technologies 
NE-PER™ cytoplasmic and nuclear extraction reagents Pierce 
pGeneGrip™ fluorescein PNA label Gene Therapy Systems 
pGeneGrip™ maleimide PNA label Gene Therapy Systems 
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2.1.9. Molecular mass markers 
Table 2.14. Molecular mass markers used in this study. 
Name 
GeneRuler 1kb DNA ladder 
1kb Plus DNA ladder 
Benchmark protein ladder 
Benchmark Pre-stained protein 
Ladder 
2.1.10. Miscellaneous materials 
Application 
DNA agarose gels 
(500 kb to 10 000 kb) 
DNA agarose gels 
(100 bp to 12 000 bp) 
SDS-P AGE (Coomassie blue stain) 
SDS-PAGE (Western blot) 
All other materials used in this study are described in the text. 
2.2. GENERAL DNA METHODS 
2.2.1. E. coli cells 
2.2.1.1. Preparation of competent cells 
Company 
Fermentas 
Fermentas 
GibcoBRL 
Invitrogen 
E. coli cells competent for transformation by heat shock were prepared using CaCb. E. coli cells 
were spread onto an agar plate and cultured overnight at 37°C. A single colony was used to 
inoculate 3 ml of LB, which was incubated overnight at 37°C with agitation at 220 rpm in a 
Controlled Environment Incubator Shaker (New Brunswick Scientific Co. Inc., USA). This 
culture was used to inoculate a second overnight culture of 100 ml, which in tum was used to 
inoculate 400 ml LB the following morning. This was cultured to an OD600 of 0.8 - 1.0 at 37°C 
with vigorous shaking. The cultures were chilled on ice for 15 min, the cell suspension 
transferred into 500 ml centrifuge tubes and centrifuged in a GS-3 rotor (Sorvall RC5C, Sorvall 
Instruments, DuPont) for 15 minutes at 4800 rpm and 4 °C. The supernatant was discarded and 
the pellet resuspended in 50 ml of cold, sterile CaCb (0.1 M). After overnight incubation at 4 
°C, the cell suspension was centrifuged for 5 minutes at 5000 g. The supernatant was removed 
and the pellet resuspended in 5 ml of cold 0.1 M CaCb/glycerol (85:15, v/v). The cell 
suspension was transferred in aliquots of 100 µl into pre-chilled Eppendorf tubes and stored at 
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-70 °C. Bacterial stocks were stored for no longer than 6 months. 
2.2.1.2. Transformation of competent cells by heat shock 
Transformation of competent bacteria was achieved using heat shock, based on the procedure 
described by Sambrook et al. (1989). Competent cells were removed from storage at -70°C and 
thawed on ice for 10 minutes. Plasmid DNA (1 - 10 ng) was pipetted into the vial containing 
competent cells (100 µl) and incubated on ice for a further 30 min. The cells were plunged into 
a 42°C water bath for 45 seconds and then returned to ice for 2 minutes. Following this, 1 ml of 
LB or SOC medium (Table 2.1) was added and the cell suspension incubated for 1 hour at 3 7°C 
with agitation at 220 rpm. For routine plasmid transformations, 50 - 200 µl of the transformation 
culture was plated onto agar plates containing suitable antibiotic(s) for selection. In the case of 
ligations, 50 µl of the bacterial culture was spread and the remaining culture centrifuged, 
resuspended in 50 µl of LB and then spread onto agar. Agar plates were incubated at 3 7°C 
overnight. Individual colonies were selected the following day and used to inoculate 5 ml 
overnight cultures for DNA or protein purification. 
2.2.1.3. Long-term storage 
For storage purposes, E. coli strains transformed with various plasmids were cultured to late log 
phase (OD6oonm ~ 1.0). Together, 850 µl of bacterial culture and 150 µl sterile 80 % glycerol/LB 
were pipetted into sterile cryotubes (Nunc ). The cell suspension was gently mixed and stored at 
-70°C. 
2.2.2. Plasmid purification 
Purification ofup to 500 µg of plasmid DNA was carried out using kits (Table 2.13); the Qiagen 
MiniPrep kit was used for plasmid purification from 2 ml of bacterial culture, whereas the 
MaxiPrep kit was used to purify plasmid from 200 ml of bacterial culture. Bacteria were 
cultured at 37°C overnight with agitation at 220 rpm in the presence of appropriate antibiotic. 
Bacterial cells were collected by centrifugation and plasmid DNA purified according to the 
protocol recommended by the manufacturer. All buffers used were supplied in the kits and were 
stored according to the manufacturer's instructions. Purified plasmid DNA was quantitated 
using spectrophotometry (Section 2.2.3) and quality was verified by agarose gel electrophoresis 
(Section 2.2.4). 
51 
2.2.3. Quantitation of DNA 
DNA samples were quantitated spectrophotometrically. Samples were measured in quartz 
cuvettes, having a path length of 1 cm. The absorbance readings were measured at 260 nm and 
280 nm and were normalised to reference solutions. The concentration of DNA in plasmid 
preparations was calculated using the equation: 
Concentration (µg/ml) = Absorbance260 nm x 50 x dilution factor 
2.2.4. Agarose gel electrophoresis 
Separation of DNA fragments greater than 100 bp was performed by electrophoresis through 
horizontal slab agarose gels (BioRad gel apparatus) in TAE buffer (Table 2.2). Depending on 
the separation required, 1 or 1.5 % agarose gels were used. Samples were typically made up to a 
final volume of 12 µl using TE and 6 x DNA loading dye (Table 2.2). Electrophoresis was 
performed at a voltage between 60 - 120 V for 2 - 4 h, or until the marker dye front reached the 
end of the gel. Agarose gels were stained in 0.5 µg/ml ethidium bromide for 20 minutes with 
gentle agitation, followed by destaining in ddH20 for an equal period of time. DNA fragments 
were visualised under UV light (Gel Documentation System, Novaline). 
2.2.5. DNA extraction from agarose gels 
DNA fragments were separated using agarose gel electrophoresis (see above). The band of 
interest was located using a UV transilluminator (Gel Documentation System, Novaline) and 
excised with a scalpel. The piece of gel was placed into an eppendorf tube and the DNA 
extracted using a gel extraction kit according to the manufacturer's instructions (BRESAGEN; 
Table 2.13). 
2.2.6. Phenol/chloroform/isoamyl alcohol purification 
An equal volume of phenoVchloroform/isoamyl alcohol (24: 1: 1 v/v/v, Sigma) was added to the 
DNA sample to be purified. Thorough mixing was achieved by vortexing for ~ 20 seconds. 
Samples were centrifuged at 14000 rpm for 10 minutes (Eppendorf centrifuge, 54 l 5C). The 
aqueous phase was transferred into a clean eppendorf tube. Ethanol precipitation of the DNA 
was carried out as described in the next section. 
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2.2. 7. Ethanol precipitation 
For precipitation, to the sample containing DNA, 1/10 of the sample volume of 3M NaOAc (pH 
5.2) and 2.5 x the sample volume of ice-cold 100% EtOH were added. Samples were incubated 
overnight at -70°C. Precipitated DNA was collected by centrifugation at 14000 rpm for 30 
minutes (Eppendorf centrifuge, 5415C) and at 4°C. The supernatant was discarded and the pellet 
briefly rinsed in 500 µl of cold 70% EtOH and re-centrifuged at 14000 rpm for 10 minutes at 
4°C (Eppendorf centrifuge, 5415C). The resulting supernatant was carefully aspirated and the 
DNA pellet was air-dried in order to remove any trace of EtOH. The pellet was resuspended in 
TE buffer (Table 2.2) and stored at either 4°C or -20°C until use. 
2.2.8. Ammonium acetate precipitation 
Ammonium acetate (N&OAc) was used preferentially for precipitation of DNA in the 
supercoiling assay (Section 2.5.4). To each of the DNA samples, 53 µl of 7.5 M ~OAc and 
265 µl of ice-cold 100 % ethanol were added. Samples were retained at -70°C for 1 hour, after 
which DNA was collected by centrifugation, as described above. 
2.2.9. Restriction endonuclease digestion 
Plasmid DNA or oligonucleotides were digested using 1 unit of a restriction endonuclease (see 
Table 2.11) per µg of DNA in the presence of the appropriate buffer (supplied by the 
manufacturer) and BSA (1 µg/ml final concentration). Reactions were typically carried out in a 
total volume of 10 µI. Digestion was allowed to proceed for 1 - 3 h at the optimal temperature 
for enzymatic activity (usually 37°C). The progress of the reaction was monitored using agarose 
gel electrophoresis (Section 2.2.4). The reaction was terminated by heating at 65 - 85°C for 15 -
20 minutes. For the digestion of more than 1 µg of DNA, reactions were scaled up accordingly. 
For use in ligation reactions, the digested DNA was purified using agarose gel electrophoresis 
and gel extraction (Section 2.2.4 and 2.2.5). 
2.2.10. Dephosphorylation 
Linearised plasmid DNA was dephosphorylated before blunt-ended ligations were performed. 
Calf intestinal phosphatase (CIP, Boehringer) was added to a final concentration of 0.5 U/µg of 
plasmid DNA in One-Phor-All buffer (Gibco BRL, Pharmacia). Reactions were incubated at 
37°C for 15 min. This was followed by heat inactivation of the enzyme at 45°C for 5 minutes 
and 85°C for 15 minutes. Phenol/chloroform/isoamyl alcohol purification (Section 2.2.6) 
followed by ethanol precipitation (Section 2.2.7) were performed in order to remove the CIP 
and purify the DNA. 
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2.2.11. Ligation 
Ligation of DNA fragments was achieved by combining the insert DNA with the linearised 
vector at a molar ratio of 10: 1. The ligation mixture also contained 1 x T4 DNA ligase buffer 
(Baeringer) and 400 U T4 DNA ligase (Boehringer). If blunt ended ligations were performed 
(see Section 2.2.10), 1 x polyethylene glycol (Boehringer) was also included in the reaction mix. 
The final reaction volume was 20 µ1. Reactions were incubated at 22°C for 4 hours or at l 5°C 
overnight. Half of the ligation mix was used to transform competent E. coli cells using the heat 
shock method (Section 2.2.1.2). In order to confirm that ligation had occurred, 500 ng of DNA 
from each component of the ligation reaction (insert, vector, ligation mix before addition of 
ligase and ligation mix after the reaction) was analysed using agarose gel electrophoresis 
(Section 2.2.4). The presence of high molecular weight bands and the disappearance of the 
insert band in the post-ligation sample indicated a successful ligation. A negative control in 
which the DNA insert was replaced with an equal volume of ddH2O was included in all ligation 
experiments in order to establish the probability of re-ligation of the vector. 
2.2.12. Polymerase chain reaction (PCR) 
PCR was carried out to amplify DNA fragments for cloning or to screen for the insertion of a 
fragment of interest in recombinant plasmids. High fidelity Pfu Turbo DNA polymerase was 
used for cloning experiments, whereas Taq DNA polymerase was used for analysis or screening 
purposes. Polymerase enzymes were purchased with the requisite nucleotides and buffers (Table 
2.11). The primers used are shown in Table 2.10. 
PCR reactions were assembled on ice. Into each sterile PCR tube was added 4 µl of dNTP 
cocktail, comprising of2.5 mM each of dATP, dCTP, dGTP and dTTP, 5µ1 of 10 x PCR buffer 
(100 mM Tris-HCl, 15 mM MgCh and 500 mM KCl pH 8.3), a final concentration of 250 nM 
of each primer, 0.5 units of Taq polymerase ( or 2.5 units of Pfu turbo) and sterile ddH2O to a 
final volume of 48 µl. The remaining 2 µl was made up by DNA of concentration 50 ng/µl ( or 
sterile ddH2O to constitute the 'blank' control sample). 
Conditions for PCR were optimised for each DNA fragment with respect to DNA concentration 
and thermal cycling, using a temperature gradient (BioRad i-cycler). Typically, the reactions 
were carried out under the following conditions: pre-amplification denaturation ('hot start') at 
94°C for 30 seconds, followed by 30 cycles, each consisting of denaturation 94°C for 30 
seconds, primer annealing at temperatures 4 - 10°C below the Tm of the primers for 30 seconds, 
and extension at 72°C for 1 minute per kilobase of the product (Taq polymerase) or 2 minutes 
per kilo base of the product (Pfu turbo). A 10 µl aliquot of each PCR product was analysed using 
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agarose gel electrophoresis (Section 2.2.4). Samples were retained at 4°C until use. 
2.2.13. Polymerase chain reaction from bacterial colonies 
PCR performed directly on transformed E. coli cells was used to screen for the presence of the 
DNA insert of interest. Single colonies were picked with a sterile pipette tip and spotted onto a 
fresh agar plate before resuspending in 50 µ1 of sterile water. Lysis was completed by heating 
for 10 min at 65°C. The lysate was retained on ice while the PCR reaction was prepared 
essentially as described above, with the exception that the final volume of the reaction mix was 
45 µ1, with the remaining volume being 5 µl of lysate. The thermal cycle program was used, as 
described above. PCR products were analysed using 1 % agarose gel electrophoresis (Section 
2.2.4). 
2.2.14. DNA sequencing 
Cloning was verified by restriction digest analysis and direct sequencing of DNA. Each 
sequencing reaction contained 500 ng of plasmid, 3.2 pmol of sequencing primer, 8 µ1 of 
BigDye Terminator Mix (ABI Prism) and sterile water, to a total volume of 20 µl. The 
sequencing reaction was performed through 25 thermal cycles consisting · of 96°C for 10 
seconds, 50°C for 5 seconds, and 60°C for 4 minutes (BioRad i-cycler). Unincorporated dye-
labelled terminator nucleotides were removed from the mixture by ethanol precipitation (by 
adding 2 µ1 3M NaOAC and 50 µ1 100% EtOH). The mixture was incubated on ice for 7 
minutes and centrifuged at 14000 rpm for 30 minutes in a benchtop centrifuge (Eppendorf 
centrifuge, 5415C). The supernatant was discarded and the pellet was washed briefly with 500 
µ1 70% EtOH. The pellet was re-centrifuged at 14000 rpm for 10 minutes and air-dried. The 
sequence was determined using the Perkin Elmer ABI Prism 377 DNA sequencer (Biomolecular 
Resource Facility, JCSMR). 
2.2.15. Generation of the reporter plasmid used in this study using the Gateway™ cloning 
system 
Gateway™ cloning technology (Life Technologies) was used to generate the reporter plasmid, 
pGeneGrip-RFP, used in this study. The Gateway™ cloning system is based on site-specific 
recombination reactions ofbateriophage A in E. coli, mediated by proteins from both organisms. 
Recombination sites (att) flank the genes of interest and interact during two sequential events: 
attB x attP • attL-flanked gene within the Entry clone 
attL x attR • attB-flanked gene within the Expression clone. 
The cloning technology involves generation of an Entry vector containing the gene of interest, 
flanked by attL sites. The gene of interest is recombined into a cassette flanked by attR sites 
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within a Destination vector containing the plasmid backbone of interest. This recombination 
produces an Expression clone comprising the plasmid backbone of interest into which the gene 
of interest has been transferred. 
2.2.15.1. Construction of the Entry clone using the 'BP recombination reaction' 
The coding region of the red fluorescent protein (RFP) was PCR amplified (Pfu Turbo, Section 
2.2.12) from pDSRed (Table 2.9) (Clontech) using custom-made primers designed to insert attB 
sites flanking the gene (Table 2.1 O; thermal cycling at 95°C for 5 minutes, 25 cycles of 95°C for 
30 seconds, 74°C for 30 seconds, 72°C for 2 minutes and an extension of 72°C for 5 minutes). 
The PCR product (attB-flanked RFP gene) was gel purified (Section 2.2.5). pDONR201™ 
(Table 2.9) was amplified by bacterial culture and purified using a plasmid miniprep kit 
(Qiagen; Section 2.2.2). The plasmid was further purified by phenol/chloroform/isoamyl alcohol 
extraction (Section 2.2.6). The attB-flanked RFP gene and pDONR201 ™ were recombined in 
the presence of BP clonase™ enzyme mix in a 'BP reaction' according to the manufacturer's 
protocol (Life Technologies; Table 2.11). From the reaction mix, 1 µl was used to transform 
competent DH5a E. coli cells (Table 2.8) using the heat shock method (Section 2.2.1.2). 
Transformed cells were selected overnight at 37°C on agar plates containing 50 µg/ml 
kanamycin. Colonies were picked the following morning and positive recombination clones 
were identified by restriction digest analysis using Hpal and SacII (Section 2.2.9). A positive 
clone was selected, amplified by bacterial culture and purified using the plasmid maxiprep kit 
(Qiagen) for use in the 'LR recombination reaction' (Section 2.2.15.3). This clone was named 
pEntry-RFP. 
2.2.15.2. Construction of the Destination vector 
pGeneGrip™ (Table 2.9) was converted into a Gateway™-compatible Destination vector by 
inserting a suitable reading frame Destination cassette ( ccdB gene, ChloramphenicolR; 
Gateway™ vector conversion system, Life Technologies). Destination cassette A was inserted 
by blunt-end ligation into the EcoRV site within the multiple cloning site (MCS) of pGeneGrip 
(see Sections 2.2.9, 2.2.10 and 2.2.11). The ligation product was transformed into DB3. 1 ™ 
competent cells (Table 2.8, donated by M. Roberston, Plant Industries, CSIRO, Canberra) using 
the heat shock method (Section 2.2.1.2) and plated onto agar containing chloramphenicol (3 0 
µg/ml). Positive clones were identified by restriction digest analysis using EcoRV and Sall 
(Section 2.2.9) and colony PCR (Taq polymerase, Section 2.2.13) using the pGeneGrip 
sequencing primers designed to sequence across the pGeneGrip MCS (Gene Therapy Systems; 
Table 2.1 O; thermal cycling at 95°C for 5 minutes, 25 cycles of 95°C for 30 seconds, 55°C for 
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30 seconds, 72°C for 30 seconds minutes and an extension of 72°C for 5 minutes). A positive 
clone, pGeneGrip-DestA (KanamycinR/ChloramphenicolR; Table 2.9) was amplified in DB3.1 TM 
E. coli cells (Table 2.8) which contain a gyrase mutation conferring resistance to the otherwise 
lethal ccdB gene within the Destination cassette. pGeneGrip-DestA was purified using the 
plasmid maxiprep kit (Section 2.2.2; Qiagen). 
2.2.15.3. Construction of the Expression clone using the 'LR recombination reaction' 
The pGeneGrip-DestA destination vector and the pEntry-RFP entry clone were recombined 
according to the protocol provided by Life Technologies using an 'LR reaction', mediated by 
LR Clonase™ (Life Technologies). The recombination reaction was transformed into competent 
DH5a E. coli cells (Table 2.8) using the heat shock method (Section 2.2.1.2) and plated onto 
agar. Kanamycin (50 µg/ml) resistance and the loss of the ccdB gene, which permitted 
propagation of DH5a E. coli cells, provided the basis for selection of positive recombination 
clones containing the pGeneGrip vector with the RFP gene. Colonies were screened by PCR 
(Taq polymerase, Section 2.2.13) using primers for the pGeneGrip MCS (Gene Therapy 
Systems; Table 2.1 0; thermal cycling at 95°C for 5 minutes, 25 cycles of 95°C for 30 seconds, 
55°C for 30 seconds, 72°C for 30 seconds minutes and an extension of 72°C for 5 minutes). 
Restriction digestion using EcoRV and Xhol was performed also to verify the presence and 
orientation of the inserted RFP gene (Section 2.2.9). The resulting expression vector was named 
pGeneGrip-RFP. pGeneGrip-RFP served as the reporter plasmid used in this study. 
2.2.16. Labelling of pGeneGrip-RFP using peptide nucleic acid hybridisation 
pGeneGrip TM vector ( Gene Therapy Systems) contains a region comprising 8 concatameric 
binding sites to which short, linear peptide nucleic acid (PNA) molecules can hybridise in a 
sequence specific manner and with high affinity (Zelphati et al., 2000; Zelphati et al., 1999). 
PNA 'clamps' have been conjugated to a variety of molecules, such as fluorescein and 
maleimide. In this study, PNA chemistry was used to label the pGeneGrip-RFP reporter plasmid 
with fluorescein, which allowed tracking of the DNA within transfected cells. PNA-maleimide 
labelling facilitates coupling of peptides containing a cysteine residue by thiol alkylation 
chemistry and was used to conjugate optimised NLS peptide to the pGeneGrip-RFP reporter 
plasmid. Fluoresceination of the NLS peptide enabled DNA tracking of the NLS-coupled 
plasmid. As the plasmid DNA retains a supercoiled conformation and is transcriptionally active 
(Gene Therapy Systems), expression of a reporter gene is unhindered by the labelling process, 
permitting DNA tracking and gene expression to be analysed in tandem. 
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2.2.16.1. pGeneGrip-RFP labelling with PNA-fluorescein 
The PNA-fluorescein labelling kit (Table 2.13) was purchased from Gene Therapy Systems and 
the protocol followed was according to the manufacturer's instructions. Briefly, pGeneGrip-
RFP was purified by phenol/chloroform/isoamyl alcohol (Sections 2.2.6 and 2.2. 7) and 
resuspended in 50 µl ddH20 according to the calculation: 
X = [(plasmid size in kb)/5] x 100, where Xis µg of plasmid DNA 
To the DNA solution, 100µ1 of 2 x labelling buffer and 50µ1 PNA-fluorescein label were added. 
The labelling reaction was incubated at 37°C for 2 hours. To remove unincorporated label, 
isopropanol precipitation was used. The salt concentration was brought to 1 M using 3 M 
NaOAc (pH 5.6) (100 µl) and 0.7 x the volume of isopropanol (210 µl) was added. The solution 
was mixed well by pipetting and centrifuged at 14000 rpm for 20 minutes (Eppendorf 
centrifuge, 5415C). The supernatant was discarded, the DNA pellet rinsed with 500µ1 of 70% 
ethanol and re-centrifuged to recover the DNA. The pellet was air-dried for 10 minutes and the 
plasmid resuspended in 100 µl of 1 x labelling buffer. The labeled DNA was quantitated 
spectrophotometrically (Section 2.2.3) and used immediately for assembly into chromatin 
(Section 2.5.2), during the dialysis procedure of which, any remaining unbound label was 
further removed. 
PNA-fluorescein labelling was verified using agarose gel electrophoresis (Section 2.2.4). A 50 
ml horizontal slab agarose gel was prepared. An ethidium-free gel apparatus was used. 
pGeneGrip-RFP and fluorescein-labelled pGeneGrip-RFP were electrophoresed side-by-side 
(1.2 and 2.4 µg/well). The presence of fluorescein was visualised using a Fluorimager (FLA-
3000, Fuji, excitation 473 nm; emission 538 nm). DNA was visualised by EtBr staining under 
UV illumination (FLA-3000, Fuji, excitation 473 nm; emission 580 nm). Co-incidence of 
fluorescein-positive and EtBr stained bands confirmed labelling. 
2.2.16.2. Conjugation of NLS peptide, with and without FITC, to pGeneGrip-RFP using 
PNA-maleimide 
The pGeneGrip-RFP plasmid was labelled with PNA-maleimide using the PNA-maleimide 
labelling kit (Table 2.13) as recommended by the manufacturer (Gene Therapy Systems), 
essentially as described above for PNA-fluorescein. 
An optimised NLS peptide (Xiao and Jans, 1998; Xiao et al., 1998; Hubner et al., 1997), 
comprising the SV 40 T-ag amino acids CG 110PGSDDEAAADAQHAAPPKKKRKV132GY was 
synthesised with and without an FITC group on the N-terminal cysteine residue (K.N. 
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McAndrew, Biomolecular Resource Facility, JCSMR). The N-terminal cysteine residue was 
included in the NLS peptide in order to provide the means for coupling to the maleimide moiety 
using thiol alkylation chemistry (see Figure 6.6). The final product is formed via a chemically 
stable thioether bond involving the nucleophilic addition of cysteine-thiolate to the maleimide 
derivative. 
Immediately after performing the PNA-maleimide labelling reaction, 6 nmoles of NLS peptide 
+ FITC ( corresponding to a 20-fold molar excess) was added, as recommended by Gene 
Therapy Systems. The reaction mix was incubated at room temperature for 4 hours and then 
retained at 4°C overnight. The following day, labelled DNA was precipitated using isopropanol 
( as described above in Section 2.2.16.1) and the pellet resuspended in 1 x labelling buffer. This 
step was repeated to ensure removal of excess PNA-maleimide and NLS peptide. The labeled 
DNA was quantitated spectrophotometrically (Section 2.2.3) and used immediately for 
chromatin assembly (Section 2.5.2). Any remaining unbound label was further removed during 
the chromatin dialysis procedure. 
2.3. GENERAL PROTEIN METHODS 
2.3.1. Quantitation 
2.3.1.1. BioRad protein assay 
The concentration of proteins was determined using the BioRad protein assay according to 
manufacturer's instructions (BioRad). Briefly, solutions containing 2 - 14 µg of bovine serum 
albumin (BSA) made up to 800 µl in ddH20 were used to produce a standard curve. Similarly, 
dilutions of the test protein were prepared. The BioRad protein binding reagent was added (200 
µl) to the solutions to a final volume of 1 ml and mixed thoroughly by pipetting. Reactions were 
incubated for 10 minutes at room temperature. Absorbance was measured at 595 nm and values 
were corrected using a reference solution containing 800 µl of ddH20 and 200 µl of BioRad 
reagent. The concentration of protein was calculated using the BSA standard curve. 
2.3.1.2. Spectrophotometry 
The concentrations of individual histones and the reconstituted octamers were determined 
spectrophotometrically at 276 nm. Histone solutions were normalised to background at 600 nm. 
Absorbance was then measured at 276 nm and 320 nm. The absorbance at 320 nm was 
subtracted from the absorbance at 276 nm and the average of three readings was calculated. The 
equation A = eel where l is 1 cm and e is the extinction coefficient, provided in Luger et al. 
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(1999) was used to determine c, the concentration in mg/ml. 
2.3.2. SDS-polyacrylamide gel electrophoresis 
Proteins were separated using SDS-polyacrylamide gel electrophoresis (SDS-P AGE), providing 
information on their purity and molecular weight. Typically, 18 % SDS-P AGE was used for 
analysis of his tones. 
A protein mini-gel apparatus (BioRad) was assembled. The 18 % running gel solution was 
prepared in a final volume of 10 ml (18 % acrylamide-bis, 0.39 M Tris-HCl pH 8.8, 0.1 % SDS, 
0.5 % ammonium persulphate, 0.05 % TEMED) and pipetted between the glass plates to 1 cm 
below the lower edge of the comb. The gel was overlaid with butanol (which facilitates setting 
to yield a smooth gel surface) and allowed to polymerise for at least 1 hour at room temperature. 
The butanol was removed and a 4% stacking gel prepared in a final volume of 4 ml (4 % 
acrylamide-bis, 0.125 M Tris-HCl pH 6.8, 1 % SDS, 1 % ammonium persulphate, 0.1 % 
TEMED) was carefully layered above the running gel. The comb was inserted and the gel was 
also allowed to set for 1 hour. 
Protein samples were prepared for loading into the gel by adding an equal volume of 2 x SDS 
loading buffer (Table 2.3). Each lane accommodated 20 µl of sample. Electrophoresis was 
carried out in 1 x SDS-PAGE buffer (Table 2.3), initially at 80 V until the bromophenol blue 
dye marker reached the top of running gel and then at 120 V through the running gel. Gels were 
either stained with Coomassie brilliant blue or prepared for Western blot transfer (Sections 2.3.3 
and 2.3.4). 
2.3.3. Coomassie blue staining 
Gels were stained in Coomassie brilliant blue solution (Table 2.3) overnight and destained for at 
least 2 - 5 hours with several changes of destaining buffer (Table 2.3). Destaining was 
performed with gentle rocking on a Platform rocker (setting 5, Bio-line, Edwards Instrument 
Company). The molecular weight of the protein was estimated by comparison with the bands of 
a standardised pre-stained molecular weight marker (Benchmark Pre-stained protein ladder, 
GibcoBRL). 
2.3.4. Western blot 
Western blotting (immunoblotting) to detect the protein of interest consisted of three stages: 
transfer of the protein onto a nitrocellulose (NC) membrane, probing the membrane with 
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antibodies and visualisation using chemiluminescence. 
Protein samples were electrophoresed through duplicate 18 % SDS-polyacrylamide gels. A 
'transfer sandwich' was constructed consisting of layers in order of, firstly, foam backing, 
followed by Whatman paper (Advantec MFS), the SDS- polyacrylamide gel, one NC transfer 
membrane (Optitran BA-S 85, Schleicher & Schuell) ( cut to the size of the gel), Whatman paper 
and lastly, foam backing. Air-bubbles were removed from the 'sandwich' by gently rolling over 
with a pipette. All components were equilibrated briefly in transfer buffer (Table 2.3). The 
transfer apparatus (Mini Trans-Blot Transfer apparatus, BioRad) was assembled according to 
the manufacturer's instructions and filled with transfer buffer (Table 2.3). Transfer was 
performed at room temperature overnight at 10 V and with stirring of the buffer. The remaining 
duplicate gel was analysed using Coomassie blue staining (Section 2.3.3). 
The efficiency of transfer was monitored by staining the NC membrane in Ponceau S (Table 
2.3) for 15 minutes at room temperature with gentle agitation (setting 5, Bio-line, Edwards 
Instrument Company). The membrane was destained in two steps of 5 minutes each in Ponceau 
S destain (Table 2.3), before rinsing with ddH20. A digital image of the Ponceau S-stained NC 
membrane was captured using the LAS-1000 imaging system (Fuji, Japan). The NC membrane 
was placed in Blocking solution (Table 2.3) and incubated overnight at 4°C, with gentle 
agitation (setting 5, Bio-line, Edwards Instrument Company). 
The NC membrane was incubated in primary antibody (Table 2.12; diluted in Blocking 
solution) for 90 minutes at room temperature, washed 3 times for 10 minutes each time with 
TBST solution (Table 2.3) and incubated for an additional hour at room temperature in 
secondary antibody (Table 2.12; diluted in Blocking solution). This was followed by another 
series of washes using TBST and a final brief rinse in ddH20. All incubations and washing steps 
were carried out with gentle agitation (setting 5, Bio-line, Edwards Instrument Company). For 
visualisation of the protein of interest, the SuperSignal detection kit (Table 2.13 ; Pierce) was 
used. The protocol supplied by the manufacturer was followed. Digital images were captured 
using the LAS-1000 (Fuji, Japan) on 'chemiluminescence' settings. 
2.3.5. Silver staining 
After SOS-PAGE (Section 2.3.2) was performed, gels were fixed in 50 % MeOH for 40 
minutes, with gentle agitation on a platform rocker (setting 5, Bio-line, Edwards Instrument 
Company). A solution of0.36 % NaOH (0.9 ml of 10 M NaOH in 100ml ddH20) was prepared 
and 21 ml was transferred into a clean beaker. To this, 1.4 ml of concentrated NILiOH was 
added. In a Falcon tube, 0.8 g of silver nitrate was dissolved in 4 ml ddH20. This solution was 
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carefully added drop-wise to the NaOH solution, with vigorous stirring to ensure that the silver 
remained in solution. The volume was made up to 100 ml with ddH2O. The MeOH solution was 
poured off and the gel briefly rinsed in ddH2O. The silver stain was poured onto the gel and 
incubated with gentle rocking for 15 minutes at room temperature. The gel was thereafter rinsed 
3 times with ddH2O and developed in developing solution (0.05 % formaldehyde, 0.005 % citric 
acid) until a desired level of staining was reached. The reaction was stopped with replacement 
of the developing solution with a solution of 40 % MeOH, 10 % acetic acid. All water used in 
the silver staining protocol was Milli Q filtered. 
2.4. PREPARATION OF RECOMBINANT PROTEINS 
2.4.1. Importin-GST fusion proteins 
Importin a2 (pTAC5 8) and importin ~ 1 (pTAC97) subunits from mouse were expressed as 
glutathione-S-transferase (GST)-fusion proteins and purified by glutathione affinity 
chromatography by Dr C-Y Xiao, A.P. John, C.L. Barton and L. Wijeyewickrema (Nuclear 
Signalling Laboratory, JCSMR), as described previously (Jans and Jans, 1994; Rihs et al., 
1991 ). All samples were stored in 20 µ1 aliquots at -70 °C until use. 
2.4.2. Core histone proteins 
Recombinant Xenopus laevis histones H2A and H2B were purified according to the method of 
Luger et al. (Luger et al., 1999), described below in Sections 2.4.2.1 and 2.4.2.2. Recombinant 
Xenopus laevis histones H3 and H4 were kindly donated by Dr J-Y. Fan (Chromatin and 
Transcriptional Regulation Group, JCSMR). Histone dimers H2A/2B and H2AZ/2B were 
prepared according to the method of Hayes and Lee (Hayes and Lee, 1997), as described in 
Section 2.4.2.4. Histone dimers H2AZ/2B were kindly donated by M. Clarkson (Chromatin and 
Transcriptional Regulation Group, JCSMR). Histone tetramers H3/4 and acetylated H3/4 (H3/4-
ac) were purified from chicken and HeLa cells, respectively, by L. Hyman (Chromatin and 
Transcriptional Regulation Group, JCSMR), as previously described (Simon and Felsenfeld, 
1979). All chromatography was performed in the Biomolecular Resource Facility, JCSMR 
under the guidance of Dr P. Milburn. 
2.4.2.1. Expression of recombinant histones in BL21DE3lysS E.coli cells 
BL21DE3p(lysS) cells (Table 2. 8; Promega and One Shot®, Invitrogen) were transformed with 
pET3a-H2A, pET3a-H2B ( containing the coding region for Xenopus laevis histones H2A and 
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H2B, respectively; Table 2.9) or pET5a-H2A-NLS ( containing the coding region for a C-
terminal fusion of the Xenopus laevis histone H2A and the optimised SV 40 T-ag NLS; Table 
2.9) according to the manufacturer's instructions. Transformed cells were plated onto agar 
containing 100 µg/ml ampicillin and 30 µg/ml chloramphenicol and cultured overnight at 37°C. 
The following morning, colonies were selected and used to inoculate 8 to 10 5 ml starter 
cultures. These cultures were divided into 'non-induced' and 'induced' samples, according to 
treatment with 0.5 mM IPTG for 2 hours. SDS-PAGE (18 %) was used to identify the highest 
expressor (Section 2.3.2). This sample was used to inoculate a larger culture of 800 ml LB 
media (Table 2.1), containing 30µg/ml chloramphenicol and l00µg/ml ampicillin. The culture 
was incubated at 37°C and 180 rpm for,..., 2 hours or until the absorbance at 600 nm was,..., 0.6 
( optimal level for induction). At this stage, 500µ1 of culture was removed and retained as the 
'non-induced' sample. IPTG was added to a final concentration of 0.5 mM and the culture was 
incubated for a further 3 - 4 hours at 3 7°C and 180 rpm and then overnight at room temperature 
with gentle shaking (100 rpm). Another 500 µ1 sample ('post-induction') was retained for SDS-
PAGE analysis. The culture was centrifuged at 4500 rpm for 15 min at room temperature (GSA 
rotor, Sorvall). The cell pellet was resuspended in 20 ml Wash buffer (Table 2.4) and stored at -
20°C until further purification. 
2.4.2.2. Purification of recombinant histones 
Histone purification involved three steps; preparation of inclusion bodies, gel filtration and ion 
exchange chromatography. The purification procedure was essentially carried out as described 
by Luger et al. (1999), but was scaled down accordingly for a 1 litre bacterial culture. The 
buffers used for these procedures were also from Luger et al. (Luger et al. , 1999) and are 
detailed in Table 2.4. A Superdex 200 HR 10/30 column (Amersham Pharmacia Bio tech) was 
used for gel filtration. A Resource S ion exchange column (Amersham Pharmacia) was used to 
recover the core histone proteins using a 200 - 600 mM NaCl gradient (SAU-200 and SAU-600, 
Table 2.4). Purified histones were lyophilised and stored at -20°C until reconstitution into an 
octamer, as described below. 
2.4.2.3. Reconstitution of histone octamers from purified recombinant histones 
Purified recombinant Xenopus laevis histones H2A, H2B, H3 and H4 (Section 2.4.2.1 and 
2.4.2.2) were reconstituted into octamers as described by Luger et al. (1999). The recombinant 
purified histones stored in lyophilised form were carefully solubilised by mixing, using a 
pasteur pipette, in 1.5 ml of Unfolding buffer (Table 2.4). Unfolding was allowed to proceed at 
room temperature for between 30 minutes and 3 hours, after which the concentration of histones 
was determined by measuring the absorbance at 276 nm, as described in Section 2.3.1.2. H2A 
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and H2B were mixed in equimolar proportions and H3 and H4 were added at 98 % that of H2A, 
so that the final molar ratios of H2A:H2B:H4:H4 were 1: 1 :0.98 0.98. The molar excess of H2A 
and H2B ensures maximal incorporation of H3 and H4 into the octamer as, under 
octamerisation conditions, excess H3 and H4 form tetramers which are difficult to purify from 
the octamer using gel filtration chromatography (Luger et al., 1999). The concentration of the 
histone mix was determined and the final concentration adjusted to 1 mg/ml by adding 
Unfolding buffer (Table 2.4). The histone mix (typically having a volume between 2 - 4 ml ) 
was transferred into dialysis tubing with a molecular weight cut off (MWCO) of 6000 - 8000 
Da (Spectra/Por® membrane, flat width 10 mm, Spectrum Laboratories) and dialysed against 4 
1 of Refolding buffer (Table 2.4) at 4°C overnight, with at least 3 changes of buffer. 
After overnight dialysis, the sample was concentrated to around 1 ml using a Centricon filter 
device (YM-10, Amicon) at 3000 rpm (Allegra 6 Centrifuge, Beckman) over a period of 3 
hours. During this time, the gel filtration column (HiLoad 16/60 Superdex 200 prep grade, 
Pharmacia) was prepared by washing extensively with ddH20 and then equilibrating in two 
column volumes ( ~ 120ml) of Refolding buffer (Table 2.4). Gel filtration was carried out at 4°C. 
The flow rate was set to 1 ml/min. A chromatogram was generated at 276 nm. The first 40 ml of 
flowthrough (waste material) was collected into a 50 ml Falcon tube, after which the fraction 
collector was set to recover 1 ml fractions every minute. 
The fractions corresponding to peaks on the chromatogram were analysed using 18 % SDS-
PAGE (Section 2.3.2). Fractions containing equimolar amounts of the constituent histones 
(indicating octamer formation) were pooled. The concentration of octamer was determined 
spectrophotometrically as described in Section 2.3 .1.2 using the equation A = sci. The 
extinction co-efficient ( £) for the reconstituted histone octamer is 0.45 (Luger et al., 1999). 
Protease inhibitors were added (PMSF, 5.75 µl for every 10 ml from a 100 mM stock; Pepstatin 
A, 8 µl from 2.5 mg/ml stock; Leupeptin, 2 µl from a 10 mg/ml stock) and purified histone 
octamers were stored at 4 °C until use. 
2.4.2.4. Dimerisation and refolding of recombinant H2A/2B 
Equimolar amounts of recombinant Xenopus laevis H2A and H2B (Section 2.4.2.1 and 2.4.2.2) 
(typically of volume 2.5 ml) were pipetted into dialysis tubing with MWCO 6000 - 8000 Da 
(Spectra/Par® membrane, flat width 10 mm, Spectrum Laboratories). Dialysis was carried out 
overnight at 4°C against 0.5 M NaCl buffer I (500 mM NaCl, 50 mM HEPES pH 7.5, 1 mM 
DIT, 0.1 % NP-40, 0.05 mM PMSF), with one change the following morning. BioRex-70 resin 
was prepared by equilibrating 1 gin 0.5 M NaCl buffer II (500 mM NaCl, 50 mM HEPES pH 
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7.5, 0.05 mM PMSF) for 1 hour at 4°C. The resin was poured into a 14 ml round-bottomed 
Falcon tube to 1ml of settled volume and as much buffer as possible was aspirated. The dialysed 
histone sample was added to the resin. Following incubation at 4°C for 1 - 2 hours with gentle 
agitation (setting 5, Bio-line, Edwards Instrument Company), the resin slurry was transferred 
into a 10 ml poly-prep chromatography column (BioRad) and washed with 10 column volumes 
of 0.5 M NaCl buffer II. H2A/2B dimers were eluted by gravitational flow using 0.5 M NaCl 
buffer II. A total of 10 fractions of 300 µ1 each were collected. Typically, the dimers appeared 
in the second and third fractions. 
Fractions containing the highest concentration of dimers were identified by SDS-PAGE (15 %, 
see Section 2.3.2) and silver staining (Section 2.3.5). These fractions were pooled and dialysed 
against H2A/2B buffer (200 mM NaCl, 10 mM HEPES pH 7.5, 0.1 mM EDTA). Aliquots of 
H2A/2B were stored at -70°C until use. 
2.4.3. Recombinant chromatin assembly proteins NAP-1 and Nl/N2 
Recombinant NAP-1 and Nl/N2 were kindly donated by N. Siddon (Chromatin and Transcriptional 
Regulation Group, JCSMR). Recombinant NAP-1 and Nl/N2 were expressed from the plasmids 
pQE-Nl/N2 and pQE-NAP-1 as described in Johnson-Saliba et al. (2000). 
2.5. CHROMATIN METHODS 
2.5.1. Chromatin assembly using NAP-1 
Small scale assembly of 300 ng of plasmid DNA into chromatin was carried out using the NAP-
1-based system for the purpose of performing a supercoiling assay (Section 2.5.4). The 
assembly reaction comprised of purified chicken H3/4 tetramer (Section 2.4.1), recombinant 
Xenopus laevis H2A/2B dimer (Section 2.4.2.4), recombinant NAP-1 (Section 2.4.3), 300 ng of 
plasmid DNA, 2 units Topoisomerase I (Promega) and 1.5 mM ATP. The reaction was 
performed in 1 x EB buffer (1 mM EGTA, 20 mM HEPES pH 7.0, 5 mM KCl, 10 % glycerol 
(v/v), 0.5 mM DTT and 10 mM P-glycerol phosphate) in a total volume of 12 µ1. As each 
preparation of recombinant components of the reaction differed in their ability to induce 
supercoiling (Section 2.5.4), the volumes of the H2A/2B dimer, H3/4 tetramer.and NAP-1 were 
determined by titration. Typically, 1.5 - 3 µ1 of H2A/2B dimer, 0.5 - 1 µl of H3/4 tetramer and 
1 - 4 µl ofNAP-1 were used. The reaction was performed at 27°C for 4 hours. 
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2.5.2. Chromatin assembly using octamer transfer by salt dialysis 
Large scale assembly of 30 - 100 µg of plasmid DNA into chromatin was performed using 
purified recombinant histone octamers (Section 2.4.2.3) by stepwise dialysis from a high to low 
salt buffer essentially according to the method originally described by Thomas an_d Butler 
(Luger et al., 1999; Richmond et al., 1988; Thomas and Butler, 1977). The originally described 
dialysis buffers contained EDT A which is known to chelate metal ions, thus inhibiting the 
function of several key enzymes required for cell survival. This was believed to be responsible 
for cell lysis that was observed by light microscopy in the initial transfection experiments that 
were conducted using chromatin constructs in EDT A-containing buffer. Consequently, EDT A 
was thereafter omitted from the salt dialysis procedure, without any impact on the formation of 
chromatin. The physiological nucleosome density is 1 for every ~ 230 bps of DNA. The 
pGeneGrip-RFP reporter plasmid used in this study comprises 5889 bp and was calculated to be 
saturated (physiological nucleosome density) with 25 histone octamers. Chromatin constructs 
were therefore assembled at a stoichiometry of 0, 1, 2, 4, 10, 25 or 40 histone octamers per 
plasmid. 
The chromatin assembly reaction contained DNA, 5 M NaCl/TE, histone octamer and TE, as set 
out below. All solutions were stored at 4°C but were retained on ice while the assembly reaction 
was composed. The reaction components were pipetted into eppendorf tubes in the following 
order: 1. DNA 
2. TE (to final volume of 400 µl) 
3. 5 M NaCl/TE 
4. histone octamer. 
Typically, 50 µg of pGeneGrip-RFP was assembled into chromatin per assembly reaction. 
The volume of his tone octamer was calculated using the equation: 
r = moles of octamer 
moles of DNA 
, where r is the ratio of octamers to DNA 
- cone. of octamer x volume 
molar mass of octamer 
mass of DNA 
molar mass of DNA 
The molar mass of a histone octamer containing H2A, [2(H2A/H2B)/(H3i H42)], is 108486 
µg/µmol. The molar mass of a histone octamer containing H2AZ, [2(H2AZ/H2B)/(H32/H~)], is 
107 408 µg/µmol. 
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The initial salt concentration of the assembly reaction was set to 2 Musing 5 M NaCl/TE in 
order to maintain octamer stability ( as the salt concentration falls below 2 M, the octamer is 
prone to dissociation). The volume of 5 M NaCl/TE added was calculated with respect to the 
volume of octamer using the equation: 
5 M x X µl = 2 M x (total reaction volume - volume of octamer) 
TE was added to bring the final reaction volume to 400 µ1. The assembly reactions were 
carefully transferred into dialysis tubing with a MWCO of 6000 - 8000 Da (Spectra/Por® 
membrane, flat width 10 mm, Spectrum Laboratories) that had been pre-soaked in the first 
dialysis buffer, 1 M NaCl/Tris-HCl (Table 2.5). Dialysis was performed at 4°C, with gentle 
stirring.The first stage of dialysis was carried out against 1 M NaCl buffer (Table 2.5) for 3 - 4 
hours. The assembly reactions were thereafter transferred into 0.75 M NaCl buffer (Table 2.5) 
for a further 3 - 4 hours. The final dialysis step was carried out against 135 mM NaCl buffer 
(Table 2.5), overnight. 
The DNA content of the chromatin constructs was quantitated spectrophotometrically (Section 
2.2.3). Chromatin samples were stored at 4°C until use, for no longer than 6 weeks. 
2.5.3. Sedimentation velocity ultracentrifugation 
Sedimentation coefficients (s-values; Svedberg units, S) of the various chromatin constructs 
(Section 2.5.2) were determined using analytical ultracentrifugation, as described by Schwarz 
and Hansen (1994) and Carruthers et al. (1998). For sedimentation velocity ultracentrifugation 
experiments, chromatin was dialysed against a final buffer containing 2.5 mM NaCl/TE. This 
was to prevent the induction of non-specific salt-induced compaction that has been observed at 
physiological salt concentration of 135 mM (Section 2.5.2) (Carruthers et al. , 1998; Schwarz 
and Hansen, 1994). 
Chromatin samples containing 6 µg of DNA were analysed in 2.5mM NaCl/TE buffer at a final 
volume of 380 µ1. The reference sample contained 2.5mM NaCl/TE buffer alone at a final 
volume of 400 µ1. Samples were transferred into ultracentrifuge cells and equilibrated at 20000 
rpm for 1 hour and at 21 °C (Beckman XL-A). The initial absorbance at 260 nm was 0.6 - 0.8. 
Ultracentrifugation was carried out overnight at 23000 rpm and 21 °C. Typically, 30 absorbance 
scans were collected. Data were analysed as described by van Holde and Weischet (1978) using 
Ultrascan software (Linux), in which an algorithm divides each scan into 20 - 70 horizontal 
divisions and apparent s-values are calculated from the radial point of each division. The 
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apparent s-values are plotted against the inverse square root of time, generating a van Holde and 
Weischet extrapolation plot. The Ultrascan software (Linux) generates linear extrapolations 
through each series of horizontal divisions, which intercept the Y-axis. These intercepts are the 
trues-values for each boundary fraction. The boundary fraction was plotted against the s-values 
to obtain a van Holde and Weischet integral distribution plot. The sedimentation coeffic_ient was 
read at the 0.5 (50%) boundary fraction. 
2.5.4. Supercoiling assay 
Prior to chromatin assembly, DNA was incubated with Topoisomerase I (Promega, 10 units/µl 
and used at 1 unit per µg DNA) for 1 hour at 27°C. Topoisomerase I cleaves one strand of the 
DNA duplex to remove negative supercoils from covalently closed circular DNA so that a 
relaxed, open circular structure is produced. 
The chromatin assembly reactions were carried out as described (Sections 2.5.1 and 2.5.2) and 
the DNA content quantitated by spectrophotometry (Section 2.2.3). Around 500 ng of DNA was 
transferred into a clean Eppendorf tube and the volume adjusted to 50 µl with ddH2O. SDS (2%, 
w/v) and proteinase K (10 mg/ml) were added at a volume of 8 µ1 each and the reaction was 
incubated either at 37°C overnight. Following this, 53 µl of 7.5 M ammominum acetate and 265 
µl of ice-cold 100 % ethanol were added and the samples were retained for 1 hour at -70°C. 
DNA was precipitated as described (Section 2.2.8). The recovered DNA was air-dried for 10 
minutes and resuspended in 10 µl of TE buffer. To each sample, 2 µl of 6 x DNA loading dye 
was added (see Table 2.2) and analysis was performed using agarose gel electrophoresis (1 %, 
90 V; Section 2.2.4). 
2.5.5. Micrococcal nuclease digestion assay 
Chromatin constructs were assembled at various stoichiometries of histone octamers (Section 
2.5.2) and the DNA content was quantitated spectrophotometrically (Section 2.2.3). 
Chromatinised constructs containing 4µg of DNA was aliquotted for the micrococcal nuclease 
(MNase) assay. MNase S7 (Roche, 50 units/µl) was diluted one thousand fold in nuclease free 
ddH2O (Pro mega, P 119C) and retained on ice. The digestion reaction contained 2 mM CaCh, 10 
mM Tris-Cl and 4 µg of DNA. The final reaction volume was 400µ1, which was made up with 
nuclease free ddH2O (Promega, Pl 19C). To this,-25 milliunits of MNase per µg of DNA were 
added and reactions were allowed to proceed at room temperature. Reactions were stopped at 2, 
10, 20 and 60 min by transferring 1 µg of DNA ( 100µ1 of each reaction) into 5 x Stop solution 
(2.5 % sarkosyl/1 00mM EDT A; 25 µl). 
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Digested DNA was purified using phenol-chloroform-isoamyl alcohol (Section 2.2.6) and 
recovered by ethanol precipitation (Section 2.2. 7). Recovered samples were resuspended in 10µ1 
of TE (pH 7.8), to which 2µ1 of 6 x DNA loading dye was added (Table 2.2). Sample analysis 
was performed by agarose gel electrophoresis ( 1. 5 %, 200 ml horizontal slab gel, 90 V for 
around 4 hours, or until the marker dye front had migrated three quarters down the length of the 
gel; Section 2.2.4). 
2.5.6. Atomic force microscopy 
Chromatin assembly of the fully nucleosome-saturated 25 octamers per plasmid construct was 
carried out as described in Section 2.5.2. Non-chromatinised, naked plasmid DNA and the 25 
octamers per plasmid samples were diluted to a final concentration of 10 ng/µ1 in 135mM 
NaCl/Tris-HCl. 
Atomic force microscopy (AFM) was carried out as essentially as described by Hansma et al. 
(1998). Squares of mica (1.5 cm2) were cleaved freshly, onto which 10 µ1 of sample was 
spotted. Samples were allowed to adsorb to the mica surface for 5 minutes, after which the 
surface was rinsed 3 times using 100 µ1 of sterile ddH20. Samples were dried briefly with a 
stream of compressed air. The AFM (MultiMode AFM and Nanoscope III, Digital Instruments) 
was operated by Dr T. Senden (Department of Applied Mathematics, Research School of 
Physical Sciences and Engineering, ANU). Tapping mode was performed using a 125 µm 
silicon cantilever, at a scanning rate of 1 - 2 Hz and oscillation 400 kHz. Images were analysed 
using Nanoscope software (Digital Instruments). 
2.6. CELL CULTURE METHODS 
2.6.1. HTC and Cos-7 cells 
Hepatic tumour cells (HTC) derived from the rat Morris hepatoma 7288C cell line (Flow 
Laboratories, Bonn, Germany) were maintained in Dulbecco ' s modified Eagle ' s medium 
(DMEM; Table 2.1) containing 10 % foetal calf serum (FCS; CSL, Lot no. 097059101) which 
had been heat inactivated (56°C for 45 minutes). Cells were cultured in 25 cm2 tissue culture 
flasks (Nunc) in a humidified incubator with atmosphere of 5 % CO2 and maintained at 3 7°C 
(Forma Scientific Inc). Cells were subcultured every 3 - 4 days in a laminar flow hood (Airpure, 
Email Westinghouse) as described in Section 2.6.3. 
The Cos-7 cell line, derived from the African green monkey, was provided by S. Ford (Cytokine 
Molecular Biology and Signalling Laboratory, JCSMR) and maintained as described above. As 
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the media used for HTC and Cos-7 cell culture were the same, two separate sets of culture 
media were used so as to minimise the possibility of cross-contamination. 
For the purposes of transfection, HTC and Cos-7 cells were typically grown to 90 - 95 % 
confluence in 175 cm2 tissue culture flasks (Nunc). 
2.6.2. Jurkat cells 
The human leukaemic T-cell line, Jurkat, was kindly provided by K. Bunting (Cytokine Gene 
Expression Group, JCSMR). Cells were maintained in suspension in 175 cm2 tissue culture 
flasks (Nunc) in RPMI-1640 media (Table 2.1), supplemented with 10 % FCS (heat-inactivated; 
56°C for 45 minutes), in a humidified incubator with atmosphere of 5 % CO2 and at 37°C 
(Forma Scientific Inc). The presence of a pH indicator in the cell media was typically used to 
determine qualitatively when subculturing was required. Subculturing was carried out in a 
laminar flow hood (Airpure, Email Westinghouse) by physically agitating the cells in order to 
reduce the presence of clumps. Cells were counted (Section 2.6.4) and then diluted to the 
desired cell density using RPMVl 0 % FCS. Cells were typically cultured to a concentration of 
5 x 105 cells/ml prior to transfection experiments. 
2.6.3. Harvesting of adherent cells 
Culture media were aspirated and cells were rinsed briefly using sterile PBS. Detachment from 
the substratum was achieved by incubating HTC cells in 10 ml 1/ 10 (v/v) 0.25% Trysin-
EDTA/PBS (Sigma) and Cos-7 cells in 10 ml of undiluted 0.25% Trysin/EDTA (Sigma) for up 
to 5 minutes in the incubator (Form.a Scientific Inc). Detachment was aided by gentle physical 
agitation, after which the reaction was inhibited with the addition of 25 ml DMEM/10% FCS. 
The trypsinised cell suspension was transferred into a 50 ml Falcon tube and centrifuged at 640g 
( ~ 1640 rpm. ) (Allegra 6 Centrifuge, Beckman). The supernatant was discarded and the cell 
pellet was washed by resuspending in 30 ml PBS and re-centrifuging. Cells were thereafter 
resuspended in 2 ml PBS for counting and reseeding (Section 2.6.4) or in 500 µl PBS for 
analysis using flow cytometry (Section 2.9.1). 
2.6.4. Cell counting 
Cells were counted using a haemocytometer. Cell suspensions were diluted 1/1 0 in PBS, of 
hich 1 0µl was applied onto the haemocytometer. Two separate fields were counted and the 
a erage count expressed as: number of cells/ml = average cell count x 104 x dilution factor. 
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2.6.5. Freezing and thawing cells 
HTC and Cos-7 cells were routinely stored in liquid nitrogen. Cells were initially transferred 
onto dry ice from liquid nitrogen and then plunged into a water bath at 37°C until thawing was 
complete. Warm DMEM/10 % FCS (1 ml) was added drop wise to the thawed cells to a final 
volume of 10 ml. The cell suspension was centrifuged at 640 g (~ 1640 r.p.m.) (Allegra 6 
Centrifuge, Beckman) and the supernatant ( containing DMSO) discarded. Cells were 
resuspended in 10 ml DMEM/10 % FCS, transferred into 25 cm2 tissue culture flasks (Nunc) 
and maintained as described in Section 2.6.1. Media were replaced the following day. 
Cells were periodically frozen at low passage number. Cells were grown to confluence, 
detached from the substratum using trypsin (Section 2.6.3), resuspended in 2 ml of DMEM/10 
% FCS and counted using a haemocytometer (Section 2.6.4). For storage, cells were 
resuspended at a final concentration of 5xl06 cells/ml in DMEM/10 % FCS with 10 % DMSO 
(Sigma). Aliquots of 1 ml were transferred into cryotubes (Nunc) and retained on ice for 10 
minutes, - 20 °C for 2 hours and - 70 °C overnight. The cryotubes were transferred into liquid 
nitrogen the following day. 
2.7. TRANSFECTION OF CELLS IN CULTURE 
2.7.1. Electroporation 
Electroporation was carried out on HTC cells. Cells were aliquotted at a density of 5 x 106 cells 
in 200 µl in PBS (see Sections 2.6.1, 2.6.3 and 2.6.4) into electroporation cuvettes (BioRad, 0.4 
cm gap), which had been previously sterilised by UV irradiation for 30 minutes in the laminar 
flow hood (Airpure, Email Westinghouse). Cuvettes were maintained on ice. 
Chromatin constructs, assembled as described in Section 2.5.2, containing 10 µg of 
chromatinised DNA (or naked control plasmid) were transferred into sterile Eppendorf tubes 
and were brought to a final volume of 200 µl using 135 mM NaCI/Tris-HCl (Table 2.5). 
Chromatin samples were introduced carefully into the cell suspension and incubated on ice for 
10 minutes. 
Electroporation was carried out using a BioRad GenePulser II, with the pulse controller set to 
'high range' and capacitance set to 'high capacity'. The optimal electroporation parameters 
were determined using FITC-labelled dextrans (see Sections 2.11.1 and 4.5.1). Subsequent 
electroporation experiments were carried out at 300 V and capacitance 500 µF. The cuvettes 
were pulsed (pulse times were typically around 25 msec) and were retained on ice for a further 
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1 O minutes to allow the cells to recover. The electroporated cell suspensions were transferred, 
including the layer of dead cells, into 25 cm2 tissue culture flasks (Nunc) containing 10 ml 
DMEM/10 % FCS. Transfected cells were cultured at 37°C in a humidified 5% CO2 atomsphere 
(Forma Scientific Inc incubator) for 48 hours prior to analysis of reporter gene expression 
(Section 2.9.1). 
2. 7 .2. Lipofection 
HTC, Cos-7 and Jurkat cells were transfected using lipofection. HTC and Cos-7 cells were 
seeded at a density of 2x 105 cells per 2 ml of DMEM/10 % FCS in each well of 6-well tissue 
culture plates (Nurre) prior to the day of transf ection and were incubated overnight. Jurkat cells 
were seeded at a cell density of 5xl05 cells per 0.5 ml ofRPMI/10 % FCS into each well of24-
well tissue culture plates (Nunc) on the day of transfection. 
Aliquots of chromatin samples containing 1 µg of chromatinised DNA ( or naked control 
plasmid) were prepared for lipofection into each well. The aliquots were standardised to the 
maximum volume of each set of chromatin samples using chromatin buffer (CB, 135 mM 
NaCl/Tris-HCl; Table 2.5). The volume was brought to a final volume of 50 µl with serum-free 
DMEM for HTC and Cos-7 cells, or RPMI for Jurkat cells. Lipofectamine™ 2000 reagent 
(Invitrogen) was diluted 1 :25 (v/v) in serum-free media and 50 µl was mixed promptly with 50 
µl of each chromatin sample preparation. Formation of liposome/DNA complexes was allowed 
to proceed for 20 minutes at room temperature. During this time, the cell culture media of HTC 
and Cos-7 cells (D MEM/ 10 % FC S) were aspirated and cells were rinsed twice with serum-free 
media, which was also aspirated. Lipofectamine/DNA complexes (100 µl per well) were 
carefully distributed drop wise over the cells. Jurkat cells were returned to the incubator (Forma 
Scientific Inc incubator), while HTC and Cos-7 cells were incubated for a further 20 minutes 
and then overlaid with 2 ml of DMEM/DMEM with 10 % FCS (50/50, v/v) before returning to 
the incubator. 
Cells were cultured at 37°C and in a humidified 5% CO2 atomsphere (Forma Scientific Inc 
incubator) for 48 hours prior to analysis of reporter gene expression (Section 2.9). 
2.8. ISOLATION OF NUCLEI 
Subcellular fractionation was performed in order to obtain pure nuclei in order to ascertain the 
level of DNA uptake into the nucleus following transfection of fluorescein-labelled 
chromatinised plasmid (Section 2.2.16). Cos-7 and HTC cells were harvested (Section 2.6.3) 
and resuspended in 500 µl of PBS. Cells were divided into two aliquots; one aliquot of which 
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was analysed as intact cells using flow cytometry (Section 2.9.1), the other aliquot of which was 
used to isolate nuclei, which were thereafter analysed using flow cytometry (Section 2.9.1). 
Nuclei were obtained using the method described in Rao et al. (2001) or using the NE-PER™ 
nuclear and cytoplasmic extraction kit (Pierce; Table 2.13). 
Using the first method (Rao et al., 2001), cells were collected by centrifugation at 640g (~ 1640 
rpm; Allegra 6 Centrifuge, Beckman) and resuspended in 200 µl of ice-cold Nonidet P-40 lysis 
buffer containing 10 mM Tris (pH 7.4), 10 mM NaCl, 3 mM MgC12, 0.5 % Nonidet P-40, 0.15 
mM spermine and 0. 5 mM spermidine. The cell suspension was incubated on ice for 5 minutes. 
Nuclei were recovered by centrifugation at 1000 rpm for 10 minutes (Eppendorf centrifuge, 
model 5415C). The supernatant was discarded and the pellet, containing the nuclei, was 
resuspended in 200 µl of PBS. 
The second method involved using the NE-PER™ nuclear and cytoplasmic extraction kit 
(Pierce). Results obtained were consistent with the method described above. Reagents were used 
according to the manufacturer's protocol, with some adaptations. Briefly, the volumes of each 
reagent used were based on a packed cell volume of ~ 20 µl , corresponding to 5 x 106 cells. 
Samples were retained on ice throughout the procedure. The resupended cells were centrifuged 
at 1200 rpm for 5 minutes (Eppendorf centrifuge, model 5415C) in order to recover the cell 
pellet. Cell pellets were resuspended in 200 µl CER I reagent by vortexing for 15 seconds. 
Following a 10 minute incubation period on ice, 11 µl of CER II reagent was added to each 
sample. The samples were vortexed for 5 seconds and incubated for a further minute on ice. The 
samples were re-vortexed for 5 seconds and centrifuged at maximum speed in a benchtop 
centrifuge ( 14000 rpm, Eppendorf centrifuge, model 5415C) for 5 minutes. The supernatant, 
containing the cytoplasmic fraction, was discarded. The pellets, comprising the nuclei, were 
resuspended in 200 µl PBS by vortexing for 15 seconds in the first instance and then for 15 
seconds every 10 minutes over a total period of 40 minutes with the samples retained on ice in 
between. 
For both methods used, DNase I (Roche, 10 U/µl) was added to the final suspension of nuclei to 
disperse clumping (2 µl per sample). The samples were mixed gently by pipetting. If clumping 
persisted, an additional 2 µl of DNase I was added and the sample was incubated for a further 
15 minutes. The nuclei suspension was brought to a final volume of 500 µl (in PBS) for analysis 
using flow cytometry (Section 2.9.1). 
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2.9. ANALYSIS OF TRANSFECTION EFFICIENCY 
2.9.1. Flow cytometry 
Flow cytometric (F ACS) analysis was performed for the quantitation of transfection ~fficiency 
using the pGeneGrip-RFP plasmid (F AC Scan, F ACScalibur or LSR, Becton Dickinson 
Immunocytometry Systems Inc; Flow Cytometry Unit, JCSMR). Cultured cells were transfected 
as described in Section 2.7. For FACS analysis, whole cells were resuspended in 500 µl (see 
Section 2.6.3 for harvesting of adherent cells) or nuclei were prepared (Section 2.8). The flow 
rate was set to 'medium'. When transfection experiments were conducted in order to ascertain 
reporter gene expression in whole cells, 100000 events were acquired in each scan. When 
transf ection experiments were conducted using fluoresce in-labelled chromatinised plasmids 
(Section 2.2.16) in order to relate plasmid uptake into the nucleus to reporter gene expression in 
whole cells, 30000 events were acquired in each scan for the whole cells and 5000 events for 
nuclei. For the analysis of whole cells, the forward light scatter parameter was set on a linear 
scale; for the analysis of nuclei, forward light scatter was set on a logarithmic scale. Events were 
analysed using CellQuest software (Becton Dickinson, Macintosh). Quadrants or regions were 
set according to negative control samples (non-transfected cells, 'no DNA transfections' with 
empty liposomes or non-labelled plasmid) or positive control samples (which generated known 
fluorescence events). The percentage of fluorescent events (cells) and the arithmetic and 
geometric means of fluorescence intensity were quantitated by the CellQuest software 
(Macintosh). Further mathematical analyses were performed using Microsoft Excel and 
SigmaPlot software. 
Channel settings for the detection of fluorescence are indicated below. Multi-channel analyses 
were also performed, where possible, to ascertain the presence of several fluorescent molecules 
per cell. 
2.9.1.1. Determination of cell viability using propidium iodide or 7-amino-actinomycin D 
Cell viability was analysed using propidium iodide (PI, 5 µg/ml final concentration) or 7-amino-
actinomycin D (7-AAD, 20 µ1/sample; Via-Probe™, Roche). These reagents were added to the 
cell suspensions and were incubated in the dark for 10 minutes prior to F ACS analysis. PI 
fluorescence was detected through channel FL2 using a standard filter configuration on the 
F AC Scan or F ACScalibur or band pass filters 57 5/45 on the LSR. 7-AAD fluorescence was 
detected through channel FL3 using a standard filter configuration on the F AC Scan or 
F ACScalibur or a 650 nm, long pass filter on the LSR. 
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2.9.1.2. Quantitation of RFP reporter gene expression 
RFP fluorescence was detected through channel FL2 using a standard filter configuration on the 
FACScan or FACScalibur or band pass filter 575/45 on the LSR. 
2.9.1.3. Quantitation of tluorescein fluorescence 
Fluorescein (FITC) fluorescence was detected through channel FL 1 usmg a standard filter 
configuration on the FACScan or FACScalibur or band pass filter 530/30 on the LSR. Nuclear 
FITC fluorescence originating from the FITC-labelled chromatin constructs was quantitated 
relative to nuclei isolated from cells transfected with either no construct or unlabelled construct. 
2.9.2. Luciferase assay 
The luciferase reporter plasmid pGMCSF-1(2)TK-luc+ was kindly provided by K. Bunting, 
Cytokine Gene Expression Group, JCSMR (pGMLuc; Table 2.9). pGMLuc was 6.1 kb and was 
calculated on the basis of physiological nucleosome density ( ~ 230 bps per nucleosome) to be 
saturated with 26 histone octamers. Chromatin constructs were assembled at stoichiometries of 
0, 1, 2, 4 and 26 octamers per plasmid (Section 2.5.2). Jurkat cells were transfected by 
lipofection, as described in Section 2.7.2. Cells were allowed to recover post-lipofection for 30 -
34 hours before the pharmacological stimuli phorbol-12-myristate-13-acetate (PMA, Sigma) 
and calcium ionophore ( A23187, Boehringer) were added to final concentration 20 ng/ml and 1 
µM, respectively. Cells were cultured for a further 8 hours. 
Cells were harvested by centrifugation for 5 minutes at 640 g (~ 1640 rpm; Allegra 6 
Centrifuge, Beckman). Cells were washed twice with PBS, the cell pellets collected by re-
centrifugation after each wash and the supernatants carefully aspirated. All material was 
thereafter retained on ice for the duration of the assay. The luciferase assay was conducted as set 
out by Himes and Shannon (2000). Briefly, cells were resuspended in 200 µl lysis buffer (Table 
2.6) and lysed in three rounds of freezing and thawing using an ethanol/dry ice bath. Lysed cells 
were centrifuged at 14000 rpm for 5 minutes at 4 °C (Eppendorf centrifuge, 5415C). The 
supernatant was retained and the protein concentration was determined using the BioRad protein 
assay (Section 2.3.1.1 ). Typically 50 µg (80 µl) of cell extract was pipetted per well of a 96-well 
black micro titre plate (Nunc ). Luc if erase assay buff er was assembled (Table 2. 6) and allowed to 
equilibrate to room temperature, after which 200 µl were added to each well. In order to initiate 
the light reaction, 40 µl of D-luciferin (Table 2.6) was added. Luminescence was quantitated 
using a Top Count scintillation/luminescence counter (Packard). 
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2.10. ELISA 
The importin binding affinities of histones, DNA or chromatin samples were determined using a 
modified enzyme-linked immunosorbent assay (ELISA), described previously (Hu and Jans, 
1999; Hubner et al., 1997; Xiao et al., 1997a). This assay was conducted over three _days and 
comprised three stages: adsorption the protein of interest, interaction with importins and, finally, 
analysis of the interaction based on visualisation using alkaline phosphatase. 
Samples were brought to a concentration in the range of 0.1 to 1 µg per 100 µl in coating buffer 
(Table 2.7) and coated onto the surface of each well of a 96-well microtitre plate (Immuno™ 
plate MaxiSorp™ Surface, Nunc) in a volume of 100 µl per well. Plates were incubated 
overnight at 4°C to maximise adsorption. 
The following day, the sample coating buffer was discarded and wells were rinsed briefly with 
hybridisation buffer (HB) containing 1 % BSA (HB/BSA, 300 µl per well) (Table 2.7). 
Blocking was carried out .in HB/BSA (Table 2.7) for 1 hour at room temperature with gentle 
agitation (setting 5, Platform Rocker, Bio-line, Edwards Instrument Company). Following this, 
the wells were briefly rinsed again. This procedure was repeated using HB free of BSA (Table 
2. 7). Serial dilutions of the GST-tagged importin a (0 to 405 nM) and importin ~ (0 to 270 nM; 
see Section 2.4.1) were prepared in HB/BSA (Table 2. 7). Importin a and ~ were also associated 
into a heterodimer by incubation of equimolar amounts (270 nM) at room temperature for 15 
minutes in 1 x 1B containing lmM DTT (Table 2.7). Following pre-complexation, the 
heterodimer was similarly diluted in HB/BSA (Table 2. 7). Each dilution of importin was added 
to triplicate wells at 100 µl , and incubated overnight at 4°C, with agitation (setting 5, Platform 
Rocker, Bio-line, Edwards Instrument Company). 
The microtitre plates were washed 3 times using HB/BSA (Table 2.7), including incubation for 
15 minutes at room temperature with gentle agitation (setting 5, Platform Rocker, Bio-line, 
Edwards Instrument Company). The anti-GST primary antibody (Table 2.12) was diluted in 
Antibody buffer (Table 2.7) and aliquotted at 500 ng per well. The reaction was incubated for 3 
hours at room temperature on the platform rocker (setting 5, Bio-line, Edwards Instrument 
Company). Following extensive washing (10 times) using Wash buffer (Table 2.7), alkaline-
phosphatase conjugated anti-goat secondary antibody (Table 2.12) was diluted 1 :25000 in 
Antibody buffer (Table 2. 7) and 100 µl were added per well. The reaction was incubated for 1 
hour at room temperature, with gentle rocking, ·as described before. Following this, the plates 
were washed extensively using Wash buffer (Table 2.7). The protein/importin interaction was 
analysed using 1 mg/ml para-nitophenyl phosphate (Sigma) in 10 % diethanolamine buffer 
(Table 2. 7), added at 100 µ 1/ per well. The change in absorbance was monitored at 405 nm over 
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90 minutes using a microtitre plate reader (Molecular Devices) and SoftMax™ software 
(Macintosh). Raw data were analysed using Microsoft Excel software. Values were corrected 
against the background absorbance at O minutes and wells which were incubated without 
importin. Data in the linear range were selected and the change in absorbance was plotted 
against time (KaleidaGraph software, Macintosh). The value of each gradient (OD/minute) was 
plotted against importin concentration. The resulting curves were fitted using the function: 
B(x) = Bmax (1 - e-kx) 
where x is the concentration of importin, B is the level of importin bound and k is the slope of 
the curve (KaleidaGraph software, Macintosh or SigmaPlot, Jandel Scientific). The apparent 
dissociation constant (Ko) of the importin/protein interaction was determined from this equation 
as 0.693/k and represents the concentration of importins at which the level of binding was half 
the maximum. 
2.11. CONFOCAL LASER SCANNING MICROSCOPY 
The localisation of fluorescently labelled dextrans and DNA was monitored within the cell 
using confocal laser scanning microscopy (CLSM; MRC-600 and Radiance 2000, BioRad). 
Images obtained using CLSM were analysed using the NIH Image J 1.30 public domain 
software. 
2.11.1. Subcellular localisation of FITC-dextrans following electroporation into cells 
In order to determine the parameters for electroporation which would permit transfection of 
plasmid DNA exclusively into the cytoplasm of cells, while maintaining the integrity of the NE, 
the subcellular localisation of fluorescently labelled dextrans (FITC-dextran) introduced into 
HTC cells by electroporation was determined using CLSM. FITC-dextrans of MW 20 kDa and 
70 kDa were included at a final concentration of 0.5 mg/ml in the electroporation mix. HTC 
cells were electroporated at a range of voltages from 200 - 300 V ( essentially as described in 
Section 2.7.1, with FITC-dextrans substituted for DNA). Following post-electroporation 
recovery on ice for 10 minutes, cells were collected by centrifugation at 1500 rpm for 5 minutes 
(Eppendorf centrifuge, 5415C). The supernatant was discarded and the cells were rinsed twice 
in 500 µl of PBS, each time collected by centrifugation at 1500 rpm for 5 minutes (Eppendorf 
centrifuge, 5415C). Cells were finally resuspended in 500 µl of PBS. 
Slides were prepared for microscopy by creating a 'chamber' on each slide using 0.1-mm-thick 
double-sided pressure-sensitive tape (Scotch 3M) into which a hole of 0.8 mm in diameter was 
punched. A volume of 5 µl of the cell suspension was pipetted into this well. The well was 
sealed using a coverslip. Cells were brought into focus using 60 x magnification with oil 
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immersion (Bio-Rad MRC-600). CLSM images were captured using 5 scans in Kalman filter 
mode at speed 1 scan/second and gain 900. 
2.11.2. In vitro nuclear transport assay 
Nuclear import was analysed at the single cell level using CLSM, as described in Jans et al. 
(Jans et al., 1991), Efthymiadis et al. (1998) and Xiao et al. (1996a). HTC cells were used for 
the nuclear transport assay. Cells were grown on coverslips in 6-well tissue culture plates 
(Nunc) for 36 hours to 50 - 70 % confluence. In each well, DMEM media was replaced prior to 
use for the analysis of nuclear import with 2 ml of DMEM without phenol red and glutamine 
(ICN) containing 1 M HEPES/10% FCS. The cells grown on glass coverslips were rinsed with 1 
x IB (see Table 2.7) and excess liquid was drained by gravity flow. This was followed by 
addition of 3 µl 1 x IB to the layer of cells, onto which a single layer of tissue paper was placed. 
After 3 seconds, cells were mechanically perforated by rapidly removing the tissue paper. 
Slides were prepared as described above (Section 2.11.1 ). Reconstituted nuclear import mix was 
pipetted into the 'chamber' created on the slide. The nuclear import mix contained BSA (30 
mg/ml) or cytosolic extract (untreated reticulocyte lysate, Promega), an ATP-regenerating 
system (0.125 mg/ml creatine kinase, 30 mM creatine phosphate, 2 mM ATP) and the transport 
substrate or a control sample (70-kDa fluorescein isothiocyanate- or Texas-red-labelled dextran; 
Sigma) to assess nuclear integrity. The total volume was 5 µ1. The coverslip with perforated 
cells was placed with the cell-bearing surface face-down to the nuclear import mix and sealed 
with nail polish to prevent dehydration during the experiment. Experiments were performed at 
room temperature. 
Cells were brought into focus using a 60 x magnification oil immersion lens (Radiance 2000, 
BioRad). Scans were performed using settings of 5 scans in Kalman filter mode, scan speed 166 
ps, iris to 1.8 - 2.8 with offset 0 or 1. For each image, the laser power level, iris and offset were 
adjusted to achieve optimal resolution and brightness. Images were captured every 3 - 4 minutes 
over 15 - 45 minutes. 
2.12. STATISTICAL ANALYSES 
The Student's 2-tailed t-test for paired or unpaired experiments was used, as appropriate, for all 
statistical analyses (Microsoft Excel). The level of significance was set at p < 0.05. 
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CHAPTER3 
Importin binding properties of histones 
and chromatin assembly factors 
3.1. INTRODUCTION 
Histones are synthesised in the cytoplasm and, thus, must be translocated subsequently into the 
nucleus, where, once inside, they participate in an ordered sequential process of folding and 
compaction of DNA into chromatin. This process involves chromatin assembly factors such as 
NAP-1 (Ito et al., 1996; Fujiinakata et al., 1992) and Nl/N2 (Chang et al. , 1997; Dilworth et 
al., 1987). Acetylated histones and histone variants are often present in regions of chromatin 
that have higher transcriptional activity and are thought to play a role in the ordered 
disassembly of chromatin that enables gene transcription (Vermaak et al., 2003; Wade and 
Wolffe, 1997). Other proteins associated with chromatin, such as the high mobility group 
(HMG) proteins HMG-14 and -17, also play a role in remodelling to a more transcriptionally 
active structure by binding the nucleosome directly in such a way that nucleosome stability and, 
potentially, chromatin folding is altered (Bustin et al., 1995; Tremethick, 1994; Bustin et al. , 
1991). 
At the outset of this study, very little was known with respect to the mechanism for the nuclear 
transport of histones and other proteins associated with chromatin such as HMG-14, HMG-17, 
NAP-1 and Nl/N2. Sequence motifs similar to the T-ag NLS had been identified in histones Hl 
(Schwambom et al., 1998) and H2B (Moreland et al., 1987) only, while Nl/N2, HMG-14 and -
17 had been shown to harbour bipartite NLSs (Hu and Jans, 1999; Hock et al. , 1998; Table 3.2). 
Generally, protein import into the nucleus is mediated via the conventional NLS-dependent 
nuclear import pathway by the nuclear import proteins (importins) which bind NLSs within the 
protein to be transported (see Section 1.3.3). The extensive requirement for histones in the 
assembly of new chromatin during DNA replication implies the necessity for efficient 
mechanisms of nuclear import. As a first step towards understanding the nuclear import of 
histones, nucleosome-associated proteins and chromatin assembly factors, a modified ELISA 
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method was used to determine their binding properties to importin a, importin P and the alp 
heterodimer. 
3.2. HlSTONES ARE BOUND WITH IDGH AFFINITY BY IMPORTIN ~ 
An assay based on the ELISA ( described in detail in Section 2.10), previously used to quantitate 
the importin binding properties of a number of NLS-containing proteins that localise to the 
nucleus (Hubner et al., 1997; Xiao et al., 1997a), was used in this study also to the determine 
binding constants for histones. 
Briefly, the assay involved adsorbing the protein of interest to a microtitre plate. The coated 
wells were incubated with importins over a series of concentrations, each in triplicate. The 
importins used were mouse importin a2 and importin P 1, expressed as OST-fusion proteins 
(Section 2.4.1). Binding affinity was determined for importin a and ~' individually, and also 
when associated into a heterodimer. The binding interaction was quantitated colourimetrically, 
based on alkaline phosphatase conversion of para-nitrophenyl phosphate, over a period of 90 
minutes. Absorbance data in the linear range were selected and the change in absorbance 
plotted against time (KaleidaGraph 2.13, Macintosh). The values of each gradient were plotted 
against the importin concentration and the resulting curves were fitted to the function B(x) = 
Bmax (1 - e-1cx), where x is the concentration of importin, B is the level of importin bound and k is 
the slope of the curve. The apparent dissociation constant (KD) of the importin/protein 
interaction, representing the concentration of importin at which the level of binding is half-
maximal, was calculated using from this function (0.693/k). 
Peptide Pl0l (1 10PGSDDEAAADAQHAAPPKKKRKV132; Hubner et al., 1997) which 
includes the archetypal T-ag-NLS (highlighted in bold type-face) was used as a positive control 
for importin alp binding (Figure. 3 .1 ). P 101 demonstrated high affinity binding with importin 
alp having a KD of 3.2 + 0.3 nM (n = 7). This binding occurred predominantly through the a 
subunit, which showed a KD of 40.7 + 11.2 nM (n = 3) compared to the KD for the importin P 
subunit of 202.1 + 28.9 nM (n = 2). The role of the a subunit was also apparent in the level of 
maximal binding. When expressed as a percentage of importin a!P, the a subunit showed 
maximal binding around 81 %, whereas that of the p subunit was 8 %. 
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Figure. 3.1. The archetypal T-ag NLS is recognised with high affinity by importin a!P through 
importin a binding. Binding curves of PlOl, comprising the T-ag NLS, for importin a, p and the wp 
heterodimer are shown. Data were generated using an ELISA, in which microtitre plates were coated with 
1 µg of peptide Pl O 1 per well and incubated with increasing concentrations of importins (Section 2.10). 
Data were fitted using the function B(x) = Bmax (1 - e-kx), where x is the concentration of importin, B is 
the level of importin bound and k is the slope of the curve. The apparent dissociation constants (Kn) were 
calculated as 0.693/k and are indicated. Results shown are from a single typical experiment, performed in 
triplicate. 
The histones analysed were Hl ( calf thymus, Boehringer), the H2A/2B dimer (recombinant, 
Xenopus laevis sp., see Section 2.4.2), the H2AZ/2B dimer which contains the H2A variant 
histone, H2AZ (Faast et al., 2001; Clarkson et al., 1999; recombinant mouse histone; provided 
by M. Clarkson, Chromatin and Transcriptional Regulation Group, JCSMR) and the H3/4 
tetramer (non-acetylated, isolated from chicken long chromatin, and acetylated, isolated from 
HeLa cells; provided by L. Hyman, Chromatin and Transcriptional Regulation Group, JCSMR). 
When these experiments were conducted, histones H2A and H2B had been proposed to be 
transported to the nucleus as heterodimers (Moreland et al., 1987) and H3 and H4 as a 
heterotetramers ( Chang et al., 1997) and, hence, importin binding was determined for the 
dimeric and tetrameric forms ofH2A/2B and H3/4, respectively. 
All of the histones tested bound with high affinity to the importin a/~ heterodimer and this 
interaction appeared to be mediated largely through importin ~' since maximal binding by 
importin ~ was 85 to 100 % that of importin a/~ (Figures 3.2 and 3.3; Table 3.1). Binding by 
importin a was low in all cases (Kos > 50 nM). 
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Table 3.1. Binding properties of importins to histones and chromatin associated proteins. 
lmportin a/~ Importin a lmportin ~ 
Protein K0 (nM)A Bmax A Kn (nM) Bmax Relative Kn (nM) Bmax Relative 
Brnax(¾)8 Bmax(¾)8 
Hl 1.4 ± 0.6 (3) 10.7 ± 0.2 96.3 ± 11.4 (3) 5.2 ± 0.5 48 2.7 ± 0.2 (3) 10.6 ± 1.0 99 
H2A/2B 9.2 ± 3.6 (4) 3.8 ± 0.8 207.2 ± 82.2 (3) 4.2 ± 1.2 . 109 5.5 ± 0.5 (3) 3.3 ± 1.3 87 
H2AZ/2B 1. 1 ± 0.4 (3) 8.0 ± 1.0 56.1 ± 13.1 (2) 5.7 ± 0.9 71 4.0 ± 1.6 (3) 8.9 ± 1.6 111 
H3/4 3.7 ± 1.4 (3) 6.3 ± 0.3 152.7 ± 26. 7 (3) 4.5 ± 1.0 72 8.2 ± 0.1 (3) 5.4 ± 0.3 86 
H3/4-acc 56.6 ± 10.4 (4) 2.6 ± 0.5 252.6 ± 43.6 (3) 3.5 ± 1.1 134 29.0 ± 3.4 (3) 1.1 ± 0.1 41 
HMG-14 15.5 ± 4.0 (3) 8.8 ± 2.2 200.5 ± 6.1 (3) 3.1 ±0.8 35 173.8 ± 38.0 (4) 2.5 ±0.6 29 
HMG-17 3.5 ± 1.2 (4) 9.7 ± 1.6 187.0 ± 29.4 (3) 4.2 ± 0.7 43 149.0 ± 2.0 (3) 2.5 ±0.8 26 
Nl/N2 1.6 ± 0.1 (3) 10.7±3.1 150.4 ± 32.5 (3) 2.9 ± 0.6 17 197.2 ± 31.4 (3) 3.9 ± 1.3 23 
NAP-1 115.0 ± 29.0 (3) 1.5 ± 0.3 248.0 ± 23.4 (4) 2.8 ±0.3 183 89.4 ± 8.7 (3) 1.0 ± 0.4 68 
A Binding parameters were determined using an ELISA-based assay (see Figures 3 .2 - 3 .5), as described in the Materials and Methods (Section 2.10). Curves were fitted to 
experimental data using the function B(x) = Bmax (1-e-kx), where xis the concentration of importin, Bis the level ofimportin bound and k is the slope of the curve. Kn, the 
apparent dissociation constant representing the importin concentration at which binding is half-maximal, was calculated as 0.693/k. Bmax is the maximum level of importin 
binding. Results represent the mean+ SEM. Individual experiments were performed in triplicate, with the number of experiments indicated in parentheses. 8 The relative Bmax is expressed as a percentage of the Bmax for a/~. 
c Acetylated hi stone H3/4; see Table 3 .2 for the sites of acetylation. 
Of the histones, Hl showed the highest binding affinity for importin p with a Ko of 2.7 + 0.2 
nM (n = 3) (Table 3.1; Figure 3.2). The lack of a significant difference between the binding 
affinity for importin p and importin a!P (p = 0.1, n = 3) indicates the essential role of importin 
p in the binding of H 1 to importin. 
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Figure 3.2. Histone Hl is recognised with higher affinity by importin ~ than importin a. Microtitre 
plates were coated with 4 pmol of histone Hl, and binding affinity of importin a, ~ and the a/~ 
heterodimer determined using an ELISA (Section 2.10). Binding curves for importin a, ~ and the ex/~ 
heterodimer are shown. The apparent dissociation constants (K0 ) were calculated as 0.693/k from the 
function B(x) = Bmax (1 - e-kx) where xis the concentration of importin, B is the level of importin bound 
and k is the slope of the curve. Results represent a single typical experiment, performed in triplicate. 
Pooled data are shown in Table 3 .1. 
H2A/2B and H2AZ/2B displayed different importin binding affinities. Importin a, P and the 
alp heterodimer all showed markedly higher binding to H2AZ/2B than to H2A/2B (p = 0.009 
for importin alp, Table 3.1; Figure 3.3a). This was indicated by both the lower Ko values and 
the higher maximal binding (greater than 50 %) by importin a!P and p to H2AZ/2B. For both 
H2A/2B and H2AZ/2B, however, importin binding occurred predominantly through importin p. 
Binding of H3/4 tetramers, with and without acetylation, by importin subunits was compared 
also. The affinity of importins a!P and p for H3/4 was significantly diminished when H3/4 was 
acetylated (p = 0.01, n = 4 and p = 0.0009, n = 3, respectively), as was the level of maximal 
binding (by greater than 60%; Table 3.1; Figure 3.3b), although, binding remained 
predominantly mediated by the importin p rather than the a subunit. 
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Figure 3.3. Importin ~ binds core histones with high affinity. Importin binding curves for H2A/2B 
and H2AZ/2B are shown in (a) and for acetylated and non-acetylated H3/4 are shown in (b). Microtitre 
plates were coated with 0.14 µg ofhistones (4 pmol) per well and binding affinity data for importin a,~ 
and the a/~ heterodimer was collected and analysed as described previously (Section 2.10). Results for 
importin a/~, a and ~ and are shown in the left, middle and right panels, respectively. The binding data 
were fitted to the function B(x) = Bmax (1 - e-kx), where xis the concentration of importin, B is the level of 
importin bound and k is the slope of the curve, from which the apparent dissociation constants (Ko) were 
calculated (0.693/k). The K0 values indicated represent the results from this single typical experiment, 
performed in triplicate. Pooled data are shown in Table 3 .1. 
3.3. IMPORTIN BINDING PROPERTIES OF THE CHROMATIN-ASSOCIATED PROTEINS HMG-14 
AND-17 
The ELISA was used to assess importin binding to the nucleosome associated proteins HMG-
14 and -17 (provided by L. Hyman, Chromatin and Transcriptional Regulation Group, JCSMR). 
Unlike the observation for the core histones, the importin a/~ heterodimer dominated HMG-14 
and -1 7 binding. Importin a mediated binding in_ the context of the importin a/~ heterodimer. 
This is reflected in the maximal level of binding by importin a being greater than that by 
importin ~ alone (Table 3.1; Figure 3.4). HMG-14 and -17 were bound with similar affinity by 
the importin a/~ heterodimer and the individual subunits (Figure 3.4). This result may stem 
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from the high sequence conservation within the proposed NLS motifs of these proteins (Hock et 
al., 1998). 
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Figure 3.4. Importin binding to the chromatin-associated proteins HMG-14 and -17. Binding curves 
for both HMG-14 and -17 by importin a/~, a and ~ are shown in the left, middle and right panels, 
respectively. Experimental data were generated and analysed as described in the legend to Figure 3.3. 
Note that the scale of the y-axis is higher for the left panel. Results represent a single typical experiment, 
performed in triplicate, with pooled data shown in Table 3 .1. 
3.4. IMPORTIN BINDING PROPERTIES OF THE CHROMATIN ASSEMBLY FACTORS NAP-1 AND 
Nl/N2 
The affinity of importin for the chromatin assembly factors Nl/N2 and NAP-1 (provided by N. 
Siddon, Chromatin and Transcriptional Regulation Group, JCSMR) was also assessed by the 
ELISA. Importin a/~ demonstrated high binding affinity for Nl/N2 (Ko= 1.6 + 0.1 nM, n = 3), 
similar to that of the Pl0l positive control peptide which contains the T-ag-NLS (Ko= 3.2 + 
0.3 nM, n = 7; see Section 3.2). Separately, each of the importin subunits demonstrated similar 
binding affinities and levels of maximal binding (Table 3.1; Figure 3.5). Overall, these 
interactions were much weaker than importin a/~. 
In contrast, NAP-1 was bound with low affinity by importin a/~ (Ko= 115 + 29 nM, n = 3) and 
this interaction appeared to be mediated through the ~ subunit, which contributed higher 
binding affinity than the a subunit (Table 3 .1; Figure 3. 5). 
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Figure 3.5. lmportin binding to the chromatin assembly proteins Nl/N2 and NAP-1. Microtitre 
plates were coated with 0.1 µg ofNl/N2 and NAP-1 per well and binding affinity data of importin a,~ 
and the ex/~ heterodimer were collected using an ELISA (Section 2.10). Data were analysed as described 
previously and binding curves for importin a, ~ and the ex/~ heterodimer are shown. Note that the scale 
of the y-axis is higher for the left panel. The apparent dissociation constants (Kn) indicated represent the 
results from this single typical experiment. Pooled data are shown are Table 3 .1. 
3.5. DISCUSSION 
At the outset of this study, the nuclear import pathways for histones and other chromatin-
associated proteins were ill-defined. The results presented in this chapter were the first 
quantitative data for the binding of histones, other chromatin-associated nuclear proteins and 
chromatin assembly factors by importins (Johnson-Saliba et al., 2000). The results indicated 
that the import of histones into the nucleus may be mediated exclusively by importin p, whereas 
import of the chromatin-associated proteins and Nl/N2 relies on the previously well-
documented importin alp pathway. 
Despite the presence of multiple sequence elements in Hl resembling the T-ag NLS (see Table 
3.2; Schwa1nborn et al., 1998), which is recognised by importin alp, Hl import into the nucleus 
had been shown (using an in vitro permeabilised cell system and fluorescence microscopy) to 
be mediated by importin p in a heterodimeric association with importin 7 (Jakel et al., 1999). 
The data presented here are consistent with these findings. The ELISA method used also 
revealed a high affinity interaction between importin p and histone Hl (in the nM range, around 
50-fold greater than that between importin a and Hl - see Table 3.1). While this is in contrast 
to the importin binding properties of conventional NLS-containing proteins, such as T-ag, 
where importin a mediates NLS recognition, importin p has been implicated as the sole 
mediator of nuclear import of several other proteins including HIV-1 Rev (Truant and Cullen, 
1999; Henderson and Percipalle, 1997), GAL4 (Chan et al., 1998), CREB, Fos, Jun (Forwood 
et al., 2001a), SRY (Forwood et al., 2001b) and TRF (Forwood and Jans, 2002). These proteins 
have in common with histones the fact that they all bind either DNA or RNA. High affinity 
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binding by importin ~ may therefore be an emerging feature of proteins which may be broadly 
classified as DNA/RNA-binding. Some proteins such as cyclin Bl (Moore et al., 1999) and 
PTHrP (Lam et al., 1999), which do not appear to bind DNA or RNA, however, also seem to be 
imported into the nucleus by this pathway. 
Table 3.2. NLS sequences and acetylation sites in histones and other chromatin-associated 
proteins. 
Protein 
Hl 0 
H2A 
H2AZ8 
H2B 
H3 
NLSA 
PVKKAKKKLAA TPKKAKK159 
KTVKAKPVKASKPKKAKPVKPKAKSSAKRAGKKK 193 
SGRGKQGGKARAKAKSRSSRAGLQFPVGRVH 
RLLRKGNYAERVGAG46 
AGGKAGKDSGKAKTKAVSRSQRAGLQFPVG 
RTHRHLKSRTT40 
PEPAKSAPAPKKGSKKALTKAQKKDGKKRKRM 
SRKESYSIYIYKVLKQVHPD52 
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGV 
KKPHRYRRPGTV ALREIRRYQST58 
H4 SGRGKGGKGLGKGGAKRHRKVLRDNIQGITKP AIRR 
LARRGG42 
HMG-14 PKRK4 ....... KPKK32 . : ..... KGKRG54 
HMG-17 PKRK4 ....... PKKKAP AKK.48 ....... PKGKKG58 
Nl/N2 RKKRKTEEESPLKDKAKKSK554 
References 
(Schwambom et al. , 
1998) 
(Balicki et al., 2002; 
Baake et al., 2001a; 
Mosammaparast et al. , 
2001) 
Putative 
(Baake et al., 2001 a; 
Mosammaparast et al. , 
2001; Moreland et al., 
1987) 
(Mosammaparast et 
al., 2002b; Baake et 
al., 2001a) 
(Mosammaparast et 
al., 2002b; Baake et 
al. , 2001a) 
(Hock et al. , 1998) 
(Hock et al. , 1998) 
(Hu and Jans, 1999) 
A The NLSs are highlighted in bold type-face. The basic sequence is the amino acid consensus sequence 
for each histone, reported in Wells and McBride (1989). 
8 The H2AZ putative NLS is the N-terminal region, amino acids 1 - 40, based on NLS location within 
the other core histones. The sequence is from Suto et al. (2000). No studies have been performed 
defining the H2AZ NLS. 
Acetylation sites are indicated by arrows (Siddon and Tremethick, 1999). These can be seen to occur at 
lysine residues in the histone N-termini, close to the putative NLSs. 
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At the time of this study, a conventional NLS-like motif had been identified only in H2B (yeast, 
GKKKRSKA33 ; Moreland et al., 1987). Since this NLS closely resembled the T-ag NLS, it was 
believed that H2A/2B nuclear import would be mediated through the 'conventional importin 
a)~ pathway'. The results presented in this chapter, however, are not consistent with this idea. 
While the H2A/2B dimer was found to bind importin a/~ with high affinity, this interaction was 
not mediated by importin a, but rather by importin ~- This was found to be true for the H3/4 
tetramer also. 
Since this section of the study was completed, distinct NLSs have been identified within the N-
terminal domains of all the core histones in mammalian cells (Balicki et al., 2002; Baake et al., 
2001 b; Baake et al., 2001 a; Muhlhausser et al., 2001) and yeast (Mosamrnaparast et al., 2002a; 
Mosamrnaparast et al., 2002b; Mosamrnaparast et al., 2001 ). These studies are presented in 
detail in Section 1.5.2 but, briefly, fragments spanning the length of the core histones were 
generated as fusion proteins and nuclear import was reconstituted in permeabilised cells. While 
the minimal NLS-containing sequence in the H2B N-terminal was indeed found to localise the 
~-galactosidase fusion protein to the nucleus in an importin a/~-dependent manner, when in the 
context of the whole protein, it was indeed importin ~ that was shown to be the key mediator of 
nuclear import (Baake et al., 2001 b ). The nuclear import of H2A, H3 and H4 were also shown 
to be importin ~-mediated (Mosamrnaparast et al., 2002a; Mosamrnaparast et al., 2002b; Baake 
et al., 2001b; Baake et al., 2001a; Mosammaparast et al. , 2001; Muhlhausser et al. , 2001). 
In addition to the N-terminal NLSs, the central globular domains of the histones were proposed 
to form 'topogenic NLSs' which played a fundamental role in the overall importin binding 
properties (Mosamrnaparast et al., 2002b; Baake et al., 2001b; Baake et al., 2001a; 
Mosammaparast et al., 2001 ). The globular domains of the histones are involved in inter-
histone contacts, as revealed by analysis of the crystal structure of the nucleosome core particle 
(Luger et al., 1997). This implies topological masking of the globular domain NLSs in the 
context of histone transport to the nucleus in the form of the H2A/2B dimer and H3/4 tetramer. 
It is therefore likely to be the NLS within the histone N-terminus that directs nuclear 
translocation (Baake et al., 2001 a). Given this, it is possible that the H2AZ NLS sequence may 
be more readily recognised by importins than that of H2A, accounting for the higher binding 
affinity observed for the H2AZ/2B dimer than the H2A/2B dimer to importins (Table 3.1). 
Importin binding affinity for histones may be reduced by chemical masking of the NLSs. This 
may indeed be the case for the acetylated histones H3 and H4 as the sites of acetylation lie 
within the N-terminal NLS-containing regions (Table 3.2; Mosammaparast et al., 2002b; Baake 
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et al., 2001a) and would explain the lower affinity binding of importin a/~ and ~ to acetylated 
H3/4 compared to non-acetylated H3/4 (Figure 3.3b ). 
Although they also play a crucial role in nucleosome structure, the chromatin associated 
proteins differ from histones in that they do not bind DNA directly but instead interact with 
histones to mediate structural changes in chromatin (Bustin and Reeves, 1996). Importin a had 
been shown to be involved in the nuclear uptake of HMG-14 and HMG-17, which harbour 
bipartite NLSs (Hock et al., 1998; Table 3.2). This was demonstrated by fluorescence 
microscopy in experiments conducted using reconstituted Xenopus laevis nuclei and 
permeabilised mammalian cells (Hock et al., 1998). The ELISA results presented here 
demonstrate that HMG interacts primarily with importin a and provide a quantitative measure 
of this interaction. Similarly, Nl/N2, which also has a functional bipartite NLS, participates in a 
high affinity interaction with importin a/~, with a preference for importin a, consistent with the 
findings of a previous kinetic study (Hu and Jans, 1999; see Table 3.2). 
NAP-1 does not contain a typical NLS consensus motif (Fujiinakata et al., 1992) but does 
undergo nuclear localisation during the S-phase of cell division (Moss et al., 1976). Moreover, 
as it was found to be associated with H2A/2B in the cytoplasm (Ito et al., 1996; Fujiinakata et 
al., 1992), NAP-1 was assigned a role as the shuttle protein for H2A/2B translocation into the 
nucleus (Ito et al., 1996). Recently, the dual function of NAP-1 in the nuclear import and 
deposition of the H2A/2B cargo onto newly assembling chromatin was delineated 
(Mosammaparast et al., 2002a). This is presented in Section 1.5.2 and shown schematically in 
Figure 1.9. Briefly, Mosammaparast et al. (2002a) showed, using affinity chromatography and 
immunofluorescence studies in fixed cells, that yeast Nap 1 p simultaneously binds H2A/2B and 
Kap 114 ( corresponding to the mammalian importin ~ homologue importin 7), by which the 
entire complex is transported into the nucleus. Naplp was not found to interact with the other 
importins. The ELISA data presented in this section of work is consistent with this finding, 
indicating, similarly, that of the importins tested, the highest affinity for NAP-1 was exhibited 
by importin ~ (Table 3.1). H2A/2B was shown to localise to the nucleus also in the absence of 
Naplp, mediated by Kap114 (importin ~) alone (Baake et al., 2001b; Baake et al., 2001a; 
Mosammaparast et al., 2001 ). The ELISA used here demonstrated that this interaction was of 
greater affinity than the NAP-1/importin ~ interaction (see Table 3.1; Johnson-Saliba et al., 
2000). Together, these findings suggest that several pathways exist to ensure the nuclear import 
ofH2A/2B. 
The results presented here, together with those of others (Mosammaparast et al., 2002b; Baake 
et al., 2001b; Baake et al., 2001a; Mosammaparast et al., 2001; Muhlhausser et al., 2001; Jakel 
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et al. , 1999) suggest that histones are transported into the nucleus along distinct and efficient 
pathways. Despite falling well below the MWCO of the NPC ( ~ 45 kDa), which would permit 
nuclear uptake by passive diffusion, the existence of these pathways is consistent with the 
unconditional requirement for histones within the nucleus. Functionally, they may provide the 
cell with the means to regulate histone nuclear import, perhaps according to the changing 
requirements during the cell cycle. Practically, for the purposes of gene delivery, these 
pathways might provide an efficient route into the nucleus for a histone-mediated DNA-carrier 
system. 
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CHAPTER4 
In vitro assembly and transfection 
of chromatinised plasmid 
4.1. INTRODUCTION 
Given the high affinity interaction between histones and importins ( see Section 3 .2 and 
Johnson-Saliba et al., 2000), the existence of importin-mediated nuclear import pathways 
(Mosammaparast et al., 2002b; Baake et al., 2001b; Baake et al., 2001a; Mosammaparast et al. , 
2001; Muhlhausser et al., 2001) and the absolute requirement for histones in the nucleus, it is 
reasonable to propose that histones have potential as DNA-carrier proteins for gene delivery 
purposes. While the use of individual histones as DNA-carrier proteins for gene delivery has 
been described (reviewed in Section 1.5.3), their use in the form of histone octamers as found in 
chromatin has not. Gene delivery and expression might be enhanced by the assembly of plasmid 
DNA with histone octamers into chromatin, since the octameric structure may present multiple 
NLSs (see Table 3.2), thereby facilitating importin-mediated nuclear import. In addition, histone 
octamers provide a greater capacity to condense DNA than individual histones, thereby offering 
a greater degree of protection from cytosolic degradation; another key element to ensure 
efficient gene delivery. 
Histone octamers were reconstituted from recombinant histones H2A, H2B, H3 and H4 
(Xenopus laevis). The same recombinant histones were employed in solving the crystal structure 
of the nucleosome core particle (Luger et al., 1997) and, furthermore, may be generated in large 
quantities using a bacterial expression system (Luger et al., 1999). Histone octamers were 
assembled at various stoichiometries with a reporter plasmid. For the purposes of this work, this 
plasmid/histone octamer assembly is referred to as 'chromatin' and the different stoichiometries 
of octamers to plasmid as 'chromatin constructs'. Plasmid not assembled into chromatin is 
referred to as 'naked' while chromatin constructs are regarded as being 'more extensively 
chromatinised' or 'less extensively chromatinised' at high or low nucleosome densities, 
respectively, depending on the stoichiometry of the histone octamers. Each chromatin assembly 
was characterised usmg a variety of techniques, including sedimentation velocity 
ultracentrifugation, atomic force microscopy (AFM), a DNA supercoiling assay and 
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micrococcal nuclease (MNase) digestion. The chromatin constructs were introduced into 
cultured cells, using two different transfection methods ( electroporation and lipofection) and 
their suitability as vectors for gene delivery was assessed by detection of reporter gene 
expression using F ACS. 
4.2. CONSTRUCTION OF A REPORTER PLASMID FOR GENE EXPRESSION AND SUBCELLULAR 
TRACKING STUDIES 
The pGeneGrip™ plasmid (Gene Therapy Systems; Table 2.9) was chosen as the core plasmid 
for this study. pGeneGrip™ contains a NICS for the insertion of a gene of interest, the 
expression of which is driven by the CMV promoter and enhancer sequence. The plasmid also 
harbours specific sites (Grip™) for the attachment of a 'peptide nucleic acid label', such as a 
fluorescent probe for gene tracking experiments. This technology enables analysis of gene 
expression and DNA tracking to be performed in the same transfection experiment and is 
described in more detail in Section 2.2.16. The 'peptide nucleic acid labels' are comprised of 
two identical repeated sequences of nucleotides, in which the deoxyribose-phosphate backbone 
has been substituted for a peptide backbone (hence peptide nucleic acid or 'PNA'), linked by a 
hairpin loop at one end. At one of the free ends, the peptide backbone is derivatised with a 
functional group, such as fluorescein (to enable DNA tracking) or maleimide (to enable the 
attachment of peptides by thiol alkylation chemistry). The Grip™ site and PNA labels have 
complementary sequences and hybridisation is thus able to occur initially by Watson-Crick 
bonding. Ultimately, a triple helix hairpin loop structure is formed through PNA-DNA-PNA 
hybridisation, which has been shown to be stronger than DNA-DNA hybridisation and, thus, 
extremely stable under conditions of varying temperature and pH (Zelphati et al., 2000; Zelphati 
et al., 1999). 
Red fluorescent protein (RFP) was chosen as the reporter gene for this study. It permits the 
analysis of trans gene expression by virtue of its fluorescence characteristics ( excitation 
maximum at 558 nm and emission maximum at 583 nm). The Gateway™ cloning system (Life 
Technologies) was used to insert the coding region of RFP, from the pDsRed-Cl vector (Table 
2. 9), into the MCS of pGeneGrip ™ ( described in Section 2.2.15). Briefly, the cloning 
technology is based on site-specific recombination events of bateriophage A. Complementary 
attenuation (att) sites within the vectors recombine in reactions mediated by proteins from 
phage A and E. coli, which facilitate the exchange of DNA flanked by the sites. Cloning 
involved the generation of an Entry vector containing the RFP coding sequence, followed by 
recombination with a Destination vector engineered from pGeneGrip™. The product was the 
Expression vector pGeneGrip-RFP, comprising the coding RFP sequence inserted into the 
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pGeneGrip™ plasmid. These reaction schemes are presented in Figures 4.1 - 4.3 (all vectors 
and inserts are colour coded throughout the recombination reactions). 
a 
b 
PCR product 
~ 876 bps 
pEntry-RFP 
~ 3130 bps 
, 
I 
1306 
Hind.III 
1333 
II 
C 
Hpal 
Hpal 
l ~ 132 
BP recombination 
By-product 
d 
1 2 3 
4000 
3000 
SacII 
2000 
~830 1650 
~ 
I 
Hindill (unique site) 
SacII e 
l 
1 2 3 
f 
Hindill (un ique site) 
Figure 4.1. Generation of a Gateway~ompatible Entry vector containing the RFP cocling 
sequence. The generation of pEntry-RFP using the BP recombination reaction (Section 2.2.15.1 ) is 
shown. The coding region of RFP from pDsRed-Cl was PCR-amplified using custom primers including 
attB sites flanking the RFP gene (Table 2.10). The 'BP recombination reaction' between the attB-flanked 
RFP gene and attP-flanked pDONR201 TM vector cassette to produce the Entry clone containing the RFP 
gene flanked by attL sites is represented in (a), with the resultant plasmid restriction map shown in (b ) . 
The restriction analysis diagram ( c ), with the RFP insertion represented in red, shows the use of HindIII 
to verify the presence of an RFP-unique site, and HpaI and SacII to confirm directional cloning. A 
positive 'recombination' clone was confirmed by the presence of a unique HindIII site, shown in (d) lane 
3. The release of a fragment between 7 50 and 1000 bps ( ~ 83 0 bps) upon HpaI/SacII digestion confirmed 
orientation is shown in ( e) lane 3. 
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In order to generate the Entry vector (Figure 4.1; see Section 2.2.15.1 for detailed 
methodology), the coding region of RFP was PCR amplified from pDsRed-Cl (Clontech; Table 
2. 9) using custom primers (Life Technologies; Table 2.10) designed to insert attB sites flanking 
the gene. The RFP gene and plasmid pDONR201 ™ (Table 2.9) were recombined to generate 
pEntry-RFP by means of the 'BP clonase' reaction between the attB sites flanking the RFP gene 
and attP sites within pDONR20l™ (Figure 4.la and b). The recombination product was 
transformed into DH5a E. coli cells (Table 2.8; Section 2.2.1.2.) and colonies were screened by 
restriction analysis. The presence of an RFP-unique HindIII site and directional analysis using 
Hpal and SacII confirmed the identity of the desired plasmid, termed pEntry-RFP (see Figure 
4.l c- e). 
The Destination vector, pGeneGrip-DestA, was generated by inserting Destination cassette A 
(Gateway™ vector conversion system, Life Technologies) into the EcoRV site within the MCS 
of pGeneGrip by blunt-end ligation (Figure 4.2a and b; see Section 2.2.15.2 for detailed 
methodology). DB3. 1 ™ E. coli cells (Table 2.8; Section 2.2.1.2.) were transformed with the 
product of the ligation reaction, since they are resistant ( through a gyrase mutation) to the 
otherwise lethal ccdB gene found in the Destination cassette. Directional cloning restriction 
analysis (Figure 4.2c and d) was used to confirm the presence and orientation of the Destination 
cassette within selected clones. PCR analysis of the MCS (Table 2.10; Section 2.2.13) within 
the positive clones identified by restriction digestion (Figure 4.2d, lanes 3 and 7) confirmed the 
presence of the Destination cassette A (Figure 4.2e, lanes 2 and 3). 
The pEntry-RFP plasmid was reacted with pGeneGrip-DestA (described in Section 2.2.15.3). 
'LR clonase' was used to mediate recombination events between the attL-flanked RFP gene 
within pEntry-RFP and the attR-flanked Destination cassette A within pGeneGrip-DestA 
(Figure 4.3a and b ). The product of the recombination reaction was transformed into DH5a E. 
coli cells (Table 2.8; Section 2.2. 1.2.). Survival of DH5a E. coli colonies indicated loss of the 
lethal ccdB gene and hence successful recombination of the plasmids. The resulting clone, 
pGeneGrip-RFP, served as the reporter plasmid in this study. Colony PCR (5' and 3' 
pGeneGrip™ MCS primers, Gene Therapy Systems; Table 2.10; Section 2.2.13) was used to 
identify the presence and orientation of the inserted RFP gene within a number of colonies 
(Figure 4.3c). The positive colony was characterised by restriction digestion also with EcoRV, 
which released the inserted RFP gene and Xhol, which revealed the presence of a second 
restriction site due to the insertion of the RFP gene (Figure 4.3d and e ). 
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Figure 4.2. The production of the Destination vector, pGeneGrip-DestA. Destination cassette A (Life 
Technologies), flanked by attR sites, was blunt-end ligated into the EcoRV site within the MCS of 
pGeneGrip™ (a) to produce pGeneGrip-DestA, shown in (b) (see Section 2.2.15.2) as a restriction map 
The restriction analysis diagram in ( c) shows the boundaries of the Destination cassette A (in orange) at 
EcoRV restriction sites. The use of Sall for orientation cloning analysis is indicated. Sall digestion 
produced two fragments of 1595 and 5158 bps, which can be seen in agarose gel insert in ( d) (lanes 3 and 
7). This was confirmed by PCR analysis across the MCS of the vector (5' and 3' pGeneGrip™ primers; 
see Table 2.10), shown in ( e ), where lanes 2 and 3 represent the positive clones corr~sponding to lanes 3 
and 7 in ( d). Lane 4 represents the pGeneGrip vector with the low molecular weight band corresponding 
to the MCS (61 bps). Controls included the ddH20 blank for the PCR reaction (lane 5) and Destination 
cassette A (lane 6). 
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Figure 4.3. Recombination of the Entry vector pEntry-RFP with the Destination vector pGeneGrip-
DestA produces the Expression vector pGeneGrip-RFP. The generation of pGeneGrip-RFP using the 
'LR recombination reaction' between pEntry-RFP and pGeneGrip-DestA (see Section 2.2.15.3), is 
shown. LR clonase recombines the attL and attR sites in an 'LR recombination' (a) to produce the 
Expression vector, pGeneGrip-RFP, the restriction map of which is shown in (b). The agarose gel image in ( c) shows the components of the LR reaction and PCR verification of the Expression vector. Lane 2 
contains the pEntry-RFP and pGeneGrip-DestA mix before recombination. Lanes 3 - 5 contain 3 separate 
LR reactions. Disappearance of the band corresponding to pEntry-RFP and the appearance of higher 
molecular weight bands in lane 3 implies a successful recombination. Lanes 7 - 10 contain the PCR 
amplification products of 4 recombination colonies arising from LR reaction 1 (5' and 3' pGeneGrip™ primers; see Table 2.10). Lane 7 shows an insert corresponding in size to RFP (above 850 bps). A 
restriction analysis diagram in (d), with RFP coloured in red, shows the use of EcoRV (flanking the RFP insert) and Xhol (additional Xhol site due to RFP) to confirm the recombination reaction. Digestion products of the constituent recombination vectors can be seen in the agarose gel image in ( e ). Xhol has 
single restriction sites in both the RFP gene and in pGeneGrip, and therefore produces single cuts in 
pEntry-RFP and pGeneGrip-DestA, but releases 2 fragments of 2901 and 2926 bps from pGeneGrip-RFP. 
EcoRV does not digest pEntry-RFP, but releases the Destination cassette A (1700 bps) from pGeneGrip-
DestA and releases RFP (864 bps) from pGeneGrip-RFP. 
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4.3. RECONSTITUTION OF THE IDSTONE OCTAMER AND ASSEMBLY OF THE REPORTER 
PLASMID INTO CHROMA TIN 
Recombinant core histones H2A, H2B, H3 and H4 (Xenopus laevis) were purified from 
BL21DE3plysS E. coli cells ( described in Sections 2.4.2.1 and 2.4.2.2) and were assembled into 
histone octamers (illustrated schematically in Figure 4.4a) according to the method described by 
Luger et al. (1999) (see Section 2.4.2.3). 
Briefly, each lyophilised histone was solubilised in 1.5 ml of Unfolding buffer containing 7 M 
urea and the concentrations were determined spectrophotometrically by absorbance at 2 7 6 nm. 
The H2A and H2B solutions were adjusted to equimolar concentration using Unfolding buffer. 
The concentrations of H3 and H4 were adjusted similarly, but were 98 % that of H2A. The 
slight molar excess of H2A and H2B ensures maximal incorporation of H3 and H4 into the 
octamer, since under octamerisation conditions excess H3 and H4 form tetramers (H32/H42) that 
are difficult to purify away from the octamer (Luger et al., 1999). The histone solutions were 
mixed, the final concentration was adjusted to 1 mg/ml of total protein using Unfolding buffer 
and the octamer assembly reaction was transferred into dialysis tubing (MWCO 6000 - 8000 
Da, Spectra/Par® membrane, flat width 10 mm, Spectrum Laboratories). 
The octamer assembly reaction was dialysed ( overnight, at 4 °C) against three changes of 
Refolding buffer (containing 2.2 M NaCl) and thereafter concentrated to around 1 ml (Centricon 
filter, YM-10, Amicon). The reconstituted octamers were purified using gel filtration (HiLoad 
16/60 Superdex 200 prep grade column, Pharmacia) in the presence of Refolding buffer. 
Fractions corresponding to peaks on the chromatogram generated at 276 nm were analysed 
using SDS-PAGE (18 % polyacrylamide; Section 2.3.2). A typical chromatogram and gel 
analysis are presented in Figure 4.4b and c, respectively. Fractions containing the highest level 
of octamer (represented by an equimolar amount of each of the four constituent histones, as seen 
in Figure 4.4c fractions 64 - 70) were pooled and quantitated spectrophotometrically at 27 6 nm 
(E = 0.45; Luger et al., 1999) before use. 
The number of histone octamers required to yield a physiological nucleosome density on the 
pGeneGrip-RFP reporter plasmid (5889 bps), based on the spacing of one histone octamer for 
every 230 bps (~150 bps per octamer plus ~80 bp of linker DNA), was calculated to be around 
25. The purified octamers and pGeneGrip-RFP were assembled into chromatin constructs using 
the octamer transfer salt gradient method described by Thomas and Butler (Luger et al. , 1999; 
Richmond et al., 1988; Thomas and Butler, 1977). The methodology, described in detail in 
Section 2.5.2, is based on the principle of progressively decreasing the salt concentration 
97 
a 
b 
C 
Fractions 
kDa 
26.0 -
19.6 -
14.9 -
8.4 -
H3/4 
tetramer 
62 64 
l 
66 68 
J-13• 
70 
High MW 
aggregates 
72 74 
( 
\. 
Histone 
octamer 
\. 
Unincorporated 
Octamer H2N2B 
control 76 78 80 82 
• 
84 
. 
' 
l 
86 
H2A 
H2N2B 
dimer 
88 
H3 
/ H2B 
--H2A 
H4 
Figure 4.4. Histone octamer purification. Core histones H2A, H2B, H3 and H4 were reconstituted into 
octamers, shown schematically in (a). H2A and H2B form a dimer, two of which associate with the 
tetramer formed by H3 and H4 to form an octamer comprising [2(H2A/H2B)/(H3i/H42)]. Histone 
octamers were purified using gel filtration chromatography as described in Section 2.4.23 The 
chromatogram and corresponding SDS-PAGE analysis of fractions corresponding to peaks (indicated by 
arrows) on the chromatogram are shown in (b) and ( c), respectively. Gel filtration was performed using a 
HiLoad 16/60 Superdex 200 prep grade column (Pharmacia) in Refolding buffer (see Table 2.4) at 4°C. 
The chromatogram was generated at 276 nm. The chart recording speed was 2 mm/minute. Fractions of 1 
ml were collected every minute. The first peak (fractions 42 - 48) was comprised of high MW 
aggregation products. The second peak (fractions 62 - 75) was comprised of the reconstituted octamer as 
seen by equimolar amounts of the four constituent histones in the gel analysis (shown in c). The third 
peak contained excess H2A/2B (fractions 76 - 88), with traces of H3 and H4 (c). For this preparation, 
fractions 63 - 72 were pooled and the concentration of octamer determined spectrophotometrically at 276 
nm. The control sample (boxed) was previously reconstituted H2A-octamer (with proven biological 
activity). The identity of the constituent histones is indicated; H2A and H2B co-migrate. 
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of the chromatin assembly buffer to facilitate DNA association with the octamers (Kunze and 
Netz, 2000). Lowering the initial salt concentration of the buffer from 2.2 M to physiological 
salt concentration (135 mM) would destabilise the octamer but interactions with DNA are able 
to substitute for the electrostatic stabilising effect of salt. DNA thus associates with the octamer 
to form a nucleosome, the basic structural unit of chromatin (see Figure 1.8). Typically, 50 µg 
of plasmid was assembled into chromatin to produce a range of constructs at stoichiometries of 
0, 1, 2, 4, 10, 25 or 40 histone octamers per plasmid. The yield of chromatin was determined 
spectrophotometrically on the basis of DNA absorbance at 260 nm. 
Before proceeding with the transfection studies, it was important to ensure that authentic 
chromatin had been assembled by using a variety of analytical approaches. These are described 
in the following section. 
4.4. CHARACTERISATION OF THE CHROMATINISED REPORTER PLASMID 
Sedimentation velocity ultracentrifugation, DNA supercoiling and atomic force microscopy 
(AFM) were used to characterise the nature of the chromatin structure formed upon the 
interaction of the plasmid DNA and histone octamers. However, as a definitive measure of 
chromatinisation of the pGeneGrip-RFP reporter plasmid, the formation of nucleosomes was 
verified using the micrococcal nuclease (MNase) digestion assay for each chromatin assembly 
reaction carried out for this study. 
4.4.1. Sedimentation velocity ultracentrifugation reveals association of histone octamers 
with pGeneGrip-RFP 
Analytical ultracentrifugation was used to determine the sedimentation coefficients (s-values; 
Svedberg units, S) of the various chromatin constructs, as described in Section 2.5.3. The rate of 
sedimentation depends on a number of factors, including the molecular mass, size and shape of 
the molecules of interest. Information may also be derived about sample purity, conformational 
changes, subunit stoichiometry and assembly or dissociation of multimeric macromolecular 
complexes. Macromolecules move in a characteristic formation, called a lamella or 'boundary' , 
towards the bottom of the ultracentrifugation cell under the influence of a strong centrifugal 
field at a rate which is proportional to theirs-value. 
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Figure 4.5. Sedimentation velocity ultracentrifugation analysis of the reporter plasmid, pGeneGrip-
RFP. Sedimentation velocity ultracentrifugation was used to determine the sedimentation coefficient (s-
value) of pGeneGrip-RFP, as described in Section 2.5.3. 6 µg of DNA were analysed in TE buffer, 
compared to a reference sample containing TE alone. Sedimentation was carried out overnight at 23000 
rpm and 21 °C. Typical ultracentrifugation-generated data analysed according to the method of van Holde 
and Weischet (1978) using Ultrascan software (Linux) is shown. The velocity plot, in (a), shows 30 
absorbance scans at 260 nm of the DNA molecule boundary as it migrates towards the base of the 
centrifugation cell. The distance from the centre of rotation is represented on the x-axis; absorbance is 
represented on the y-axis. The van Holde and Weischet algorithm divides each boundary scan into 20 - 70 
horizontal divisions and calculates an apparent s-value at each division. These are plotted against the 
inverse square root of time to produce an extrapolation plot, shown in (b ). Linear extrapolations through 
each series of horizontal divisions intercept the y-axis, providing the true s-values for each boundary 
fraction . The boundary fraction is plotted against the s-values to obtain an integral distribution plot, 
shown in (c). Boundary fraction is represented on the y-axis expressed as a percentage; the sedimentation 
coefficient is represented on the x-axis. The sedimentation coefficient (S) is read at the 50 % boundary 
fraction , delineated in red. 
Figure 4.5a is a typical example of a velocity plot of the unchromatinised reporter plasmid, 
pGeneGrip-RFP, showing a series of absorbance curves of the sample migrating towards the 
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bottom of the ultracentrifugation cell. This data was analysed using the UltraScan software 
(Linux) according to the method of van Holde and Weischet, in which the s-value is determined 
by measuring the rate of movement of the boundary midpoint (Hansen et al. , 1994; Van Holde 
and Weischet, 1978). An algorithm divides each scan into 20 - 70 horizontal divisions and 
calculates apparent s-values from the radial point of each division. The apparent s-values are 
plotted against the inverse square root of time to generate a van Holde and Weischet 
extrapolation plot (Figure 4.5b). Linear extrapolations are made through each series of 
horizontal divisions and intercept the Y-axis. These are the true s-values for each boundary 
fraction. Finally, the boundary fraction is plotted against the s-values to obtain a van Holde and 
Weischet integral distribution plot (Figure 4.5c). The sedimentation coefficient may then be 
read as the averages-value occurring at the 0.5 boundary fraction (50% on the distribution plot, 
Figure 4.5c). The sedimentation coefficient for pGeneGrip-RFP was found to be 23 ± 0 S (n = 
2). 
pGeneGrip-RFP was assembled into chromatin constructs at histone octamer stoichiometries of 
1, 10, 25 and 40 per plasmid (described in Section 2.5.2), which were analysed similarly. 
Sedimentation velocity ultracentrifugation analysis revealed that as the number of octamers 
associated with the plasmid increased the sedimentation curves shifted towards the right 
compared to the reporter plasmid alone (0 octamers per plasmid), in accordance with increasing 
s-values (Figure 4.6a; Table 4.1). The number of octamers associated with the plasmid was 
found to be directly proportional to the sedimentation coefficient (Figure 4.6b; linear regression 
R2 = 0.995). This confirmed that the octamers had assembled quantitatively onto the plasmid 
DNA. 
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Figure 4.6. Sedimentation velocity ultracentrifugation analysis of the chromatin constructs. 
Chromatin constructs were assembled at 0, 1, 10, 25 and 40 molar ratios of octamers to DNA 
(pGeneGrip-RFP) using the octamer transfer salt dialysis method (Section 2.5.2) and sedimentation 
velocity ultracentrifugation was used to determine the sedimentation coefficients (s-values). 
Sedimentation data was captured and analysed as described in Section 2.5 .3. Van Holde and Weischet 
distribution plots for each chromatin construct from a single experiment are shown in (a). The s-value is 
read at the midpoint of each curve, which is indicated in red. The sedimentation coefficients (S) were 
plotted against the number of octamers associated with the plasmid, shown in (b ). Each point represents 
the average of two experiments, except for 10 octamers per plasmid which was performed once. Error 
bars represent the mean+ range/2 and where not shown fall within the symbols. See also Table 4.1. 
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Table 4.1. Sedimentation coefficients of the chromatin 
constructs. 
Octamers/plasmid 
0 
1 
10 
25 
40 
Sedimentation 
coefficient (S)A 
23 ± 0 
25.5 ± 0.4 
34 
53 ± 2.1 
66± 0 
Calculated 
MW8 (Da) 
3.89 X 106 
4.00 X 106 
4.97 X 106 
6.60 X 106 
8.23 X 106 
A Sedimentation coefficients (s-values, S) were determined using 
sedimentation velocity ultracentrifugation analysis, as described 
in Section 2.5.3 (see Figures 4.5 and 4.6). Results represent the 
mean + range/2 for two separate estimations, with the exception 
of 10 octamers per plasmid which was performed once. 
8 The calculated molecular weight (MW) was based on the MW 
of the histone octamer (108486 Da) and pGeneGrip-RFP (5889 
bps, which equates to 3886740 Da). 
4.4.2. Assembly of pGeneGrip-RFP into chromatin in vitro induces supercoiling 
The supercoiling assay was used in order to verify that the increase ins-values observed were 
due to nucleosome formation and not simply due to his tones binding stochastically to the DNA. 
The degree of supercoiling of a plasmid following chromatin assembly provides a sensitive 
assay with which to examine nucleosome formation (see Section 2.5.4 for detailed method). 
One nucleosome introduces one negative supercoil in the plasmid DNA. The assay is based on 
the premise that supercoiling may be observed by agarose gel analysis once the histones are 
removed from the DNA using SDS and proteinase K digestion. 
Topoisomerase I is used to remove intrinsic negative supercoils from the plasmid, changing its 
conformation from supercoiled to open circular. The ' relaxed' plasmid migrates with an 
electrophoretic mobility consistent with the 'open circular form ' on an agarose gel (see Figure 
4.7a lane 2 and 4.7b lane 2). Once this is accomplished, histones are titrated into the chromatin 
assembly reaction. As the histones interact with the DNA, supercoiled forms of the plasmid are 
induced due to nucleosome formation, even in the presence of Topoisomerase I (see Figure 4.7a 
lanes 2 - 5 and 7 - 8 and 4.7b lane 3). 
This assay was used to demonstrate the feasibility of assembling a large plasmid into chromatin, 
as smaller plasmids such as the 3.4 kb pHBTS had been assembled into chromatin in the 
laboratory but larger plasmids such as the 5.9 kb pGeneGrip-RFP reporter plasmid, used in this 
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study, had not. A small scale chromatin assembly using the NAP-I-dependent method (Section 
2.5.1) was carried out on the small pHBTS plasmid (Figure 4.7a lanes 1 - 5) and then on the 
larger pTRCA-GFP plasmid (5.1 kb) as a proof-of-principle (Figure 4.7a, lanes 6 - 8). Addition 
of only the H3/4 tetramer did not generate the supercoiled form (seen in Figure 4.7a, lanes 2 and 
7). Topoisomers formed in the presence of the H3/4 tetramer with increasing amounts of the 
H2A/2B dimer and extended into the supercoiled form of the plasmid (Figure 4.7a, lanes 3 - 5 
and 8). H2A/2B dimer titration beyond the optimal supercoiled state resulted in the reversion to 
more relaxed states of the plasmid (not shown). 
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Figure 4.7. Supercoiling analysis of chromatinised pGeneGrip-RFP. Generation of the supercoiled 
form of the reporter plasmid, pGeneGrip-RFP, in the presence of core histones was monitored using the 
supercoiling assay (described in Section 2.5.4). The agarose gel analysis (1 %) is shown for pHBTS (3.4 
kb) and pTRCA-GFP (5.1 kb) in (a) , before the reaction was scaled up for the larger plasm.id pGeneGrip-
RFP (5.9 kb) shown in (b). Prior to the assay, plasmids were incubated with Topoisomerase I to induce a 
conformational change from the supercoiled state to open circular; (a) lanes 2 and 7 and (b) lane 2 . Upon 
the further addition of increasing amounts of the H2A/2B dimer topoisomers are formed; (a) lanes 3 - 5 
and lane 8. The optimal supercoiled state is shown in (a) lanes 5 and 8 and (b) lane 3. Molar ratios of 
DNA, H2A/2B and H3/4 are denoted. 
103 
Based on these results, the NAP-1 chromatin assembly reaction for pGeneGrip-RFP plasmid 
(5.9 kb) was scaled up accordingly. As seen in Figure 4.7b (lane 3), supercoiling was also 
induced in pGeneGrip-RFP. This demonstrated that the larger pGeneGrip-RFP plasmid could be 
efficiently assembled into chromatin also. 
4.4.3. Micrococcal nuclease digestion reveals the presence of nucleosomes in chromatinised 
pGeneGrip-RFP 
Resistance to digestion by MNase (see Section 2.5.5 for methodology) provides definitive proof 
of nucleosome formation upon reaction of plasmid DNA with histone octamers and, for this 
reason, was used to verify each chromatin assembly reaction carried out for this study. 
Chromatin constructs were assembled, using the octamer transfer by salt dialysis method 
(Section 2.5.2), at stoichiometries of 0, 1, 10, 25 and 40 histone octamers per pGeneGrip-RFP 
plasmid. 
In principle, MNase digests the unprotected linker DNA between consecutive nucleosomes, 
leaving the DNA associated with nucieosomes intact (see Figure 4.8a). Digestion is monitored 
over a course of time, upon completion of which, DNA is recovered and analysed using agarose 
gel electrophoresis (Figure 4.8b). 
The hallmark of chromatin is the generation of a ladder of bands following digestion with 
MNase. These bands correspond to DNA associated with a single nucleosome (mono-
nucleosomal DNA), two tandem nucleosomes ( di-nucleosomal DNA), three tandem 
nucleosomes (tri-nucleosomal DNA), and so on depending on the degree of accessibilty of the 
DNA during the time period of the experiment. The appearance of such a banding pattern 
demonstrates the formation of a nucleosomal array definitively (indicated with arrows in Figure 
4.8), each protecting about 140 bps of DNA. 
Apart from indicating the presence of nucleosomes, gel analysis also provides information on 
the degree of DNA protection since the rate of cutting is proportional to the degree of 
chromatinisation ( or, in other words, the density of nucleosomes). For instance, the construct 
harbouring only one octamer was digested rapidly (similar to free DNA; not shown), with the 
appearance of the mono-nucleosomal band after only 10 minutes of incubation with MNase. As 
the incubation time with the enzyme increased to 20 and 60 minutes, this band migrated even 
further, indicating that over time the MNase gained access to and digested the free ends of the 
nucleosomal DNA as well. In contrast, plasmid assembled into chromatin with greater 
nucleosomal density took longer to be digested to the mono-nucleosome level, indicating 
greater MNase inaccessibility. Even after 60 minutes the extent of DNA protection was such 
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that di-nucleosomes and tri-nucleosomes could still clearly be seen to persist in the chromatin 
constructs containing 25 and 40 octamers per plasmid. 
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Figure 4.8. Micrococcal nuclease digestion of the chromatin constructs reveals the presence of 
nucleosomes. The principle of the MNase assay is based on digestion of unprotected linker DNA, while 
nucleosomal DNA remains intact, as illustrated in (a). An example of a typical MNase digestion of 
chromatinised plasmid analysed using agarose gel electrophoresis is shown in (b ). Chromatin constructs 
containing 1, 10, 25 and 40 octamers per plasmid were incubated at room temperature for 2, 10, 20 and 60 
minutes with MNase (25 mU/µg DNA), DNA recovered using 3M NaOAc precipitation and analysed on 
a 1.5 % agarose gel ( described in Section 2.5 .5). Each lane represents a different time point for the 
reaction (as indicated) and lanes are grouped according to the chromatin construct. The characteristic 
banding pattern corresponds to nucleosomal DNA (indicated by the red arrows). 
Resistance to MNase digestion also has implications for the protection of DNA once transfected 
into cells. The observed resilience of the chromatin constructs to MNase digestion is an 
indication that within the cellular environment they should be more resistant to cytosolic 
nucleases (Pollard et al., 2001; Lechardeur et al., 1999). 
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4.4.4. Atomic force microscopy reveals compaction of chromatinised plasmid from 
open loops into extended rod-like structures 
The topological structure of the pGeneGrip-RFP when naked and chromatinised at 
physiological nucleosome density (25 octamers per plasmid) was investigated using AFM 
(described in detail in Section 2.5.6). Briefly, samples of 10 µ1 containing 100 ng of DNA were 
adsorbed onto freshly cleaved mica squares for a period of 5 minutes. The mica surface was 
scanned using a tapping mode setting (MultiMode AFM and N anoscope III, Digital 
Instruments). 
The naked plasmid was observed in open loop confonnations (Figure 4.9a). After 
chromatinisation, the plasmid appeared to be condensed into rod-like structures (Figure 4.9b ). 
These structures were the predominant form for the chromatinised plasmid. 
The images obtained by AFM provided visual confirmation that chromatinisation of the plasmid 
DNA resulted in the formation of rod-like condensates, in agreement with previously published 
data (Hansen and Wolffe, 1992; Simpson et al., 1985). 
a b 
200mn 200 run 
Figure 4.9. AFM images comparing naked and chromatinised plasmid DNA. pGeneGrip-RFP was 
subjected to chromatin assembly in the absence of histone octamers (naked plasmid) and at physiological 
nucleosome density (25 octamers per plasmid) (Section 2.5.2). Samples containing 100 ng of DNA were 
adsorbed onto freshly cleaved mica in a volume of 10 µl of chromatin buffer (1 35 mM NaCl/ IO mM Tris-
HCl). AFM was performed in tapping mode (MultiMode AFM and Nanoscope III, Digital Instruments) 
using a 125 µm silicon cantilever, with scanning rate 1 - 2 Hz and oscillation 400 kHz. Images were 
analysed using Nanoscope software (Digital Instruments). Images of the naked plasmid and extended 
structures formed upon chromatinisation at physiological nucleosome density of the plasmid (25 octamers 
per plasmid) are shown to scale 200 nm in (a) and (b ), respectively. 
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4.5. DELIVERY OF CHROMATINISED REPORTER PLASMID INTO CELLS IN CULTURE USING 
ELECTROPORATION 
In order to test whether chromatinisation of plasmid DNA would enhance transfection 
efficiency in vitro, the chromatin constructs were introduced into cells in culture. 
Electroporation was chosen as the method for the first line of investigation of the potential of 
chromatin for gene delivery as it allows introduction of transfection constructs directly into the 
cytoplasm. 
4.5.1. Optimisation of electroporation parameters for investigation of transport from the 
cytoplasm to the nucleus 
4.5.1.1. Selecting an electroporation voltage which preserves the nuclear membrane 
In order to be able to relate reporter gene expression directly to the efficiency of translocation 
into the nucleus, it was important to ensure that the transfection constructs were initially taken 
up into the cytoplasm exclusively and not into the nucleus. For this reason, a voltage for 
electroporation was sought that facilitated permeabilisation of the cell membrane but kept the 
NE intact. 
HTC cells were selected as the cell type for the electroporation experiments because these cells 
were routinely used as the model cell type in a mechanically perforated cell system to 
investigate protein import into the nucleus in vitro (Chan et al., 2000; Hu and Jans, 1999; Xiao 
and Jans, 1998), which had been established previously in the laboratory. In order to determine 
an optimal voltage that maximised electroporation but minimised NE damage, electroporation 
of HTC cells was carried out in PBS over a range of voltages, from 200 to 400 V, at a fixed 
capacitance of 500 µF in the presence of FITC-labelled dextrans of molecular masses 20 kDa 
and 70 kDa (see Sections 2. 7.1 and 2.11.1 for detailed methods). FITC-dextran of MW 20 kDa 
is able to permeate the nucleus, being below the MWCO of the NPC ( 45 kDa); hence, 
fluorescence should be visible throughout the entire cell following electroporation. FITC-
dextran with a MW of 70 kDa would, on the other hand, be excluded from the nucleus provided 
that the NE is intact. In this case, the resulting fluorescence would be localised to the cytoplasm. 
In the absence of electroporation, both dextrans should be excluded from the cell. 
Following electroporation, FITC-dextran that had not been taken up by the cells was removed 
from the extracellular medium (PBS) by two rounds of centrifugation and washing in PBS 
( 6000 rpm, Eppendorf centrifuge) before final resuspension of the cells in fresh PBS. Cells were 
divided into two aliquots. The resulting subcellular fluorescence was visualised in the first 
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aliquot of cells by confocal laser scanning microscopy (CLSM; described in Section 2.11.1 ). 
Cellular uptake of FITC-dextrans in the second aliquot of cells was analysed using fluorescence 
activated cell sorting (F ACS). Prior to the analyses, these cells were incubated in propidium 
iodide (PI; Section 2.9.1.1) in order to assess the effect of electroporation on cell viability 
simultaneously (see Section 4.5.1.2). Dual FITC- and PI-fluorescence were detected (channels 
FLl and FL2, respectively, FACScan, Becton Dickinson; see Section 2.9.1). FITC-fluorescence 
was quantitated relative to cells incubated in the presence of FITC-dextran but which had not 
been electroporated. For each test sample, 100000 events (cells) were recorded and analysed 
(CellQuest software, Macintosh). The FACS dot plots are shown in Figure 4.10, paired with the 
corresponding CLSM images. Qualitative results from the 70 kDa FITC-dextran optimisation 
are presented in Table 4.2. 
Of the cells electroporated at 200 V with 70 kDa FITC-dextran 70.6 % were positive for FITC-
fluorescence by F ACS analysis but the geometric mean intensity within the cells was low. Due 
to the low fluorescence intensity, scoring the subcellular fluorescence in sufficient cells in the 
corresponding CLSM images could not be accomplished but, qualitatively, it appeared to be 
predominantly cytoplasmic (Figure 4.1 Ob; Table 4.2). In contrast, almost all of the cells 
electroporated at 400 V had taken up the FITC-dextran and the geometric mean fluorescence 
was higher than in cells electroporated at 200 V (Figure 4.1 Ob, F ACS dot plot; Table 4.2). 
CLSM revealed that while some cells showed exclusively cytoplasmic fluorescence, in most of 
the cells fluorescence could be seen throughout the entire cell, including the nucleus, indicating 
that the NE had been permeabilised (Figure 4.1 Ob, CLSM image; Table 4.2). This implied that 
400 V was not suitable for the intended transfection experiments where transport from the 
cytoplasm to the nucleus was to be the parameter under investigation and thus required an intact 
nucleus. Electroporation at 300 V yielded levels of geometric mean fluorescence intensity 
greater than those seen with electroporation at 200 V and F ACS analysis showed that almost all 
of the cells had taken up fluorescence (Table 4.2). Importantly, CLSM results for 
electroporation at 300 V indicated integrity of the NE, with fluorescence being exclusively 
cytoplasmic in 70 % of the cells and only 20 % not being permeabilised at the plasma 
membrane level (Figure 4.1 Ob; Table 4.2). In order to show that the NE was still competent for 
passive transport after electroporation at 300 V, cells were electroporated in the presence of 20 
kDa FITC-dextran. This dextran was found to distribute throughout the entire cell, 
demonstrating that the NE retained is passive permeability properties (Figure 4.1 0a). 
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Figure 4.10. Determination of an optimal voltage for electroporation of HTC cells. Cells were 
electroporated in the presence ofFITC-dextran of MW 20 kDa, shown in panel (a), or 70 kDa, shown in 
panel (b), at a range of voltages (2.5xl07 cells/ml, total volume 400 µl , PBS buffer, BioRad 0.4cm gap 
cuvettes, 500 µF, BioRad GenePulser), and cellular uptake was monitored by CLSM and FACS (see 
Sections 2.11.1 and 2.9 .1.3 for respective methods). Within each FITC-dextran group, the upper row of 
panels shows typical images captured using CLSM (BioRad, zoom 1, gain 900, Kalman 5) and the lower 
row of panels shows the corresponding F ACS dot plot scans (F ACScan, Becton Dickson). FITC was 
detected though channel FLl and is represented on the x-axis; PI was detected though channel FL2 and is 
represented on the y-axis. The quadrants were set according to HTC cells which were incubated with 
FITC-dextran and PI, but not electroporated ( a, 0 V). The results represent a single experiment. Collated 
data is presented in Table 4.2. 
109 
4.5.1.2. Assessment of cell viability at a range of electroporation voltages 
Optimal transfection using electroporation may be accompanied by up to 30 - 50 % cell death. 
Cell viability after electroporation at various voltages in the presence of the 20 kDa and 70 kDa 
FITC-dextrans was determined using PI staining and FACS analysis, where failure of cells to 
exclude PI served as the indicator of cell death. As described in Section 4.5.1.1 , cells were 
analysed on the basis of dual FITC- and PI-fluorescence (channels FLl and FL2, respectively, 
FACScan; see Sections 2.9.1.1 and 2.9.1.3). PI-fluorescence was quantitated relative to cells 
that had not been electroporated. 
Electroporation at 300 V resulted in not more than 30 % cell death, 400 V around 50 % cell 
death, whereas at 200 V 13.7 % of the total number of cells were not viable (n = 1) (see Figure 
4.1 O; Table 4.2). Based on these results, together with the results for optimising the voltage for 
NE permeabilisation, 300 V was selected as the optimal voltage for the transfection 
experiments. 
4.5.1.3. Optimising the amount of DNA required for transfection 
Typically, 10 - 40 µg of DNA is used in an electroporation experiment. Electroporation is 
therefore a 'costly ' transfection method in terms of the amount of DNA and histone octamer 
material used (50 µg of plasmid DNA was assembled into chromatin using 2 - 56 µg of histone 
octamers for each construct generated). In this context, it was important to determine the 
minimal dose of plasmid DNA for effective transfection. Moreover, this dose would have to be 
sufficient to yield detectable reporter gene expression but not be at the limit of saturation so that 
room for improvement with regard to gene transfer efficiency could be accommodated (through 
chromatinisation or other modifications). 
Varying amounts of the pGeneGrip-RFP plasmid were electroporated at 300 V and 500 µFinto 
HTC cells (see Section 2.7.1 for detailed method). Transfected cells were cultured for 48 hours, 
following which RFP expression was detected using F ACS analysis, as described in Section 
2.9 .1.2. RFP positive cells were detected ( channel FL2) relative to cells that had been subjected 
to the electroporation pulse in the absence of DNA. 
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C e l l s  w e r e  e l e c t r o p o r a t e d  i n  t h e  p r e s e n c e  o f F I T C - d e x t r a n  o f  7 0 0 0 0  M W  a t  v o l t a g e s  i n d i c a t e d  a n d  a n a l y s e d  b y  C L S M  a n d  
F A C S ,  a s  d e s c r i b e d  i n  S e c t i o n s  4 . 5 . 1 . 1  a n d  4 . 5 . 1 . 2 .  
A  C e l l s  w e r e  c o u n t e d  f o r  a t  l e a s t  1 0  s e p a r a t e  C L S M  i m a g e s  p e r  v o l t a g e .  C e l l s  w e r e  q u a l i t a t i v e l y  a s s e s s e d  f o r  c y t o p l a s m i c  
f l u o r e s c e n c e  ( C y t  F I T C ) ,  n u c l e a r  f l u o r e s c e n c e  ( N u c  F I T C )  o r  n o t  p e r m e a b i l i s e d  ( N o n - p e r m )  ( s e e  F i g u r e  4 . 1 0 ) .  R e s u l t s  a r e  
p r e s e n t e d  a s  a  p e r c e n t a g e  o f  t o t a l  c e l l s  c o u n t e d .  
B  F  A C S  d a t a  w e r e  g e n e r a t e d  a s  d e s c r i b e d  i n  S e c t i o n  2 . 9  . 1 ,  w i t h  1 0 0 0 0 0  c e l l s  a n a l y s e d  u s i n g  C e l l  Q u e s t  s o f t w a r e  
( M a c i n t o s h ) .  R e s u l t s  r e p r e s e n t  t h e  m e a n  +  r a n g e / 2  o f  t w o  e x p e r i m e n t s ,  w i t h  t h e  e x c e p t i o n  o f  2 0 0  V ,  w h i c h  w a s  p e r f o r m e d  
o n c e .  
c  F I T C - p o s i t i v e  c e l l s  w e r e  d e t e c t e d  t h r o u g h  c h a n n e l  F L l - H ,  r e l a t i v e  t o  c e l l s  w h i c h  h a d  n o t  b e e n  e l e c t r o p o r a t e d  ( s e e  F i g u r e  
4 . 1 0 ) .  R e s u l t s  a r e  p r e s e n t e d  a s  a  p e r c e n t a g e  o f  t o t a l  c e l l s  a n a l y s e d .  
D  G e o m e t r i c  m e a n  v a l u e s  o f  F I T C  f l u o r e s c e n c e .  
E  N o n - v i a b l e  c e l l s  w e r e  a s s e s s e d  o n  t h e  b a s i s  o f  P I  f l u o r e s c e n c e  d e t e c t e d  t h r o u g h  c h a n n e l  F L 2 - H  r e l a t i v e  t o  c e l l s  w h i c h  
h a d  n o t  b e e n  e l e c t r o p o r a t e d  ( s e e  F i g u r e  4 . 1 0 ) .  R e s u l t s  a r e  p r e s e n t e d  a s  a  p e r c e n t a g e  o f  t o t a l  c e l l s  a n a l y s e d .  
F  N o t  d e t e r m i n e d .  C e l l s  c o u l d  n o t  b e  s c o r e d  o n  t h e  b a s i s  o f  n o  f l u o r e s c e n t  s i g n a l  i n  t h e  0  V  s a m p l e s  a n d  w e a k  f l u o r e s c e n c e  
i n  t h e  2 0 0  V  s a m p l e s .  
The results obtained, shown in Figure 4.11 , indicated that electroporation of 20 µg of plasmid 
DNA yielded the highest level of gene expression, with 4.5 ± 1.9 % of the cells positive for RFP 
fluorescence, followed by 10 µg with 1.9 ± 0.9 % RFP positive cells and 1 µg with 0.2 ± 0 % 
RFP positive cells (n = 2; see Figure 4.1 la for typical FACS-generated profiles). Although the 
transfection efficiency was low (less than 10 % RFP positive cells), due mainly to the stringent 
transfection conditions, both the percentage of cells and fluorescence intensity were able to be 
analysed in terms of fluctuations in trans gene expression levels (Figure 4.11 b and c, 
respectively). 
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Figure 4.11. Titratio n of pGeneGrip-RFP for electroporation of HTC cells. 1, 10 and 20 µg of 
pGeneGrip-RFP were transfected into HTC cells by electroporation (5x 106 cells, 400 µl total volume, 
PBS buffer, BioRad 0.4cm gap cuvettes, 500 µF, 300 V, BioRad GenePulser; Section 2.7.1). RFP 
expression was analysed by FACS 48 hours later (channel FL2; Section 2.9.1.2). The FACS dot plots 
shown in (a) represent the gene expression profiles from varying amounts of DNA, as indicated. Data 
from these were analysed using CellQuest software (Macintosh) and the percentage of cells expressing 
RFP and their corresponding geometric mean fluorescence values were plotted against the amount of 
D A transfected, as shown in (b) and (c), respectively. Each point represents the mean+ range/2 of 2 
separate experiments. 
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Based on these results, 10 µg of DNA were transfected in the subsequent electroporation 
experiments aimed at establishing the proof-of-principle of using a DNA delivery construct in 
the form of in vitro assembled chromatin. 
4.5.2. Reporter gene expression in HTC cells electroporated with chromatinised plasmid 
Chromatin constructs assembled at stoichiometries of 0, 2, 4, 25 and 40 octamers per 
pGeneGrip-RFP reporter plasmid were prepared using the histone octamer transfer salt dialysis 
method as described in Section 2.5.2. The DNA content was determined spectrophotometrically 
at 260 nm for each chromatin construct and 10 µg of DNA were aliquotted for electroporation. 
HTC cells were electroporated in the presence of the chromatin constructs according to the 
parameters established in Section 4.5.1 (10 µg DNA, 300 V, 500 µF) and in a constant volume 
and salt concentration of 400 µland 135 mM NaCl (PBS), respectively (Section 2.7.1). In order 
to establish if the relative level of gene expression was due to the presence of histones in the 
transfection mix or the effect of octamers in causing compaction of the plasmid, transf ections 
were performed using 'associations' of pGeneGrip-RFP reporter plasmid and histones. Each 
'association' contained the amount of octamer corresponding to that in the chromatinised 
constructs. These were assembled under conditions which would not permit chromatinisation. 
Histone octamers were transferred into chromatin buffer (CB, 135 mM NaCl/10 mM Tris-HCl); 
histone octamers are not stable below 2.2 M NaCl in the absence of DNA and therefore 
dissociation would occur. Plasmid was added subsequently and incubated for no longer than 10 
minutes ( 5 minutes of which were on ice). 
The percentages of cells expressmg RFP from the range of chromatin constructs and 
'DNA/histone associations' were determined by FACS 48 hours post-transfection (described in 
Section 2.9.1.2). As the density of octamers per plasmid increased, the percentage of cells 
showing RFP reporter gene expression decreased (Figure 4.12; Table 4.3). Relative to the naked 
plasmid (0 octamers per plasmid), a 2-fold decrease in the percentages of cells expressing RFP 
occurred with transfection of the 4 octamers per plasmid construct ( although this did not reach 
statistical significance; p = 0.09, n = 2), as well as with the 25 and the 40 octamers per plasmid 
constructs (p = 0.00001 and 0.003, respectively). Similarly, but more dramatically, RFP 
expressing cells diminished to 14.3 ± 8.6 % (p = 0.002, n = 3) and 17.0 ± 7.4 % (p = 0.002, n = 
3) when pGeneGrip-RFP had been 'associated' just prior to electroporation with the amount 
histones corresponding to the 25 and 40 octamers per plasmid constructs, respectively (see 
Table 4.3). 
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Figure 4.12. Gene expression in HTC cells transfected by electroporation with chromatinised 
pGeneGrip-RFP. HTC cells were transfected by electroporation (10 µg of DNA in chromatinised form, 
300 V, 500 µF; Section 2.7.1) with chromatin constructs assembled at a range of histone octarrier 
stoichiometries (Section 2.5 .2). RFP expression was detected 48 hours post-transfection using F ACS 
( channel FL2-H) ( described in Section 2.9 .1.2). Data were collected for 100000 events and analysed 
using CellQuest software (Macintosh). Representative FACS dotplots are shown in (a) for transfections 
with no DNA, 0 octamers per plasmid and 25 octamers per plasmid, as indicated. Cells expressing RFP 
were determined relative to the 'no DNA' control. Histogram analysis of pooled data is shown in (b). 
Results are presented as a percentage of RFP-expressing cells relative to the 0 octamers per plasmid 
transfections. Bars represent the means of 2 - 7 experiments, with the range/2 or SEM shown (see Table 
4.3). 
The results indicated, unexpectedly, that plasmid chromatinisation with histone octamers had 
inhibited transfection efficiency. As a similar pattern was observed upon transfection of the 
plasmid/octamer 'associations', this appeared to be an effect distinct from chromatin-induced 
plasmid condensation. 
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4.6. DELIVERY OF CHROMATINISED REPORTER PLASMID INTO CELLS IN CULTURE USING 
LIPOFECTION 
In order to determine whether the decrease in transfection efficiency upon increasing 
chromatinisation of the reporter plasmid was specific to electroporation and to HTC cells, an 
alternative transfection method and cell type were investigated. Since electroporation consumed 
such a large amount of chromatinised material, lipofection was chosen as a material-saving 
alternative. This enabled smaller scale transfection experiments to be performed, requ1nng 
fewer cultured cells as well as a smaller amount of chromatinised DNA. 
4.6.1. Assessing the effect of lipofection conditions on cell viability and reporter gene 
expression 
The effects of the lipofection reagent and chromatin buffer conditions on cell viability and RFP 
reporter gene expression were assessed in a series of experiments similar to those conducted to 
assess parameters for transfection using electroporation. 
Lipofectamine™ 2000 (lnvitrogen) was used as the lipofection reagent, according to the 
manufacturer's instructions (Section 2.7.2). HTC and Cos-7 cells were plated into 6-well tissue 
culture plates at a density of 1x105 cells per well 24 hours prior to experimentation. In order to 
ensure that the transfection method would not adversely affect cell survival, as is typical for 
electroporation experiments, the effect of Lipofectamine™ 2000 on cell viability was assessed. 
Mock transfection experiments were conducted in which cells were transf ected using 
Lipofectamine™ 2000 but in the absence of DNA. Cells were detached from the substratum 48 
hours post-transfection and were resuspended in PBS (500 µl) for analysis by FACS. As PI and 
RFP are both detected through channel FL2, 7-amino-actinomycin D (7-AAD), which is 
detected though channel FL3, was chosen as an alternative cell viability indicator (see Section 
2.9.1.1). 7-AAD was added to the cell suspension 10 minutes prior to FACS analysis. 
Fluorescent cells were detected relative to cells which had not been exposed to transfection 
reagent or 7-AAD. The data, analysed using CellQuest software (Macintosh), showed that 
neither of the cell lines tested experienced effects of toxicity due to Lipofectamine™ 2000 
treatment, with cell viability consistently> 99 % (Figure 4.13a). 
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Figure 4.13. The effect of lipofection conditions on cell survival and reporter gene expression. Cos-7 
(left panels) and HTC cells (right panels) were assessed for the effect on cell viability ofLipofectamine™ 
2000, shown in panel (a) and chromatin buffer (CB; 135 mM NaCl/10 mM Tris, pH 7.4), shown in panel 
(b). The effect of chromatin buffer on RFP reporter gene expression is shown in panel (c). Lipofection 
was carried out as described in Section 2.7.2. The test transfection conditions are denoted on the x-axis of 
each histogram analysis. Control cells were not exposed to any of the test conditions. Cells were analysed 
48 hours post-transfection using FACS. 100000 events (cells) were recorded and data were analysed 
using Cell Quest software (Macintosh). For cell viability studies (panels a, b ), 7-AAD fluorescence was 
detected through channel FL3 (see Section 2.9.1.1 ). Non-viable cells are represented as a percentage of 
total cells on the Y-axis. For reporter gene expression studies (panel c), RFP fluorescence was detected 
through channel FL2 (see Section 2.9.1.2). Cells expressing RFP are represented on the y-axis as a 
percentage relative to cells expressing RFP in the O octamers per plasmid transfections. All bars represent 
the mean of 4 experiments+ SEM. 
In order to determine whether either the transfection material or buffer conditions of the 
experiment would have an effect on cell viability or reporter gene expression, chromatin buffer 
alone (CB, 135 mM aCl/1 0 mM Tris, pH 7.4), pGeneGrip-RFP dialysed into CB or histone 
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octamers dialysed into CB were lipofected into cells. Cell viability and RFP reporter gene 
expression were assessed 48 hours post-transfection by FACS, as described previously (see 
Sections 2.9.1.1 and 2.9.1.2). The test conditions and control cells which had not been 
transfected produced similar cell viability profiles based on 7-AAD fluorescence (Figure 4.13b ), 
indicating that neither the buff er conditions of transfection nor the transfection material 
adversely affected cell viability. In terms of reporter gene expression, FACS analysis of RFP-
expressing cells revealed that the percentages of RFP expressing cells were not significantly 
different for the 0 octamers per plasmid chromatin construct, pGeneGrip-RFP solubilised in 
ddH20 or pGeneGrip-RFP solubilised in chromatin buffer (HTC cells, n = 4, p > 0.17 ; Cos-7 
cells, n = 4, p > 0.53; Figure 4.13c). 
These experiments showed that Lipofectamine™ 2000, CB, histone octamers or the reporter 
plasmid did not adversely affect cell viability. Also, reporter gene expression was found to be 
similar when the pGeneGrip-RFP reporter plasmid was transfected in ddH20 or CB, implying 
that the conditions under which chromatin assembly was carried out were compatible with 
transfection experiments. The absolute percentage of HTC cells transfected using Lipofectamine 
2000 was similar to the percentage of cells transfected using electroporation, typically less that 
10 % (data not shown). In contrast, around 20 % ofCos-7 cells were typically RFP-positive (see 
Figure 4.14). 
4.6.2. Reporter gene expression in Cos-7 and HTC cells lipofected with chromatinised 
plasmid 
Chromatin constructs for transfection assembled at stoichiometries of 0, 1, 2, 4, 25 and 40 
histone octamers per pGeneGrip-RFP reporter plasmid were produced as described previously 
(Section 2.5.2). The concentration of DNA within the chromatin constructs was determined 
spectrophotometrically at 260 nm and aliquots containing 1 µg of DNA were prepared for 
lipofection in a constant volume of 50 µI/well. HTC and Cos-7 cells were plated into 6-well 
tissue culture plates at a density of 1x105 cells per well 24 hours prior to transfection. Cells were 
transfected as described in Section 2. 7 .2. RFP expression was quantitated by F ACS 48 hours 
post-transfection, as described in Section 2.9.1.2. 
Lipofection of the chromatin constructs (Figure 4.14) produced a pattern of relative reporter 
gene expression similar to that obtained by electroporation (summarised in Table 4.3). 
However, when lipofection was used, RFP expression observed upon transfection of the 4 
octamers per plasmid construct was similar to that of the naked plasmid (0 octamers per 
plasmid), unlike electroporation which resulted in markedly reduced reporter gene expression 
(Figure 4.14; Table 4.3). This was followed by a 2-fold decrease in gene expression to the 25 
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octamers per plasmid level (p = 0.007, n = 7) and a 2.5-fold decrease to the 40 octamers per 
plasmid level (p = 0.011 , n = 4) in Cos-7 cells. In HTC cells, the percentage of cells expressing 
RFP from the 25 and 40 octamers per constructs decreased 5-fold (p < 0.0001, n = 7 and 4, 
respectively) (see Figure 4.14; Table 4.3). Thus, in both cell types tested, the percentage of RFP 
expressing cells decreased with increasing molar ratio of histone octamers to DNA. 
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Figure 4.14. Expression of RFP in Cos-7 and HTC transfected by lipofection. Cos-7 and HTC cells 
were transfected using Lipofectamine™ 2000 (described in Section 2.7.2) with chromatin constructs 
assembled at a range of histone octamer stoichiometries ( described in Section 2.5 .2). Percentages of cells 
expressing RFP were determined by F ACS ( channel FL2, F ACscan) 48 hours post-transfection ( described 
in Section 2 .9.1.2) and data for 100000 cells were analysed using Cell Quest software (Macintosh). A 
typical series of F ACS dot plots showing differential RFP expression for the no DNA control, 0 octamers 
per plasmid and 25 octamers per plasmid are shown in (a) for Cos-7 cells and in (b) for HTC cells. The 
RFP-positive quadrant was set relative to the no DNA control sample. Collated data is presented in 
histogram format in (c). Results are presented as a percentage relative to the number of cells expressing 
RFP in the O octamer per plasmid transfections, with each histogram representing the mean+ SEM of at 
least 3 independent experiments. 
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As described for the electroporation experiments (Section 4.5.2), pGeneGrip-RFP was 
incubated with the amounts of octamers corresponding to those in the chromatinised constructs 
under conditions which do not permit nucleosome formation, thus enabling assessment of an 
effect due to histones distinct from chromatinisation. These DNA/histone 'associations' were 
transfected into cells in a series of paired experiments with the chromatin constructs (Table 4.3). 
Similar to the chromatinised plasmid, in both cell lines, at low levels of histone density 
( corresponding to 1, 2 and 4 octamers per plasmid), the percentages of cells expressing RFP 
were similar to the naked plasmid (0 octamers per plasmid; Table 4.3). In Cos-7 cells, decreases 
in reporter gene expression relative to the naked plasmid were observed with the 25 and 40 
octamer 'associations' (p = 0.046, n = 7 and p = 0.011, n = 3, respectively). While a similar 
trend appeared to have occurred in the HTC cells (Table 4.3), the difference between the 
DNA/histone associations and the naked plasmid were not statistically significant (p > 0.068). 
Table 4.3. Relative percentages of cells expressing RFP upon transfection by 
electroporation or lipofection. 
Electroporation Lipofection 
HTC Cos-7 HTC 
Octamers/plasmid n % cells n % cells n 
0 100 ± 0 7 100 ± 0 7 100 ± 0 7 
1 NDB 82.9 ± 18.6 7 71.6 ± 18.7 7 
2 95.5 ± 25.9 2 78.4 ± 8.0 3 78.6 ± 22.2 3 
4 49.6 ± 7.6 2 98.9±11.1 3 122.1 ± 34.5 3 
25 43.9 ± 2.1 5 58.8 ± 10.2 7 19.2 ± 2.4 7 
40 40.8 ± 9.2 5 43.5 ± 9.3 4 17.8 ± 2.1 4 
plasmid+ 1 octc ND 97.8 ± 9.9 6 138.0 ± 23 .8 7 
plasmid + 2 oct ND 97.3 ± 12.6 3 114.7 ± 53.2 3 
plasmid + 4 oct ND 92.3±17.1 3 102.2 ± 45 .8 3 
plasmid + 25 oct 14.3 ± 8.6 4 60.1 ± 15.9 7 93.7 ± 15.8 7 
plasmid+ 40 oct 17.0±7.4 4 49.9 ± 5.2 3 74.2 ± 6.2 4 
Chromatin constructs assembled at differential histone octamer stoichiometries (Section 2.5.2) were 
transfected into HTC and Cos-7 cells by electroporation (Section 2. 7 .1) or lipofection (Section 2. 7 .2) and 
cells expressing RFP were detected by FACS (Section 2.9.1.2). FACS data were analysed using 
CellQuest software (Macintosh). . 
A Results are expressed as a percentage relative to RFP expressing cells transfected with O octamers per 
plasmid, and represent the mean + SEM, with the number of times the experiment was performed 
indicated by n. Where n is 2, the mean+ range/2 is shown. 
8 Not done. 
c Constructs comprising histones associated with plasmid DNA under non-chromatinising conditions at 
stoichiometries indicated. 
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These results indicated that chromatinisation of the plasmid resulted in diminished levels of 
reporter gene expression using both electroporation and lipofection transfection methods. The 
similar trends observed in transgene expression for the range of chromatin constructs and 
corresponding 'DNA/histone associations' suggested that the presence of histones alone was a 
contributing factor to reduced reporter gene expression, distinct from chromatinisation .. 
4. 7. DISCUSSION 
The first use of chromatin as a vehicle for gene delivery is reported in this chapter. Despite 
potentially having properties considered advantageous for the purpose of gene delivery, 
chromatinisation of the reporter plasmid at increasing nucleosome densities appeared to be 
associated with decreased transfection efficiency of the reporter gene. 
The reporter plasmid used in this study was generated by recombination events between two 
plasmids, pGeneGrip™ and pDsRed-Cl, using the Gateway™ cloning system (Life 
Technologies, see Section 2.2.15 for a detailed description). This involved constructing several 
intermediate Gateway™-compatible vectors before pGeneGrip-RFP was generated through the 
final recombination reaction (Figures 4.1 - 4.3). pGeneGrip-RFP was able to be assembled into 
chromatin by incubation with pre-formed histone octamers, using a method based on the 
principle of decreasing the salt concentration of the reaction buffer to facilitate transfer of the 
histone octamers onto the DNA (Kunze and Netz, 2000; Thomas and Butler, 1977). Since this 
method had been described originally for the association of histone octamers with a defined 
sequence of linear DNA in order to assemble a regularly spaced array of nucleosomes (Luger et 
al. , 1997; Richmond et al., 1988), it was imperative to verify chromatin formation when using a 
large plasmid as the DNA template. 
Data from analytical ultracentrifugation studies showed increasing s-coefficients upon 
increasing the molar ratio of histone octamers to DNA, demonstrating that the octamers had 
associated with D A (Figure 4.6). The existence of nucleosomes was verified using the 
supercoiling- and MNase digestion assays. In addition, the ~ase assay indicated that 
chromatinised plasmid assembled with stoichiometries of 25 and 40 octamers was more 
resistant to digestion ( di- and tri-nucleosomes, as well as higher molecular weight smearing 
were still evident after 60 minutes of digestion, see Figure 4.8) than plasmid assembled with 
fewer octamers. Since it has been shown that naked plasmid DNA degrades rapidly when 
introduced into the cytoplasm (Lechardeur et al., 1999), this is an important observation with 
implications for protection of the chromatin constructs against cytosolic degradation. 
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The chromatin constructs were transfected into cells in culture usmg electroporation. 
Unexpectedly, upon electroporation into HTC cells chromatinised plasmids assembled at 
increasing molar ratios of octamers were found to yield 2-fold fewer cells that expressed the 
reporter gene compared to the naked plasmid (Figure 4.12; Table 4.3). Briefly incubating the 
reporter plasmid with histone octamers under conditions of low salt and low temperature, to 
produce DNA/histone 'associations' that would lack higher order chromatin structures, resulted 
in a more marked decrease of around 5-fold in the number of cells expressing RFP (Figure 4.12; 
Table 4.3). This suggested that reduced gene expression may have been a result of the 
association of histone octamers, distinct from any condensation effect on the reporter plasmid. 
In order to ensure that these observations were not a consequence of the transfection method or 
cell type, transfections were performed using lipofection and Cos-7 cells also. Consistent with 
the trend observed using electroporation, progressively fewer cells expressing RFP ensued upon 
increasing the stoichiometry of octamers assembled onto the reporter plasmid (Figure 4.14; 
Table 4.3). However, unlike the data obtained from electroporation where RFP expression 
diminished to around 50 % at low levels of nucleosome density (see 4 octamers per plasmid, 
Table 4.3), lipofection resulted in diminished RFP expression at the higher levels of nucleosome 
density, which were obtained with 25 and 40 octamers per plasmid (Table 4.3). While 
lipofection of DNA/histone 'associations', resulted similarly in a pattern of decreased RFP 
expression, the dramatic decrease that had been observed when the amount of histones 
associated with the plasmid was increased was specific to electroporation (see Table 4.3). 
The composition of the liposome/DNA transfection complex would undoubtedly change as the 
ratio of octamers to plasmid is increased; however, sufficient internucleosomal DNA remains to 
enable association with the cationic lipid. The rate limiting step in lipofection is endosomal 
escape, which is primarily mediated by the interaction of the cationic transfection lipids with the 
anionic endosomal lipids (Zahner et al., 1995; Xu and Szoka, 1996). The contribution arising 
from the presence of histone octamers in the lipoplex to the processes of endosomal escape is 
unknown but given the overwhelming excess of cationic lipid is likely to be negligible. The 
presence of histone octamers is, similarly, unlikely to have an effect on other processes 
important for lipofection, such as cell association and internalisation. Compromised lipofection 
is therefore unlikely to account for the diminished RFP expression. 
The size and hence MW of the plasmid DNA may play a role in gene transfer efficiency. 
Fluorescently-labelled DNA of similar size to the pGeneGrip-RFP reporter plasmid used in this 
study (6000 bps) was reported to have markedly diminished mobility in the cytoplasm (Lukacs 
et al., 2000). Using spot photobleaching measurements (fluorescence recovery after 
photobleaching, FRAP), a 20-fold reduction in the diffusion coefficient was found for a> 2000 
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bp DNA fragment compared to a 100 bp DNA fragment. Beyond 2000 bp, DNA was essentially 
immobile in the cytoplasm. This was in contrast to the smaller DNA fragments (<500 bps) 
which distributed throughout the cytoplasm and nucleus within a few minutes of cytoplasmic 
micro injection (Lukacs et al., 2000). 
Increasing the cytoplasmic mobility by compaction of plasmid DNA might provide one 
mechanism by which to enhance gene delivery efficiency. While no quantitative information 
exists on the cytoplasmic diffusion coefficients of compacted DNA, evidence from studies of in 
vitro reconstituted nuclear import suggest that transfection constructs compacted using pLy may 
accumulate in the nucleus more readily (Chan et al., 2000). No consensus has yet been reached 
on a relationship between transfection efficiency and DNA condensation, however, a bias 
towards a positive correlation seems to exist in the literature (for reviews see Vijayanathan et 
al., 2002; Bloomfield, 1996). Upon chromatinisation, at the first level of compaction, DNA is 
condensed in length by a factor of 5. This involves the formation of nucleosomes and results in 
the canonical 'beads-on-a-string' fibre (Van Holde et al., 1980; see Figure 1.8). Further 
compaction into structures resembling the '30 nm fibre' is facilitated by the N-terminal tails of 
the core hi stones which participate in inter-nucleosome contacts (Tse and Hansen, 1997; 
Fletcher and Hansen, 1995; Schwarz and Hansen, 1994). Hl linker histones serve to stabilise 
this structure (Carruthers et al., 1998; Leuba et al., 1998). AFM revealed that the super-structure 
of the plasmid used in this study when chromatinised at physiological nucleosome density (25 
octamers per plasmid) was an extended rod shape (Figure 4.9). This was consistent with 
previously published data which suggested that circular chromatin constructs led to the 
generation of compacted extended structures (Ladoux et al., 2000; Hansen and Wolffe, 1992; 
Simpson et al., 1985), most likely caused by inter-nucleosomal interactions (Luger et al., 1997; 
Tse and Hansen, 1997; Fletcher and Hansen, 1995; Schwarz and Hansen, 1994; Yao et al., 
1991; Simpson et al., 1985). In this study, however, despite chromatin-induced plasmid 
condensation, overall transfection efficiency was diminished as reflected in the decreased 
percentages of cells expressing RFP with increased chromatinisation. 
While chromatinisation at physiological nucleosome density (25 octamers per pGeneGrip-RFP) 
caused compaction of the plasmid, it simultaneously increased the relative molecular weight by 
~2-fold (see Table 4.1). According to Seksek et al. (1997) and Lukacs et al. (2000), diffusion of 
molecules of this MW (6.6x 106 Da; Table 4.1) is very slow through the cytoplasm, implying 
that the more extensively chromatinised constructs should have progressively lower diffusion 
rates. Indeed, decreased RFP expression from both the extensively chromatinised plasmids and 
the plasmids 'associated' with the corresponding amount of histone octamers (Table 4.3) may 
be as a result of decreased cytoplasmic mobility due to increased MW. This would, in turn, 
reduce the probability of plasmid entry into the nucleus. 
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It is apparent, nonetheless, that the chromatin constructs do reach the nucleus since reporter 
gene expression is observed. The reduced numbers of cells that were positive for transgene 
expression, observed in association with increased chromatinisation of the reporter plasmid, 
may be a reflection of the encumbering molecular weight of the constructs. This brings into 
question the degree of translocation of the chromatin constructs from the cytoplasm into the 
nucleus. In this context, the role of importin binding to the histones within the in vitro 
assembled chromatin constructs becomes important in facilitating nuclear import of the 
transfection constructs as a whole. These central issues concerning nuclear translocation are 
addressed in the experiments described in the following chapter. 
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CHAPTERS 
Limitations of chromatin as a gene delivery vehicle 
5.1. INTRODUCTION 
Translocation into the nucleus is a limiting process for non-viral gene delivery methods. The 
driving hypothesis of this study was that chromatin has several features that might enhance 
nuclear translocation, thus potentiating transgene delivery. DNA compaction had been reported 
previously by a number of groups to enhance transfection efficiency (Deas et al., 2002; Dauty et 
al., 2001; Fritz et al., 1996; Gao and Huang, 1996; Wagner et al., 1991), an effect almost 
certainly attributable to improved nuclear uptake. This was reflected in a study by Chan and 
Jans (Chan et al., 2000) who reported that during the course of plasmid DNA condensation 
induced by pLy, plasmid morphology passed through several structural intermediates to finally 
adopt a fully compacted spheroid structure, which could be correlated with a corresponding 7-
fold increase in nuclear uptake of the plasmid. Chromatinisation was seen to induce plasmid 
compaction from open loop into rod-like structures (see Section 4.4.4) and, therefore, could be 
expected to facilitate enhance nuclear uptake. 
Another important feature of in vitro assembled chromatin, according to the initial hypothesis of 
this study, is the presentation of multiple histone NLSs which, in principle, should increase the 
potential for nuclear uptake. The MWCO of the NPC ( ~ 45 kDa) dictates that the large 
chromatinised constructs would require importin-facilitated nuclear uptake, mediated by NLSs. 
In theory, this requirement for NLSs should be met by the histone octamers which, in addition 
to the high importin ~-binding affinity exhibited individually by its constituent histones (see 
Section 3.2), should present a total of 8 NLSs ( one from each histone ). 
Despite these potentially positive contributions to transgene delivery, the data presented in 
Chapter 4 revealed that chromatinisation of the model plasmid, pGeneGrip-RFP, resulted in 
diminished transfection efficiency of the reporter plasmid. In this chapter, experiments aimed at 
elucidating the mechanisms for the reduced reporter gene expression are described, with a focus 
on nuclear uptake as a limiting factor. Determining the reasons for reduced transfection 
efficiency was important in order to be able to design strategies that circumvent these 
shortcomings, as chromatinisation of DNA still has potentially useful properties such as the 
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ability to accommodate large lengths of DNA, protect the DNA from cytoplasmic nucleases and 
the potential to couple targeting signals, such as additional NLSs. 
In order to determine the degree of nuclear accumulation of the chromatin constructs in an in 
vitro reconstituted nuclear import system comprising permeabilised cells (Chan and Jans, 1999; 
Hu and Jans, 1999; Xiao et al., 1998), the reporter plasmid was labelled fluorescently with a 
DNA-sequence-specific PNA probe to which FITC had been conjugated. However, using 
CLSM, the fluorescence signal could not be detected above cellular autofluorescence. An 
altemati ve method was therefore used to assay the nuclear uptake in transfected cells. This was 
based on F ACS analysis of nuclei that were isolated from the transfected cells. Importantly, this 
method allowed determination of reporter gene expression and nuclear accumulation of the 
chromatin constructs from the same pool of transfected cells. 
Since, contrary to the working hypothesis of this study, chromatinisation of the reporter plasmid 
did not enhance transgene expression, the assumption that histone octamers assembled into 
chromatin would retain their ability to bind importins and, therefore, increase the probability of 
nuclear uptake of the chromatinised plasmids was tested using the modified ELISA method. 
While electroporation and lipof ection are widely employed as methods for transfection, the 
possibility of transfection-induced damage to the chromatinised constructs had not been 
excluded as a reason for the decreased transfection efficiency observed. This possibility was 
investigated first. 
5.2. THE EFFECT OF ELECTROPORATION AND LIPOFECTAI\flNE TRANSFECTION CONDITIONS 
ON CHROMATIN STRUCTURE 
In order to determine whether either electroporation or lipofection had any effect on chromatin 
structure, the supercoiling and MNase assays were used to investigate the stability of chromatin 
under the transfection conditions. 
For the supercoiling assay ( described in Section 2.5.4), pGeneGrip-RFP was incubated with 
Topoisomerase I in order to induce the open, circular form of the plasmid. Following this , a 
range of chromatin constructs were assembled at histone octamer stoichiometries of 0, 1, 25 and 
40, using the octamer transfer by salt dialysis method (Section 2.5.2). Each chromatin construct 
was quantitated spectrophotometrically based on DNA content and apportioned for either 
electroporation (10 µg DNA) or lipofection (1 µg DNA) treatment. 
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Electroporation conditions were as described in Section 2. 7 .1, except that cells were absent; the 
cell-containing aliquot being replaced by an equivalent volume of PBS. The supercoiled status 
of the chromatin constructs was determined before and after electroporation. While the 
supercoiled form of the plasmid was still evident after electroporation, higher molecular weight 
smearing can be seen in the agarose gel analysis (Figure 5. la, lanes 7 - 10). This implied that 
the conditions of electroporation had induced aggregation of the constructs. 
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Figure 5.1. The effect of electroporation and lipofection on the supercoiled structure of the 
chromatinised plasmids. Agarose gel (1 % ) images of supercoiling within chromatin constructs are 
shown after electroporation in (a) and after incubation with Lipofectamine™ 2000 in (b ). The 
supercoiling assay was carried out as described in Section 2.5.4. After incubating with Topoisomerase I, 
pGeneGrip-RFP was assembled into a range of chromatin constructs using the octamer transfer salt 
dialysis method (Section 2.5.2), as denoted. Chromatin constructs were subjected to electroporation in the 
absence of cells (PBS buffer, 300 V, 500 µF, 10 µg DNA, final volume 400 µl ; Section 2.7.1 ) or 
incorporated into liposomes using Lipofectamine™ 2000 (1 :50 v/v serum-free media, 1 µg DNA, final 
volume 100 µ1; Section 2.7.2). Relaxed and supercoiled forms of the plasmid are labelled. Note the 
presence of extensive smearing at high molecular weight in samples that were subjected to 
electroporation (a, lanes 7 - 10). Incubation times with Lipofectamine™ 2000 are indicated. Liposomal 
lipids were dissociated from the plasmid DNA by SDS (Section 2.5.4). 
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Lipofection conditions were as described in Section 2. 7 .2, except that cells were absent. 
Chromatin constructs were prepared with Lipofectamine TM 2000 and were incubated at room 
temperature for 20 minutes before aliquots were removed for assaying, as these are the 
conditions recommended by the manufacturer (Invitrogen) to allow liposome/DNA complexes 
to form prior to addition to cells (see Section 2.7.2). Liposome/chromatin complexes were 
incubated for an additional 24 hours at 37°C to simulate conditions of the post-transfection cell 
culture ( except in the absence of cells). Supercoiled status was compared for the 
Lipofectamine™ 2000-treated samples and the control chromatin samples which had not been 
exposed to the reagent (0 min; Figure 5.lb). Supercoiling was found to be equivalent between 
the 'O minutes' control constructs and constructs that had been incubated in Lipofectamine™ 
2000 for up to 24 hours. 
As electroporation appeared to cause aggregation of the chromatinised plasmids, the effect on 
nucleosome structure was tested using the MNase assay with the 25 octamers per plasmid 
construct as a model. Electroporation was carried out in the absence of cells, as described in the 
previous section, after which the MNase assay was conducted as described in Section 2.5.5. 
Preliminary experiments conducted on the 25 octamers per plasmid chromatin construct 
subjected to the electroporation pulse (300 V, 500 µF) indicated that the constructs failed to be 
digested by MNase. This was a drastic loss in MNase activity when compared to activity 
observed in the control digestion which was conducted in chromatin buffer (CB, 135 mM 
NaCl/10 mM Tris; Table 2.5) and had not been exposed to any of the conditions for 
electroporation. Apart from the electric current, the possibility existed that the electroporation 
buffer itself had a detrimental effect. It may be that possible precipitation of the Ca2+ compon.ent 
(2 mM CaCb) in the MNase assay buffer by the phosphate component of the PBS 
electroporation buffer. Ca2+ -phosphate precipitation could have depleted Ca2+ from the reaction 
mix, thereby abolishing enzyme activity as Ca2+ is an essential co-factor for MNase. 
In order to exclude this possibility, the electroporation and non-electroporation test-samples 
were dialysed from the PBS electroporation buffer into CB prior to MNase digestion. A control 
sample of chromatinised plasmid (25 octamers per plasmid) in CB that had not been exposed to 
PBS was included, as described above, to verify the activity of the MNase enzyme. Using the 
recommended amount of 25 mU of MNase per µg of DNA (for 4 µg of DNA; 100 mU), the 
characteristic MN ase digestion banding pattern indicating the presence of nucleosomes was 
seen in the control and the 'non-electroporated' samples, whereas the sample that had been 
subjected to electroporation conditions still appeared to be resistant to digestion (Figure 5.2a). 
Only when 3 times more MNase was added was the 'electroporated ' sample digested to the 
extent that enabled nucleosomes to be clearly identified (Figure 5.2b ). 
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Figure 5.2. Electroporation increases the resistance of chromatin to MNase digestion. Agarose gel 
electrophoresis of MNase digestion of chromatin constructs after electroporation is shown (1.5 % 
agarose). Chromatin samples comprising 25 octamers per plasmid were subjected to electroporation (10 
µg DNA, PBS buffer, 0.4 cm gap BioRad electroporation cuvettes, 300 V, 500 µF) in the absence of 
cells, essentially as described in Section 2.7.1 Samples were dialysed overnight into chromatin buffer 
(CB, 135 mM NaCl/IO mM Tris) and the MNase assay conducted as described using an aliquot of 4 µg of 
chromatinised DNA (Section 2.5.5). The control sample was maintained in CB and had not been exposed 
to PBS or electroporation. Digestions using a total of 100 mU and 300 mU of MNase are shown in (a) 
and (b ), respectively. Bands corresponding to nucleosomal DNA are denoted in red. 
Collectively, these results suggested that electroporation had a detrimental effect on chromatin 
structure by inducing the formation of MNase-resistant, aggregated structures which migrated in 
an agarose gel at higher molecular weight that non-electroporated chromatin. As the chromatin 
structure appeared to be retained in the presence of Lipofectamine™ 2000, lipofection was 
employed as the method of transfection for the remainder of the study. 
5.3. DETERMINATION OF THE EFFICIENCY OF CHROMATINISED PLASMID UPTAKE INTO THE 
NUCLEUS 
In order to visualise the subcellular distribution properties of the chromatin constructs in situ, 
pGeneGrip-RFP was labelled with FITC. Labelling was achieved using the GeneGrip™ site 
(Gene Therapy Systems) within the pGeneGrip-RFP reporter plasmid, which contains a 
sequence comprising 8 consecutive binding sites to which short, linear FITC-PNA molecules 
were hybridised (see Section 4.2 for a description of PNA chemistry). While reconstituted 
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permeabilised cell systems and studies involving microinjection have provided valuable 
evidence of the fate of DNA in the cytoplasm (Salman et al., 2001; Ludtke et al., 1999; Wilson 
et al., 1999; Dean, 1997; Hagstrom et al., 1997; Dowty et al., 1995; Capecchi, 1980), very few 
studies have investigated nuclear uptake of DNA in the context of transfection into live cells 
(Brisson et al., 1999; Wilke et al., 1996; Dowty et al., 1995). The use of PNA labels allows the 
plasmid to retain its transcriptional activity and hence the functional activity of the construct 
may also assessed in conjunction with the DNA tracking studies (Gene Therapy Systems). 
5.3.1. Generation of fluorescein-labelled reporter plasmid and assembly into chromatin 
PNA conjugated to FITC (PNA-FITC labelling kit, Gene Therapy Systems) was incubated with 
pGeneGrip-RFP in a labelling reaction according to the manufacturer's instructions (Section 
2.2.16.1 ). Unbound PNA-FITC was removed by precipitating labelled DNA and further 
washing in 70 % EtOH, before resuspending labelled DNA in 1 x labelling buffer (Gene 
Therapy Systems). FITC-labelling was verified using agarose gel electrophoresis (Figure 5.3). 
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Figure 5.3. FITC-PNA labelling of pGeneGrip-RFP. pGeneGrip-RFP (100 µg) was labelled with FITC 
at the GeneGrip™ site using PNA-FITC (8 PNA-FITC labels/plasmid, Gene Therapy Systems; Section 
2.2 .16.1 ). Labelling was carried out at 3 7°C for 2 hours, after which unbound label was removed by 
precipitating the labelled DNA in 3M NaOAC and isopropanol, followed by washing in 70 % EtOH. 
Labelled DNA was resuspended in 1 x labelling buffer (Gene Therapy Systems). Labelling was verified 
using agarose gel electrophoresis (1 %, 100 V for 90 minutes). The presence of FITC was visualised 
using a Fluorimager (FLA-3000, Fuji, excitation 473 nm; emission 538 nm), shown in (a). DNA was 
visualised by EtBr staining under UV illumination (FLA-3000, Fuji, excitation 473 nm; emission 580 
nm), shown in (b). FITC-labelled pGeneGrip-RFP can be seen in lanes 3 and 5. 
The FITC-label was visualised in the gel usmg a Fluorimager (FLA-3000, Fuji), with 
parameters of excitation at 473 nm and emission at 538nm for FITC (Figure 5.3a). Fluorescence 
can be seen in lanes 3 and 5 in Figure 5.3a. EtBr staining of the DNA (visualised using the 
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FLA-3000, Fuji, excitation at 473 nm and emission at 580nm for EtBr) confirmed the source of 
fluorescence to be the FITC-labelled pGeneGrip-RFP plasmid (Figure 5.3b, lanes 3 and 5), as 
the unlabelled plasmid control (Figure 5.3b, lanes 2 and 4) did not produce a fluorescent signal 
(Figure 5.3a, lanes 2 and 4). 
PNA-FITC-labelled pGeneGrip-RFP (pGeneGrip-RFP-FITC) was assembled into chromatin 
containing a 0, 1, 2, 4, 25 or 40 molar ratios of histone octamers to DNA using the octamer 
transfer salt dialysis method (Section 2.5.2). The MNase digestion assay (Section 2.5.5) was 
used to verify chromatinisation by monitoring the formation of nucleosomes. In order to serve 
as a control reaction, unlabelled pGeneGrip-RFP, which was previously shown to form 
nucleosomes upon chromatinisation (see Figure 4.8), was assembled into chromatin in parallel 
(Figure 5.4). 
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Figure 5.4. Nucleosome formation confirms chromatinisation of pGeneGrip-RFP-FITC. PNA-FITC-
labelled pGeneGrip-RFP was assembled into a range of chromatin constructs by the octamer transfer salt 
dialysis method, in parallel with the unlabelled plasmid (Section 2.5.2). MNase digestion of unlabelled 
and labelled chromatin constructs containing 1 and 25 octamers per plasmid is shown. 4 µg of 
chromatinised plasmid constructs were incubated for 2, 10, 20 and 60 minutes with MNase (100 mU), 
DNA was recovered by NaOAc precipitation overnight and electrophoresed through 1.5 % agarose at 90 
V (described in Section 2.5.5). The gel was stained in EtBr for 20 minutes, destained in ddH20 for half of 
that time and visualised under UV illumination. Bands corresponding to nucleosomal DNA are indicated 
with red arrows. 
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Chromatinisation of pGeneGrip-RFP-FITC generated MNase digestion products that were 
consistent with the presence of nucleosomes and identical to the digestion pattern of unlabelled 
chromatinised pGeneGrip-RFP. This confirmed that chromatin assembly was not inhibited in 
the presence of the PNA-FITC label. 
5.3.2. Gene expression and nuclear accumulation of fluorescein-labelled chromatinised 
reporter plasmid 
The in vitro nuclear transport assay, described in detail in Section 2.11.2 was investigated as a 
means to determine the kinetic parameters of nuclear uptake using the fluoresceinated chromatin 
constructs. HTC cells grown on coverslips were permeabilised mechanically and cytosolic 
extract and an ATP-regenerating system, required for protein import into the nucleus, were 
added together with the test sample to a final volume of 5 µ1. The test sample, as recommended 
by the manufacturer (0.1 - 1 µg of fluorescently labelled pGeneGrip DNA for confocal 
microscopy, Gene Therapy Systems), comprised 1 µg of the FITC-labelled plasmid, 
pGeneGrip-RFP-FITC, but the fluorescence signal could not be detected. The methodology was 
verified when fluorescence was visualised easily using a T-ag NLS-green fluorescent protein 
fusion (provided by Prof D. Jans, Nuclear Signalling Laboratory, Monash University) as a 
positive control for nuclear uptake in this system. The amount of pGeneGrip-RFP-FITC was 
increased to the maximum volume that could be accommodated in the system and was 3 times 
the amount recommended by the manufacturer of the FITC label (Gene Therapy Systems). 
However, despite this, a fluorescence signal still could not be visualised. The level of 
fluorescence from the fluoresceinated pGeneGrip-RFP plasmid thus appeared to be below the 
detection threshold for CLSM. 
An alternative means of monitoring nuclear accumulation was investigated using F ACS. F ACS 
provides the means to simultaneously detect both the fluorescence originating from the labelled 
plamsid and from expression of the trans gene in the same cell. The initial strategy was therefore 
to determine the percentage of cells in the transfected population that were positive for both 
FITC-fluorescence originating from the transfected plasmids and RFP fluorescence originating 
from their expression. Following this, isolation of nuclei and analysis by F ACS would indicate 
the proportion of nuclei that had accumulated the FITC-labelled chromatin constructs. Collation 
of these results with the proportion of RFP positive cells could provide the means to establish a 
relationship between nuclear accumulation of the transfection constructs and transgene 
expression. 
HTC and Cos-7 cells were transfected using lipofection (Section 2. 7 .2) with the range of 
differentially chromatinised constructs assembled usmg FITC-labelled pGeneGrip-RFP (see 
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Section 5.3.1). Cells were analysed by FACS 48 hours post-transfection for both RFP 
fluorescence, detected through channel FL2, relative to cells which had been transfected in the 
absence of DNA (Lipofectamine™ 2000 only), and FITC fluorescence, detected through 
channel FLl relative to cells which had been transfected with unlabelled plasmid (see Sections 
2.9.1.2 and 2.9.1.3, respectively). Representative FACS dot plots for Cos-7 cells are shown in 
Figure 5.5. 
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Figure 5.5. Highly fluorescent RFP is also detected in channel FLl and masks the detection of 
FITC. Cos-7 cells were transfected with a range of fluorescein-conjugated pGeneGrip-RFP chromatin 
constructs (see Sections 2.2.16.1, 2.5.2 and 2.7.2). 48 hours post-transfection dual detection of RFP 
expression and FITC-fluorescence was determined by FACS (channels FL2 and FLl , respectively; 
Section 2.9.1). Typical FACS dot plots are shown for the no DNA control, unlabelled pGeneGrip-RFP 0 
octamers per plasmid and FITC-labelled pGeneGrip-RFP O octamers per plasmid transfections. RFP 
fluorescence is represented on the y-axis, in region 1 (Rl) and FITC-fluorescence on the x-axis , in region 
2 (R2). RI was set according to the distribution of RFP expressing cells using the unlabelled O octamers 
per plasmid construct. R2 was set, thereafter, according to the distribution of FITC-positive cells using 
the FITC-labelled O octamers per plasmid construct. RFP-positive cells in the unlabelled (no FITC) 0 
octamers per plasmid dot plot accumulate at the upper end of the detection limit of channel FL2 (boxed) 
and score highly on the FITC-fluorescence scale (boxed). Other possible FITC-positive cells are 
demarcated in the green square and all possible RFP-positive cells may lie above the red line. 
Cells that were FITC-positive could not be detected with confidence because RFP expression 
from the unlabelled (no FITC) transfections could be detected ('bleed-through') in the FITC 
channel, FLl (Figure 5.5). The FITC signal appeared to be weak, consistent with the difficulties 
experienced using CLSM (see above), with fluorescence intensity ranging from 101 - 102 units. 
In comparison, fluorescence originating from cells electroporated in the presence of FITC-
dextran was between 102 - 103 fluorescence units (compare Figure 4.10). The problem thus was 
therefore one of very high RFP fluorescence and low FITC fluorescence, such that reliable 
identification of true RFP/FITC double-positive cells above the background of RFP-positive 
cells was deemed to be not possible in the whole cell context and for this reason had to be 
abandoned. However, quantitation of RFP-positive intact cells (analysed as illustrated in Figures 
4.14a and b) and quantitation of FITC-positive isolated nuclei was pursued, separately. This 
method still provided a basis from which to investigate the parameter of interest - nuclear 
accumulation of the differentially chromatinised plasmids. It also permitted the levels of nuclear 
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accumulation of the chromatin constructs in a population of nuclei to be related to the level of 
RFP transgene expression observed in the same population of cells. 
With appropriate size detection settings (forward scatter), subcellular components, such as 
nuclei, may be investigated by flow cytometry (Petersen, 1986). For the detection of whole 
cells, the forward scatter parameter was set on a linear scale due to the large size of the particles, 
while for the detection of nuclei, the forward scatter was set on a logarithmic scale. This meant 
that the comparatively smaller nuclei appeared between the first and second decades and the 
larger cells, if present, would form a distinct population at the upper limit of the logarithmic 
scale, enabling their exclusion from the analysis. 
Cells that were transfected with each of the FITC-labelled chromatin constructs were harvested 
for F ACS analysis 48 hours post-transfection and divided into two aliquots. One aliquot of 
intact cells was analysed for RFP expression, as described previously (Section 2.9.1.2). Nuclei 
were isolated (as described in Section 2.8) from the second aliquot of cells and were analysed 
for FITC-fluorescence (see Section 2.9.1). RFP expression and nuclear accumulation of the 
transfection constructs were thus determined separately but from the same transf ection 
experiment, enabling a direct comparison of these parameters. A total of 30000 cells were 
recorded for the RFP analysis, while 5000 nuclei were analysed. The majority of nuclei events 
fell between 10 and 100 units on the forward scatter, compared to forward scatter of intact cells 
which fell between 400 and 1000 units (Figure 5.6). The absence of a distinct population of 
events at the upper end of the forward scatter scale of the nuclei implied a homogeneous 
population had been isolated. 
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Figure 5.6. Qualitative analysis by FACS reveals a homogenous population of intact isolated nuclei. 
FACS analyses of whole cells (Cos-7) and nuclei isolated using NE-PER™ cell extraction reagents, as 
described in Section 2.8, are shown. Cells and nuclei were analysed on the basis of forward light scatter 
(x-axis) and side light scatter (y-axis). Forward scatter settings were on a linear scale for whole cells and 
on a logarithmic scale for nuclei. The majority of nuclear events fall between the first and second decades 
of log (10 - 100 units Forward scatter), whereas cellular events fall between the second and third decades 
of log (500 - 1000 units Forward scatter). 
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Nuclear FITC fluorescence originating from the FITC-labelled chromatin constructs was 
quantitated relative to nuclei isolated from cells transfected with either no construct (no DNA 
control) or unlabelled construct (0 octamers per plasmid). Channel FLl was set so that FITC-
negative events fell within the first decade of log on the FITC fluorescence axis. Figure 5.7a 
shows typical series of F ACS dot plots obtained from nuclear accumulation analyses for a range 
of FITC-labelled chromatin constructs in Cos-7 cells. Collated data comparing RFP expression 
from the whole-cell analyses and FITC accumulation from the isolated nuclei analyses of Cos-7 
cells are presented in Figure 5.7b and Table 5.1. Data obtained from an identical series of 
experiments performed using HTC cells are also presented in Table 5.1. 
In both Cos-7 and HTC cells, the percentage of nuclei that took up the constructs chromatinised 
at lower nucleosome densities (1, 2 and 4 octamers per plasmid) were not significantly different 
from the naked plasmid (0 octamers per plasmid) (p > 0.31 for Cos-7 cells; p > 0.09 for HTC 
cells; see Table 5.1). In contrast, the constructs more extensively chromatinised at higher 
nucleosome densities, 25 and 40 octamers per plasmid, accumulated in significantly fewer 
nuclei in Cos-7 cells when compared to the naked plasmid (p = 0.038 and 0.041, respectively; 
see Table 5.1). Similarly, fewer HTC nuclei accumulated the 25 octamers per plasmid construct 
than naked plasmid (p = 0.04; see Table 5.1). 
The tendency for RFP expression to be reduced upon increasing the chromatinisation of the 
reporter plasmid was consistent with the results observed previously (see Table 4.3). The 
relative percentages of cells expressing RFP from the less densely chromatinised constructs (1, 
2 and 4 octamers per plasmid) were not significantly different from the percentages of nuclei 
that showed their accumulation, in both Cos-7 (p > 0.562; Figure 5.7b; Table 5.1) and HTC cells 
(p > 0.192; see Table 5.1 ). This suggested that of the nuclei that took up transfection constructs, 
a similar proportion had facilitated RFP expression. This was in contrast to the relationship 
between nuclear accumulation and transgene expression observed with more extensive 
chromatinisation at 25 octamers per plasmid (Table 5.1 ). Here, 3-fold fewer Cos-7 cells 
expressed RFP than nuclei that took up the construct (p = 0.032) and around 8-fold fewer in 
HTC cells (p = 0.041). A similar trend was observed for the 40 octamers per plasmid construct 
in Cos-7 cells. These results suggested that, in addition to decreased nuclear accumulation, the 
greater the degree of chromatinisation of the constructs the greater the inhibition of gene 
expression. 
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Figure 5.7. Nuclear accumulation of fluorescein-labelled chromatin constructs and corresponding 
RFP reporter gene expression in whole cells. Cos-7 cells were transfected with a range of differentially 
chromatinised fluorescein-labelled pGeneGrip-RFP constructs as described in Section 2.7.2. RFP 
expression was determined by F ACS 48 hours post-transfection ( channel FL2; Section 2.9 .1.2). Nuclei 
were isolated (Section 2.8) and FITC-positive nuclei quantified also by FACS ( channel FLl ; Section 
2.9.1.3). A typical series of FACS dot plots showing differential nuclear accumulation for a range of 
chromatin constructs can be seen in (a), with FITC-positive events represented within the polygon 
labelled Rl and coloured in green. Histogram analysis of pooled data is shown in (b ). Red bars represent 
RFP-positive cells and the shaded green bars represent FITC-positive nuclei. The results are expressed as 
the percentage of cells or nuclei relative to the O octamers per FITC-labelled plasmid transfections and 
represent the mean ± SEM of 2 - 5 experiments. Experiments performed twice are represented by the 
mean± range/2 . 
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Table 5.1. Relative percentages of cells expressing RFP and nuclei positive for FITC. 
Cos-7 cells 
¾RFP ¾FITC 
positive cells* positive 
nuclei 
Octamers/plasmid 
0 100+0 100 +0 
1 110.8 + 20.2 92.2 + 10.7 
2 96.5 + 6.2 123.3 + 31.9 
4 58.8 + 5.9 64.7 + 18.6 
25 20.2 + 7.2 59.3 + 13.4 
40 24.3 + 9.5 48.9 + 10.7 
plasmid 54.3 + 15.3 109.1 + 18.6 
+ 25 octamers8 
n 
5 
5 
2 
2 
5 
3 
5 
HTC cells 
¾RFP 
positive cells* 
100 + 0 
100.1 + 7.1 
87.4 + 15.6 
52.1+5.7 
4.9 + 2.8 
NDA 
24.9 + 6.2 
¾FITC 
positive 
nuclei 
100 +o 
60.6 + 18.4 
66.9 + 21.3 
65.9 + 10.9 
40.8 + 11.8 
ND 
66.1 + 18.7 
n 
3 
3 
3 
3 
3 
3 
Cos-7 and HTC cells were transfected (see Section 2.7.2) with fluorescein-labelled pGeneGrip-RFP 
(PNA-FITC labelling kit, Gene Therapy Systems; see Section 2.2.16.1) assembled into chromatin 
constructs at a range of histone octamer stoichiometries (Section 2.5.3). Cells were harvested 48 hours 
post-transfection and divided into two aliquots. In one of the aliquots of cells, RFP expression was 
determined byFACS (channel FL2; Section 2.9.1.2). Nuclei were isolated from the other aliquot (Section 
2.8) and FITC-positive nuclei detected by FACS (channel FLI; Section 2.9.1.3). Data were analysed 
using CellQuest software (Macintosh). Results represent the mean+ SEM, expressed as the percentage of 
RFP-positive cells or FITC-positive nuclei relative to the O octamers per FITC-labelled plasmid 
transfections. The number of times the experiment was performed is indicated by n. For experiments 
performed twice, the mean + range/2 is shown. Only experiments in which RFP-expressing cells and 
FITC-nuclei were determined in the same pool of transfected cells are presented. 
A Not done. 
8 Construct comprising histones associated with pGeneGrip-RFP under non-chromatinising conditions at 
stoichiometry 25 octamers per plasmid. 
* Note that the differences between the percentages of RFP-positive cells reported in Tables 5.1 and 4.3 
are attributable to the presence of the PNA-FITC label. 
In order to separate the specific effect of chromatinisation from the histone binding effect, the 
reporter plasmid was 'associated' with histones at a stoichiometry corresponding to 25 octamers 
per plasmid (plasmid+ 25 octamers; see Table 5.1). As described in Sections 4.5.2 and 4.6.2, 
this was achieved by an initial incubation of the octamers in 135 mM NaCVl0 mM Tris (CB), 
followed by addition of pGeneGrip-RFP and then a further incubation for 10 minutes on ice, 
under which conditions chro1natin cannot form. Unlike the observation for the chromatinised 
constructs, the levels of nuclear accumulation were not significantly lower -than those of the 
naked plasmid, in Cos-7 (p = 0.67) or HTC cells (p = 0.21 ). This suggested that the decrease in 
nuclear accumulation observed when the reporter plasmid was loaded with high densities of 
histone octamers was specific to chromatinisation. However, as the relative percentages of RFP 
positive cells were significantly lower than the relative percentages of FITC-positive nuclei in 
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both Cos-7 (p = 0.03) and HTC cells (p = 0.05) for transfection with the 25 octamers per 
plasmid 'association', it appeared that the inhibition of gene expression at high densities of 
histone octamers was not specific to chromatinisation. 
These results demonstrated that chromatinisation resulted in reduced nuclear uptake of the 
transf ection constructs. Furthermore, the presence of hi stones either as chromatin or 
stochastically bound appeared to result in inhibition of gene expression. The trend of reduced 
RFP expression observed upon increasing chromatinisation of the reporter plasmid could thus 
be related both to reduced nuclear uptake and to inhibition of gene expression. 
5.4. THE IMPORTIN BINDING PROPERTIES OF CHROMATIN 
Given that importin p binds core histones with high affinity (see Section 3.2; Johnson-Saliba et 
al., 2000), effective regulated transport of his tones into the nucleus is implied ( see also Section 
1.5.2). One of the potential benefits of using an in vitro assembled chromatin system for the 
purposes of gene delivery was the possibility to exploit the nuclear import pathways of histones. 
This relied on the accessibility of importins to the histone NLSs in the context of a 
chromatinised plasmid. Since increasing the density of nucleosomes on the chromatinised 
reporter plasmid resulted in decreased levels of nuclear accumulation, it was important to verify 
whether the histones retained their importin binding affinity in the presence of DNA and were 
therefore able to contribute to the nuclear import of the chromatin constructs. The ELISA 
method, described in Chapter 3 to determine the importin binding affinities of histones (and 
other chromatin-associated proteins), was used here to determine importin binding to the histone 
octamer in the presence of DNA. 
5.4.1. Importin binding to the core histone H3/4 is reduced in the presence of DNA 
Importin binding to the core histone H3/4 tetramer in the absence and presence of DNA was 
investigated as a first step towards elucidating the importin binding properties of chromatin. 
This was because the H3/4 tetramers associate with DNA to induce the initial formation of 
topoisomers, but do not form the compacted, chromatinised structure. 
Using the NAP-1 method of chromatin assembly (Section 2.5.1), H3/4 tetramers (isolated from 
chicken long chromatin; provided by L. Hyman, Chromatin and Transcriptional Regulation 
Group, JCSMR) were associated with plasmid DNA (in the absence of H2A/2B) and the 
supercoiling assay was used to determine plasmid conformation (Section 2.5.4). Agarose gel 
electrophoretic analysis of the supercoiled status revealed that plasmid DNA associated with 
H3/4 formed topoisomers, but occurred predominantly in the open circular (relaxed) 
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conformation of DNA (Figure 5.8a, lane 1), consistent with the absence of nucleosomes. The 
topoisomers tended towards the supercoiled conformation of the plasmid (Figure 5. 8a, lane 2) 
only when H2A/2B dimers (recombinant Xenopus laevis, see Section 2.4.2.4) were added to 
H3/4 in the assembly reaction. The supercoiled state was reached at a stoichiometry of H2A/2B 
dimer to H3/4 tetramer of2:1, mimicking that within the histone octamer (Figure 5.8a, lane 3). 
Using the ELISA method (see Section 2.10 for method), the binding properties of the importin 
a/~ heterodimer and importin ~ were determined for the H3/4-DNA association (seen in Figure 
5.8a lane 1) and compared to that of the H3/4 tetramer alone. 
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Figure 5.8. Importin binding properties of the core histone H3/4 in the presence of DNA. H3/4 was 
associated with DNA using the NAP-1 chromatin assembly method (see Section 2 .5.1) and importin 
binding properties were determined using the ELISA method (see Section 2.10). The supercoiling assay 
following the H3/4-DNA association is shown in (a). The plasmid was relaxed using Topoisomerase I, 
and H3/4 added. A band corresponding to the relaxed form of the plasmid can be seen in Lane 1. 
Successive lanes (2 and 3) represent titration of H2A/2B onto the H3/4-DNA association, with 
topoisomers seen to tend towards the supercoiled form, evident at a stoichiometry -of H2A/2B to H3 /4 of 
2:1 (lane 3). Importin binding of the H3/4-DNA association represented in (a) lane 1 was compared to 
that of H3/4 alone. The binding curves, corrected for the presence of DNA alone, are shown for the 
importin o:/~ heterodimer in (b) and for importin ~ in (c). Results represent a typical experiment, 
performed in triplicate. Curves were fitted in Sigma Plot (Jandel Scientific) using the function B(x) = 
Brnax(l - e-~, where xis the concentration ofimportin and Bis the level of importin bound. The apparent 
dissociation constants (Ko) were calculated from k, the slope of the curve, using 0.693/k. See Table 5.2 
for pooled data. 
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To remove the contribution from the importin/DNA binding component, the H3/4-DNA binding 
data was corrected using binding data for an equivalent amount of DNA, which had been 
subjected to the NAP-1 chromatin assembly process in the absence of histones. The corrected 
data showed that the effect of DNA was to lower the maximum level of importin alp binding to 
H3/4 tetramers by 4-fold (p = 0.001) (Figure 5.8b; Table 5.2), consistent with occlusion of 
importin binding sites. The Ko values were not significantly different in the presence of DNA, 
indicating that the affinity of the available importin binding sites in H3/4 was unchanged. 
Similarly, the maximal level of importin P binding to H3/4 was reduced in the presence of 
DNA, up to 4-fold (p = 0.004), with no significant difference in the Ko values (Figure 5.8c; 
Table 5.2). 
Table 5.2. Importin binding affinities for the chromatin constructs. 
Importin a/~ Importin ~ 
Ko (nM) Bmax n Ko (nM) Bmax n 
Histones or chromatin 
H3/4 4.5 + 2.8 7.3 +0.8 2 5.1+0.7 6.1 + 0.8 2 
H3/4/DNA 15.7 + 7.6 1.3 + 0.9 2 9.5 + 2.2 1.4 + 0.3 2 
Histone octamer 59.0 + 26.6 3.4+0.1 2 39.3 + 9.5 3.8 + 0.4 2 
1 oct/plasmid No bindin~ No binding 2 No binding No binding 2 
25 oct/plasmid No binding No binding 2 No binding No binding 2 
Dissociation constants were determined using the modified ELISA method ( described in Section 2.10) 
and analysed using Sigma Plot (Jandel Scientific) according to the function B(x) = Bmax(l - e-1cx), where x 
is the concentration of importin and B is the level of importin bound. The apparent dissociation constants 
(KD), levels of maximum binding (Bmax) and the number of times each experiment was performed (n) are 
shown. Results represent the mean + range/2 for experiments. Individual experiments were performed in 
triplicate. 
A Could not be determined due to low levels of binding. See Figure 5.9. 
5.4.2. Importin binding to the core histone octamer is abolished in the presence of DNA 
The importin binding properties of chromatin constructs assembled at stoichiometries of 1 and 
25 histone octamers per pGeneGrip-RFP plasmid were determined using the ELISA method 
(Section 2.10) and compared to those of the histone octamer alone (Table 5.2). The amount of 
-
histone octamers was kept constant in each well of the ELISA microtitre plate at 4 pmol. 
Importin binding to pGeneGrip-RFP plasmid DNA corresponding to the amount in each of the 
140 
chromatin constructs was determined in order to correct for non-specific binding of importins to 
DNA. 
A peptide comprising residues 67 - 94 of PTHrP was used as a positive control for importin ~ 
binding (Lam et al., 1999) and demonstrated a high binding affinity, having a KD of 0.8 + 0.3 
nM (n = 2) and maximal binding level of 24.2 + 1.3 (n = 2) ( data not shown). The histone 
octamer alone exhibited binding to the importin a/~ heterodimer (KD = 59.0 + 26.6 nM) and to 
importin ~ (KD = 39.3 + 9.5 nM) (Figure 5.9; Table 5.2), although this was of lower affinity 
than that of its components - the H2A/2B dimer and the H3/4 tetramer (a reduction of around 
10-fold; see Table 3.1). Unlike H3/4/DNA, however, which still exhibited an importin binding 
component in the presence of DNA (Figure 5.8b and c; Table 5.2), no binding could be 
attributed to the histone octamer after chromatinisation at neither 1 nor 25 octamers per plasmid, 
as the binding curves for pGeneGrip-RFP DNA and the chromatin constructs were 
superimposable (Figure 5.9). 
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Figure 5.9. Assembly of the core histone octamer into chromatin abolishes importin binding. 
Importin binding curves of the histone octamer alone and chromatin constructs containing 1 and 25 
octamers per plasmid are shown. Microtitre plates were coated with 4 pmol per well of octamer, 
irrespective of the stoichiometry of the chromatin samples. The amount of plasmid DNA corresponding to 
that in the 1 and 25 octamers per plasmid samples served as the control for non-specific binding to the 
chromatin constructs. Data were determined using the modified ELISA method (Section 2.10) . 
Comparative binding curves for the octamer, 1 octamer/plasmid and 25 octamers/plasmid are shown in 
(a) for importin al~ and in (b) for importin ~- Data were analysed using Sigma Plot (Jandel Scientific) 
according to the function B(x) = Brnax( 1- e-kx) where xis the concentration of importin and B is the level 
of importin bound. The apparent dissociation constants (Kn) were calculated from ~ the slope of the 
curve as 0.693/k. The Kn values are denoted for the histone octamer but binding was too low to allow 
their determination for the chromatin constructs. These results represent a single typical experiment, 
performed in triplicate. Pooled data is presented in Table 5.2. 
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Overall, these results demonstrated that the association of DNA with the histone octamer in the 
context of chromatin abrogated binding by importins. Contrary to the original prediction, it is 
therefore highly improbable that nuclear import of the chromatinised constructs could be 
mediated by the importin a/~ or importin ~ pathways. 
5.5. DISCUSSION 
Some of the possible mechanisms for the reduction observed in transgene expression upon 
increasing the chromatinisation of the reporter plasmid were examined in this chapter, 
specifically the degree of nuclear accumulation of the chromatin constructs and the 
importin/histone binding properties. 
The transfection methods used in this study, namely electroporation and lipofection, were 
assessed in terms of their effects on the structure of the chromatinised plasmid constructs. While 
the supercoiled conformation of the chromatin constructs was maintained in the presence of the 
lipofection reagent, the agarose gel analysis revealed that high molecular weight aggregates had 
formed upon electroporation (Figure 5.1). The effect of electroporation was further examined in 
terms of nucleosomal structure and was found to induce resistance of the chromatin constructs 
to digestion by MNase (Figure 5.2). The formation of MNase-resistant aggregates may explain 
the anomalies observed between the relative levels of RFP expression using electroporation or 
lipofection, where electroporation was seen to bring about dramatic decreases in the percentages 
of cells expressing the transgene at chromatinisation with low nucleosome density (see Table 
4.3). For this reason, electroporation was abandoned as a method of transfection and lipofection 
was used in the remainder of the study. 
In order to determine the nuclear accumulation properties of the differentially chromatinised 
constructs, the reporter plasmid was coupled to fluorescein using a site-specific PNA-FITC 
hybridisation label. The presence of the FITC label did not hinder assembly of the plasmid into 
chromatin (Figure 5.4). The visualisation of fluorescein-labelled chromatin constructs in an in 
vitro permeabilised cell system using CLSM was not possible due to the limiting sensitivity 
against the background of cellular autofluorescence. Flow cytometry was adopted as an 
alternative method. However, the reliable detection in whole cells of transfected FITC-labelled 
chromatin constructs was also not possible in tandem with detection of RFP-expressing cells due 
to RFP 'bleed through' into the FITC detector. FITC-fluorescence could be detected in isolated 
nuclei. Consequently, RFP reporter gene expression was detected in whole cells and the FITC-
fluorescence originating from the labelled chromatinised plasmids was detected in the isolated 
nuclei from pools of cells within the same transfection experiment. 
142 
Compared to the naked construct (0 octamers per plasmid), nuclear accumulation of the 
constructs chromatinised at lower nucleosome densities ( 1, 2 and 4 octamers per plasmid) was 
unchanged. In contrast, significantly fewer nuclei accumulated the transfection constructs 
chromatinised at higher nucleosome densities (25 and 40 octamers per plasmid; ~50 % fewer; 
Table 5 .1 ). As discussed in Section 4. 7, the findings of Lukacs et al. (2000) suggest that the high 
MW of the chromatin complexes (6.6 x 106 Da for the 25 octamers per plasmid construct 
compared to 3.9 x 106 Da for the naked plasmid; see Table 4.1) may hinder diffusion through the 
cytoplasm and, consequently, reduce the amount of transfection constructs presenting at the NPC 
for import into the nucleus. Interestingly, a construct harbouring the theoretical MW equivalent 
to the 25 octamers per plasmid construct (but non-chromatinised) accumulated to a similar 
degree as the naked plasmid (Table 5 .1 ). This suggests that MW per se was not an issue in this 
case and that it was in fact chromatinisation that inhibited nuclear uptake. This will be discussed 
in detail in Chapter 7 in the context of DNA compaction and nuclear accumulation efficiency. 
Of the cells transfected with the constructs chromatinised at higher nucleosome densities (25 
and 40 octamers per plasmid), markedly fewer showed RFP expression compared to the 
percentage of nuclei which had accumulated FITC fluorescence (Figure 5. 7 and Table 5 .1 ). This 
may indicate that gene expression was repressed at higher molar ratios of histone octamers to 
plasmid and raises the important issue of the transcription efficiency of the transgene. When 
using 'non-physiological' vehicles for non-viral gene delivery, such as pLy or PEI, it is crucial 
that DNA is released from the carrier once in the nucleus so that it may be transcribed. A 
proposed advantage of using a chromatinised plasmid for gene delivery was that this mimics the 
physiological 'packing' of the DNA template, for which endogenous processes exist to facilitate 
'unpacking' prior to transcription. Chromatin assembly (using the method employed here) at 
high levels of nucleosome density has been shown to be transcriptionally repressive in vitro 
(Sandaltzopoulos et al., 1994; Hansen and Wolffe, 1992; Izban and Luse, 1992). However, 
addition of appropriate chromatin remodelling enzymes can overcome this repression (Logie 
and Peterson, 1997; Ng et al., 1997). In vivo, cells have specialised transcription complexes that 
re-model localised regions of chromatin by inducing sliding of the nucleosome away from the 
promoter region of the gene in order to facilitate transcription (for reviews see Luger, 2003; 
Orphanides and Reinberg, 2000; Kadonaga, 1998). In this study, pGeneGrip-RFP was expressed 
in fewer cells, when chromatinised at high nucleosome density. One possible explanation for 
this may be that the in vitro assembled chromatin could not be re-modelled efficiently in vivo in 
order for transcription to have occurred unhindered. 
The data presented in this chapter suggests that reduced nuclear uptake and inhibition of 
transcription were pivotal factors leading to reduced transgene expression. While some nuclear 
entry of the chromatinised plasmids would have occured during the process of cell division 
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(Escriou et al., 2001; Wilke et al., l 996), as the duration of the reporter gene assay was 48 hours, 
it is assumed that this nuclear accumulation would be equivalent for the different constructs. 
Nuclear import at other times would occur only through the NPC, as this is the established route 
for all transport into the nucleus (see Section 1.3.3.1). The reduced nuclear import observed in 
conjunction with increased chromatinisation may therefore be considered to arise from inhibition 
of this component of nuclear uptake. 
The accumulation of low molecular weight nucleic acids is well documented (Zelphati and 
Szoka, 1996) and the possibility that some of the nuclear fluorescence quantitated in the 
experiments reported here (Table 5.1) may be due to accumulation of degraded chromatinised 
constructs cannot be excluded. This degradation may result from the action of nucleases. Firstly, 
DNase I, which was added to the isolated nuclei in order to prevent their aggregation, may act on 
any plasmids should they may remain associated with the outside of the nucleus. Nuclear 
'adherent' plasmids, however, seem unlikely as the nuclei underwent various wash steps during 
the isolation procedure (Section 2.8). Secomdly, cytosolic nucleases may degrade the 
cytoplasmically-localised transfected plasmids (Pollard et al., 2001; Leuchardeur et al., 1999). 
Since association with histone octamers protects the DNA from degradation (Section 4.4.3), it 
may therefore be argued that the low frequency of FITC-positive nuclei is simply due to the 
lowered incidence of fluorescently labelled degradation products accumulating in the nucleus. 
Conversely, in the event of high levels of degradation of the plasmid, as may occur in the 
absence of his tone octamers ( the low nucleosome density constructs), a high frequency of FITC-
posi tive nuclei would occur. In this case, expression of the trans gene would be abrogated. On the 
contrary, the frequency of RFP-expressing cells tracks the frequency of FITC-positive nuclei. 
This indicates that degraded plasmid as the source of nuclear fluorescence is highly improbable 
and the levels of nuclear fluorescence observed are indeed representative of the accumulation ( or 
lack thereof) of the series of chromatin constructs. 
The possibility exists that a proportion of the chromatin constructs remained bound at the NPC 
and never entered the nucleus to allow transcription and gene expression to occur. The source of 
some of the nuclear-associated fluorescence could possibly, therefore, have been at the nuclear 
envelope, rather than the nucleoplasm. Although this possibility cannot be excluded, the fact 
that transcriptional repression occurs at high levels of histone octamer density, both in vitro 
(Sandaltzopoulos et al., 1994; Hansen and Wolffe, 1992; Izban and Luse, 1992) and in vivo 
(Luger, 2003; Orphanides and Reinberg, 2000; Kadonaga, 1998), makes a more likely 
explanation that some nuclear transport did occur and that transcription of these constructs was 
repressed. Further evidence for this stems from the observation that despite uninhibited nuclear 
accumulation of the 25 octamers per plasmid 'association', only half that proportion of cells 
expressed the reporter gene (Table 5 .1 ). 
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At the outset of this study, it was proposed that the importin-mediated uptake of histones would 
be extended to chromatin nuclear import. In light of both the decreased levels of cells expressing 
RFP and nuclear accumulation of the constructs with increasing plasmid chromatinisation, the 
ability of histones to retain their importin binding affinity (Section 3.2) when simultaneously 
bound to DNA was investigated. Results generated using the modified ELISA method indicated 
that the core histone octamer was bound by importins with reduced affinity and at 2-fold lower 
levels of maximal binding when compared to the binding affinity of its constituent H2A/2B 
dimers and H3/4 tetramer (compare Tables 3.1 and 5.2). In crystal structure studies ofa single 
nucleosome, amino acids 16 - 24 of H4 have been shown to bind to a specific domain of the 
H2A/2B dimer on the surface of the histone octamer (Luger et al., 1997). As this region of H4 
has also been shown to contain an NLS (see Table 3.2; Mosammaparast et al., 2002b; Baake et 
al., 2001a; Muhlhausser et al., 2001), it may be postulated that this intra-octamer contact may 
preclude the NLS from importin-binding, thus reducing the level of maximal binding by 
importins. Moreover, the level of maximal importin binding to H3/4 was observed to be reduced 
in the presence of DNA, suggesting further occlusion of available importin binding sites (Figure 
5.8a). When associated with DNA, the H3/4 tetramer was able to contribute to importin binding, 
possibly as a more open form of the plasmid was predominant which may have allowed importin 
accessibility. In contrast, when associated with DNA through chromatinisation there was no 
measurable binding contributed by the octamer. Thus, in chromatinised plasmids, DNA may 
mask the histone NLSs and abrogate importin binding. This finding is consistent with those of 
others showing that some proteins are mutually exclusive for DNA and importin binding 
(Forwood et al., 2001b; Chan et al., 1998). 
The results presented in this chapter suggest that key limiting steps for the success of using in 
vitro assembled chromatin for gene delivery purposes are the efficiency of nuclear uptake and 
transcription of the reporter plasmid. Strategies to overcome these limitations are explored in the 
next chapter. 
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CHAPTER6 
Strategies to enhance transgene expression 
from the chromatinised plasmids 
6.1. INTRODUCTION 
The results presented in Chapter 5 indicated that the trend of decreased transfection efficiency 
observed with increasing levels of plasmid chromatinisation may be partly attributed to reduced 
nuclear uptake. It was also apparent that not all of the plasmid-containing nuclei supported 
transcription of the reporter gene from the plasmids chromatinised at high nucleosome densities, 
as reflected in the marked decrease in the proportion of cells expressing the reporter gene 
compared to the proportion of cells that showed nuclear accumulation of the transfection 
constructs (Figure 5.7; Table 5.1). Therefore, the impairment of transcriptional activity 
concomitant with increasing chromatinisation was implicated as another contributor to 
decreased reporter gene expression (Section 5.3.2). In this chapter, the approaches undertaken to 
address the problems of reduced nuclear import and inhibited transcription are described. 
Several studies have described the inclusion of NLSs in the transfection constructs in order to 
enhance nuclear import (reviewed in Escriou et al., 2003; Cartier and Reszka, 2002; Bremner et 
al., 2001 ). Since importin binding to the intrinsic NLSs of the histone octamer was found to be 
abrogated in the context of DNA-induced nucleosome formation (Section 5.4), NLSs additional 
to those present in the · his tones were incorporated into the chromatin constructs. Enhanced 
uptake of the transfection constructs by the nucleus should increase the probability for 
transcription and, ultimately, expression levels of the reporter gene. Inclusion of the NLS in the 
chromatin transfection constructs was explored at two levels. Firstly, at the level of the DNA-
carrier protein, a histone-NLS fusion protein was generated for assembly into histone octamers 
and, secondly, at the level of the DNA, by directly coupling a NLS to specific sites within the 
reporter plasmid. The NLS that was employed was a peptide sequence derived from the SV40 
T-ag, which had been optimised with the inclusion of a nuclear-import-enhancing site 
previously (P 1 0 1; Hubner et al., 1997). The use of this peptide allowed the possibility for the 
nuclear entry of the chromatinised constructs by the 'conventional' importin cx,,l~-mediated 
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pathway (see Section 3.2). This strategy of switching to an alternative nuclear import pathway 
was first employed by Chan et al. (2001), who found that the DNA binding protein used 
(GAL4) in their gene delivery construct was mutually exclusive for importin ~- and DNA-
binding (Chan et al., 1998). Inclusion of an SV40 T-ag peptide in the GAL4-based gene 
delivery construct restored nuclear import via the importin a/~-mediated pathway and transgene 
expression was shown to be enhanced. 
Comparison of the relative levels of nuclear accumulation and the reporter gene expression of 
the chromatin constructs reported in Section 5. 3 .2 suggested that impairment of gene expression 
may have arisen also as a result of inefficient transcription of the more extensively 
chromatinised constructs that had entered the nucleus. One of the reasons for introducing 
transfection constructs into cells in the form of in vitro assembled chromatin was that chromatin 
is the physiological form in which DNA exists in the cell. While it is known that regions of 
chromatin heavily associated with nucleosomes are generally refractory to transcription in vitro 
(Sandaltzopoulos et al., 1994; Hansen and Wolffe, 1992; lzban and Luse, 1992), mechanisms 
exist in the cell to re-model nucleosome density, moving nucleosomes away from the promoter 
regions of the genes so that transcription can occur (Orphanides and Reinberg, 2000; Kadonaga, 
1998). It was expected that the CMV promoter and enhancer region, which is constitutively 
active (pGeneGrip ™, Gene Therapy Systems), would drive expression of the reporter gene 
when transfected into cells in culture, even when the reporter plasmid was chromatinised. The 
discrepancy between the proportion of nuclei that had accumulated the chromatinised plasmids 
and cells that had expressed the reporter gene suggests that this may not have been the case and 
that chromatinisation had inhibited transcription of the trans gene. 
In order to test the hypothesis that chromatinisation inhibited transgene expression, two 
strategies were adopted to determine if the putative transcriptional block could be overcome and 
if the transcriptional permissiveness of the chromatinised constructs could be potentiated. In the 
first approach, chromatinisation of the reporter plasmid with histone octamers that incorporated 
the H2AZ variant histone instead of H2A was investigated. Fan et al. demonstrated that H2AZ-
octamers inhibited the formation of highly condensed chromatin fibres (Fan et al., 2002). The 
presence of H2AZ might therefore facilitate the formation of transcriptionally competent 
chromatin domains. In addition, it had been demonstrated that H2AZ/2B dimers had greater 
affinity for importin ~ than H2A/2B dimers in the ELISA-based binding studies (Section 3.2). 
This may be extrapolated to mean that H2AZ-containing chromatin may be transported to the 
-
nucleus more efficiently than H2A-containing chromatin (provided that the NLSs are not 
masked to the same extent as in H2A-chromatin; Section 5.4). 
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In the second approach, an alternative transgene expression system was investigated. This 
approach was based upon the premise that regions of condensed chromatin, which are refractory 
to transcription, undergo 're-modelling' in vivo to become transcriptionally active when targeted 
by appropriate re-modelling complexes (Orphanides and Reinberg, 2000; Kadonaga, 1998). The 
ability of the T-cell specific GMCSF promoter, which can recruit transcription complexes in the 
model T-cell line, Jurkat (Rao et al., 2001; Himes et al., 1993), was tested for its potential to 
drive reporter gene expression when in the context of in vitro assembled chromatin. 
6.2. INCLUSION OF EXTRINSIC NLSS IN THE CHROMA TIN TRANSFECTION CONSTRUCTS 
The in vitro binding studies reported in Section 5.3.2 showed that when DNA was associated 
with the histone octamers in nucleosomes, the intrinsic importin ~-specific NLSs within the 
histones no longer mediated high affinity binding. This implied that the importin ~-mediated 
pathway was unlikely to facilitate efficient nuclear import of the chromatin constructs. 
Consequently, extrinsic SV 40 T -ag optimised NLS peptide sequences 
(GPGSDDEAAADAQHAAPPKKKRKVGY; the NLS is highlighted in bold type-face) which 
target the importin a/~-mediated nuclear import pathway and had been shown previously to 
enhance nuclear delivery of plasmid DNA (Chan and Jans, 2001; Chan et al. , 2000; Akhlynina 
et al., 1999; Chan and Jans, 1999; Akhlynina et al., 1997) were incorporated into the chromatin 
constructs. 
6.2.1. Generation of a histone-NLS fusion protein and its incorporation into histone 
octamers 
6.2.1.1. Construction of an H2A-NLS expression plasmid 
The coding region of H2A (Xenopus laevis) was subcloned from the plasmid pET3a-H2A 
(Table 2.9), together with the SV40 T-ag NLS subcloned from plasmid pPR28 (Table 2.9) 
which contains the optimised T-ag NLS, into the pET5a vector by Dr M. Lam (Nuclear 
Signalling Laboratory, JCSMR; see Figure 6. la - c for the ligation strategy). A candidate clone, 
containing H2A fused at the C-terminal to the NLS, was identified by restriction analysis using 
the restriction endonuclease Spel, which would digest at a unique site present as a consequence 
of the NLS PCR product insertion. The candidate clone, termed pET5a-H2A-NLS (Figure 6. ld) 
was sequenced (described in Section 2.2.14) using the 'forward sense' sequencing primer 
H2A5' (Table 2.10). This confirmed the presence of the H2A coding region and the C-terminal 
insertion of the NLS coding region ( denoted in Figure 6.1 d). 
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Figure 6.1. Generation of an H2A-NLS expression plasmid. A schematic representation of the strategy 
employed to clone a plasmid for the expression of the H2A-NLS fusion protein is shown in (a - c). H2A 
was PCR amplified from pET3a-H2A (a) and the NLS was PCR amplified from pPR28 (b) using custom 
primers designed to introduce restriction sites (shown in lower case font) (see Tables 2.9 and 2.1 O; 
Section 2.2.12). Cloning of both PCR products into pET5a was carried out simultaneously, using ' sticky-
end ' ligation of the restriction sites indicated in {c) by Dr M. Lam (Nuclear Signalling Laboratory, 
JCSMR). A clone identified by restriction digest analysis with Spel was sequenced ('forward ' primer 
H2A5' , see Table 2. 10 and Section 2.2.14; Perkin Elmer ABI Prism 377 DNA sequencer) to confirm the 
presence of the H2A-NLS fusion. The nucleotide profile is shown in (d) . The NLS coding sequence is 
boxed in red, with the single letter amino acid code translation shown. The H2A coding sequence is 
indicated by the black arrow. 
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6.2.1.2. Expression ofH2A-NLS in BL21DE3lysS E.coli cells 
For protein expression, pET5a-H2A-NLS was transformed into BL21DE3lysS E. coli cells 
using the heat shock method (Section 2.2.1.2; Table 2.8). A detailed description of H2A-NLS 
expression is set out in Section 2.4.2.1 but, briefly, an overnight starter culture was established 
from an H2A-NLS bacterial colony selected on the basis of ampicillin and chloramphenicol 
resistance on solid agar medium. This was used the fallowing morning to inoculate a larger 
culture of 800 ml. This culture was incubated at 37°C with agitation until an 00600nm of between 
0.6 and 0.8 was reached, at which point IPTG was added to a final concentration of 0.5 mM. 
The culture was incubated for a further 2 hours at 37°C and thereafter agitated gently overnight 
at room temperature. Samples of culture, removed before the addition of IPTG and 24 hours 
later, were analysed by 18 % SDS-P AGE and Coomassie staining. Induced expression of a 
protein of MW between 14.9 and 19.6 kDa was evident, in accordance with the predicted value 
for H2A-NLS of 16.7 kDa (H2A, 13960 Da; NLS, 2760 Da; see Figure 6.2a). 
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Figure 6.2. Expression of H2A-NLS in BL21DE3lysS E. coli cells and isolation of inclusion bodies. 
BL21DE3lysS E. coli cells were transformed by heat shock with pET5a-H2A-NLS (see Section 2.2.1.2). 
Samples of culture, removed before addition of IPTG and 24 hours later, analysed by 18 % SDS-P AGE 
and Coomassie staining, are shown in (a). An overexpressed protein between 14.9 and 19.6 kDa, 
corresponding in MW to H2A-NLS (16.7 kDa) is indicated by the red arrow. Inclusion bodies were 
purified (Section 2.4.2.2) and samples removed at each stage. Samples were electrophoresed through 18 
% SDS-polyacrylamide. Protein transfer onto a nitrocellulose membrane was carried out overnight at 10 
Vin the presence of Transfer buffer (Section 2.3.4; Table 2.3). The nitrocellulose membrane was probed 
for the presence of H2A-NLS using an IDA-antibody (Table 2.13; Section 2.3.4). Antibody reactivity 
visualised by chemiluminesence (Pierce, see Table 2.14) is shown in (b ). Inclusion bodies purification 
steps are denoted(+ IPTG is 24 hours post induction, WB is Wash buffer; TW is Wash buffer/1 % Triton 
X-100; Table 2.4). The H2A positive control and H2A-NLS are indicated by red arrows. 
151 
Inclusion bodies were prepared from the IPTG-induced cultures by following the protocol of 
Luger et al. for the purification of recombinant histones (Luger et al., 1999; see Section 2.4.2.2). 
A sample was removed at each step in the purification procedure and the presence of H2A-NLS 
was monitored using immunoblotting with an antibody directed against the C-terminal sequence 
of H2A (see Table 2.12; Section 2.3.4). Immunoblotting revealed an increase in MW of the 
H2A-immunorecative IPTG-induced protein compared to the H2A positive control sample (see 
Figure 6.2b). This verified that the H2A-NLS fusion protein had been expressed and had 
accumulated in the inclusion bodies. 
6.2.1.3. Purification of H2A-NLS using cation-exchange chromatography 
Inclusion bodies containing H2A-NLS were solubilised in Unfolding buffer containing 7M urea 
(Table 2.4) prior to purification using cation-ion exchange chromatography according to the 
method of Luger et al. (1999), described in Section 2.4.2.2. Purification of H2A-NLS was 
achieved by elution with a 200 - 600 mM NaCl gradient (see Table 2.4 for composition of 
buffers SAU-200 and -SAU-600) using a 1 ml Resource S FPLC column (Amersham 
Pharmacia). The elution profile was monitored at 276 nm (Figure 6.3a) and fractions 
corresponding to peaks in the chromatogram were analysed by immunoblotting (Figure 6.3b and 
c). Those fractions containing the highest concentration of H2A-NLS were pooled and 
lyophilised. H2A-NLS was stored at -20°C prior to assembly into an octamer together with 
H2B, H3 and H4. 
6.2.1.4. Comparison of H2A-NLS with H2A for its ability to assemble into an octamer with 
H2B, H3 and H4 
The procedure used for assembling histone octamers was repeated using H2A-NLS in place of 
H2A (see Section 2.4.2.3 for method). Briefly, lyophilised H2A-NLS was solubilised in 1.5 ml 
of Unfolding buffer, containing 7 M urea (see Table 2.4). The concentrations of each of the 
octamer's constituent histones, H2A-NLS, H2B, H3 and H4, were determined by absorbance at 
276 nm. The concentrations of H2A-NLS and H2B were adjusted to equimolarity using 
Unfolding buffer (Table 2.4). Similarly, the concentrations of H3 and H4 were adjusted to 
equimolarity but were 98 % that of H2A-NLS to ensure maximal incorporation of H3 and H4 
into the octamer (Luger et al., 1999). The final concentration of the histone mix was determined 
by measuring the absorbance at 276 nm and was adjusted to 1 mg/ml using Unfolding buffer 
(final volume ~ 2 ml). For comparison, H2A-containing octamers were assembled in parallel 
with H2A-NLS containing octamers in an identical manner. 
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Figure 6.3. Purification of H2A-NLS. H2A-NLS was· purified from isolated inclusion bodies using 
cationic exchange chromatography (1 ml Resource S column, Amersham Pharmacia) eluting in 1 ml 
fractions with a linear NaCl gradient (200 - 600 mM) at a flow rate of 1 ml/min. The chromatographic 
trace captured at 276 nm is shown in (a). 10 µl samples of the loading material, column flowthrough and 
peak fractions A9, Al 3 and B8 (indicated by arrows) were electrophoresed through duplicate 18 % SDS-
polyacrylamide gels and transferred onto nitrocellulose, overnight at 1 0V (Section 2.3 .4 ). One 
nitrocellulose membrane was stained using Ponceau-S and imaged digitally using the LAS-1000 imaging 
system (Fuji), shown in (b ). The other nitrocellulose membrane was immunoblotted using an H2A 
antibody (Section 2.3.4; Table 2.12). This identified H2A-NLS in the loading material and peak fraction 
A9. Chemiluminescence was used for visualisation (Pierce, Table 2.14) and the image captured digitally 
using 'chemiluminescence' settings on the LAS-1000 imaging system (Fuji) is shown in (c). Fractions A7 
-Al0 were pooled and lyophilised for assembly into octamers. 
The octamer assembly reactions were dialysed (MWCO 6000 - 8000 Da, Spectra/Por® 
membrane, flat width 10 mm, Spectrum Laboratories) overnight against three changes of 
Refolding buffer ( containing 2.2 M NaCl; see Table 2.4 and Section 2.4.2.3) and thereafter 
concentrated to a volume around 1 ml (Centricon filter, YM-10, Am.icon). Histone octamers 
were purified using gel filtration chromatography (HiLoad 16/60 Superdex 200 prep grade 
column, Pharmacia) in Refolding buffer, as described before (Section 2.4.2.3; Table 2.4). The 
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eluate was monitored at 276 nm and the chromatograms for both H2A-containing octamers and 
H2A-NLS-containing octamers are shown in Figure 6.4. 
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Figure 6.4. Analysis of H2A- and H2A-NLS-octamer assembly reactions by gel filtration 
chromatography. Product profiles from H2A- and H2A-NLS-octamer assemblies (see text and Section 
2.4.2.3 for details) are shown in (a) and (b), respectively. Chromatography was performed using a 
HiLoad 16/60 Superdex 200 prep grade column (Pharmacia) in Refolding buffer (see Table 2.4) at 4°C. 
Chromatograms were generated at absorbance 276 nm and fractions of 1 ml were collected every minute. 
Peaks corresponding to the octamer and excess H2A/2B are labelled on the chromatogram. Fraction for 
analysis by SDS-PAGE are also labelled. 
The chromatogram representing H2A-octamer assembly was typical of previously assembled 
H2A-containing octamers, displaying the characteristic peaks corresponding to the octamer and 
excess H2A/2B dimer (Figure 6.4a; compare Figure 4.4b and c). The peak corresponding to 
H2A-containing octamer was symmetrical. This indicated the absence of excess H3/4 tetramer 
and that an equimolar association of the constituent histones had occurred. The chromatogram 
of the H2A-NLS-octamer assembly product differed greatly from that of the H2A-octamer. 
Based on the elution volume of the H2A-octamer, the peak corresponding to the H2A-NLS-
containing octamer was a leading shoulder (indicated in Figure 6.4b ). This suggested that a 
small amount of H2A-NLS-octamer may have formed, but the main peak would comprise 
excess H3/ 4 tetramer. 
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Figure 6.5. SDS-PAGE analysis of the H2A-NLS octamer purification. Fractions Dl, E7, Ell and F8 
corresponding to peaks on the H2A-NLS chromatogram were analysed by 18 % SDS-PAGE and 
immunoblotting using an antibody directed against H2A, essentially as described in the legend to Figure 
6.3. The Coomassie blue stained SDS-PAGE analysis and corresponding chemiluminescent visualisation 
of antibody reactivity are shown in (a) and (b ), respectively. The antibody positive control was H2A-
containing octamer from fraction ElO of the parallel H2A-octamer reconstitution (Figure 6.4a). The 
FPLC fractions are denoted according to the chromatographic trace in Figure 6.4b. 
The 18 % SDS-PAGE analysis revealed that the peak corresponding to fraction ElO of the 
chromatographic trace shown in Figure 6.4a contained equimolar amounts of the constituent 
histones (Figure 6.5a, lane 1 ), implying assembly of the H2A-containing octamer. The presence 
of H2A in the purified H2A-containing octamer fraction was confirmed by immunoblotting 
using an antibody directed against H2A (Figure 6.5b, lane 2). Indeed, immunoblotting analysis 
of the fractions corresponding to peaks on the H2A-NLS chromatogram revealed that the H2A-
NLS-containing octamer had not formed in a quantity greater than the detection limit of the 
analysis procedure (Figure 6.5b). The immunoblot analysis failed to detect H2A-NLS in any of 
the fractions analysed from the H2A-NLS-containing octamer assembly (Figure 6.5b, lanes 3 -
6). Furthermore, the SDS-P AGE analysis showed that the material loaded onto the gel filtration 
column containing the post-dialysis assembly reaction of the H2A-NLS-octamer appeared to 
comprise H2B, H3 and H4, with only a faint band corresponding in MW to H2A-NLS (Figure 
6.5a, lane 2). This anomaly was unexpected since all the constituent histones in the assembly 
reaction were measured to equimolarity by absorbance at 276 nm prior to dialysis. Since H2B, 
H3 and H4 were clearly present, it appears that H2A-NLS may have precipitated out of solution 
during the dialysis or subsequent concentration procedures rather than incorporate into an 
octamer. Perusal of the H2A-NLS octamer assembly reaction chromatographic profile revealed 
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concordance with that of unassembled octamers (Luger et al., 1999). The first peak fraction 
(D1), corresponding to high MW aggregated material, resolved to a band of the MW of H2B 
(Figure 6.5a, lane 3). The shoulder peak (fraction E7), which was most likely to include H2A-
NLS-containing histone octamers, revealed no material. This was presumably because the 
amount of material was insufficient to reach the detection limit of the stains used (Figure 6.5a 
and b, lane 4). The next peak (fraction Ell; Figure 6.5a, lane 5) resolved to bands 
corresponding to H3 and H4 only, which would have associated during the octamerisation 
reaction as tetramers; a result typical of failed histone octamer assembly reactions. Other gels 
(not shown) showed that fraction F8 contained some H2B and H4, while no protein was 
detected in fractions H6 or 13 (fractions are denoted in Figure 6.4b ). 
The inability of H2A-NLS to be incorporated into a histone octamer suggests that core histones 
do not tolerate changes to their sequence ( or structure). Alterations to the core histones 
themselves may therefore not be an option in order to include additional NLSs in the chromatin 
constructs using the octamer transfer method of chromatin assembly employed in this study. 
However, this may still be a viable option if the NLS-modified histones are to be used as DNA-
carriers in their own right (Fritz et al., 1996). 
6.2.2. The effect on transf ection efficiency of direct coupling of NLSs to the reporter 
plasmid 
6.2.2.1. Coupling of the NLS peptide to pGeneGrip-RFP using a PNA-maleimide linker 
In an alternative approach to enhance the nuclear uptake properties of the chromatin constructs, 
the pGeneGrip-RFP plasmid was coupled to the optimised T-ag NLS peptide. The NLS peptide 
was synthesised with and without an FITC group by K.N. McAndrew (Biomolecular Resource 
Facility, JCSMR) (see amino acid sequence in Figure 6.6a). 
The NLS coupling procedure was achieved through exploitation of the GeneGrip™ site in 
pGeneGrip-RFP in two steps; firstly, attachment of a chemically reactive maleimide moiety to 
the plasmid and, secondly, reaction of maleimide with the N-terminal cysteine residue of the 
NLS peptide. The first step involved hybridisation of PNA-maleimide (PNA-maleimide 
labelling kit, Gene Therapy Systems) to the GeneGrip™ site, in a manner similar to the PNA-
FITC labelling reaction described in Section 5.3.1 (see also Section 2.2.16.2.). Immediately 
following this reaction, cross-linking of the peptide to maleimide was carried out, following the 
manufacturer's instructions. The NLS peptide was incubated, at around 30-fold molar excess, 
with the PNA-maleimide labelled plasmid at 4°C overnight in 1 x Labelling buffer (provided in 
the PNA-maleimide labelling kit, Gene Therapy Systems). The molar excess of NLS results in 
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the formation of a covalent thioether bond between the PNA-maleimide and the free sulphydryl 
group of the terminal cysteine residue of the NLS peptide (Figure 6.6b ). The bond formed is 
stable and irreversible. Unbound PNA-maleimide and peptide were removed by isopropanol 
precipitation of the plasmid DNA and washing in 70 % EtOH. Plasmid was resuspended in 1 x 
Labelling buffer (Gene Therapy Systems). This procedure was repeated to ensure removal of 
excess label. The modified plasmid was termed pGeneGrip-RFP-NLS. As the pGeneGrip™ 
plasmid has 8 binding sites within the GeneGrip™ region for the hybridisation of PNA labels, 
potentially 8 NLS peptides may be coupled to the plasmid. The fluorescein-conjugated NLS 
peptide was coupled to pGeneGrip-RFP in exactly the same manner. 
a 
b 
GPGSDDEAAADAQHAAPPKKKRKVGY 
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FITC 
pGeneGrip-RFP 
Figure 6.6. Conjugation of an NLS peptide to pGeneGrip-RFP. An optimised SV40 T-ag NLS-
containing peptide was coupled to pGeneGrip-RFP using PNA-maleimide as a linker. The optimised T-ag 
NLS peptide, in single-letter amino acid code is shown in (a), with the T-ag NLS coloured in red, the 
nuclear-import-enhancing protein kinase CK2 site in blue and the terminal cysteine residue which through 
its free sulphydryl group facilitates binding to the maleimide-PNA molecule in orange. An FITC group 
(in green) was attached to the N-terminal amine of the cysteine residue within the NLS peptide to form 
NLS-FITC. The conjugate, pGeneGrip-RFP-NLS is shown in (b ). PNA-maleimide was hybridised to the 
GeneGrip™ site of pGeneGrip-RFP (PNA-maleimide labelling kit, Gene Therapy Systems; Section 
2.2.16.2.). Reaction between the sulphydryl group of the terminal cysteine residue (in orange) of the NLS 
peptide and the reactive maleimide group facilitates the formation of a stable thioether bond. Note that the 
GeneGrip™ sequence contains 8 consecutive sites for the hybridisation of PNA-labels; only one label is 
represented. 
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6.2.2.2. Assembly of pGeneGrip-RFP-NLS into chromatin constructs 
The plasmid, pGeneGrip-RFP-NLS (+ FITC), was reconstituted into chromatin with H2A-
containing histone octamers. Chromatin constructs comprising 0, 1, 4, 25 and 40 molar ratios of 
octamer to DNA were generated using the octamer transfer salt dialysis procedure ( described in 
Section 2.5.2). Digestion of the chromatinised constructs with MNase (Section 2.5.5) revealed 
the characteristic digestion-resistance pattern corresponding to the formation of nucleosomes 
(see Figure 6.7 for chromatinised pGeneGrip-RFP-NLS MNase digestion; identical results were 
obtained in the presence of the NLS-FITC label). This demonstrated that attachment of the 
PNA-maleimide-NLS (+ FITC) did not hinder chromatinisation of the plasmids. 
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Figure 6.7. MNase digestion confirms nucleosome formation in NLS-coupled pGeneGrip-RFP. 
pGeneGrip-RFP-NLS was assembled into a range of chromatin constructs by octamer transfer salt 
dialysis (Section 2.5.2) and subjected to MNase digestion (Section 2.5.5) to verify chromatinisation. 
Agarose gel electrophoresis analysis (1.5 % agarose; 100 V) of the MNase reaction is shown. The 
stoichiometries of histone octamers to plasmid DNA are denoted for each of the chromatin constructs. 
Bands corresponding to nucleosomal DNA are indicated in red. 
6.2.2.3. Transfection efficiency of chromatinised pGeneGrip-RFP is altered in the presence 
of NLSs 
Aliquots of the differentially chromatinised NLS-coupled constructs containing 1 µg of plasmid 
DNA were prepared for transfection using Lipofectamine™ 2000 into cultured HTC and Cos-7 
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cells, along with non-NLS coupled pGeneGrip-RFP, as described previously (Section 2.7.2). 
Flow cytometry was used to detect RFP-expressing cells (channel FL2) 48 hours post-
transfection (Section 2.9.1.2). FACS dot plot analysis quadrants were set relative to 'negative ' 
transfections performed with no DNA and to cells which had been transfected with pGeneGrip-
RFP only (0 octamers/plasmid, non-NLS), known to express RFP. The FACS dot plots for Cos-
7 transfected cells are shown in Figure 6.8a. Data were analysed in two ways. In order to 
ascertain the effect of chromatinisation on the transfection efficiency of the reporter plasmid, 
data were analysed relative to the O octamers/plasmid-NLS transfections. Collated data for Cos-
7 and HTC cells are presented in histogram format in Figure 6.8b. In order to ascertain the 
effect of the NLSs on the transfection efficiency of the chromatin constructs per se, data were 
analysed relative to control transfections with O octamers per plasmid (non-NLS). This data is 
presented in Table 6.1. 
Table 6.1. Comparison of the relative percentages of cells expressing RFP from chromatin 
constructs in the absence and presence of coupled NLS peptides. 
Cos-7 HTC 
(relative% RFP expressing cells) A (relative% RFP expressing cells) A 
Octamers No NLS 8 NLS No NLS 8 NLS /:Qlasmid n n n n 
0 100 ± 0 9 44.4 ± 6.6 6 100± 0 8 45.1±20.1 3 
1 89.5± 15.1 9 71.3±11.0 3 71.6± 18.7 7 NDC 3 
4 98.9±11.1 3 39.9 ± 8.3 3 122.1 ± 34.5 3 42.1±22.1 3 
25 53.1 ± 8.7 9 54.2 ± 11.0 6 19.2 ± 2.4 7 27.4 ± 4.7 3 
40 36.7 ± 7.4 6 34.6 ± 4.9 3 17.8±2.1 4 ND 3 
pGeneGrip-RFP-NLS was assembled into chromatin constructs at the stoichiometries indicated in the 
table using the octamer transfer sait dialysis method (Section 2.5.2). Constructs were transfected into Cos-
7 and HTC cells by lipofection (Section 2.7.2). RFP-expressing cells were determined by FACS (channel 
FL2) relative to RFP-negative 'no DNA' transfections (Section 2.9.1.2). Data were analysed using 
CellQuest software (Macintosh). 
A Results are expressed relative to the percentage RFP-expressing cells in the O octamers/plasmid control 
transfections (no NLS) as the mean + SEM. n indicates the number of times experiments were performed. 
8 Results for 'no NLS' are from the series of experiments reported in Table 4.3. 
cNot done. 
Unexpectedly, the proportion of RFP expressing cells from the NLS-coupled O octamers per 
plasmid transfections decreased significantly to around 50% that of transfections with the non-
NLS O octamers per plasmid (Table 6.1; Cos-7 cells, p < 0.001; HTC cells, p = 0.002). 
However, there was no significant difference in the percentages of cells expressing RFP within 
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the series of differentially chromatinised NLS-coupled constructs in Cos-7 or HTC cells (Figure 
6.8). The reduction in percentages of cells expressing RFP that had been observed with 
increasing plasmid chromatinisation to the level of 40 octamers per plasmid in the absence of 
the extrinsic NLSs (Table 4.3) appeared to be abrogated in the presence of the NLS peptides 
(Figure 6.8b; Table 6.1 ). 
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Figure 6.8. RFP expression is insensitive to increasing degrees of chromatinisation of the reporter 
plasmid when coupled to NLSs. Cos-7 and HTC cells were transfected with a range of chromatinised 
NLS-coupled pGeneGrip-RFP constructs, as indicated, using Lipofectamine™ 2000 (Section 2.7.2). Cells 
expressing RFP were quantitated by F ACS ( channel FL2) 48 hours post-transfection and data were 
analysed using Cell Quest software (Macintosh) (Section 2.9 .1.2). Typical FACS dot plots of Cos-7 cells 
showing the density of RFP-expressing cells for transfection of a range of NLS-coupled chromatin 
constructs is shown in (a). Quadrants were set relative to the 'no DNA' transfection and the known RFP-
positive control, 0 octamers/plasmid. RFP-positive cells are represented within the upper right quadrant, 
coloured in red. Collated data for Cos-7 and HTC cells are represented in histogram format in (b ). Each 
bar represents the mean of at least 3 experiments ± SEM. Data is presented relative to the NLS-coupled 
non-chromatinised reporter plasmid (0 octamers/plasmid-NLS). See also Table 6.1. 
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Thus, while the incorporation of NLSs via the GeneGrip™ site did not enhance the number of 
cells expressing the reporter gene relative to the non-NLS chromatinised plasmids per se, 
transfection efficiency in Cos-7 and HTC cells did, however, appear to be rendered insensitive 
to the degree of chromatinisation. 
6.2.2.4. Nuclear accumulation of the chromatinised pGeneGrip-RFP-NLS-FITC 
constructs 
Experiments analogous to those described in Section 5.3.2 were performed with fluorescein-
conjugated T-ag NLS peptide in order to relate the proportion of RFP expressing cells to the 
proportion of nuclei that had taken up the NLS-coupled chromatin constructs. Briefly, NLS-
FITC-coupled pGeneGrip-RFP that had been assembled into chromatin constructs at 
stoichiometries of 0, 4 or 25 histone octamers per plasmid (see Section 6.2.2.2) were prepared in 
equivalent aliquots containing 1 µg of plasmid DNA for each transfection into Cos-7 and HTC 
cells (Lipofectamine™ 2000; Section 2.7.2). Transfected cells were incubated for 48 hours for 
optimum expression of RFP, as carried out previously. Following this, cells for each 
transfection were divided into two aliquots for separate analysis of whole cell RFP fluorescence 
and nuclear FITC-fluorescence using FACS (Section 2.9.1). 
The number of whole cells expressing RFP were quantitated ( channel FL2, as described in 
Section 2.9.1.2; Figure 6.9a) in the first aliquot of cells, relative to 'negative control' cells 
transfected with no DNA (Lipofectamine only) and to 'positive control' cells which had been 
transfected with pGeneGrip-RFP (0 octamers/plasmid, non-NLS). 
Nuclei were isolated from the second aliquot of cells (see Section 2.8 for detailed methodology). 
The number of nuclei positive for FITC fluorescence were determined (channel FLl, as 
described in Section 2.9.1.3; Figure 6.9b) relative to isolated nuclei from 'FITC-negative control 
cells' transfected with the NLS-coupled non-chromatinised construct (0 octamers per plasmid-
NLS; prepared as described in Sections 6.2.2.1 and 6.2.2.2) and to isolated nuclei from 'FITC-
positive control cells' transfected with the FITC-coupled non-chromatinised construct (0 
octamers per plasmid-FITC; prepared as described in Section 5.3.1). Representative FACS dot 
plot are shown in Figure 6.9b. 
Nuclei data were analysed in two ways, as described in the previous section. Data were 
normalised relative to cells transfected with O octamers per plasmid-NLS-FITC in order to 
ascertain the effect of increasing degrees of chromatinisation on the nuclear accumulation of the 
reporter plasmid with coupled T-ag NLSs (Figure 6.9c). Data were also normalised relative to 
cells transfected with FITC-coupled O octamers per plasmid (non-NLS, naked) in order to 
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ascertain the effect of the NLSs on nuclear accumulation of the chromatin constructs per se 
(presented in Table 6.2). 
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Figure 6.9. Nuclear accumulation of NLS-coupled chromatin transfection constructs and 
corresponding RFP expression. Cos-7 and HTC cells were transfected with fluorescein-conjugated 
NLS-coupled pGeneGrip-RFP assembled into chromatin at stoichiometries of 0, 4 and 25 histone 
octan1ers per plasmid (see Sections 2.7.2, 2.2.16.2 and 2.5.2, respectively). Cells were harvested 48 hours 
post-transfection and were divided into 2 aliquots for whole cell analysis of RFP expression and isolated 
nuclei analysis ofFITC by FACS (Section 2.9.1; channels FL2 and FLl, respectively). FACS dot-plots of 
Cos-7 cell transfections are shown. Whole cells analysed for RFP expression are shown in panel (a). 
Quantitation was relative to the 'no DNA negative control' transfection and to the 0 octamers/plasmid 
(No NLS/No FITC) 'RFP-positive control transfection'. RFP-positive events are represented within the 
upper right quadrant, Rl , coloured in red. Isolated nuclei analysed for FITC are shown in panel (b). 
Quantitation was relative to the 'No NLS/No FITC' 0 octamers/plasmid 'FITC-negative control' 
transfection and to the 'FITC' 0 octamers/plasmid 'FITC-positive control' transfection. FITC-positive 
events are represented within the region marked, Rl, coloured in green. Collated data for Cos-7 and HTC 
cells are represented in histogram format in (c). Red bars represent RFP-positive cells; shaded green bars 
represent FITC-positive nuclei. Data is presented as a percentage of cells or nuclei relative to 
transfections with the FITC-NLS-coupled plasmid (0 octamers/plasmid-NLS-FITC). Each bar represents 
the mean of 3 experiments± SEM. See also Table 6.2. 
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Table 6.2. Comparison of the relative percentages of cells expressing RFP and nuclei 
accumulating the FITC-labelled chromatin constructs with and without coupled NLSs. 
Octamers 
/plasmid 
0 
4 
25 
Octamers 
/plasmid 
0 
4 
25 
Cos-7 
Relative% RFP-positive cellsA 
No NLSD 
100 + oc 
58.8 + 5.9 
20.2 + 7.2 
n NLS n 
5 57.5 + 10.9c 2 
2 41.5 + 6.2 2 
5 23.4+ 5.9 2 
HTC 
% RFP-positive cells 
NoNLS n NLS n 
100+ 0 3 49.7 + 7.2 3 
52.1 + 5.7 3 33.3 + 6.1 3 
4.9 + 2.8 3 21.9 + 3.2 3 
Relative% FITC-positive nucleiB 
NoNLS 
100+ 0 
64.7 + 18.6 
59.3 + 13.4 
n NLS 
5 43.4+ 17.5 
2 33.9 + 14.7 
5 28.3 + 9.8 
% FITC-positive nuclei 
NoNLS n NLS 
100 + 0 3 47.7 + 17.5 
65.9 + 10.9 3 46.4 + 11.3 
40.8 + 11.8 3 36.1+8.8 
n 
3 
3 
3 
n 
3 
3 
3 
The table shows data for two sets of chromatin constructs. Data marked 'No NLS' represents 
chromatin constructs reconstituted using the FITC-coupled pGeneGrip-RFP plasmid. Data marked 
'NLS' represents chromatin constructs reconstituted using the FITC-NLS-coupled pGeneGrip-RFP 
plasmid. 
Cos-7 and HTC cells were transfected by lipofection as described in Section 2.7.2. 48 hours post-
transfection, cells were divided into two aliquots for analysis by FACS (see Section 2.9.1) of whole 
cells and isolated nuclei (see Section 2.8). 
A% RFP-positive cells were quantitated by F ACS ( channel FL2) relative to RFP-negative transfections 
in the absence of DNA (lipofectamine only). 
8 % FITC-positive nuclei were quantitated by FACS (channel FLl) relative to FITC-negative 'O 
octamers per plasmid' transfections. 
c All results are expressed relative to FITC-coupled O octamers per plasmid transfections (no NLS, 
non-chromatinised). The number of times the experiment was performed is represented by n. Results 
represent the mean± SEM. Where n is 2, the mean ± range/2 is shown. 
0 Results for 'no NLS' are from experiments reported in Table 5 .1. 
Compared to the FITC-labelled naked plasmid (0 octamers per plasmid-FITC) 60 % fewer 
nuclei accumulated the FITC-NLS-coupled naked plasmid (0 octamers per plasmid-NLS-FITC) 
(Table 6.2). The reduction was significant in HTC nuclei (p = 0.046, n = 3) and approaching 
significance in Cos-7 nuclei (p = 0.085, n = 3). This might explain the reduced levels of cells 
expressing RFP observed in transfections with the FITC-NLS-coupled O octamers per plasmid 
control construct relative to transfections with the non-NLS FITC-labelled O octamers per 
plasmid control construct in both Cos-7 (57.5 + 10.9 %, n = 2) and HTC cells (49.7 + 7.2 % n = 
2) (Table 6.2; see also Table 6.1 ). Comparison of the relative percentages of nuclei that had 
accumulated the chromatin constructs in the presence of the NLSs revealed no statistically 
significant difference between the O and 25 octamers per plasmid constructs in Cos-7 (p = 
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0.149) nor HTC cells (p = 0.597; Figure 6.9; Table 6.2). This was in contrast to the nuclear 
accumulation data for the non-NLS reporter plasmid constructs, where a significant reduction 
(Cos-7, p = 0.038; HTC, p = 0.04) was seen upon increased chromatinisation of the reporter 
plasmid (see Table 5.1; Table 6.2). 
At the level of more extensive chromatinisation with a nucleosome density of 25 octamers per 
plasmid, although there appeared to be a~ 2-fold difference between the relative percentages of 
nuclei that had accumulated the non-NLS and NLS-coupled constructs, this difference was not 
statistically significant. At this level of chromatinisation (25 octamers per plasmid), the relative 
percentages of RFP-positive cells and FITC-positive nuclei were similar in the presence of 
coupled NLSs (Cos-7, p = 0. 7 4; HTC, p = 0.2; Table 6.2; Figure 6.10). This was in contrast to 
the results obtained from cells transfected without coupled NLSs, where greater percentages of 
nuclei accumulated the constructs than cells that expressed RFP (Cos-7, p = 0.032; HTC, p = 
0.041 ; see Table 5.1; Figure 6.10). 
These results suggest that the presence of the NLSs coupled to the plasmid did not enhance 
nuclear import of the chromatin constructs and, in fact, appeared to have reduced transfection 
efficiency overall. 
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Figure 6.10. The proportion of cells expressing RFP relative to the proportion of nuclei 
accumulating the 25 octamers per plasmid construct are similar in the presence of coupled NLSs. 
Relative percentages of whole cells expressing RFP and isolated nuclei accumulating the 25 octamers per 
plasmid construct are compared in the absence and presence of coupled NLS peptides in Cos-7 and HTC 
cells, as indicated. The red bars represent RFP-positive cells and the shaded green bars represent FITC-
positive nuclei. Results are expressed as the percentage of cells or nuclei relative to O octamers per 
pGeneGrip-RFP-FITC transfections. Bars represent 5 experiments in the 'No NLS ' and 2 - 3 experiments 
in the 'NLS' group. Results are tabulated in Tables 5.1 and 6.2. 
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6.3. INVESTIGATING MEANS TO ENHANCE THE TRANSCRIPTIONAL PERMISSIVENESS OF THE 
CHROMA TINISED REPORTER PLASMID 
Two approaches having the aim of enhancing transgene expression by facilitating transcription 
of the chromatinised reporter plasmids are described in this section. Firstly, chromatin was 
assembled using H2AZ-containing histone octamers, which might create transcriptionally 
primed regions of chromatin (Fan et al., 2002). Secondly, since the pGeneGrip-RFP model may 
not be a universal indicator of transfection efficiency using chromatinised plasmids, a different 
expression system containing an endogenous promoter, namely GMCSF, able to recruit 
transcription complexes in GMCSF-specific Jurkat cells (Himes et al., 1993) was investigated. 
6.3.1. Transfection of chromatin constructs assembled with octamers containing the 
variant histone H2AZ 
6.3.1.1. Assembly of pGeneGrip-RFP into chromatin with H2AZ-containing histone 
octamers 
H2AZ-containing octamers, in which recombinant H2AZ (mouse) had been substituted for H2A 
within the reconstituted histone core particle [2(H2AZ/H2B)/(H3i/H42)], were provided by Dr 
J-Y. Fan (Chromatin and Transcriptional Regulation Group, JCSMR). The pGeneGrip-RFP 
plasmid was assembled into chromatin constructs with stoichiometries of 1, 4, 25 and 40 H2AZ-
octamers per plasmid (using the octamer transfer by salt dialysis method; see Section 2.5.2). As 
done previously, sample containing only pGeneGrip-RFP was included also to serve as the 
naked plasmid control (0 octamers per plasmid) in the transfection experiments. The formation 
of chromatin was verified using the MN ase digestion assay ( described in Section 2. 5. 5), which 
revealed the presence of nucleosomal DNA fragments (Figure 6.11; see Figure 4. 8 for 
comparison with H2A-containing chromatin constructs). 
6.3.1.2. Reporter gene expression in Cos-7 and HTC cells transfected with H2AZ-
chromatin constructs 
Chromatin constructed using the H2AZ-containing histone octamer at stoichiometries of 0, 1, 4, 
25 and 40 octamers per plasmid were prepared for lipofection in 1 µg DNA aliquots (Section 
2.7.2). In addition, aliquots of 1 µg of pGeneGrip-RFP were prepared under non-chromatinising 
conditions (as described previously; Section 4.5.2) with the amount of H2AZ-containing histone 
octamer corresponding to that in each of the chromatin constructs. The resulting H2AZ-
octamer/DNA 'associations' were a means to determine the role of the histone octamers on gene 
expression independent of a chromatinisation effect ( as had been determined for the chromatin 
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Figure 6.11. MNase digestion of chromatin constructs assembled with H2AZ-octamers. pGeneGrip-
RFP was reconstituted into chromatin with H2AZ-containing histone octamers at various stoichiometries 
using the octarner transfer · salt dialysis method, as described in Section 2.5.2. MNase digestion was 
carried out (100 mU/DNA sample; Section 2.5.5) and samples were electrophoresed through 1.5 % 
agarose at 90 V, followed by EtBr staining and destaining in ddH20, before visualisation under UV light. 
MNase digestion is shown for the H2AZ-containing construct reconstituted at a stoichiometry of 25 
octamers per plasmid. The presence of bands corresponding to nucleosomal DNA (indicated in red) 
confirmed the formation of chromatin using the H2AZ-containing octamer. 
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Figure 6.12. RFP expression in Cos-7 and HTC cells transfected with chromatinised constructs 
containing H2AZ-octamers. Chromatin constructs comprising 0, 1, 4, 25 and 40 H2AZ-octamers per 
plasmid ( assembled as described in Section 2.5 .2) were transfected into Cos-7 and HTC cells using 
Lipofectamine™ 2000 (Section 2.7.2). RFP expression was determined by FACS 48 hours after 
transfection ( channel FL2) and raw data were analys-ed using Cell Quest software for Macintosh (Section 
2.9 .1.2). Percentages of cells expressing RFP are presented relative to cells transfected with the 0 
octamers per plasmid control construct. Each histogram represents the mean of at least 3 experiments 
with SEM, except for the 4 octamers per plasmid construct in Cos-7 cells which represents the mean + 
range/2. Collated data is presented in Table 6.3 
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constructs comprising histone octamers containing H2A; Sections 4.5.2 and 4.6.2). HTC and 
Cos-7 cells (plated into 6-well tissue culture plates at a density of 1x105 cells per well 24 hours 
prior to transfection) were transfected using Lipofectamine™ 2000 (see Section 2.7.2 for 
methodology). The number of cells expressing RFP was determined by F ACS 48 post-
transfection, as described previously (Section 2.9.1.2). 
Consistent with the trend observed usmg the chromatin constructs prepared from H2A-
containing octamers, the percentage of RFP-expressing cells decreased concomitantly with 
increasing nucleosome densities in the H2AZ-containing chromatin constructs in both of the cell 
lines tested (Figure 6.12; Table 6.3). 
In Cos-7 cells, a 2-fold reduction in RFP positive cells was observed when transf ected with the 
25 octamers per plasmid construct relative to the 0 octamers per plasmid naked construct (p = 
0.004, n = 5). The relative percentages of RFP-expressing cells were reduced a further 3-fold 
when the 40 octamers per plasmid construct was transfected (p = 0.03, n = 3). Chromatin-
induced suppression of transfection efficiency was more pronounced in HTC than in Cos-7 
cells. A 2-fold reduction in the percentage of HTC cells expressing RFP was observed upon 
transfection of 1 octamer per plasmid chromatinised construct (p = 0.05, n = 2). The percentages 
of RFP positive cells were significantly reduced for all of the remaining stoichiometries of 
H2AZ-containing octamers relative to the naked plasmid (p < 0.05). 
Transfection of the DNA/H2AZ-octamer-associated plasmids produced a pattern of RFP-
expressing cells, relative to the extent of octamer density, similar to that seen for the 
DNAIH2A-octamer 'associations' (Figure 6.12; Table 6.3). In Cos-7 cells, a statistically 
significant reduction in the proportion of cells expressing RFP relative to the naked plasmid (0 
octamers per plasmid) was observed at the level of association of 40 octamers per plasmid (p = 
0.04, n = 2). In HTC cells the relative number of RFP-expressing cells was reduced significantly 
when both 25 and 40 octamers were associated per reporter plasmid (p = 0.01, n = 3; p = 0.05, n 
= 3, respectively). The DNA/H2AZ-octamer 'associations' corresponding to lower levels of 
octamer density yielded populations of RFP-expressing cells not significantly different from 
those obtained upon transfection of the naked plasmid. 
The relative percentages of RFP-expressing cells when transfecting chromatin assembled with 
H2A-containing octamers are compared to when transfecting chromatin assembled with H2AZ-
containing octamers in Table 6.3. In Cos-7 cells, the proportion of RFP-positive cells was 
significantly different only at the level of the 40 octamers per plasmid, with the H2AZ-
chromatin transfection being significantly lower than H2A-chromatin (p = 0.004). In HTC cells, 
transfections with H2AZ-chromatin constructs yielded significantly fewer relative numbers of 
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Table 6.3. Relative percentages of cells expressing RFP transfected with H2A and H2AZ-chromatin constructs. 
H2A-containing chromatin constructs A H2AZ-containing chromatin constructs 
Cos-7 n HTC n Cos-7 n HTC n 
Octamers/plasmid 
0 100 ± 0 7 100 ± 0 7 100 ± 0 5 100 ± 0 3 
1 82.9 ± 18.6 7 71.6 ± 18.7 7 119.8 ± 23.5 5 49.3 ± 12.1 3 
2 78.4 ± 8 3 78.6 ± 22.2 3 NDC ND 
4 98.9 ± 11.1 3 122.1 ± 34.5 3 84.8 ± 14.0 2 46.4 ± 10.7 3 
25 58.8 ± 10.2 7 19.2 ± 2.4 7 40.4 ± 10.2 5 6.3 ± 2.3 3 
40 43 .5 ± 9.3 4 17.8±2.1 4 12.2 ± 1.2 3 5.2 ± 2.5 3 
plasmid+ 1 oct8 97.8 ± 9.9 6 138.0 ± 23.8 7 109.8 ± 5.1 4 114.4 ± 14.9 3 
plasmid+ 2 oct 97.3 ± 12.6 3 114.7 ± 53.2 3 ND ND 
plasmid+ 4 oct 92.3±17.1 3 102.2 ± 45.8 3 119.1 ± 3.6 2 91.6 ± 8.6 3 
plasmid+ 25 oct 60.1 ± 15.9 7 93.7 ± 15.8 7 82.4 ± 11.6 5 31.7 ± 8.0 3 
plasmid+ 40 oct 49.9 ± 5.2 3 74.2 ± 6.2 4 15.6 ± 11.6 2 34.2 ± 15.4 3 
Chromatin constructs assembled with either H2A-containing or H2AZ-containing histone octamers (see Section 2.5.2 for method) were 
transfected into Cos-7 and HTC cells using lipofection (see Section 2.7.2). Cells expressing RFP were detected by FACS 48 hours post 
transfection ( channel FL2H, see Section 2.9 .1.2) and analysed using Cell Quest software (Macintosh). The number of times the experiment 
was performed is represented by n. Values shown reflect the percentage of RFP positive cells, expressed relative to O octamers per plasmid, 
and represent the mean± SEM. Where n is 2 the mean+ range/2 is shown. 
A Data presented was taken from Table 4.3 . 
8 Constructs comprising histones associated with plasmid DNA were generated under non-chromatinising conditions at the stoichiometries 
indicated. Transfections using the plasmid/histone octamer 'associations' were performed in paired experiments with the chromatinised 
constructs. 
c Not done. 
RFP-expressing cells than transfections with H2A-chromatin for the 25 - (p = 0.01) and the 40 
octamers per plasmid chromatinised constructs (p = 0.01). 
The results showed that, overall, the trend of transfection efficiency was similar when the 
reporter plasmid was chromatinised or 'associated' with either H2A-containing histone 
octamers or H2AZ-containing histone octamers. At higher levels of nucleosome density (25 and 
40 octamers per plasmid, see Table 6.3) H2AZ-octamer chromatinisation and 'association' 
appeared to reduce the pool of RFP-positive cells even further than that observed with 
transfections comprising the H2A-containing octamers. 
6.3.2. Investigation of the effect of plasmid chromatinisation in a transgene expression 
system driven by an endogenous promoter 
6.3.2.1. Assembly of pGMCSF-1(2}TK-luc+ into chromatin 
The plasmid pGMCSF-1(2)TK-luc+ (referred to as pGMLuc, see Table 2.9; Himes et al., 1993), 
which includes a luciferase reporter gene under the control of a fragment of the human GMCSF 
promoter region (- 620 to+ 37; Figure 6.13a), was kindly provided by K. Bunting (Cytokine 
Gene Expression Laboratory, JCSMR). A large scale bacterial culture was prepared and plasmid 
was purified (Qiagen MaxiPrep kit, see Section 2.2.2). 
On the basis of physiological nucleosome density, pGMLuc was calculated to be saturated with 
26 histone octamers (6.1 kb, at 1 nucleosome per 230 bps). Chromatin constructs comprising 1, 
2, 4 and 26 octamers per plasmid were thus generated, as described previously (with H2A-
containing histone octamers, using the octamer transfer salt dialysis method; see Section 2.5.2). 
The pLuc plasmid was also subjected the dialysis procedure but in the absence of histone 
octamers in order to generate the naked plasmid (0 octamers per plasmid), used as the reference 
construct from which to determine the baseline expression of luciferase. Assembly into 
chromatin was verified by the appearance of nucleosomal DNA using the MNase digestion 
assay (Figure 6.13b, see Section 2.5.5 for methodology). 
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Figure 6.13 Assembly of the luciferase reporter plasmid pGMCSF-1(2}TK-luc+ into chromatin. The 
promoter and reporter gene region of pGMCSF-1(2)TK-luc+ is shown in (a), comprising the - 620 to+ 
3 7 fragment of the human GMCSF promoter region and the luciferase reporter gene. pGMLuc was 
assembled into chromatin at stoichiometries of 1, 2, 4 and 26 histone octamers per plasmid using the 
octamer transfer salt dialysis method (described in Section 2.5.2). Samples of 4 µg of DNA were digested 
with MNase (100 mU per sample; Section 2.5.5) and analysed by gel electrophoresis through 1.5 % 
agarose at 90 V. The EtBr-stained agarose gel visualised under UV light is shown in (b ). Bands 
corresponding to nucleosomal DNA are denoted in red. 
6.3.2.2. A preliminary comparison of the effect of chromatinisation on transgene 
expression from different expression systems 
Jurkat cells were prepared on the day of transfection by seeding at 5 x 105 cells per well in 24-
well tissue culture plates and were transfected with the naked (0 octamers per plasmid) and 
chromatinised pGMLuc constructs ( containing 1 µg of DNA) using Lipofectamine™ 2000 (see 
Sections 2.7.2 and 2.9.2). The pharmacological stimuli phorbol-12-myristate-13-acetate (PMA) 
and calcium ionophore were added to the cells to final concentrations of 20 ng/ml and 1 µM, 
respectively, between 30 and 34 hours post-transfection. Cells were incubated for a further 8 
hours before quantitation of luciferase reporter gene expression. Luciferase activity was 
determined using the luciferase assay ( described in Section 2.9 .2), conducted according to the 
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method of Himes and Shannon (2000). The results were normalised relative to the luminescence 
produced from transfection of the naked plasmid (0 octamers per pGMLuc ). 
The pGeneGrip-RFP plasmid was assembled in parallel into chromatin constructs with 
stoichiometries of 0, 1, 4 and 25 histone octamers per plasmid (Section 2.5.2). These were 
transfected into Jurkat cells under the same conditions as described above, in the absence and 
presence of the pharmacological stimuli. RFP-expressing cells were analysed 48 hours post 
transfection, as described in Section 2.9.1.2. In order to facilitate the comparison of transgene 
expression between the pGeneGrip-RFP and pGMLuc plasmids, the total RFP fluorescence was 
determined from the F ACS-generated data (rather than the percentage of cells expressing RFP 
as had been determined previously; CellQuest software, Macintosh). Results were normalised 
relative to the total fluorescence observed from transfection with the naked plasmid (0 octamers 
per pGeneGrip-RFP). 
Transfection of the chromatinised pGMLuc contstructs yielded a pattern of luciferase activity 
(luciferin conversion) that was insensitive to the degree of chromatinisation as, relative to the 
naked reference plasmid (0 octamers per pGMLuc), no significant difference was observed in 
transgene expression for any of the pGMLuc chromatin constructs (Figure 6.14, Table 6.4). 
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Figure 6.14. Transgene expression under the control of a tissue-specific promoter is resistant to 
chromatinisation. pGMLuc constructs, chromatinised at the stoichiometries indictated, were transfected 
into Jurkat cells using Lipofectamine™ 2000 (see Sections 2.5.2 and 2.7.2 for the respective methods). 
The luciferase assay was performed as described in Section 2.9 .2. Luciferase activity was determined 40 
hours post-transfection. Results are normalised relative to 0 octamers per pGMLuc plasmid. Each 
histogram represents the mean + SEM of at least 3 experiments, except for the 4 octamers/plasmid 
transfection which was performed twice and represents the mean± range/2. 
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In contrast, the total fluorescence output of RFP in Jurkat cells was reduced 2-fold with 
transfection of pGeneGrip-RFP which had been chromatinised at the higher level ofnucleosome 
density (25 octamers per plasmid, p = 0.006, n = 4) compared to the naked plasmid (Table 6.4) . 
This was in the absence of the pharmacological stimuli for transcription, PMA and calcium 
ionophore (Table 6.4). This trend was observed also in the presence of the pharmacological 
stimuli (Table 6.4 ). These results were consistent with the results that had been obtained with 
transfection of the chromatinised pGeneGrip-RFP constructs in Cos-7 and HTC cells (Table 
4. 3). 
Table 6.4. Comparison of reporter gene expression in Jurkat cells transfected with 
chromatin constructs comprising of different transgene expression systems. 
pGMLuc A pGeneGrip-RFP B 
% Luc if erase Unstimulated Stimulated Octamers/plasmid 
activity c n % total RFP n % total RFP n fluorescence c fluorescence c 
0 100.0 + 0.0 4 100 ± 0 5 100 1 
1 86.5 + 12.8 4 84.2 ± 9.3 5 101.6 1 
2 99.3 + 20.2 3 122.1 ± 16.5 2 NDE 1 
4 66.5 + 24.0 2 158.6 ± 20.3 2 ND 1 
25/26D 105.2 + 33 .1 4 46.8 ± 7.6 4 21.3 1 
Jurkat cells were transfected with a range of chromatin constructs using Lipofectamine™ 2000 (as 
described in Materials and Methods, Section 2.7.2). 
A pGMLuc (pGMCSF-1 (2)TK-luc+) contains the luciferase reporter gene under the control of the cell-
specific endogenous GMCSF promoter. The luciferase assay was conducted as described in Section 
2.9 .2 , according to Himes and Shannon (Himes and Shannon, 2000). 
8 pGeneGrip-RFP contains the RFP reporter gene under the control of the exogenous CMV promoter. 
RFP expression was determined using F ACS ( channel FL2) as described in Section 2.9 .1.2. 
c Results are presented as a percentage relative to the reference transfection within each experiment of 
0 octamers per plasmid, and represent the mean ± SEM. n represents the number of times experiments 
were performed. Where n is 2, the mean± range/2 is shown. 
0 The level of histone octamer saturation was 25 octamers per plasmid for pGeneGrip-RFP and 26 
octamers per plasmid for pGMLuc. 
E ot done. 
Transgene expression using the pGMLuc plasmid was not hindered even by high levels of 
chromatinisation, whereas transgene expression using the pGeneGrip-RFP plasmid was 
significantly hindered at similar degrees of chromatinisation. One main difference between the 
two expression constructs is that trans gene expression using pGMLuc is under the control of the 
Jurkat cell-specific GMCSF promoter, while transgene expression using pGeneGrip-RFP is 
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under the control of the exogenous viral CMV promoter. These results may imply, therefore, 
that gene expression under the control of an endogenous cell-specific promoter is not 
encumbered by increased levels of chromatinisation. 
6.4. DISCUSSION 
In this chapter, the two strategies investigated with the aim to enhance the transfection 
efficiency of the chromatinised plasmids, namely the incorporation of additional NLSs and the 
potentiation of transcription, are described. 
Conjugation of extrinsic NLS to the chromatinised plasmid has the potential to improve nuclear 
uptake efficiency and, hence, transgene expression. Consequently, the aim was to incorporate 
the SV 40 T-ag-derived optimised NLS peptide into the delivery vehicle as a fusion with the 
DNA-binding component of the chromatin transfection construct (the histone octamer) and 
coupled to the DNA itself. Of the NLSs documented to date, the SV 40 T-ag NLS has been the 
most extensively investigated and, in the context of enhancing nuclear import of gene delivery 
constructs, the most frequently used (Escriou et al., 2003; Cartier and Reszka, 2002; Bremner et 
al., 2001). 
In order to incorporate the NLS into the histone octamers, a C-terminal H2A-T-ag NLS fusion 
protein was generated. The expression and purification of H2A-NLS proved to be highly 
problematical due to frequent failure of the E. coli strain to express the protein in sufficient 
quantities. Moreover, the H2A-NLS fusion protein did not incorporate together with H2B, H3 
and H4 into an octamer under the standard octamerisation conditions used and came out of 
solution during the dialysis step of the procedure (Section 6.2.1.4). Other recombinant histones 
with modifications to either their N- or C-termini, or variant forms of histones such as the H2A 
variant H2A-Bbd, have not only been found to be problematic to purify but, also, frequently do 
to not form octamers readily using the method of chromatin assembly described in this thesis 
(see Luger et al., 1997; personal communications, Drs J-Y. Fan and J. Zhou, Chromatin and 
Transcription Regulational Group, JCSMR). This may be attributed to the critical functionality 
of the histone tail regions in nucleosome stability, reflected in the high sequence conservation 
across species (Luger and Richmond, 1998). In order to reconstitute chromatin using histones 
that will not form octamers in vitro, more intricate methods of assembly into chromatin are 
required which involve titration of the H2A/2B dimers and H3/4 tetramers onto the assembling 
DNA template (similar to the NAP-1 based method described in Section 2.5.1). These methods 
are better suited to small scale reconstitution of DNA into chromatin, in the order of less than 1 
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µg, but become cumbersome in the large scale reconstitutions required for this study ( ~ 50 µg 
DNA). 
Using the GeneGrip™ technology (Gene Therapy Systems), the T-ag NLS peptide was coupled 
to pGeneGrip-RFP via a PNA-maleimide linker (Figure 6.6). Surprisingly, compared to 
transfections with the non-NLS-coupled plasmid, the conjugated NLSs appeared to reduce the 
proportion of cells expressing the reporter gene to around 60 %. While several studies have 
reported little or no enhancement of gene expression upon covalent attachment of exogenous 
NLSs to the plasmid (Roulon et al., 2002; Ciolina et al., 1999; Neves et al., 1999a; Sebestyen et 
al., 1998), one other study has also reported a similar decrease in expression (50 - 60 %; Ciolina 
et al., 1999). This result, however, was obtained upon conjugation of 43 NLSs to the plasmid ( 6 
NLSs/1 kb); the authors suggesting that the covalent association of so many peptides at random 
sites throughout the plasmid might have inhibited gene transcription. In the experiments 
described in this Chapter, the number of RFP-expressing cells was not reduced in the presence 
of the PNA-maleimide linker at the GeneGrip™ site (83.3 + 6.8 %, n = 2, relative to non-
maleimide-coupled pGeneGrip-RFP; Cos-7 cells; data not shown). This suggests that the 
reduction in the proportion of RFP-positive cells was not due to inhibition of gene expression as 
a result of the labelling process. Moreover, the use of fluorescein-conjugated NLS-coupled 
plasmids to monitor nuclear uptake demonstrated that the number of nuclei that took up the 
NLS-coupled plasmid was reduced to around 50 % relative to that of the non-NLS plasmid. This 
could indeed account for the reduction in reporter gene expression observed. 
Interestingly, in the presence of NLSs, the relative proportions of cells expressing RFP were 
similar upon transfection of the differentially chromatinised constructs (Tables 6.1 and 6.2). 
This was in contrast to the pattern observed in the absence of NLSs, where the relative 
proportions of RFP-expressing cells decreased upon increasing chromatinisation of pGeneGrip-
RFP (Tables 4.3). The relative number of nuclei that took up the transfection constructs 
chromatinised at higher nucleosome densities (25 octamers per plasmid) was not enhanced by 
the exogenous T-ag NLSs. Contrary to the findings in the absence of the NLS (Table 5.1), 
similar percentages of isolated nuclei showed FITC fluorescence as cells that showed RFP 
fluorescence. One possible reason for this effect may derive from the proximity of the 
GeneGrip™ site to the reporter gene (the PNA-labelling site lies~ 400 bps upstream of the RFP 
reporter gene). While pGeneGrip-RFP-NLS assembly into chromatin was verified by the 
presence of nucleosomes (Figure 6. 7), the positioning of those nucleosomes is not controlled 
using the octamer transfer by salt dialysis method. It may be possible that the binding of 
multiple P A-maleimide-NLS (+ FITC) moieties at the GeneGrip™ site disrupted the pattern 
of nucleosome positioning at or near the reporter gene. This might, consequently, have 
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increased the transcriptional permissiveness of the trans gene region (Ng et al., 1997; Hansen 
and Wolffe, 1992; Izban and Luse, 1992). In order to investigate whether the conjugated NLS 
peptides indeed brought about alteration of nucleosome positioning at the reporter gene, further 
studies involving DNA footprinting and in vitro transcription assays (Ng et al., 1997; Hansen 
and Wolffe, 1992; Izban and Luse, 1992) would be required. A mutated or reversed form of the 
NLS peptide, known to be devoid of nuclear import functionality, was not included in this study 
as the sequence specificity of this NLS had been demonstrated previously (Chan and Jans, 2001; 
Chan et al., 2000; Chan and Jans, 1999). In hindsight, inclusion of this peptide in the chromatin 
constructs might have been able to elucidate whether the (unexpected) reduction in the number 
of nuclei that took up the constructs was specific to the NLS peptide sequence or simply due to 
conjugation of a peptide per se. 
In light of the results, the degree of accessibility of the coupled NLSs to importin a/~ within the 
chromatin constructs is difficult to assess. Due to prohibitive amounts of the NLS-coupled 
constructs required to quantitate importin binding affinity using the ELISA method employed in 
this study, this could not be determined and transfection efficiency was employed instead as a 
measure of NLS functionality. By deduction, if the NLSs were not accessible, patterns of 
nuclear accumulation and reporter gene expression similar to those observed in the absence of 
NLSs could be expected (Table 5 .1 ). Due to the similar nuclear accumulation levels of the 
differentially chromatinised NLS-coupled constructs (Table 6.2), it is tempting to suggest that 
the NLSs were equally accessible to importins in all the constructs. Importin-mediated nuclear 
import is non-restrictive to size and would therefore allow the naked and chromatinised 
plasmids to accumulate to similar degrees. The fact that 50 % fewer nuclei accumulated the 
naked NLS-coupled plasmid compared to the naked non-NLS plasmid suggests that nuclear 
uptake may have been inhibited by the presence of the conjugated peptide. The reason for this is 
unclear. 
Based on the postulate that H2AZ-chromatin would generate a more transcriptionally 
permissive DNA template (Fan et al., 2002), the reporter plasmid was assembled into chromatin 
with histone octamers that included H2AZ (in place of the usual H2A). Reporter gene 
expression from the constructs chromatinised at higher nucleosome densities (25 and 40 
octamers per plasmid) appeared to be even more inhibited with H2AZ-chromatin than with 
H2A-chromatin (Table 6.3). This implied that the use of H2AZ-containing histone octamers did 
not improve the transcriptional permissiveness of the chromatinised reporter plasmid to a 
significant degree. In an attempt to explain these results in light of the approaches used in the 
Fan study (Fan et al., 2002), sedimentation velocity ultracentrifugation was carried out ( as 
described in Section 4.4.1 ). The H2AZ-containing chromatin construct assembled at 25 
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octamers per plasmid yielded an s-value of 64 S (not shown). Interestingly, this s-value was 
similar to that of the H2A-containing chromatin construct assembled at 40 octamers per plasmid 
(66 S; see Table 4.1). Indeed, perusal of Table 6.3 shows that similar proportions of cells 
express RFP for the 25 H2AZ-octamers per plasmid and 40 H2A-octamers per plasmid 
transfections. The s-value suggests, amongst other properties, a high nucleosome density, which 
in tum has been associated with transcriptional repression in vitro (Sandaltzopoulos et al., 1994; 
Hansen and Wolffe, 1992). This may account for the comparatively lower levels of RFP 
expression observed for the 25 H2AZ-octamers per plasmid construct compared to the 25 H2A-
octamers per plasmid construct. 
It was considered possible that the results obtained with the pGeneGrip-RFP transgene 
expression system used might not be typical and hence another expression system was 
investigated. Luciferase activity was similar for the GMCSF promoter-containing reporter 
constructs chromatinised at low and high nucleosome densities. In contrast, the expression of 
the RFP transgene in Jurkat cells from the differentially chromatinised pGeneGrip-RFP reporter 
constructs replicated the trends observed in Cos-7 and HTC cells (Table 4.3). The GMCSF 
promoter/Jurkat cell system was chosen because the GMCSF promoter has the ability to recruit 
appropriate chromatin remodelling complexes in Jurkat cells which overcome transcriptional 
repression that occurs due to the presence of nucleosomes occluding the reporter gene region 
(Rao et al., 2001; Himes et al., 1993). The level of transgene activity observed using the 
pGMLuc plasmid may be a reflection of this ability. The poor level of RFP trans gene expression 
using the pGeneGrip-RFP plasmid may be a reflection of its inability to recruit transcription 
complexes efficiently in the cell lines tested. These results may implicate a transcriptional block 
as a likely contributor to the poor level of RFP reporter gene expression observed upon 
chromatinisation of the pGeneGrip-RFP plasmid. 
These comparisons between the two gene expression systems, however, are made cautiously as 
two different assays for reporter gene expression and two different reporter plasmids were used 
( even though the plasmids were of similar size and expression of the reporter genes was 
determined after similar durations). Nonetheless, this preliminary result may provide the basis 
from which to initiate a future study which may prove to have exciting implications for 
promoter-driven cell-specific expression of transfection constructs. Future work may involve 
constructing the pGeneGrip-RFP plasmid containing the GMCSF promoter and, conversely, the 
pGMLuc plasmid containing the CMV promoter. Transfection into Jurkat cells would enable 
the direct comparison of the effect of chromatinisation on transgene expression between the 
different plasmids. Another interesting series of experiments would be to investigate the 
importance of cell-specificity; for instance, transfection of the proposed GMCSF-containing 
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pGeneGrip-RFP into non-GMCSF-specific cells, such as Cos-7 and HTC. This might also 
address the question of whether the GMCSF promoter may be more active than the CMV 
promoter. Using fluorescein-labelled plasmids, the relationship between nuclear accumulation 
and reporter gene expression may be determined also. Furthermore, microinjection of the 
chromatinised GMCSF promoter-containing and CMV promoter-containing constructs directly 
into the nucleus would enable assessment of the ability of each promoter to recruit transcription 
complexes and may be a first step towards investigating whether the promoter region plays an 
important role in transgene expression. 
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CHAPTER 7 
General Discussion 
The ability to cure human disease at the genetic level is undeniably tantalising and, arguably, 
makes gene therapy one of the most exciting areas of experimental therapeutic research. The 
use of non-viral gene delivery vectors is not marred by the safety issues associated with the use 
of viral vectors, however viral-mediated gene delivery still represents the largest proportion of 
gene therapy trials. This is largely due to the superior transfection efficiency of viral vectors 
compared to non-viral vectors. One of the most significant hurdles in non-viral gene delivery is 
the efficient transfer of transfection constructs into the nucleus. The design of efficient non-
viral gene delivery vectors with improved nuclear transfer capacity is therefore of paramount 
importance. With this in mind, the use of individual histones, which have inherent nuclear 
import properties, as DNA-carrier vehicles for gene delivery purposes has been evaluated 
previously (see Section 1.5.3). Although no real consensus was reached regarding the efficiency 
of each individual histone, as transfection outcomes appeared to be dependant on the cell types 
tested, results overall indicated that histones showed promise as gene transfer vehicles. The 
novel use of histones in the form of the histone core octamer assembled with plasmid DNA into 
chromatin to facilitate gene transfer is described in this thesis. 
The fundamental hypothesis at the outset of this thesis was that chromatinisation of the gene 
delivery plasmid might have several features that could enhance the potential for gene transfer 
applications. It was proposed that the feature of DNA compaction would shield the DNA from 
degradation in the cytoplasm, accommodate the transfer of large plasmids and facilitate passage 
through the NE. In addition, histones were shown to be bound by the importin ~ nuclear 
transport protein with high affinity (see Section 3.2) and were subsequently shown to be 
transported into the nucleus along this importin-facilitated pathway (see Section 1.5.2). These 
findings suggested a definite basis for a gene delivery construct coupled to the nuclear import 
of histones as the nuclear import pathway could provide a conduit into the nucleus for DNA 
assembled with histones into chromatin. Furthermore, chromatin is the physiological form in 
which condensed DNA occurs in vivo. As mechanisms exist within the nucleus to de-condense 
chromatin into a readily transcribable form, the problems related to the inhibition of gene 
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expression when plasmid DNA is complexed with artificial compacting agents (Bielinska et al., 
1997; Zabner et al., 1995) might be circumvented when the transfected plasmid is presented in 
a form recognisable by the nuclear transcription machinery. 
The findings presented in this thesis suggest that chromatinisation of the reporter plasmid used 
in this study, pGeneGrip-RFP, does not provide a superior gene delivery vehicle. 
Chromatinisation of pGeneGrip-RFP was demonstrated using several analytical techniques, 
including sedimentation velocity ultracentrifugation (that demonstrated quantitative association 
of histone octamers with the plasmid), a supercoiling assay (that demonstrated plasmid 
topology) and digestion with MNase (that demonstrated nucleosome formation). The assembled 
chromatin constructs were indeed expressed upon transfection into Cos-7 and HTC cells but 
increasing the levels of chromatinisation of the reporter plasmid reduced the proportion of cells 
that expressed the transgene. This observation could be related in part to reduced nuclear 
accumulation of the transfection constructs that was observed at the more extensive levels of 
chromatinisation (see Section 5.3.2). Furthermore, the nuclear accumulation data suggested that 
gene expression was repressed at higher levels of chromatinisation (Section 5.3.2). 
Several strategies were tested with the aim of improving the poor outcome transfection 
efficiency. As the DNA-induced structure within the chromatin constructs abolished binding of 
importins to the intrinsic NLSs in the histones (see Section 5.4), these NLSs were unable to 
contribute to facilitated nuclear transport. The SV 40 T-ag NLS peptide had been shown 
previously in a number of studies to enhance nuclear import and, hence, reporter gene 
expression when coupled to the transfection construct (for reviews see Escriou et al., 2003; 
Cartier and Reszka, 2002; Bremner et al., 2001 ). SV 40 T-ag NLS peptides were therefore 
included as additional extrinsic NLSs in the chromatin constructs by coupling to the plasmid. 
Transfection efficiency of the chromatin transfection constructs was not enhanced with the 
inclusion of these NLS peptides (see Section 6.2.2.3 and 6.2.2.4). 
In order to facilitate the transcriptional perrn1ss1veness of the chromatinised plasmid, 
pGeneGrip-RFP was assembled into chromatin using H2AZ-containing histone octamers since 
H2AZ-chromatin has been associated with less compact, transcriptionally poised chromatin 
fibres (Fan et al., 2002). The suppression of reporter gene expression observed with extensive 
H2A-chromatinisation, however, persisted with H2AZ-chromatin. 
In this study, reporter gene expression had been investigated principally using the pGeneGrip-
RFP plasmid, under control of the CMV promoter. As the discrepancy between the proportions 
of nuclei that had accumulated the transfected constructs at high levels of chromatinisation and 
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cells that expressed the transgene had brought to light the possibility of transcriptional 
repression, an interesting prospect was the use of an endogenous promoter known to recruit 
transcription complexes in the context of cell-specific transgene expression. Interestingly, 
transgene expression using the GMCSF promoter in Jurkat cells was insensitive to 
chromatinisation. This was in contrast to transgene expression using the pGeneGrip-RFP 
plasmid in Jurkat cells. This result may have interesting implications for cell-specific gene 
delivery and may provide the basis for a new study. 
In addition to previously documented limitations of non-viral gene delivery, including 
cytoplasmic degradation of the transfected DNA, endosomal sequestration and impaired nuclear 
import, the results of this thesis highlighted another limitation - the transcriptional 
permissiveness of the transfection constructs. 
7.1. HITCHING A RIDE INTO THE NUCLEUS ALONG THE NUCLEAR IMPORT PATHWAYS OF 
IDSTONES 
The results presented in Chapter 3 were the first binding affinity data for importins and histones 
and suggested for the first time the primary role of importin p I in the nuclear transport of the 
core histones (Johnson-Saliba et al., 2000) as, previously, the 'conventional' importin a/B 
pathway had been predicted to mediate in the nuclear uptake of histones (Moreland et al. , 
1987). The importin BI binding affinities determined for various histones where high (in the 
range of 3 - 8 nM; Table 3.1) and were comparable to those reported for other importin B 1 
'substrates', such as PTHrP (2 nM, Lam et al., 1999) and GAL4 (12 nM; Chan et al., 1998). 
The high binding affinities were therefore not surprising considering that importin Bl is the 
subject of stringent competition, not only from conventionally a/B-translocated proteins, but 
also from the growing list of other importin Bl-bound 'substrates' (Forwood and Jans, 2002; 
Forwood et al., 2001 a) and may also reflect the demand for histones in the nucleus. 
Subsequent to the publication of the importin-histone binding affinity data (Johnson-Saliba et 
al., 2000), several members of the importin P family were indeed shown to play a role in the 
nuclear transport of the core histones. The identity of thes_e importins in vertebrate cells was 
established by affinity chromatography and subsequent gel analysis as importin P 1, transportin, 
importin 5, importin 7 and importin 9 (Baake et al., 2001 b; Baake et al. , 200 la; Muhlhausser et 
al., 2001). In yeast, transport of core histones was attributed primarily to Kapl 14p but also to 
121p, 123p and 95p, which correspond to the mammalian importins importin 9, importin P3, 
importin P4 and importin p 1, respectively (Mosammaparast et al., 2002b; Mosammaparast et 
al., 2001). In these studies, NLSs were identified in the amino-terminal tails of the histones. 
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The overall globular structure of the histones was also found to play a role in conferring nuclear 
localisation (Mosammaparast et al., 2002b; Baake et al., 2001 a; Mosammaparast et al., 2001; 
Muhlhausser et al., 2001 ). Thus, the high affinity binding of importin ~ 1 for the core histones 
and the efficient nuclear transport processes suggested that this nuclear translocation _pathway 
might also provide an efficient route into the nucleus for plasmid DNA when associated with 
histones. 
The crystal structure of a single nucleosome revealed that the NLS-containing N-terminal tails 
of the histones protrude from the core histone octamer (Luger et al., 1997; Figure 7 .1 ). This 
suggested that the core histone NLSs were likely to be accessible to importins. 
Figure 7.1. A single nucleosome. DNA is represented in white and surrounds the core histone octamer, 
each histone of which is represented in a different colour. The NLS-containing N-terminal tails of 
histones H2A', H2B' and H3' can be seen to protrude from the core. In the context of a multi-nucleosomal 
structure, the state of compaction may obscure the NLSs from access by nuclear import proteins. From 
Luger et al. (1 997). 
However, the association of core histones into an octamer resulted in reduced binding affinity 
for importin ~ 1, compared to the H2A/2B dimer and H3/4 tetramer alone (Table 5.2). It is 
conceivable that when histones are associated into an octamer, their globular domains, believed 
to present topological NLSs, would be engaged in inter-histone contacts (Luger et al., 1997) 
and therefore would not be able to bind importin. In addition, while the crystal structure studies 
of a single nucleosome revealed that the tail domains of the histones exit the plane of the core 
octamer, contacts on the surface of the histone octamer between the N-terminal tail of H4 and 
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an acidic domain of the H2A/2B dimer were shown (Luger et al., 1997). This intra-octamer 
contact may diminish the capacity for importin-binding of the N-terminal H4 NLS and 
contribute also to the overall reduced binding affinity observed (see Table 3.2). 
Similarly, importin ~ binding was markedly reduced when the core histone H3/4 tetramer and 
the histone octamer were associated with the pGeneGrip-RFP plasmid by the chromatin 
assembly process (Section 5.4). As importin binding was effectively abolished for the 
chromatin constructs, occlusion of the N-terminal NLSs through the process of nucleosome 
formation was implied. This was observed in the context of a single nucleosome ( 1 octamer per 
plasmid; see Table 5.2) and may be extrapolated to the chromatin constructs generated at higher 
nucleosome density (25 octamers per plasmid). Here nucleosomes would be serially arranged 
initially and compacted further into a higher order chromatin structure (Figure 1. 1 O; Figure 4.9). 
Even though the organisation of the histone tail regions in higher order chromatin structures has 
yet to be elucidated (Luger, 2003), the tails have been shown to be engaged in the process of 
higher order chromatin folding (Carruthers et al., 1998; Leuba et al., 1998). Thus, in the context 
of the chromatinised plasmids, it may be postulated that these NLSs may have been occluded, 
which would account for the abolition of importin binding that was observed ( see Section 
5.4.2). Interestingly, as pGeneGrip-RFP assembled at histone octamer stoichiometry 
corresponding to the fully chromatinised plasmid (25 octamers per plasmid) but under non-
chromatinising conditions appeared to yield a degree of nuclear accumulation similar to the 
naked plasmid (see Table 5.1 ), the continued accessibility of importins may be implied. 
The apparent enhancement in transfection efficiency reported by others using the individual 
core histones as DNA carrier proteins (presented in Section 1.5.3) may well be due to the 
continued accessibility of the histone NLSs, since the individual core histones do not induce 
higher orders of DNA folding into compacted structures. Furthermore, single histones remain in 
an unfolded state unless associated with their partner histones, in the form of the H2A/2B dimer 
or H3/4 tetramer (Luger et al., 1997). Balicki et al. (2002) were able to localise the gene 
transfer activity of H2A to a 37-amino acid peptide within the N-terminus. The secondary 
structure and positively charged residues (NLS) of the 37-mer were shown to play a vital role in 
nuclear localisation, suggesting importin accessibility. 
As the MW of the chromatinised plasmids exceeds the MWCO of the NPC for passive 
diffusion into the nucleus ( 40 - 60 kDa), efficient translocation must be facilitated by the 
importins. However, occlusion of the histone NLSs when in a nucleosomal format precluded 
importin-mediated nuclear transport of the chromatin constructs. This would instead force entry 
into the nucleus using the highly inefficient mechanisms associated with the nuclear uptake of 
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high MW plasmids (Ludtke et al., 1999; Wilson et al., 1999; Hagstrom et al., 1997). This may 
account for the decreased nuclear accumulation observed for the more extensively 
chromatinised, higher MW constructs. 
7.2. MOLECULAR WEIGHT AS A RATE-LIMITING BARRIER IN NON-VIRAL GENE DELIVERY 
In addition to the MW restrictions imposed by the NPC, diffusion through the cytoplasm to the 
nucleus has emerged as a highly significant issue impacting upon non-viral mediated gene 
delivery. Large linear DNA fragments were found to remain mostly perinuclear and did not 
enter the nucleus, in contrast to DNA fragments less than 1 kb in length which were found in 
the nucleus within 4 hours after cytoplasmic micro injection (Ludtke et al., 1999; Wilson et al., 
1999; Hagstrom et al., 1997). Large plasmid DNAs were found to behave similarly, with no 
detectable diffusion away from the site of cytoplasmic microinjection observed during the 
duration of the experiment ( 6 hours; Ciolina et al., 1999; Neves et al., 1999b; Sebestyen et al., 
1998). 
Two properties of molecules have been found to limit diffusion through the cytoplasm; 
dimension and MW. In a seminal study, Seksek et al. (1997) showed using spot photobleaching 
that macromolecules (fluoresceinated dextrans) with a gyration radius larger than 300 A had 
reduced mobility in the cytoplasm. Lukacs et al. (2000) widened this study to investigate the 
diffusion capacity of DNA fragments in the cytoplasm. Similarly, spot photobleaching was used 
to determine that the diffusion coefficients of various sized fluorescein-labelled DNA fragments 
(21 - 6000 bps), which were microinjected into the cytoplasm, became markedly reduced for 
fragments greater than 1000 bps ( equates to 660 kDa). 
Similar in size to the largest DNA fragment used in the Lukacs study, the pGeneGrip-RFP 
plasmid used in this study was 5889 bps ( equates to 3960 kDa). When chromatinised using 
histone octamers (108486 Da per octamer), the constructs yielded a range of molecular masses 
between ~ 4069 - 6672 kDa ( corresponding to the 1 octamer per plasmid - 25 octamers per 
plasmid constructs, see Table 4.1). This was up to 10-fold greater than the critical molecular 
weight of the 1000 bp construct in the Lukacs study. While the findings of the Lukacs study 
may be used only cautiously to explain some of the findings of this study, as DNA used by 
Lukacs et al. (2000) were naked linear fragments and the transfection constructs used in this 
study were closed circular plasmids compacted w-ith histone octamers, it may be reasonable to 
suggest that the more extensively chromatinised constructs experienced hindered cytoplasmic 
diffusibility. Indeed, the decrease in the relative proportion of nuclei that had accumulated the 
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chromatin constructs with increasing levels of chromatinisation (increasing stoichiometry of 
histone octamers) lends support to this hypothesis (Section 5.3.2). 
The Lukacs model (Lukacs et al., 2000) and observations of the diminished cytoplasmic 
mobility of large DNA fragments (Ludtke et al., 1999; Wilson et al., 1999; Hagstrom et al., 
1997) predict that nuclear accumulation of DNA greater than 3000 bps would be abolished. 
Despite this, nuclear accumulation of the pGeneGrip-RFP plasmid and expression of the 
reporter gene were observed (Section 5.3.2). This may be due in part to the tendency of the 
chromatinised plasmid towards compaction. 
An important feature of the hypothesis tested in this study was that reconstituted chromatin 
would make the transfection of large plasmids possible by inducing compaction of the DNA. 
Compaction of plasmid DNA has been postulated previously to facilitate passage through the 
various membrane barriers presented by the transfected cell on the way to the nucleus and, 
experimentally, has been associated with enhanced transfection efficiency (Lucius et al., 2001; 
Chan et al., 2000; Chan and Jans, 1999; Fritz et al., 1996; Wagner et al., 1990). Atomic force 
and electron microscopy revealed that the plasmids used in these studies were compacted 
typically to diameters less than 100 nm ( 16 - 60 nm, Chan et al., 2000; 80 - 100 nm, Wagner et 
al., 1991). 
In the context of this work, the compacted state of the fully nucleosome-saturated pGeneGrip-
RFP chromatin construct (25 octamers per plasmid construct) was important. The image of the 
fully chromatinised plasmid using surface AFM, shown in Figure 4.9, provided visual 
confirmation of compaction into an extended rod shape ( compared with the open structure of 
the naked plasmid). This image was consistent with the model proposed for circular chromatin 
molecules (Ladoux et al., 2000; Hansen and Wolffe, 1992; Simpson et al., 1985) where 
compaction into structures resembling the canonical '30 nm chromatin fibre' is facilitated by 
the N-terminal tails of the core histones which participate in inter-nucleosome contacts (Tse and 
Hansen, 1997; Fletcher and Hansen, 1995; Schwarz and Hansen, 1994; Yao et al., 1991). The 
AFM of adsorbed chromatinised DNA may be somewhat distorted due to contacts made with 
the surface of the imaging 'slide' (mica). Techniques such as dynamic light scattering or AFM 
performed in solution would allow the super-structure of the chromatin constructs to be 
determined with greater assurance and facilitate accurate physical measurements of the 
structural properties. Nonetheless, MN ase digestion patterns and AFM revealed that 
chromatinisation of the plasmid at physiological nucleosome density (25 octamers per 
pGeneGrip-RFP) induced compaction through nucleosome formation, in the first instance, and 
through intemucleosomal contacts, in the second instance. 
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Despite compaction, the extensively chromatinised constructs at higher nucleosome densities 
were less effective than the constructs assembled at lower nucleosome densities in nuclear 
accumulation (see Section 5.3.2). One could argue that the higher MW of the extensively 
chromatinised constructs may well have counteracted any positive effect conferred by 
compaction but the fact that the plasmid/histone octamer 'association' with comparable MW 
(25 octamers per plasmid) accumulated in nuclei to a similar degree as the naked plasmid 
suggests that MW per se was not prohibitive. As discussed in Section 7 .1, these observations 
may be reconciled by the continued accessibility of the histone NLSs in the plasmid/histone 
octamer 'association', unlike in the chromatinised constructs (where importin binding was 
abolished). Therefore, in the absence of NLS accessibility, the chromatin constructs may have 
succumbed to MW-dependent nuclear uptake. 
7.3. INCORPORATION OF NLS PEPTIDES IN THE GENE DELIVERY VEHICLE 
Non-viral-mediated gene delivery is characterised by inefficient nuclear entry, as fewer than 10 
% of transfected DNA molecules have been shown to reach the nucleus (Zahner et al., 1995; 
Chu et al., 1990; Capecchi, 1980). Transport into the nucleus of molecules exceeding the 
MWCO of the NPC ( 40 - 60 kDa) is facilitated by the interaction between importins and an 
NLS in the 'transport substrate' (see Section 1.3.3). Since the size of most transfection 
constructs exceeds the MWCO of the NPC, in the absence of importin binding, entry into the 
nucleus becomes highly inefficient. In order to enhance the efficiency of nuclear uptake, a 
number of particular NLSs ( of which the SV 40 T-ag NLS has been the most widely studied) 
have been incorporated into the transfection constructs (for reviews see Escriou et al., 2003; 
Cartier and Reszka, 2002; Bremner et al., 2001 ). 
In this study, two approaches were taken to include a peptide derived from the SV40 T-ag NLS 
in the chromatin transfection constructs. An H2A-NLS fusion protein was generated in order to 
incorporate the NLS at the level of the DNA carrier protein as an H2A-NLS-containing histone 
octamer. However, the fusion of the NLS inhibited histone octamer formation under the 
standard octamerisation conditions used (Section 6.2.1 ). The tails of the core histones are 
important in the formation of intra-nucleosomal contacts (for review see Luger and Richmond, 
1998) and therefore modifications to the C-terminal regions may indeed translate into 
nucleosome instability. An alternative approach involved coupling of NLSs to the reporter 
plasmid directly. T-ag NLS peptides were linked to the reporter plasmid by means of 
maleimide-PNA (Section 6.2.2). The N-terminal cysteine residue in the NLS peptide provided 
the means for conjugation to PNA via a chemically stable thioether bond (Figure 6.6). The 
nucleophilic addition of a thiolate to maleimide derivatives occurs rapidly and in very high 
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yield. The site-specific hybridisation of the PN A moiety to pGeneGrip ™ proceeds via 8 
concatameric sites which are engineered into the plasmid (Gene Therapy Systems). 
The reporter gene was expressed following transfection of the chromatinised NLS-coupled 
plasmids into HTC and Cos-7 cells, which demonstrated that the coupling strategy permitted 
transcription. However, a 50 - 60 % decrease in expression of the reporter gene from non-
chromatinised NLS-coupled plasmid relative to the non-chromatinised non-NLS plasmid was 
observed (Table 6.1). Interestingly though, the proportion of cells expressing the reporter gene 
were not reduced further in accordance with increasing chromatinisation (Figure 6.8), as had 
been the previously observed pattern in the absence of the additional NLS peptides (Figure 
4.14). 
The strategy of including NLSs in the gene delivery vector as a means to improve transfection 
efficiency through increased nuclear uptake of the transfection constructs has been reviewed 
recently; inclusion of NLSs, it seems, does not always lead to an enhancement in gene 
expression (Escriou et al., 2003; Cartier and Reszka, 2002; Bremner et al., 2001). Of the 10 
studies reviewed by Cartier and Reszka (2002) in which an NLS was conjugated directly to the 
DNA, only 3 demonstrated a significant (10-fold or greater) enhancement of gene expression 
(Branden et al., 1999; Subramanian et al., 1999; Zanta et al., 1999). 
Zanta et al. achieved a 10 - 1000-fold increase in luciferase reporter gene expression using a T-
ag NLS covalently attached to a linear DNA fragment via a hairpin oligonucleotide linker 
molecule (Zanta et al., 1999). However, when this NLS-coupling technology was applied to a 
closed circular plasmid, no increase in transgene expression was observed, with the non-NLS 
control, NLS-conjugated and mutated, non-functional NLS-conjugated plasmids demonstrating 
similar levels of gene expression (Roulon et al., 2002). The authors suggested that the 
discrepancy between the two groups of published data lay in the ability of a linearised NLS-
coupled DNA fragment to negotiate through the NPC. The circular plasmid may present 
different challenges to translocation through the NPC and may have required additional NLSs. 
Indeed, the number of NLSs conjugated to the plasmid DNA appears to play an important role 
in transfection efficiency. Concatameric attachment of 2 NLSs directly to the plasmid had no 
effect on transfection efficiency, whereas 11 NLSs resulted in an 8-fold increase in gene 
expression (Branden et al., 1999). In contrast, other studies reported that the attachment of up to 
115 NLSs throughout the plasmid did not improve gene expression compared to the non-NLS 
plasmid (Ciolina et al., 1999; Neves et al., 1999b; Sebestyen et al. , 1998). 
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Detailed comparison of these studies reveals that the distribution of the NLS peptides may be 
an important factor. In most of the studies the NLSs were generally distributed throughout the 
plasmid (Ciolina et al., 1999; Neves et al., 1999b; Sebestyen et al., 1998), whereas Branden et 
al. (1999) studied the effect of concatameric NLS peptides. Random distribution of NLSs had 
been proposed previously to inhibit transcription of the reporter gene; specifically with the 
covalent attachment of 43 NLSs (6 NLSs/1 kb) being shown to decrease transgene expression 
by 60 % in one study (Ciolina et al., 1999). 
In the present study, the concatameric nature of the PN A hybridisation site, downstream of the 
reporter gene, precluded the possibility that the decreased transfection efficiency of the non-
chromatinised NLS-coupled pGeneGrip-RFP plasmid (0 octamers per plasmid; see Section 
6.2.2.3) was due to inhibited transcription. Furthermore, the percentage of cells expressing the 
reporter gene from the plasmid coupled to PNA-maleimide was similar to the non-PNA-
coupled plasmid (relative to non-maleimide labelled pGeneGrip-RFP; Cos-7 cells; data not 
shown). The nuclear accumulation studies (Table 6.2) revealed that the non-chromatinised 
fluoresceinated NLS-coupled construct entered 50 % fewer nuclei than in cells transfected with 
the equivalent non-NLS construct. This alone may be sufficient to account for the relative 
decrease in the percentage of cells expressing the reporter gene but why inhibited nuclear 
uptake had occurred remains unclear. 
Interaction of the NLS-coupled chromatinised constructs with the importin a!P heterodimer 
was not demonstrated directly in this work. However, since NLS-regulated importin-mediated 
nuclear import is independent of MW, the ability of the highly chromatinised NLS-coupled 
constructs to accumulate in a similar proportion of nuclei as the naked NLS-coupled constructs, 
suggests that nuclear uptake had indeed been facilitated by the additional coupled NLSs. 
Interaction of SV 40 T-ag NLS-coupled plasmids with importin a could be shown formally only 
when at least 10 NLS peptides were coupled to the plasmid DNA (Ciolina et al., 1999; Neves et 
al., 1999b ). While this demonstrated the competency of the NLS-coupled plasmid to be 
transported into the nucleus via the import.in alp-mediated pathway, no enhancement in gene 
expression was observed in any of these studies. The Branden study, which did show 
enhancement of gene expression, however, did not investigate whether this was due to 
enhanced nuclear accumulation of the NLS-coupled plasmids (Branden et al., 1999). The lack 
of consensus on the use of NLS peptides to enhance transgene expression due to improved 
nuclear import of the NLS-coupled plasmid is evident from the literature (for reviews see 
Cartier and Reszka, 2002; Bremner et al., 2001; Escriou et al., 2001), with a number of 
questions remaining unanswered. Which of linear or plasmid DNA is more compentent for 
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NLS-mediated nuclear uptake? Is the site of NLS coupling crucial? How many NLSs are 
required to mediate nuclear import and would gene expression still be supported under 
intensive NLS coupling? 
While the work presented here did not demonstrate an NLS-induced improvement in 
transfection efficiency, it did demonstrate the appeal of the PNA-labelling procedure. Its 
simplicity, ability to preserve gene expression and potential to enhance plasmid nuclear uptake 
(Branden et al., 1999) appear to be superior compared to other highly cumbersome procedures 
involving complex chemical reactions with molecules which are difficult to produce in practical 
quantities (Neves et al., 1999a; Zanta et al., 1999). 
7.4. TRANSCRIPTIONAL PERMISSIVENESS AND REPRESSION OF TRANSCRIPTION AS A MEANS 
TO CONTROL TRANSGENE EXPRESSION 
Despite the diffusional restrictions associated with macromolecular movement both in the 
cytoplasm and across the nuclear membrane, discussed in Section 7 .2, expression of the 
reporter gene demonstrated that a sufficient proportion of the chromatin constructs were able to 
enter the nucleus in the cell types tested. Dissociation of the condensing agent from the 
transfecting plasmid DNA is necessary for transcription and subsequent gene expression 
(Zabner et al. , 1995). It had been proposed that gene expression should not be adversely 
affected by chromatinisation as this the physiological form in which DNA is found in the 
nucleus. However, the discrepancy between the proportion of cells expressing the reporter gene 
and the proportion of nuclei that took up the more extensively chromatinised transfection 
constructs suggested otherwise. 
The most likely explanation for this discrepancy is that transcription had been inhibited at the 
higher levels of chromatinisation (Heb bes et al. , 1994 and for reviews see Luger, 2003 ; Horn 
and Peterson, 2002). Studies of reconstituted chromatin models in vitro have revealed that the 
presence of nucleosomes, nucleosome residence on the gene promoter region and compaction 
of chromatin, with increasing levels of nucleosome density towards those approximating 
physiological density, results in greater than 90 % repression of transcription (Sandaltzopoulos 
et al. , 1994; Hansen and Wolffe, 1992). 
Similarly, compaction of genomic DNA in chromatin within the nucleus in vivo (Figure 7 .2) is 
intrinsically refractory to transcription. Here, however, recruitment of chromatin re-modelling 
complexes functions to 'prime' DNA for transcription by initiating the decompaction of 
chromatin and subsequent translocation of nucleosomes from the promoter region of the gene 
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(for reviews see Horn and Peterson, 2002; Kadonaga, 1998). This facilitates the binding of the 
basal transcription machinery. Only when DNA is naked do the rates of in vitro transcription 
approximate those seen in vivo (Izban and Luse, 1992 and for review see Orphanides and 
Reinberg, 2000). 
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Figure 7.2. Chromatin folding in vivo. Cartoon showing the multiple levels of chromatin folding in vivo 
in the interphase nucleus, represented on the left. DNA folding proceeds through an ordered series of 
primary ('beads-on-a-string'), secondary ('30 nm fibre') and tertiary (chromonema fibre) structures, 
mediated predominantly through the histone tail interactions. Original figure from Horn and Peterson 
(2002). 
The pGeneGrip™ plasmid was chosen for use in this study as it enabled both gene tracking and 
expression analyses to be performed in the same experiment. However, since the RFP reporter 
gene did not seem to be readily expressed from the chromatinised pGeneGrip-RFP plasmid in 
HTC or Cos-7 cells, an alternative approach was sought. A trans gene expression system in 
which the promoter, when matched to the cell type, had been shown to recruit chromatin re-
modelling and transcription complexes and thus facilitate trans gene expression (Rao et al., 
2001; Himes et al., 1993) was investigated. When chromatinised pGMLuc constructs 
harbouring the T-cell-specific GMCSF promoter were transfected into Jurkat cells (Section 
6.3.2), luciferase reporter gene expression was not significantly different from that of the naked 
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construct (0 octamers per pGMLuc; Figure 6.14). Contrary to pGMLuc, when the 
chromatinised pGeneGrip-RFP constructs were transfected into Jurkat cells, reporter gene 
expression decreased upon increasing the degree of nucleosome density (Table 6.4), consistent 
with the pattern observed in Cos-7 and HTC cell transfections. This data may suggest that 
chromatin re-modelling of pGeneGrip-RFP was inefficient in the cell lines tested. The 
observation that gene expression driven by the GMCSF promoter was insensitive to 
chromatinisation in Jurkat cells suggests that recruitment of the appropriate transcriptional 
complexes had occurred. 
The role of the promoter and enhancer region in cellular gene expression from chromatinised 
plasmids merits further testing. In order to confirm this proposal, an interesting future study 
would be to compare the abilities of the full length GMCSF promoter region, the active 
GMCSF promoter region (- 620 to + 37 fragment, used in this study) and a non-functional 
mutated form of the GMCSF promoter with the ability of the CMV promoter ( and others) to 
drive gene expression from a chromatinised reporter plasmid in a cell-specific manner. 
'Promoter-customised' chromatin constructs may very well prove to be valuable in the context 
of cell-specific gene expression. 
In addition to the re-modelling complexes which induce changes in chromatin architecture (for 
reviews see Luger, 2003; Horn and Peterson, 2002; Orphanides and Reinberg, 2000; Kadonaga, 
1998), histone variants, such as H2AZ, are believed to alter the condensation state of chromatin 
and, thus, also play a role in gene regulation. The presence of H2AZ has been shown to inhibit 
the formation of highly condensed chromatin in vitro, suggesting that H2AZ creates localised 
areas of chromatin that are primed for transcription (Fan et al., 2002). The possibility that 
chromatin composed of H2AZ histone octamers would be more transcriptionally viable than 
chromatin comprised of H2A histone octamers and should yield higher levels of gene 
expression was tested. The results presented in Section 6.3.1.2 indicated that the relative 
percentage of cells expressing the RFP reporter gene following transfection with H2AZ-
containing chromatin constructs was actually lower than that from transfection with H2A-
containing chromatin constructs (Table 6.3). 
As discussed in Section 6.4, the sedimentation velocity profile of H2AZ-containing chromatin 
assembled at a density of 25 octamers per plasmid ( 64 S, data not shown) resembled that of 
H2A-containing chromatin at 40 octamers per plasmid (66 S; Table 4.1). These high 
sedimentation coefficients (>> 55 S) are similar to those obtained when intermolecular 
association of reconstituted nucleosomal arrays has been demonstrated (Schwarz and Hansen, 
1994). Both the apparent increase in nucleosome density (saturated H2AZ-chromatin is 
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comparable to super-saturated H2A-chromatin) and possible formation of oligomers may 
account for the relative inhibition of reporter gene expression at high levels of chromatinisation 
with H2AZ-octamers when compared to H2A-octamers. 
The results obtained using H2AZ-containing chromatin were contrary to expectation in light of 
the findings of Fan et al. (2002). However, as the Fan study was conducted strictly in vitro 
using a linear DNA template which assembled a defined array of nucleosomes to demonstrate 
structural differences between H2A-containing chromatin and H2AZ-containing chromatin, 
these findings may not extend to a closed circular plasmid. Interestingly, in vivo, H2AZ has 
been shown to be associated with both activation (Adam et al., 2001) and repression (Dhillon 
and Kamakaka, 2000) of transcription. Thus, the finding that in vitro assembled H2AZ-
chromatin appears to be more repressive to gene expression than H2A-chromatin is an 
important new discovery and the role of H2AZ in relating chromatin super-structure to 
transcriptional permissiveness awaits further elucidation. Of course, the possibility that the 
H2AZ-chromatin constructs accumulated in the nucleus to a lesser extent than H2A-chromatin 
constructs cannot be excluded but seems to be the less likely explanation. 
In addition to the presence of variant histones, modifications to the linker histones, core 
histones or the DNA itself also play a part in transcriptional viability. Acetylated histones, for 
instance, are generally associated with areas of transcriptionally active chromatin (Vermaak et 
al., 2003; Luger and Richmond, 1998). In this light, a future line of investigation may involve 
the assembly of chromatin using histone octamers containing the acetylated core histone H3/4 
tetramer (although, it was found that acetylation masks the NLS site in H3/4 (Section 3.2), ·it 
could be argued that the NLSs would be non-functional in any case (see Section 7.1) in a 
nucleosomal array). 
The results presented in Section 6.3 indicate that the transcriptional permissiveness of the 
transfection constructs appears to be another significant factor in the efficiency of non-viral 
gene delivery. The in vitro assembled chromatin system forms an ideal basis from which to 
investigate the potential to achieve transgene expression in a cell-specific manner by using 
different endogenous promoters. Furthermore, transgene expression has the potential to be 
regulated by the use of agents which can mediate reversible inhibition of promoter function 
(Burcin et al., 1999). The chromatin system also provides for the additional possibility of 
regulating transgene transcription on a more global level through the incorporation of variant 
histones or modifications, such as acetylation, that alter chromatin super-structure. 
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7 .5. LESSONS FROM NATURE - VIRUSES AND CHROMOSOMES 
The factors essential for optimising non-viral gene delivery relate strongly to ensuring cell-
specific delivery, overcoming various barriers to the passage of DNA to the nucleus and, 
ultimately, being able to regulate expression of the therapeutic gene (Zahner et al., 1995). In 
this context, there are lessons to be learned from nature. Viruses are able to overcome all of the 
membrane barriers on the way to the nucleus. Adenovirus, for instance, uses specialised cell-
surface binding proteins, a pH-sensitive endosomal escape peptide and recruits histone Hl to 
facilitate nuclear entry of its genome (see Figure 1.3). Viruses are therefore excellent models 
for the rational design of more efficient gene delivery systems in which the efficient processes 
of viral infection are combined with the advantageous properties of synthetic delivery vectors . 
An example of a hybrid viral/non-viral system is the 'virosome' approach. Here, viral capsid 
proteins have been incorporated into liposomes in order to facilitate fusion with the target cell 
membrane so that the liposomal contents are introduced directly into the cytoplasm (Ramani, 
1998; Ramani, 1997) While the majority of work has been conducted using the membrane 
fusion protein of the haemagglutinating virus of Japan (HVJ or Sendai virus; for review see 
Kaneda, 2000), other viruses investigated include vesicular stomatitis virus (Imazu et al. , 2000), 
HIV (Larsen et al., 1993), HSV (Rouse et al., 2000) and influenza virus (Schoen et al. , 1999; 
Maeda et al. , 1981). Fusion of 'virosomes' with target cells has been shown to occur rapidly 
(within 10 to 30 minutes of introduction) and fluorescently-labelled DNA could be detected in 
the nucleus 5 minutes later (Morishita et al., 1994). In contrast, cationic liposomes required 5 to 
20 hours for membrane fusion and 24 hours after the introduction of labelled DNA, 
fluorescence could be detected in endosomal compartments, but not yet in the nucleus 
(Morishita et al. , 1994). 
The ability to regulate therapeutic gene expression so that it is consistent with the normal 
physiological pattern remains a critical limitation of gene therapy. This is further complicated 
because physiological gene expression is regulated at several levels, from cell signalling 
pathways to chromatin structure. Recently, artificial chromosomes have been promoted as a 
potential solution to this problem (Lipps et al. , 2003). Artificial chromosomes have been 
constructed from a centromere, telomeres and the genomic DNA harbouring the gene of 
interest, derived from the fragmentation of natural chromosomes. These ' chromosomes ' are still 
highly experimental, but the idea that they would mimic the natural state of DNA and have an 
essentially unlimited cloning capacity is comparable to the idea of the in vitro assembled 
chromatin system presented in this thesis. The presence of regulatory elements for gene 
expression and the potential to segregate and replicate presents a distinct advantage over the in 
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vitro assembled chromatin system, however, production, manipulation, and achieving 
transfection and nuclear import of artificial chromosomes may prove highly challenging. In this 
framework, the in vitro assembled chromatin system has the potential to provide a manageable 
basis for the transf ection of large DNA constructs, once the limitations of reduced nuclear 
import and transcription repression are overcome. 
Reduced nuclear import may be addressed by optimising parameters such as the level of 
compaction of the chromatinised plasmids and the degree of accessibility of NLSs. As a first 
step towards investigating the potential of the in vitro assembled chromatin system for gene 
delivery, the first stage of chromatin compaction was used; the assembly of nucleosomes. The 
second stage of compaction involves the linker histone Hl. Histone Hl facilitates stabilisation 
of the ' 30 nm chromatin fibre' and further compaction into 100 nm fibres (see Figure 7.2; for 
review see Hansen, 2002), however, the structure and function of higher order chromatin 
organisation remain largely undefined both in vitro (Luger, 2003) and in vivo (Hom and 
Peterson, 2002). Interestingly, histone Hl showed the highest affinity for importin p 1 amongst 
the histones tested (see Section 3.2; Johnson-Saliba et al., 2000). Furthermore, there appears to 
be a consensus in the literature that of the histones trialed as DNA carrier proteins for gene 
delivery purposes, H 1 consistently enhanced gene transfer (Section 1. 5. 3 ). These points suggest 
that the inclusion of Hl in a gene delivery vector based on the in vitro assembled chromatin 
system would warrant investigation. Firstly, because Hl nucleosome-compacted plasmid DNA 
may be condensed to higher order structures beyond the '30 nm chromatin fibre' mode, 
processes such as passage through cellular membranes and diffusion through the cytoplasm 
may be potentiated. Secondly, because Hl may be able to direct nuclear import by means of 
intrinsic NLSs and since Hl binds to DNA outside of the nucleosome structure, it may not be 
subject to the same chromatin-induced masking effect as was observed for the core histones. 
The results presented in this study indicate that the accessibility of NLSs within the transfection 
constructs is vital in order to ensure importin-mediated nuclear import. While the future 
challenge in NLS-mediated nuclear import of transfection constructs is to delineate the fine 
balance required for the promotion of nuclear import with the preservation of gene expression, 
the in vitro assembled chromatin system has the potential for nuclear import enhancing 
elements to be incorporated. 
The chromatin-induced transcriptional repression may be overcome by the use of optimised 
promoter and enhancer regions to recruit the appropriate chromatin re-modelling complexes 
and drive transcription of the reporter gene. This could provide the basis for tissue-specific 
expression of the therapeutic gene. Inclusion of gene regulatory elements would provide 
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another level of control. Furthermore, incorporation of origins of replication ( Jenke et al., 2002; 
Baiker et al., 2000) into the in vitro assembled chromatin system might provide a means for the 
maintenance of the transfection construct through multiple rounds of cell division, thus 
addressing another limiting factor of non-viral gene delivery systems, that of long-term 
expression of the therapeutic gene. 
It seems that nature has provided the scaffolding for an exciting collaboration with 
biotechnology that may enable the development of that, as yet elusive, 'ideal vector' and finally 
bring gene therapy out of the realm of experimental therapeutics and into everyday medicine. 
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